11.01.2013 Views

PROGRAMMA - SIF

PROGRAMMA - SIF

PROGRAMMA - SIF

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Società Italiana<br />

di Farmacologia<br />

34° Congresso Nazionale<br />

della Società Italiana di Farmacologia<br />

<strong>PROGRAMMA</strong><br />

14-17 ottobre 2009<br />

Rimini, Palacongressi


Con l’Alto Patronato del Presidente della Repubblica<br />

e con il patricinio di:<br />

Regione Emilia Romagna<br />

Provincia di Rimini<br />

Comune di Rimini<br />

Alma Mater Studiorum Università di Bologna<br />

Polo Scientifico Didattico di Rimini<br />

Federazione Nazionale degli Ordini dei Medici Chirurghi e<br />

degli Odontoiatri<br />

Federazione Ordini Farmacisti Italiani<br />

Ordine Nazionale dei Biologi<br />

Società Italiana<br />

di Farmacologia<br />

<strong>PROGRAMMA</strong><br />

34° Congresso Nazionale<br />

della Società Italiana di Farmacologia<br />

14-17 ottobre 2009<br />

Rimini, Palacongressi<br />

I


II III<br />

L<br />

a ricerca farmacologica ha conseguito innumerevoli conquiste<br />

in campo medico, nonostante ciò nel corso degli anni è<br />

cambiato l’atteggiamento nei confronti del farmaco.<br />

In passato, ogni piccolo passo avanti veniva accolto con un entusiasmo<br />

tale da fare da viatico al passo successivo (piccolo o grande<br />

che fosse) e la disponibilità limitata di terapie farmacologiche<br />

portava a considerarle in tutto il loro valore.<br />

Oggi invece, il “bene farmaco” ha subito una notevole inflazione<br />

che riconosce le sue cause in un’eccessiva medicalizzazione, in una<br />

pressante richiesta di trattamenti anche per condizioni prima non<br />

considerate patologiche, in una babele di informazioni e disinformazioni<br />

e nella perdita dell’entusiasmo.<br />

Per risanare la nostra economia (la farmacologia) e dar nuovo<br />

corso alle nostre monete (i farmaci) è necessario contrastare questa<br />

inflazione incipiente. Come?<br />

Portando avanti una “rivoluzione culturale” che faccia nuovamente<br />

prender coscienza del valore dei farmaci, di quanto essi possano<br />

essere utili, ma anche di quanto possano essere dannosi, di<br />

quali altri progressi possano essere capaci e di quali lezioni possano<br />

impartire.<br />

La vita di un farmaco non è poi così dissimile da quella di un<br />

uomo: la nascita porta con sé dolore, fatica ed aspettativa, la crescita<br />

avviene tra esami ed ostacoli continui ed ogni impedimento<br />

affrontato e superato porta con sé maturità, esperienza e forza.<br />

Così è un farmaco dalla sua sintesi alla sperimentazione premarketing<br />

fino al lungo iter della ricerca post-marketing, così sono<br />

i giovani ricercatori rafforzati dalle difficoltà quotidiane, così sono i<br />

loro maestri che traggono dal confronto continuo l’entusiasmo, lo<br />

stesso entusiasmo del passato che non dovrà mai affievolirsi.<br />

Tutto questo è il nostro Congresso.<br />

Achille Patrizio Caputi


Consiglio Direttivo e Comitato Organizzatore Scientifico<br />

Consiglio Direttivo<br />

Presidente: Achille Patrizio Caputi (Messina)<br />

Presidente-eletto: Carlo Riccardi (Perugia)<br />

Segretario: Pier Luigi Canonico (Novara)<br />

Consiglieri: Elisabetta Cerbai (Firenze)<br />

Alessandra Concas (Cagliari)<br />

Diana Conte Camerino (Bari)<br />

Filippo Drago (Catania)<br />

Giorgio Racagni (Milano)<br />

Marco Scatigna (Milano)<br />

Past President: Giovanni Biggio (Cagliari)<br />

Comitato Organizzatore Scientifico<br />

Giorgio Cantelli Forti (Bologna)<br />

Giuseppe Cirino (Napoli)<br />

Giovanni Umberto Corsini (Pisa)<br />

Vincenzo Cuomo (Roma)<br />

Gianni De Crescenzo (Roma)<br />

Giovambattista De Sarro (Catanzaro)<br />

Sergio Dompé (Roma)<br />

Roberto Fantozzi (Torino)<br />

Flavia Franconi (Sassari)<br />

Guido Fumagalli (Verona)<br />

Corrado Galli (Milano)<br />

Maurizio Massi (Camerino)<br />

Gabriela Mazzanti (Roma)<br />

Alessandro Mugelli (Firenze)<br />

Rodolfo Paoletti (Milano)<br />

Carlo Patrono (Roma)<br />

Francesco Rossi (Napoli)<br />

Domenicantonio Rotiroti (Catanzaro)<br />

Francesco Scaglione (Milano)<br />

Cesare Sirtori (Milano)<br />

Gian Pietro Sgaragli (Siena)<br />

Maurizio Taglialatela (Campobasso)<br />

Michele Vacca (Chieti)<br />

Francesco Visioli (Parigi)<br />

Ilario Viano (Novara)<br />

Si ringraziano per la preziosa collaborazione<br />

Gold sponsors<br />

Abbott<br />

Amgen Dompé<br />

Astellas Pharma<br />

AstraZeneca<br />

Boehringer Ingelheim<br />

Bristol Myers Squibb<br />

Eli Lilly Italia<br />

GlaxoSmithKline<br />

Grünenthal-Italia<br />

Innova Pharma<br />

Novartis Farma<br />

Nycomed<br />

Pfizer Italia<br />

Roche<br />

Rottapharm Madaus<br />

Sanofi-Aventis<br />

Wyeth Lederle<br />

IV V<br />

Silver sponsors<br />

Un particolare ringraziamento a<br />

2Biological Instruments<br />

A. Menarini<br />

Allevamenti Plaisant<br />

Assogenerici<br />

Baxter<br />

Bayer<br />

Biomedica Mangoni<br />

Charles River Laboratories Italia<br />

Chiesi Farmaceutici<br />

Daiichi Sankyo Italia<br />

DiaTech<br />

Ebewe Italia<br />

Edizioni Minerva Medica<br />

Harlan Laboratories<br />

Italfarmaco<br />

Janssen-Cilag<br />

Lundbeck Italia<br />

Novo Nordisk Farmaceutici<br />

Siena Biotech<br />

Tecniplast<br />

Thomson Reuters<br />

Ugo Basile<br />

British Pharmacological Society<br />

EPHAR<br />

Farmindustria<br />

Fondazione per la Ricerca Farmacologica “Gianni Benzi” onlus<br />

Ringraziamenti


Informazioni Generali<br />

INFORMAZIONI GENERALI<br />

Segreteria Organizzativa<br />

AIM Group - Sede di Firenze<br />

Viale G. Mazzini, 70 - 50132 Firenze<br />

Tel. 055 233881 • Fax 055 2480246<br />

Informazioni generali: sif2009@aimgroup.it<br />

Registrazioni: sif2009.reg@aimgroup.it<br />

Hotel: sif2009.hotel@aimgroup.it<br />

Sede del Congresso<br />

Palacongressi<br />

Via della Fiera, 52 - 47900 Rimini<br />

Come raggiungerci<br />

IN TRENO<br />

STAZIONE FF. SS. di Rimini<br />

Piazzale Cesare Battisti, 1 - 47921 Rimini - tel. 0541 892021<br />

Orari di apertura biglietteria: 07.00 – 21.00 tutti i giorni<br />

Dalla Stazione FF SS con il bus di linea n.7 in circa 10 minuti si<br />

raggiunge il Palacongressi. Costo del biglietto per i bus di linea è<br />

di € 1,00 ed ha validità 60 minuti<br />

IN AEREO<br />

AEROPORTO INTERNAZIONALE FEDERICO FELLINI<br />

Via Flaminia, 409 – Miramare di Rimini<br />

Tel. 0541 715711 fax. 0541 373649<br />

E-mail: info@riminiairport.com - www.riminiairport.com<br />

Per raggiungere il Palacongressi (l’aeroporto dista 6 km) è possibile<br />

servirsi dell’Autobus di linea Tram Servizi: il bus di linea n. 9<br />

collega l’Aeroporto e la Stazione FF SS ogni 30 minuti circa ed<br />

ha una percorrenza di 25 minuti circa; dal terminal dei bus di<br />

linea presso la Stazione FF SS si raggiunge in 10 minuti circa il<br />

Palacongressi utilizzando il bus di linea n. 7. Costo del biglietto<br />

per i bus di linea è € 1,00 ed ha validità 60 minuti.<br />

In alternativa si può usufruire del servizio di RadioTaxi –<br />

tel. 0541 50020. Al fine di assicurare all’utenza una maggiore<br />

correttezza e trasparenza, la tariffa massima (individuata come<br />

fascia territoriale) esigibile per il tragitto Aeroporto – Rimini Centro<br />

è di € 17,00.<br />

IN AUTOMOBILE<br />

Rimini è collegata alle principali reti autostradali d’Italia. Si trova<br />

sulla Autostrada A14 Milano-Bari ed è servita da due uscite: Rimini<br />

Nord e Rimini Sud.<br />

Con la A14 Rimini si collega agevolmente alla Autostrada A4 per<br />

Venezia, alla Autostrada A1 per Milano, Firenze, Roma, Napoli ed<br />

alla Autostrada A22 per il passo del Brennero.<br />

Per raggiungere il Palacongressi di Rimini l’uscita autostradale<br />

più agevole è Rimini Sud; proseguendo sulla SS16 in direzione<br />

Ravenna - Bologna si giunge a Via della Fiera, sulla destra, dopo<br />

circa 1 km.<br />

Siti Web<br />

www.sifweb.org<br />

www.aimgroup.eu/2009/sif<br />

Segreteria in sede congressuale<br />

La Segreteria Organizzativa è a disposizione dei partecipanti in sede<br />

congressuale durante i seguenti orari:<br />

Mercoledì 14 ottobre 2009 10.00 - 19.30<br />

Giovedì 15 ottobre 2009 08.00 - 19.00<br />

Venerdì 16 ottobre 2009 08.00 - 19.00<br />

Sabato 17 ottobre 2009 08.00 - 13.30<br />

Iscrizione in sede congressuale<br />

Soci <strong>SIF</strong> € 480,00<br />

Non soci <strong>SIF</strong> € 660,00<br />

Soci <strong>SIF</strong> non strutturati<br />

di età inferiore ai 38 anni*<br />

Non soci <strong>SIF</strong> non strutturati<br />

di età inferiore ai 38 anni*<br />

€ 90,00<br />

€ 180,00<br />

Cena Sociale € 75,00<br />

* al momento dell’iscrizione è necessario presentare fotocopia della carta di identità<br />

e dichiarazione del Direttore di Dipartimento.<br />

La quota comprende:<br />

• partecipazione ai lavori scientifici • kit congressuale • attestato di<br />

partecipazione • colazioni di lavoro a buffet<br />

VI VII<br />

Informazioni Generali


Informazioni Generali<br />

Pagamento quota di partecipazione<br />

Le quote di iscrizione possono essere pagate tramite:<br />

• contanti<br />

• assegno bancario o circolare intestato ad AIM Congress srl<br />

• carta di credito (Visa - Mastercard/Eurocard)<br />

Badge<br />

A ciascun partecipante regolarmente iscritto viene consegnato un<br />

badge nominativo che deve essere sempre esibito per poter accedere<br />

alle Aule dove si svolgono le sessioni scientifiche.<br />

Guardaroba<br />

Per i partecipanti del Congresso è disponibile un guardaroba custodito<br />

che osserva gli orari dei lavori. Si prega pertanto di ritirare i<br />

propri effetti personali entro l’orario di chiusura.<br />

Internet Point<br />

Due Internet Point gratuiti saranno disponibili nell’Area Poster per<br />

tutto il periodo del Congresso.<br />

Programma Sociale<br />

Mercoledì 14 ottobre, ore 19.45<br />

Mercoledì 14 ottobre 2009, è prevista, nella sala Arcobaleno, la<br />

Cerimonia di Apertura del Congresso, alla quale seguirà un Cocktail<br />

di Benvenuto per i partecipanti al Congresso.<br />

Venerdì 16 ottobre 2009, ore 20.30<br />

La cena Sociale si svolgerà presso le Sale Quattro Colonne e Veranda<br />

del Grand Hotel Rimini (Parco Federico Fellini, 1 – Rimini)<br />

INFORMAZIONI SCIENTIFICHE<br />

Contributi scientifici<br />

COMUNICAZIONI ORALI<br />

Sono previste 24 Sessioni di Comunicazioni Orali, suddivise in 14<br />

tematiche, per un totale di 186 interventi.<br />

Si raccomanda di rispettare il tempo di 15 minuti a disposizione per<br />

ciascuna comunicazione.<br />

I files delle presentazioni devono essere realizzati in Power Point<br />

(Sistema Operativo Windows) e devono essere consegnati al<br />

Centro Proiezioni con largo anticipo.<br />

POSTER<br />

Sono previste 2 sessioni in cui i 416 Poster accettati, suddivisi in<br />

18 tematiche, potranno essere discussi. Le sessioni si svolgeranno<br />

nell’Area Poster nei seguenti orari:<br />

Giovedì 15 ottobre P-1 Ore 14.00–16.00<br />

tematiche:<br />

P-1/1 Farmacologia del Sistema Nervoso<br />

P-1/2 Recettori e meccanismi di trasduzione del segnale<br />

P-1/3 Farmacologia dei canali ionici e della trasmissione sinaptica<br />

P-1/4 Morte e proliferazione cellulare<br />

P-1/5 Farmacologia del dolore<br />

P-1/6 Sostanze d’abuso<br />

P-1/7 Invecchiamento, comportamento e tossicologia<br />

Venerdì 16 ottobre P-2 Ore 14.00-16.00<br />

tematiche:<br />

P-2/1 Farmacologia Cardiovascolare e della funzione respiratoria<br />

P-2/2 Farmacologia dell’apparato digerente<br />

P-2/3 Farmacologia del metabolismo, del sistema endocrino e<br />

della disfunzione erettile<br />

P-2/4 Chemioterapia<br />

P-2/5 Farmacologia dell’infiammazione<br />

P-2/6 Immunofarmacologia<br />

P-2/7 Farmacoepidemiologia, Farmacovigilanza, Farmacoeconomia,<br />

Informazione sul farmaco, Vaccini<br />

P-2/8 Medicine complementari<br />

P-2/9 Farmaci innovativi e biotecnologici<br />

P-2/10 Farmacogenetica<br />

P-2/11 Sperimentazione clinica dei farmaci<br />

VIII IX<br />

Informazioni Scientifiche<br />

Informazioni Scientifiche


Informazioni Scientifiche<br />

I Poster dovranno essere redatti in lingua inglese e non superare i<br />

160 cm di altezza e i 90 cm di larghezza. Dovranno essere affissi<br />

sul pannello corrispondente al numero assegnato a partire dalle ore<br />

8.00 del giorno della discussione e dovranno essere rimossi entro le<br />

ore 18.00 dello stesso giorno. La segreteria non custodirà eventuali<br />

poster non rimossi entro i termini stabiliti.<br />

Gli Abstract di tutti i lavori accettati come comunicazioni orali e<br />

poster sono consultabili nella pendrive all’interno del kit congressuale.<br />

Premi Poster<br />

Saranno assegnati 25 premi per i migliori Poster.<br />

Le commissioni discuteranno con i presentatori i loro poster e poi<br />

decideranno collegialmente, a chi assegnare i premi.<br />

Assemblea dei Soci<br />

In occasione del Congresso, l’Assemblea generale dei Soci della<br />

Società Italiana di Farmacologia è convocata venerdì 16 ottobre,<br />

presso la sala Arcobaleno, alle ore 18.45.<br />

Allestimenti tecnici e centro proiezioni<br />

Ogni sala è dotata di videoproiettore collegato a computer e tutte<br />

le presentazioni saranno trasferite via LAN ai computer di sala per<br />

la proiezione.<br />

Al fine di evitare problemi di compatibilità tra i portatili dei relatori<br />

e i proiettori delle sale e per rendere più veloce il susseguirsi delle<br />

relazioni non è possibile collegare i propri computer nelle sale.<br />

I relatori devono recarsi al Centro Proiezioni (ubicato al pianterreno,<br />

accanto alle Registrazioni) almeno due ore prima dell’intervento<br />

per permettere ai tecnici di duplicare la presentazione e inoltrarla<br />

via LAN alle sale di pertinenza.<br />

Informazioni Scientifiche<br />

Informazioni Scientifiche<br />

Crediti di Educazione Continua in Medicina<br />

Per le giornate congressuali del 15, 16 e 17 ottobre è stata inoltrata<br />

domanda di accreditamento presso la Commissione Nazionale per la<br />

Formazione Continua in Medicina (ECM) del Ministero della Salute<br />

per le figure di Medico Chirurgo, Farmacista ed Infermiere, che hanno<br />

ottenuto i seguenti crediti:<br />

15 ottobre<br />

• medico chirurgo (n. 5362-9028219) : crediti 5<br />

• farmacista (n. 5362-9028220): crediti 5<br />

• infermiere (n. 5362-9028221): in attesa di assegnazione<br />

16 ottobre<br />

• medico chirurgo (n. 5362-9028232): crediti 4<br />

• farmacista (n. 5362-9028233): crediti 5<br />

• infermiere (n. 5362-9028234): crediti 4<br />

17 ottobre<br />

• medico chirurgo (n. 5362-9028243): crediti 4<br />

• farmacista (n. 5362-9028244): crediti 4<br />

• infermiere (n. 5362-9028245): in attesa di assegnazione<br />

Per ottenere i Crediti è necessario per il partecipante:<br />

• Essere iscritti al congresso<br />

• Compilare la scheda di valutazione, il questionario di apprendimento<br />

e la scheda recapiti partecipanti presente all’interno della<br />

borsa congressuale.<br />

• Partecipare nella misura del 100% ai lavori scientifici<br />

• Al termine dell’evento riconsegnare, presso l’apposito Desk ECM,<br />

tutta la documentazione debitamente compilata e firmata<br />

Controllo Presenze<br />

L’accreditamento del Congresso rende necessario un controllo delle<br />

presenze che viene effettuato tramite sistema elettronico.<br />

Ai partecipanti viene consegnato, insieme al badge nominativo, un<br />

badge elettronico che, funzionando in radiofrequenza e mediante il<br />

passaggio del partecipante attraverso il portale, è in grado di registrarne<br />

l’effettiva presenza.<br />

I partecipanti possono rivolgersi in qualsiasi momento al Desk ECM<br />

per verificare personalmente con il proprio badge magnetico le ore<br />

di presenza accumulate. La perdita o la mancata consegna del badge<br />

magnetico comporta l’addebito per il partecipante pari a € 7,00.<br />

X XI<br />

Informazioni Scientifiche


Informazioni Scientifiche<br />

Attestati ECM<br />

Gli attestati ECM verranno inviati, entro 90 giorni dal termine<br />

dell’evento, a tutti coloro che avranno partecipato interamente alle<br />

singole giornate congressuali e che avranno riconsegnato la documentazione<br />

debitamente compilata e firmata.<br />

Attestato di partecipazione<br />

L’attestato di partecipazione verrà rilasciato a tutti gli iscritti che ne<br />

faranno richiesta alla Segreteria in Sede Congressuale, al termine<br />

dei lavori scientifici.<br />

Esposizione tecnica farmaceutica<br />

Nell’ambito del Congresso è allestita un’esposizione Tecnico-Scientifica,<br />

che osserva gli orari dei lavori Congressuali.<br />

XII<br />

Informazioni Scientifiche<br />

Scientific Program


2.30<br />

pm<br />

3.15<br />

pm<br />

3.45<br />

pm<br />

WEDNESDAY, October 14, 2009<br />

Sala Arcobaleno<br />

Welcome Ceremony<br />

OPENING REMARKS<br />

Caputi A. P., President, <strong>SIF</strong><br />

Cantelli Forti G., President, Scientific Didactic Rimini Unit<br />

Alessandra BITTO<br />

Department of Clinical and<br />

Experimental Medicine and<br />

Pharmacology<br />

University of Messina<br />

PRESIDENT’S REPORT<br />

Caputi A. P. (Messina)<br />

Award Ceremony: FARMINDUSTRIA-<strong>SIF</strong> AWARDS<br />

Caputi A. P. (Messina) – Stefanelli E. (Rome)<br />

5 Awards for <strong>SIF</strong> Members (35 years old maximum)<br />

Ornella CUOMO<br />

Department of Neurosciences<br />

University of Naples<br />

“Federico II”<br />

Daniele DE FILIPPIS<br />

Department of Experimental<br />

Pharmacology<br />

University of Naples<br />

“Federico II”<br />

Luigia DI FRANCESCO<br />

Department of Medicine and<br />

Ageing Science<br />

University of Chieti “G.<br />

d'Annunzio”<br />

Francesco Mattia NOÉ<br />

Mario Negri Research<br />

Institute, Milan<br />

Bitto A, et al.: Polydeoxyribonucleotide improves<br />

angiogenesis and wound healing in experimental<br />

thermal injury. Crit Care Med 2008; 36:1594-602.<br />

Cuomo O, et al.: “A Critical Role for the Potassium-<br />

Dependent Sodium/Calcium Exchanger NCKX2 in<br />

Protection Against Focal Ischemic Brain Damage” J<br />

Neurosci 2008; 28:2053-63.<br />

De Filippis D, et al. Melatonin reverses<br />

lipopolysaccharide-induced gastro-intestinal motility<br />

disturbances through the inhibition of oxidative stress.<br />

J Pineal Res 2008; 44:45-51.<br />

Di Francesco L et al: Induction of Prostacyclin by<br />

Steady Laminar Shear Stress Suppresses Tumor<br />

Necrosis Factor- Biosynthesis via Heme Oxygenase-1<br />

in Human Endothelial Cells. Circ Res 2009;104:506-<br />

13. (accepted 2008)<br />

Noè F, et al.: Neuropeptide Y gene therapy decreases<br />

chronic spontaneous seizures in a rat model of<br />

temporal lobe epilepsy. Brain 2008; 131:1506-1515.<br />

1<br />

WEDNESDAY, October 14, 2009


WEDNESDAY, October 14, 2009<br />

5 Awards for Pharmaceutical Industry Researchers (40 years old maximum)<br />

Paola BOGANI<br />

Novartis Pharma<br />

Paolo CAPPELLA<br />

Nerviano Medical Sciences<br />

Claudia PATRIGNANI<br />

Merck Serono<br />

Emiliano TOSO<br />

Merck Serono<br />

Claudio VALENTI<br />

Menarini Ricerche<br />

Bellosta S, Bogani P, et al.: Mediterranean diet and<br />

cardioprotection: wild artichoke inhibits<br />

metalloproteinase 9. Mol Nutr Food Res. 2008;<br />

52:1147-52.<br />

Cappella P, et al:. A novel method based on click<br />

chemistry, which overcomes limitations of cell cycle<br />

analysis by classical determination of BrdU<br />

incorporation, allowing multiplex antibody staining.<br />

Cytometry A. 2008; 73:626-36.<br />

Patrignani C, et al.: Knockout mice reveal a role for<br />

protein tyrosine phosphatase H1 in cognition. Behav<br />

Brain Funct. 2008; 4:36:1–14<br />

Toso E. Genotypic Characterisation Studies of<br />

Recombinant Cell Lines. Keeping Genetic Stability<br />

under Control. BIOforum Europe 9/2008.<br />

Valenti C, et al.:. MEN16132, a kinin B2 receptor<br />

antagonist, prevents the endogenous bradykinin<br />

effects in guinea-pigs airways. Eur J Pharmacol.<br />

2008; 579:350-356.<br />

2<br />

4.00<br />

pm<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.15<br />

pm<br />

6.35<br />

pm<br />

6.55<br />

pm<br />

7.15<br />

pm<br />

7.45<br />

pm<br />

THE VALUE OF SAFETY<br />

Stricker B. (Rotterdam)<br />

WEDNESDAY, October 14, 2009<br />

Sala Arcobaleno<br />

Plenary Lecture<br />

Introduction: Caputi A. P. (Messina)<br />

Round Table<br />

SCIENTIFIC ACTIVITY PUBLIC FUNDING AND GLOBAL ECONOMIC<br />

CRISIS: INDIVIDUAL MEASURES AND THEIR INTEGRATION<br />

Chairpersons: Maggi A. (Milan),<br />

Riccardi C. (Perugia), Rossi F. (Naples)<br />

EU SEVENTH FRAMEWORK PROGRAMME (FP7)<br />

Serafini L. (Brussels)<br />

INNOVATIVE MEDICINE INITIATIVE<br />

Ruberti G. (Monterotondo)<br />

INDUSTRY 2015<br />

Cavazza C. (Pomezia)<br />

INTEGRATION OF NATIONAL AND EUROPEAN ENTERPRISES<br />

Gaviraghi G. (Siena)<br />

PHARMACEUTICAL POSITION<br />

Stefanelli E. (Rome)<br />

PUBLIC FUNDING FOR SCIENTIFIC RESEACH IN THE CRISIS<br />

PERIOD: THE BIOTECH INDUSTRY POSITION<br />

Gradnik R. (Milan)<br />

Welcome Cocktail<br />

Commentary<br />

NEW PROPOSALS FROM CUN<br />

Cuomo V. (Rome)<br />

3<br />

WEDNESDAY, October 14, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Sala Arcobaleno – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 1)<br />

Chairpersons: Concas A. (Cagliari), Racagni G. (Milan)<br />

8.30 am ENDOCANNABINOIDS IN THE RAT BASOLATERAL<br />

AMYGDALA ENHANCE MEMORY CONSOLIDATION AND<br />

ENABLE GLUCOCORTICOID MODULATION OF MEMORY<br />

Campolongo P., Trezza V., Roozendaal B., Hauer D.,<br />

Schelling G., McGaugh J., Cuomo V. (Rome, Groningen,<br />

Munich, Irvine)<br />

8.45 am NEUROSTEROIDS AND SENSITIVITY TO STRESS IN<br />

SOCIALLY ISOLATED OFFSPRING<br />

Pisu M., Dore R., Biggio G., Serra M. (Cagliari)<br />

9.00 am REDUCED ADULT NEUROGENESIS AND ALTERED<br />

EMOTIONAL BEHAVIOURS IN AUTOIMMUNE-PRONE BAFF<br />

TRANSGENIC MICE<br />

Crupi R., Cambiaghi M., Spatz L., Hen R., Vita G., Spina<br />

E., Battaglia F. (Messina, New York, Milan)<br />

9.15 am MICRODIALYSIS STUDY OF STRIATAL DOPAMINE<br />

CHANGES IN A A-SYNUCLEIN-GENERATED RAT MODEL OF<br />

PARKINSON’S DISEASE<br />

Bazzu G., Negro A., Grigoletto J., Giusti P., Serra P.,<br />

Desole M., Miele E. (Sassari, Padua)<br />

9.30 am MATHERHOOD INCREASES BDNF, ARC AND LONG-TERM<br />

POTENTIATION IN THE RAT BRAIN: REVERSAL BY THE<br />

OFFSPRING SEPARATION<br />

Mostallino M., Secci P., Mura M., Maciocco E., Murru L.,<br />

Sanna E., Biggio G. (Cagliari)<br />

9.45 am ACUTE BEHAVIOURAL STRESS INCREASES GLUTAMATE<br />

RELEASE AND PRESYNAPTIC SNARE COMPLEX<br />

ACCUMULATION IN PREFRONTAL/FRONTAL CORTEX. THE<br />

DAMPENING ACTION OF ANTIDEPRESSANTS<br />

Tardito C., Musazzi L., Milanese M., Farisello P., Barbiero<br />

V., Zappettini S., Bonifacino T., Mallei A., Baldelli P.,<br />

Racagni G., Raiteri M., Benfenati F., Bonanno G., Popoli M.<br />

(Milan, Genoa)<br />

10.00 am 17ß-ESTRADIOL MINIMIZES INTRAVITREAL GLUTAMATE<br />

INCREASE AFTER TRANSIENT ISCHEMIA/REPERFUSION IN<br />

4<br />

RAT<br />

Cavaliere F., Russo R., Varano G., Rombolà L., Corasaniti<br />

M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />

10.15 am RANTES MODULATES CENTRAL GLUTAMATERGIC<br />

NEUROTRANSMISSION IN HUMAN AND MOUSE NEOCORTEX<br />

Summa M., Musante V., Severi P., Raiteri M., Pittaluga A.<br />

(Genoa)<br />

5<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Azzurra – 8.30-10.30 am<br />

Symposium<br />

VARIABILITY OF THE RESPONSE TO ANTIPLATELET DRUGS:<br />

CAUSES, EVIDENCE AND FUTURE PERSPECTIVES<br />

Chairpersons: Patrono C. (Rome), Tremoli E. (Milan)<br />

VARIABILITY, NOT RESISTANCE, IN THE RESPONSE TO ASPIRIN:<br />

METHODS AND EVIDENCE<br />

Rocca B. (Rome)<br />

PHARMACOKINETICS AND PHARMACOGENOMIC VARIABILITY IN<br />

THE RESPONSE TO P2Y12 BLOCKERS<br />

Cattaneo M. (Milan)<br />

ENVIRONMENT AND LIFE STYLE: CAN THEY AFFECT THE<br />

RESPONSE TO THE ANTIPLATELET AGENTS?<br />

De Gaetano G. (Campobasso)<br />

FUTURE PERSPECTIVES: NEW HYPOTHESES FOR THE OLD DRUGS<br />

AND NEW ANTIPLATELET AGENTS: STRATEGIES AGAINST<br />

VARIABILITY?<br />

Patrignani P. (Chieti)<br />

(Educational support from Eli Lilly Italia and Daiichi Sankyo)<br />

6<br />

THURSDAY, October 15, 2009<br />

Sala Blu – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOLOGY OF DEATH AND CELL PROLIFERATION<br />

(SESSION 1)<br />

Chairpersons: Cantoni O. (Urbino), Grilli M. (Novara)<br />

8.30 am THE GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ)<br />

AND ITS NEW ISOFORM L-GILZ INHIBIT MYOGENIC<br />

TERMINAL DIFFERENTIATION AND MEDIATE ANTI-<br />

MYOGENIC EFFECTS OF GLUCOCORTICOIDS<br />

Bruscoli S., Donato V., Velardi E., Di Sante M., Coppo M.,<br />

Bastianelli A., Bereshchenko O., Canarile L., Riccardi C.<br />

(Perugia)<br />

8.45 am NF-kappa1 GENE DISRUPTION RESULTS IN SELECTIVE<br />

DEFICITS IN ADULT HIPPOCAMPAL NEUROGENESIS AND<br />

IN SHORT-TERM MEMORY IMPAIRMENT<br />

Dellarole A., Francese M., Bortolotto V., Crociara P.,<br />

Quadrato G., Canonico P. L., Orsetti M., Ghi P., Memo M.,<br />

Sara Anna B., Ferrari Toninelli G., Denis-Donini S., Grilli M.<br />

(Novara, Turin, Brescia, Milan)<br />

9.00 am ACID SPHINGOMYELINASE, NITRIC OXIDE AND SYNTAXIN<br />

4: AN IMPORTANT LINK BETWEEN APOPTOSIS AND<br />

EXOCYTOSIS<br />

Perrotta C., Bizzozero L., Morlacchi S., Cazzato D.,<br />

Gulbins E., Bassi M., Rosa P., Clementi E. (Milan, Essen)<br />

9.15 am PIVOTAL ROLE OF 12-LIPOXYGENASE IN THE REGULATION<br />

OF ASTROCYTE SURVIVAL TO PEROXYNITRITE<br />

Palomba L., Cerioni L., Cantoni O. (Urbino)<br />

9.30 am R-ROSCOVITINE SENSITIZES ANAPLASTIC THYROID<br />

CARCINOMA CELLS TO TRAIL-INDUCED APOPTOSIS VIA<br />

REGULATION OF IKK/NF-KB PATHWAY<br />

Festa M., Petrella A., Alfano S., Parente L. (Fisciano)<br />

9.45 am ACTIVATION OF mGLU3 RECEPTORS STIMULATES THE<br />

PRODUCTION OF GDNF IN STRIATAL NEURONS<br />

Traficante A., Battaglia G., Molinaro G., Riozzi B., Storto<br />

M., Busceti C., Spinsanti P., Bucci D., Di Liberto V., Mudò<br />

G., Corti C., Corsi M., Nicoletti F., Belluardo N., Bruno V.<br />

(Pozzilli, Rome, Palermo, Verona)<br />

7<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

10.00 am AUTOPHAGY IN NEONATAL HYPOXIA-ISCHEMIA INDUCED<br />

BRAIN INJURY<br />

Balduini W., Carloni S., Girelli S., Buonocore G. (Urbino,<br />

Siena)<br />

10.15 am CANNABIDIOL, A NON-PSYCHOACTIVE CANNABINOID<br />

COMPOUND, INHIBITS HUMAN GLIOMA CELL MIGRATION<br />

AND INVASIVENESS<br />

Valenti M., Massi P., Bolognini D., Solinas M., Parolaro D.<br />

(Varese, Milan)<br />

8<br />

8.30<br />

am<br />

8.50<br />

am<br />

9.10<br />

am<br />

9.30<br />

am<br />

9.50<br />

am<br />

10.10<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Giardino d’Inverno – 8.30-10.30 am<br />

Symposium<br />

PATHOGENIC MECHANISMS AND DRUGABLE TARGETS IN POST-<br />

ISCHEMIC BRAIN INJURY<br />

Chairpersons: Pellegrini-Giampietro D. (Florence),<br />

Pizzi M. (Brescia)<br />

TEMPORAL AND BRAIN REGIONAL DEFINITION OF THE<br />

NEUROINFLAMMATORY RESPONSE TO TRANSIENT FOCAL<br />

CEREBRAL ISCHEMIA IN RAT<br />

Amantea D. (Castrolibero)<br />

ROLE OF THE AKAP SCAFFOLDS AND THE UBIQUITIN-<br />

PROTEASOME PATHWAY IN THE PHYSIOLOGICAL RESPONSE TO<br />

BRAIN ISCHEMIA<br />

Feliciello A. (Naples)<br />

BRAIN ISCHEMIC POSTCONDITIONING EXERTS ITS<br />

NEUROPROTECTIVE EFFECT BY MODULATING ASIC1A AND NCX3<br />

EXPRESSION IN THE ISCHEMIC PENUMBRA REGION<br />

Pignataro G. (Naples)<br />

PRE-CONDITIONING AND POST-CONDITIONING AGAINST<br />

CEREBRAL ISCHEMIA: FROM EXPERIMENTAL STRATEGIES TO<br />

CLINICAL USE<br />

Gerace E. (Florence)<br />

TARGETING NF-KB AND EPIGENETIC CHROMATIN REMODELLING<br />

IN THE THERAPY OF POST-ISCHEMIC BRAIN INJURY<br />

Sarnico I. (Brescia)<br />

ENDOGENOUS NEURAL STEM CELL-BASED THERAPIES FOR<br />

STROKE: FOCUS ON GPR17, A NEW DUAL PURINERGIC/<br />

CYSTEINYL-LEUKOTRIENE RECEPTOR<br />

Abbracchio M. P. (Milan)<br />

9<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Viola – 8.30-10.30 am<br />

Symposium<br />

HUNTINGTON DISEASE - AN ORPHAN ILLNESS WITH HIGH<br />

MEDICAL NEED<br />

Chairpersons: Gaviraghi G. (Siena), Pepeu G. (Florence)<br />

KNOCKING DOWN THE DRUGGABLE GENOME FOR HD TARGET<br />

DISCOVERY<br />

Caricasole A. (Siena)<br />

TRANSLATIONAL RESEARCH AND THE CHALLENGE OF DISEASE<br />

ANIMAL MODELS<br />

Palfi S. (Creteil)<br />

STEM CELLS AS A TOOL FOR DRUG DISCOVERY AND POTENTIAL<br />

THERAPEUTICS IN HUNTINGTON'S DISEASE<br />

Zuccato C. (Milan)<br />

DEVELOPMENT OF NOVEL PHARMACO-THERAPIES FOR HD<br />

Terstappen G. C. (Siena)<br />

(Educational support from Siena Biotech)<br />

10<br />

8.30<br />

am<br />

8.50<br />

am<br />

9.10<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Arancione – 8.30-10.30 am<br />

Symposium<br />

PALMITOYLETHANOLAMIDE ANTINFLAMMATORY/ NEURO-<br />

PROTECTIVE PROPERTIES: THE PHARMACOLOGICAL BASES FOR<br />

NOVEL PUTATIVE THERAPEUTIC AGENTS<br />

Chairpersons: Skaper S. (Harlow), Steardo L. (Rome)<br />

PALMITOYLETHANOLAMIDE CONTROL OF MAST CELL MEDIATOR<br />

RELEASE: NEW PROSPECTIVE IN CHRONIC INFLAMMATION<br />

Iuvone T. (Naples)<br />

PEA ANTIALLODYNIC AND ANTIHYPERALGESIC EFFECTS IN A<br />

MURINE MODEL OF NEUROPATHIC PAIN<br />

Costa B. (Milan)<br />

EFFECTS OF PALMITOYLETHANOLAMIDE ON THE DEVELOPMENT<br />

OF SPINAL CORD INJURY<br />

Cuzzocrea S. (Messina)<br />

ANTINFLAMMATORY/NEUROPROTECTIVE PROPERTIES OF<br />

PALMITOYLETHANOLAMIDE IN A MODEL OF ALZHEIMER’S<br />

DISEASE<br />

Scuderi C. (Rome)<br />

ANTI-INFLAMMATORY PROPERTIES OF<br />

PALMITOYLETHANOLAMIDE: IMPLICATIONS IN EXPERIMENTAL<br />

MULTIPLE SCLEROSIS<br />

Guaza C. (Madrid)<br />

11<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Bianca – 8.30-10.30 am<br />

Symposium<br />

TRP CHANNELS IN HEALTH AND DISEASE<br />

Chairpersons: Geppetti P. (Florence), Trevisani M. (Ferrara)<br />

TRPC CHANNELS AND HYPOXIA SIGNALING<br />

Gudermann T. (Munich)<br />

TRP CHANNELS IN THE GASTROINTESTINAL TRACT WITH<br />

SPECIAL REFERENCE TO PANCREATIC Β-CELLS<br />

Oberwinkler J. (Homburg)<br />

THE RISING ROLE OF TRPA1 IN ASTHMA<br />

Patacchini R. (Parma)<br />

TRP CHANNELS: FROM PLANTS TO MAMMALS<br />

Appendino G. (Novara)<br />

(Educational support from Chiesi Farmaceutici)<br />

12<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Verde – 8.30-10.30 am<br />

Symposium<br />

NON-INVASIVE METHODS AND BIOMARKERS FOR ASSESSING<br />

PHARMACOLOGICAL THERAPY OF CHRONIC OBSTRUCTIVE<br />

PULMONARY DISEASE<br />

Chairpersons: Folco G. C. (Milan), Olivieri D. (Parma)<br />

METABOLOMICS OF EXHALED BREATH CONDENSATE<br />

Montuschi P. (Rome)<br />

EXHALED NITRIC OXIDE<br />

Clini E. (Pavullo)<br />

ANALYSIS OF SPUTUM INDUCTION<br />

Aiello M., Nicolini G., Olivieri D. (Parma)<br />

LIPIDS AS PRO-AND ANTI-INFLAMMATORY AGENTS<br />

Sala A. (Milan)<br />

(Educational support from PRIN)<br />

13<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Sala Rossa – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOGENETICS<br />

Chairpersons: Fornasari D. (Milan),<br />

Genazzani A. (Novara)<br />

8.30 am ASSOCIATION BETWEEN GENOTYPES AND RESPONSE TO<br />

IMATINIB MESYLATE TREATMENT IN A SUBSET OF<br />

PREVIOUSLY UNTREATED PATIENTS AFFECTED BY<br />

GASTROINTESTINAL STROMAL TUMOURS<br />

Angelini S., Pantaleo M., Turrini E., Di Battista M., Biasco<br />

G., Cantelli Forti G., Hrelia P. (Bologna)<br />

8.45 am DIFFERENT RESPONSE TO DRUG THERAPY FROM<br />

OSTEOPOROTIC PATIENTS<br />

Conti V., Rinaldi B., Russomanno G., Toro A., Tripodi F.,<br />

Ciaramella N., Ruggiero F., Rossi F. (Naples, Mercato San<br />

Severino)<br />

9.00 am ADVERSE REACTIONS TO COMT INHIBITORS IN<br />

PARKINSON’S DISEASE PATIENTS: POSSIBLE<br />

ASSOCIATION WITH THE UGT1A9 GENE HAPLOTYPE<br />

Ferrari M., Loraschi A., Marino F., Riboldazzi G., Zangaglia<br />

R., Pianezzola C., Bono G., Lecchini S., Nappi G., Martignoli<br />

E., Cosentino M. (Varese, Pavia, Veruno, Rome)<br />

9.15 am EFFECTS OF CELECOXIB ON PROSTANOID BIOSYNTHESIS<br />

AND INFLAMMATORY AND ANGIOGENIC BIOMARKERS IN<br />

PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS<br />

Tacconelli S., Capone M., Dovizio M., Bruno A., Sciulli M.,<br />

Sala P., Signorini S., Bertario L., Dixon D., Lawson J.,<br />

FitzGerald G., Patrignani P. (Chieti, Milan, Columbia,<br />

Philadelphia)<br />

9.30 am IMPACT OF CYP2C9 AND VKORC1 POLYMORPHISMS ON<br />

PHARMACOKINETICS AND PHARMACODYNAMICS OF<br />

WARFARIN IN PATIENTS ON ANTICOAGULANT THERAPY<br />

Nisi A., Schiavon S., Zambon C., De Rosa G., Basso D.,<br />

Pengo V., Gusella M., Plebani M., Padrini R. (Padua,<br />

Rovigo)<br />

9.45 am EVALUATION OF DRUG RESPONSES IN NON-<br />

TRANSFORMED CELLS CARRYING CANCER ALLELES<br />

Gallicchio M., Di Nicolantonio F., Arena S., Zecchin D.,<br />

Martini M., Flonta S., Stella G., Lamba S., Cancelliere C.,<br />

14<br />

Russo M., Geuna M., Appendino G., Fantozzi R., Medico E.,<br />

Bardelli A. (Turin, Candiolo, Pavia, Novara, Milan)<br />

10.00 am ANALYSIS OF SEROTONIN TRANSPORTER 5HTTLPR AND<br />

CHOLECYSTOKININ TYPE 1 RECEPTOR GENE<br />

POLYMORPHISMS, CLINICAL VARIANTS AND SYMPTOM<br />

SEVERITY IN PATIENTS WITH IRRITABLE BOWEL<br />

SYNDROME<br />

Ghisu N., Colucci R., Bellini M., Rossi G., Gambaccini D.,<br />

Blandizzi C., Costa F., Marchi S., Del Tacca M. (Pisa)<br />

10.15 am GENETIC FACTORS INCREASE SUSCEPTIBILITY TO TAU<br />

PROTEIN HYPERPHOSPHORYLATION IN THE BRAIN OF<br />

MICE TREATED WITH 3,4-<br />

METHYLENDIOXYMETHAMPHETAMINE (“ECSTASY”)<br />

Biagioni F., Busceti C., Bucci D., Mastroiacovo F., Riozzi<br />

B., Battaglia G., Bruno V., Cassano T., Cuomo V., Fornai<br />

F., Nicoletti F. (Pozzilli, Rome, Foggia, Pisa)<br />

15<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

10.45<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Azzurra – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Paoletti R. (Milan)<br />

INNOVATION IN ANTIHYPERTENSIVE THERAPY: ALISKIREN<br />

Corsini A. (Milan)<br />

(Educational support from Novartis Farma)<br />

16<br />

10.45<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Blu – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Mazzei T. (Florence)<br />

AS04: THE BENEFITS OF THE NEW ADJUVANT SYSTEM FOR<br />

PREVENTION OF CERVICAL CANCER<br />

Scaglione F. (Milan)<br />

(Educational support from GlaxoSmithKline)<br />

17<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

10.45<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Giardino d’Inverno – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Danesi R. (Pisa)<br />

FIGHTING CANCER ON MULTIPLE FRONTS: THE AMGEN<br />

ONCOLOGY AND HAEMATOLOGY PIPELINE<br />

Suto T. (Zug)<br />

(Educational support from Amgen Dompé)<br />

18<br />

10.45<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Viola – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Fantozzi R. (Turin)<br />

SAFETY AND EFFICACY OF CANAKINUMAB (ACZ885) IN<br />

CHILDREN WITH CRYOPYRIN ASSOCIATED PERIODIC FEVER<br />

SYNDROME (CAPS): RESULTS OF A MULTICENTRE, RANDOMIZED<br />

DOUBLE BLIND, PHASE III STUDY<br />

Gattorno M. (Genoa)<br />

(Educational support from Novartis Farma)<br />

19<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

10.45<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Bianca – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Preziosi P. (Rome)<br />

CRITICALITIES ABOUT GENERIC DRUGS<br />

Navarra P. (Rome)<br />

(Educational support from Wyeth Lederle)<br />

20<br />

11.15<br />

am<br />

11.45<br />

am<br />

12.15<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Azzurra – 11.15 am-1.15 pm<br />

Symposium<br />

BEYOND THE CARDIOVASCULAR RISK<br />

Chairperson: Catapano A. (Milan)<br />

FOCUS ON ROSUVASTATIN: EFFICACY ON THE COMPREHENSIVE<br />

LIPID PROFILE AND INFLAMMATION<br />

Bernini F. (Parma)<br />

INFLAMMATION, LIPOPROTEINS AND ATHEROSCLEROSIS: THE<br />

NEW MARKERS<br />

Urbinati S. (Bologna)<br />

(Educational support from AstraZeneca)<br />

LECTURE<br />

Introduction: Rossi F. (Naples)<br />

THE LATE INAS: A NEW THERAPEUTIC TARGET IN ANGINA<br />

Mugelli A. (Florence)<br />

(Educational support from A. Menarini)<br />

21<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

11.15<br />

am<br />

11.45<br />

am<br />

12.15<br />

pm<br />

12.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Blu – 11.15 am-1.15 pm<br />

Symposium<br />

THERAPEUTIC APPROACH AND OPTIMIZATION OF RESOURCES IN<br />

RHEUMATIC DISEASES<br />

Chairpersons: Giusti P. (Padua), Riccardi C. (Perugia)<br />

CELLULAR AND MOLECULAR MECHANISMS UNDERLYING<br />

RHEUMATIC DISEASES<br />

Nocentini G. (Perugia)<br />

PHARMACOLOGY OF BIOLOGIC DRUGS USED IN THE TREATMENT<br />

OF RHEUMATIC DISORDERS<br />

Debetto P. (Padua)<br />

THERAPEUTIC STRATEGIES FOR CHRONIC IDIOPATHIC<br />

ARTHRITIS<br />

Montecucco C. (Pavia)<br />

RHEUMATIC DISEASES: A STUDY TO EVALUATE SOCIAL COSTS<br />

IN THE NEXT 30 YEARS IN DIFFERENT ITALIAN REGIONS<br />

Cicchetti A. (Rome)<br />

(Educational support from Abbott)<br />

22<br />

11.15<br />

am<br />

11.35<br />

am<br />

11.55<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Giardino d’Inverno – 11.15 am -0.15 pm<br />

Symposium<br />

PATIENT NEED AND OPTIMIZATION OF OSTEOPOROSIS<br />

MANAGEMENT<br />

Chairpersons: Adami S. (Verona), Canonico P. L. (Novara)<br />

POSTMENOPAUSAL OSTEOPOROSIS: CLINICAL EVALUATION,<br />

THERAPEUTIC STRATEGIES AND UNMET NEEDS<br />

Bianchi G. (Genoa)<br />

NEW PERSPECTIVES IN THE TREATMENT OF OSTEOPOROSIS<br />

Sinigaglia L. (Novara)<br />

NEW THERAPEUTIC PERSPECTIVES IN OSTEOPOROSIS: FROM<br />

MECHANISM OF ACTION TO CLINICAL CARE<br />

Adami S. (Verona)<br />

(Educational support from Amgen Dompé)<br />

23<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

11.15<br />

am<br />

11.35<br />

am<br />

11.55<br />

am<br />

12.15<br />

pm<br />

12.35<br />

pm<br />

12.55<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Viola – 11.15 am -1.15 pm<br />

<strong>SIF</strong>-<strong>SIF</strong>O Symposium<br />

INDEPENDENT DRUG INFORMATION AS A TOOL FOR AN<br />

APPROPRIATED AND SAFER USE OF MEDICINES<br />

Chairpersons: Fantozzi R. (Turin), Piacentini P. (Milan)<br />

INFORMATION AS A TOOL FOR AN APPROPRIATED AND SAFER<br />

USE OF MEDICINES<br />

Miracapillo R. (Bari)<br />

PROVIDING INDEPENDENT DRUG INFORMATION IN A UK<br />

HOSPITAL<br />

Proudlove C. (London)<br />

PROVIDING INDEPENDENT DRUG INFORMATION IN AN ITALIAN<br />

HOSPITAL<br />

Polidori P. (Palermo)<br />

INDEPENDENT DRUG INFORMATION AS A TOOL FOR A BETTER<br />

PRESCRIBING APPROPRIATENESS: THE EXPERIENCE OF<br />

“FARMACI IN EVIDENZA” A NEWSLETTER FROM THE ITALIAN<br />

SOCIETY OF PHARMACOLOGY<br />

Rosa A. C. (Turin)<br />

DRUG INFORMATION AT A REGIONAL LEVEL<br />

Venturini F. (Verona)<br />

THE ROLE OF THE ITALIAN REGULATORY AGENCY<br />

Addis A. (Rome)<br />

(Educational support from Thomson Reuters, provider of MICROMEDEX)<br />

24<br />

11.15<br />

am<br />

11.35<br />

am<br />

11.55<br />

am<br />

12.15<br />

pm<br />

12.35<br />

pm<br />

12.55<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Arancione – 11.15 am -1.15 pm<br />

Symposium<br />

PRINCIPLES OF PSYCHOTROPIC DRUG INTERACTIONS<br />

Chairpersons: Drago F. (Catania), Palmieri G. (Milan),<br />

Racagni G. (Milan)<br />

INTRODUCTION<br />

Palmieri G. (Milan)<br />

PRINCIPLES OF PHARMACOLOGICAL INTERACTIONS<br />

Racagni G. (Milan)<br />

PHARMACOVIGILANCE AND ADVERSE EVENT REPORTING<br />

Drago F. (Catania)<br />

PSYCHOTROPIC DRUG-DRUG INTERACTIONS IN PSYCHIATRY<br />

Caraci F. (Catania)<br />

PSYCHOTROPIC DRUG-DRUG INTERACTIONS IN NEUROLOGICAL<br />

SETTING<br />

Brunello N. (Modena)<br />

INTERACTIONS BETWEEN PSYCHOTROPIC AGENTS AND DRUGS<br />

USED IN INTERNAL MEDICINE<br />

Spina E. (Messina)<br />

(Educational support from Innova Pharma)<br />

25<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

11.15<br />

am<br />

12.00<br />

pm<br />

12.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Bianca – 11.15 am-1.15 pm<br />

Symposium<br />

GENERIC DRUGS: THE ITALIAN STATUS<br />

Chairpersons: Navarra P. (Rome), Saffi-Giustini E. (Pontedera)<br />

EVOLUTION OF GENERICS MARKET IN ITALY AND WORLD-WIDE<br />

Foresti G. (Milan)<br />

GENERICS AND POTENTIAL DRUG EXPENSES REDUCTION FOR<br />

NHS<br />

Giorni L. (Florence)<br />

GENERICS AND QUALITY ISSUES<br />

Tonini M. (Pavia)<br />

(Educational support from ASSOGENERICI)<br />

26<br />

11.15<br />

am<br />

11.35<br />

am<br />

11.55<br />

am<br />

THURSDAY, October 15, 2009<br />

Sala Verde – 11.15 am -12.15 pm<br />

Symposium<br />

ROFLUMILAST: A NEW THERAPEUTIC APPROACH TO COPD<br />

Chairpersons: Cirino G. (Naples), Folco G. C. (Milan),<br />

AN OVERVIEW ON PDE4 INHIBITORS<br />

Cirino G. (Naples)<br />

PATHOGENESIS OF COPD: WHICH ROLE FOR PDE4 INHIBITORS?<br />

Luisetti M. (Pavia)<br />

ROFLUMILAST, A NOVEL PDE4 INHIBITOR: PRECLINICAL PROFILE<br />

Lungarella G. (Siena)<br />

(Educational support from Nycomed)<br />

27<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/1/1<br />

P-1/1/2<br />

P-1/1/3<br />

P-1/1/4<br />

P-1/1/5<br />

Poster Session<br />

P-1/1: PHARMACOLOGY OF NERVOUS SYSTEM<br />

Poster Commission Members:<br />

President: Spano P. F. (Brescia)<br />

Members: Brunello N. (Milan), Bruno V. (Rome), Di<br />

Luca M. (Milan), Pellegrini-Giampietro D. (Florence),<br />

Serra M. (Cagliari), Sortino M.A. (Catania)<br />

OSTEOPENIA BY RISPERIDONE-INDUCED<br />

HYPERPROLACTINEMIA: A CASE REPORT<br />

Capasso A., Milan W., Milan L., Siano C., Petrella C.<br />

(Fisciano)<br />

THE GHB ANALOGUE N-(4-TRIFLUOROMETHYL)-4-<br />

METHOXYBUTANAMIDE PREVENTS THE BEHAVIORAL AND<br />

NEURODEGENERATIVE CONSEQUENCES OF REPEATED<br />

EPISODES OF ALCOHOL WITHDRAWAL, IN RATS<br />

Tacchi R., Spaccapelo L., Maccio L., Ferrari A., Rivasi F.,<br />

Bertolini A. (Modena)<br />

LIGHT AND SHADE OF THERAPEUTIC DRUG MONITORING<br />

OF ANTIEPILEPTIC DRUGS<br />

Furlanut M., Cojutti P., Franceschi L. (Udine)<br />

SEROTONIN2C RECEPTORS IN THE MEDIAL PREFRONTAL<br />

CORTEX FACILITATE COCAINE-INDUCED DOPAMINE<br />

RELEASE IN THE RAT NUCLEUS ACCUMBENS<br />

Leggio G., Cathala A., Moison D., Cunningham K., Piazza<br />

P., Spampinato U. (Bordeaux, Catania, Galveston)<br />

ASSOCIATION STUDY BETWEEN MEDICATION OVERUSE<br />

HEADACHE AND POLYMORPHIC VARIANTS OF<br />

SEROTONERGIC GENES<br />

Terrazzino S., Sances G., Cereda C., Viana M., Nappi G.,<br />

Rinaldi M., Canonico P. L., Genazzani A. (Novara, Pavia)<br />

P-1/1/6 OPPOSITE REGULATION OF CB1-MEDIATED EFFECTS BY<br />

28<br />

P-1/1/7<br />

P-1/1/8<br />

P-1/1/9<br />

P-1/1/10<br />

P-1/1/11<br />

P-1/1/12<br />

P-1/1/13<br />

PRE- AND POST-SYNAPTIC ADENOSINE A2A RECEPTORS IN<br />

THE STRIATUM<br />

Tebano M., Martire A., Kofalvi A., Chiodi V., Domenici M.,<br />

Pepponi R., Ferreira S., Ferrante A., Chen J., Cunha R.,<br />

Popoli P. (Rome, Boston, Coimbra)<br />

DEATH RESISTANT NEURAL STEM CELLS REGENERATE<br />

NEURONAL TISSUE AND PROMOTE FUNCTIONAL<br />

RECOVERY AFTER TRANSPLANTATION IN A SPINAL CORD<br />

INJURY MODEL<br />

Marfia G., Madaschi L., Merli D., Menarini M., Marra F.,<br />

Gualeni A., Naselli F., Carelli S., Di Giulio A., Gorio A.<br />

(Milan, Rozzano, Imola)<br />

DEATH RESISTANT NEURAL PROGENITORS YIELD MOSTLY<br />

NEURONS: AN ERYTHROPOIETIN-DEPENDENT PROCESS<br />

Marra F., Marfia G., Madaschi L., Merli D., Bottai D.,<br />

Carelli S., Menarini M., Di Giulio A., Gorio A. (Milan, Imola,<br />

Rozzano)<br />

ERYRHROPOIETIN INCREASES NEURONAL<br />

DIFFERENTIATION OF NEURAL STEM CELLS AND DEATH<br />

RESISTANT NEURAL STEM CELLS<br />

Gualeni A., Naselli F., Merli D., Menarini M., Marra F.,<br />

Gervasi N., Carelli S., Madaschi L., Marfia G., Di Giulio A.,<br />

Gorio A. (Milan, Imola, Rozzano)<br />

FAILURE OF THE CB1 RECEPTOR ANTAGONIST SR141716A<br />

(RIMONABANT) TO INDUCE ANTIDEPRESSANT-LIKE<br />

EFFECT IN THE RAT FORCED SWIMMING TEST<br />

Bogliolo V., Garzia A., Serra G., D'Aquila P., Serra G.<br />

(Sassari, Rome)<br />

MAGNETIC AND FLUORESCENCE LABELLING FOR IN VIVO<br />

NEURAL STEM CELL TRANSPLANTATION MONITORING<br />

Merli D., Lui R., Marfia G., Clerici M., Ottobrini L.,<br />

Lucignani G., Carelli S., Marra F., Di Giulio A., Gorio A.<br />

(Milan, Rozzano)<br />

PALMITOYLTHENOLAMIDE CONTROLS THE PRO-<br />

ANGIOGENIC PATHWAY INDUCED BY BETA AMYLOID IN<br />

GLIAL CELLS<br />

Cipriano M., Scuderi C., De Filippis D., Esposito G., Di<br />

Marzo V., Steardo L., Iuvone T. (Naples, Rome)<br />

HMGB1-EVOKES GLUTAMATE RELEASE FROM GLIOSOMES<br />

FRESHLY PREPARED FROM ADULT MOUSE BRAIN<br />

Milanese M., Bonifacino T., Zappettini S., Pedrazzi M.,<br />

Passalacqua M., Sparatore B., Melloni E., Bonanno G.<br />

(Genoa)<br />

29<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/14<br />

P-1/1/15<br />

P-1/1/16<br />

P-1/1/17<br />

P-1/1/18<br />

P-1/1/19<br />

P-1/1/20<br />

P-1/1/21<br />

ABSENCE OF ENDOGENOUS INTERLEUKIN-10 ENHANCES<br />

SECONDARY INFLAMMATORY PROCESS AFTER SPINAL<br />

CORD COMPRESSION INJURY IN MICE<br />

Genovese T., Esposito E., Mazzon E., Di Paola R.,<br />

Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S.<br />

(Messina, Naples, Catania)<br />

INTRAVENOUS MESENCHYMAL STEM CELLS<br />

ADMINISTRATION INDUCES SURVIVAL AND SYMPTOM<br />

AMELIORATION IN MUTANT SOD1 G93A MICE<br />

Bonifacino T., Zappettini S., Milanese M., Casazza S.,<br />

Caponnetto C., Uccelli A., Bonanno G. (Genoa)<br />

FAILURE OF ATYPICAL ANTIPSYCHOTICS TO INDUCE<br />

ANHEDONIA: BEHAVIOURAL EVIDENCE FOR THE ROLE OF<br />

5-HT2 RECEPTORS<br />

D'Aquila P., Cabras M., Modde C., Rassu C., Serra G.<br />

(Sassari)<br />

NEUROPROTECTIVE EFFECT OF<br />

DEYDROEPIANDROSTERONE IN HEPATIC<br />

ENCEPHALOPATHY: POSSIBLE INVOLVEMENT OF PROTEIN<br />

KINASE C, EPSILON ISOFORM<br />

Geminiani E., Corsi L., Carnevale G., Zanoli P., Baraldi M.<br />

(Modena)<br />

BB 16 AS NEW COMPOUND FOR MEMORY RELATED<br />

DISORDERS<br />

Di Viesti V., Carnevale G., Zavatti M., Zanoli P., Cannazza<br />

G., Braghiroli D., Baraldi M. (Modena)<br />

PHENOTYPICAL CHARACTERIZATION OF THIRD<br />

TRIMESTER HUMAN AMNIOTIC FLUID CELLS: A NEW<br />

RESERVOIR OF STEM CELLS?<br />

Bottai D., Cigognini D., Nicora E., Ripamonti E., Adami R.,<br />

Abrignani S., Moro M., Rebulla P., Menarini M., Di Giulio<br />

A., Gorio A. (Milan, Imola)<br />

THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH<br />

POTENTIAL FOR THERAPY IN NEURODEGENERATIVE<br />

DISORDERS<br />

Cigognini D., Nicora E., Ripamonti E., Adami R., Menarini<br />

M., Di Giulio A., Bottai D., Gorio A. (Milan, Imola)<br />

ROLE OF MATRIX METALLOPROTEINASES IN RETINAL<br />

GANGLION CELLS (RGCS) LOSS INDUCED BY RETINAL<br />

ISCHEMIA/REPERFUSION<br />

Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti<br />

M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />

P-1/1/22 MELANOCORTINS PROTECT AGAINST CENTRAL AND<br />

30<br />

P-1/1/23<br />

P-1/1/24<br />

P-1/1/25<br />

P-1/1/26<br />

P-1/1/27<br />

P-1/1/28<br />

P-1/1/29<br />

P-1/1/30<br />

PERIPHERAL DAMAGE FOLLOWING CEREBRAL ISCHEMIA<br />

THROUGH A VAGUS NERVE-MEDIATED MECHANISM<br />

Giuliani D., Ottani A., Galantucci M., Minutoli L., Bitto A.,<br />

Di Stefano V., Altavilla D., Squadrito F., Guarini S.<br />

(Modena, Messina)<br />

ROLE OF ENDOCANNABINOID SYSTEM AND VANILLOID<br />

TRPV1 CHANNELS IN THE PHENOTYPE OF DOPAMINE D3<br />

RECEPTOR KNOCK-OUT "D3(-/-)" MICE<br />

Micale V., Cristino L., Tamburella A., Petrosino S., Leggio<br />

G., Di Marzo V., Drago F. (Catania, Pozzuoli)<br />

NOOTROPICS: "SMART DRUGS"?<br />

Runci F., Fiaschi A., Barberi L., Passarello F.,<br />

Montefrancesco G., Giorgi G. (Siena)<br />

MOLECULES ACTING ON CB1 RECEPTOR AND THEIR<br />

EFFECTS ON MORPHINE WITHDRAWAL IN VITRO<br />

Festa M., Capasso A. (Salerno)<br />

COMPARISON OF THE ANTIEPILEPTOGENIC EFFECTS OF<br />

AN EARLY LONG-TERM TREATMENT WITH ETHOSUXIMIDE<br />

OR LEVETIRACETAM IN A GENETIC ANIMAL MODEL OF<br />

ABSENCE EPILEPSY<br />

Russo E., Citraro R., Scicchitano F., Marra R., Donato Di<br />

Paola E., De Fazio S., De Sarro G. (Catanzaro)<br />

NEUROCHEMICAL AND BEHAVIORAL EFFECTS OF<br />

CARVACROL<br />

Zotti M., Avato P., Trabace L. (Foggia, Bari)<br />

-LACTOALBUMIN, A WHEY PROTEIN RICH IN<br />

TRYPTOPHAN, SHOWS EFFICACY IN RODENT MODELS OF<br />

EPILEPSY<br />

Citraro R., Russo E., Scicchitano F., De Fazio S., Marra R.,<br />

Mainardi P., Perucca E., De Sarro G. (Catanzaro, Genoa,<br />

Pavia)<br />

LONG TERM ANTIEPILEPTIC DRUGS TREATMENT,<br />

ABSENCE EPILEPSY AND DEPRESSION: A CORRELATION<br />

STUDY<br />

De Fazio S., Russo E., Citraro R., Scicchitano F., De Fazio<br />

P., Segura Garcia C., Gareri P., De Sarro G. (Catanzaro)<br />

EFFECTS OF FLAVONOIDS GENISTEIN AGLYCONE AND<br />

FLAVOCOXID IN THE EXPERIMENTAL MOUSE MODEL OF<br />

DUCHENNE MUSCULAR DYSTROPHY<br />

Bitto A., Polito F., Irrera N., Messina S., Altavilla D.,<br />

Guarini S., Caputi A. P., Squadrito F. (Messina, Modena)<br />

P-1/1/31 MELATONIN REGULATES MATRIX METALLOPROTEINASE-2<br />

31<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/32<br />

P-1/1/33<br />

P-1/1/34<br />

P-1/1/35<br />

P-1/1/36<br />

P-1/1/37<br />

P-1/1/38<br />

AND -9, AND REDUCES STRESS-ACTIVATED/MITOGEN-<br />

ACTIVATED PROTEIN KINASES IN SPINAL CORD INJURY<br />

Esposito E., Genovese T., Caminiti R., Bramanti P., Meli<br />

R., Cuzzocrea S. (Messina, Naples)<br />

PRESYNAPTIC NICOTINIC AND D2 RECEPTORS<br />

FUNCTIONALLY INTERACT ON DOPAMINERGIC NERVE<br />

ENDINGS OF RAT AND MOUSE NUCLEUS ACCUMBENS<br />

Zappettini S., Grilli M., Lagomarsino F., Zoli M., Marchi M.<br />

(Genoa, Modena)<br />

MK801, A N-METHYL-D-ASPARTATE (NMDA) RECEPTOR<br />

ANTAGONIST, REDUCES SIGNALING PATHWAYS<br />

INVOLVED IN AN EXPERIMENTAL MODEL OF SPINAL CORD<br />

TRAUMA<br />

Paterniti I., Esposito E., Genovese T., Mazzon E.,<br />

Galuppo M., Bramanti P., Cuzzocrea S. (Messina)<br />

GSK3β INHIBITION PROTECTS MOUSE CORTICAL<br />

NEURONS AGAINST OXYGEN-GLUCOSE DEPRIVATION<br />

INJURY<br />

Delbarba A., Bertolotti P., Dossena M., Nisoli E., Valerio<br />

A. (Milan, Brescia)<br />

HEPATIC MITOCHONDRIA OBTAINED FROM 6-OHDA-<br />

LESIONED PARKINSONIAN RATS EXHIBIT DECREASED<br />

ENERGY CAPACITY AND MEMBRANE POTENTIAL<br />

Ferrigno A., Armentero M., Rizzo V., Ambrosi G., Richelmi<br />

P., Blandini F., Vairetti M. (Pavia)<br />

POSSIBLE ROLE OF TUNNELING NANOTUBES IN<br />

NEURODEGENERATIVE DISEASES: INTERCELLULAR<br />

TRANSFER OF MITOCHONDRIA, APP AND α-SYNUCLEIN<br />

Carone C., Genedani S., Agnati L., Filaferro M., Pederzoli<br />

F., Leo G. (Modena)<br />

β-AMYLOID FIBRILLATION AND/OR<br />

HYPERHOMOCYSTEINEMIA MODIFY STRIATAL PATTERNS<br />

OF GLYCOSAMINOGLYCANS: POSSIBLE ROLE IN THE<br />

PATHOGENESIS OF ALZHEIMER’S DISEASE<br />

Pederzoli F., Genedani S., Volpi N., Agnati L., Leo G.,<br />

Buzzega D., Maccari F., Carone C., Andreoli N., Filaferro M.<br />

(Modena)<br />

CHF5074 REDUCES BRAIN β-AMYLOID BURDEN IN A<br />

MOUSE MODEL OF ALZHEIMER’S DISEASE BY<br />

MODULATING APP AND PS1 INTERACTION<br />

Lanzillotta A., Sarnico I., Hutter-Paier B., Imbimbo B.,<br />

Windisch M., Pizzi M. (Brescia, Parma, Graz)<br />

P-1/1/39 STEERED MOLECULAR DYNAMICS SIMULATIONS TO<br />

32<br />

P-1/1/40<br />

P-1/1/41<br />

P-1/1/42<br />

P-1/1/43<br />

P-1/1/44<br />

P-1/1/45<br />

P-1/1/46<br />

INVESTIGATE THE DUAL PHARMACOLOGY OF THE NOVEL<br />

NUCLEOTIDES/LEUKOTRIENES RESPONDING RECEPTOR<br />

GPR17<br />

Parravicini C., Ranghino G., Fantucci P., Abbracchio M. P.<br />

(Milan, Bresso)<br />

SEIZURE SUSCEPTIBILITY OF HIV-1 TAT-TRANSGENIC<br />

MICE: IMPLICATIONS FOR THE ROLE OF TAT IN HIV-1<br />

ASSOCIATED NEUROPATHY (HAN)<br />

Zucchini S., Caputo A., Altavilla G., Brocca Cofano E.,<br />

Pittaluga A., Corallini A., Simonato M. (Ferrara, Padua,<br />

Bethesda, Genoa)<br />

ADENOSINE A2A RECEPTORS MODULATE ACTIVATION OF<br />

P38 MITOGEN ACTIVATED PROTEIN KINASE IN MURINE<br />

BV-2 CELLS<br />

Corti F., Cipriani S., Saura J., Lluis C., Serratosa J.,<br />

Franco R., Pedata F. (Florence, Barcelona)<br />

OXIDATIVE STRESS AND EFFECTS OF ANTIOXIDANT<br />

TREATMENT IN DISUSED SKELETAL MUSCLES OF<br />

HINDLIMB-UNLOADED MICE<br />

Digennaro C., Pierno S., Liantonio A., Giannuzzi V.,<br />

Camerino G., Dinardo M., Brocca L., Pellegrino M.,<br />

Bottinelli R., Desaphy J., Conte Camerino D. (Bari, Pavia)<br />

DISUSE-INDUCED SLOW-TWITCH MUSCLE IMPAIRMENT IS<br />

AMELIORATED BY IGF-1 OVEREXPRESSION IN HINDLIMB-<br />

UNLOADED TRANSGENIC MICE<br />

Pierno S., Liantonio A., Desaphy J., Digennaro C.,<br />

Giannuzzi V., Gramegna G., Dobrowolny G., Magnani E.,<br />

Rizzuto E., Musarò A., Conte Camerino D. (Bari, Rome)<br />

PHARMACOLOGICAL MODULATION OF THE ENZYMATIC<br />

PATHWAYS INVOLVED IN H2O2 ELEVATION LEADS TO<br />

NEUROPROTECTION IN EXPERIMENTAL ISCHEMIA<br />

Armogida M., Amantea D., Cucchiaroni M., Piccirilli S.,<br />

Guatteo E., Bagetta G., Mercuri N., Nistico R. (Rome,<br />

Rende)<br />

THE P2Y-LIKE GPR17 RECEPTOR PARTICIPATES IN<br />

OLIGODENDROCYTE POSTNATAL MATURATION AND<br />

REACTION TO ACUTE AND CHRONIC BRAIN INJURY<br />

Boda E., Mantovan T., Rosa P., Tempia F., Abbracchio<br />

MP., Buffo A. (Turin, Milan)<br />

THE CB1 AGONIST WIN55,212-2 REDUCES STRIATAL PKA<br />

HYPERACTIVITY AND TRPV1 RECEPTOR SENSITIVITY IN<br />

DYSKINETIC RATS<br />

Macheda T., Martinez A., Morgese M., Cassano T., Cuomo<br />

V., Giuffrida A. (San Antonio, Foggia, Rome)<br />

33<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/47<br />

P-1/1/48<br />

P-1/1/49<br />

P-1/1/50<br />

P-1/1/51<br />

P-1/1/52<br />

P-1/1/53<br />

P-1/1/54<br />

P-1/1/55<br />

MULTI-TARGET-DIRECTED LIGANDS: NEW HISTAMINE H3<br />

RECEPTOR ANTAGONISTS WITH ANTICHOLINESTERASE<br />

ACTIVITY<br />

Flammini L., Bertoni S., Saccani F., Incerti M., Morini G.,<br />

Ballabeni V., Barocelli E. (Parma)<br />

TEMPORAL ANALYSIS OF 17β-ESTRADIOL<br />

NEUROPROTECTIVE ACTIVITY AGAINST β-AMYLOID-<br />

INDUCED CELL DEATH IN ORGANOTYPIC HIPPOCAMPAL<br />

CULTURES<br />

Merlo S., Spampinato S., Canonico P. L., Sortino M.<br />

(Catania, Novara)<br />

APP OVEREXPRESSION AND ITS GRB2-MEDIATED<br />

SIGNALLING MODULATES MAPK ACTIVATION<br />

Nizzari M., Musso A., PasTurin M., Russo C., Florio T.<br />

(Genoa, Campobasso)<br />

PHARMACOLOGICAL ACTIVATION OF METABOTROPIC<br />

GLUTAMATE RECEPTOR SUBTYPE 1 DAMPENS SPIKE AND<br />

WAVE DISCHARGES IN THE WAG/RIJ RAT MODEL OF<br />

ABSENCE EPILEPSY<br />

Santolini I., Simonyi A., Molinaro G., Mairesse J.,<br />

Battaglia G., Bruno V., van Luijtelaar G., Ngomba R.,<br />

Nicoletti F. (Rome, Columbia, Pozzilli, Donders)<br />

A NOVEL PHARMACOLOGICAL ACTIVITY FOR THE ALPHA2-<br />

DELTA LIGANDS PREGABALIN AND GABAPENTIN: IN<br />

VITRO MODULATION OF ADULT NEUROGENESIS<br />

Valente M., Meneghini V., Francese M., Carraro L.,<br />

Canonico P. L., Grilli M. (Novara)<br />

BIOTELEMETRIC MONITORING OF STRIATAL<br />

NEUROCHEMISTRY AND BEHAVIOUR IN MPTP-INDUCED<br />

RAT MODEL OF PARKINSON’S DISEASE<br />

Puggioni G., Bazzu G., Spissu Y., Rocchitta G., Calia G.,<br />

Migheli R., Serra P. (Sassari)<br />

A NOVEL ROLE FOR THE RAGE-NF-KAPPAB AXIS IN ADULT<br />

SVZ NEUROGENESIS<br />

Meneghini V., Francese M., Carraro L., Valente M., Grilli<br />

M. (Novara)<br />

PROTECTIVE EFFECT OF TAT-PARKIN ON NEURONAL<br />

CELLS<br />

Grigoletto J., Zusso M., Debetto P., Negro A. (Padua)<br />

EFFECT OF REPEATED MPTP ADMINISTRATION ON<br />

STRIATAL ENERGY METABOLISM IN FREELY MOVING RATS<br />

Calia G., Migheli R., Rocchitta G., Puggioni G., Spissu Y.,<br />

Serra P. (Sassari)<br />

34<br />

P-1/1/56<br />

P-1/1/57<br />

P-1/1/58<br />

P-1/1/59<br />

P-1/1/60<br />

P-1/1/61<br />

P-1/1/62<br />

P-1/1/63<br />

P-1/1/64<br />

CYCLO-OXYGENASE ACTIVITY IN IMMORTALIZED<br />

HYPOTHALAMIC NEURONS GT1-7<br />

Mores N., Petrucci G., Errico S., Rugia S. (Rome, Chieti)<br />

DOMINANT ROLE OF INWARD RECTIFIERK + CHANNELS IN<br />

THE REGULATION OF CARBACHOL-INDUCED<br />

EPILEPTIFORM ACTIVITY IN RAT ENTORHINAL CORTEX<br />

Cataldi M., Avoli M. (Naples, Montreal, Rome)<br />

EXPOSURE TO RESTRAINT STRESS INCREASES NOP<br />

RECEPTOR GENE EXPRESSION IN THE CENTRAL<br />

AMYGDALA AND INCREASES THE ANXIOLYTIC-LIKE<br />

ACTION OF NOCICEPTIN<br />

Ubaldi M., De Guglielmo G., Ruggeri B., Soverchia L.,<br />

Kallupi L., Barbaro G., Massi M., Ciccocioppo R.<br />

(Camerino)<br />

SURFACE-DECORATED NANOPARTICLES AS DRUG<br />

DELIVERY AGENTS TO THE BRAIN<br />

Badiali L., Vergoni A., Tosi G., Ruozi B., Costantino L.,<br />

Bertolini A., Vandelli M., Forni F. (Modena)<br />

IN VITRO AND IN VIVO PHARMACOLOGICAL<br />

CHARACTERIZATION OF THE NEUROPEPTIDE S RECEPTOR<br />

ANTAGONIST SHA 68<br />

Ruzza C., Camarda V., Rizzi A., Trapella C., Pelà M.,<br />

Guerrini R., Regoli D., Salvadori S., Calò G. (Ferrara)<br />

NEUROPEPTIDE S EVOKES ANXIOLYTIC-LIKE EFFECTS IN<br />

RATS VIA NPSR SELECTIVE ACTIVATION<br />

Ruggieri V., Filaferro M., Romeno M., Guerrini R., Trapella<br />

C., Salvadori S., Rizzi A., Calò G., Vitale G. (Modena,<br />

Ferrara)<br />

NEUROPROTECTIVE EFFECTS OF ß-AMYLOID MONOMERS<br />

Giuffrida M., Caraci F., Pignataro B., Cataldo S., De Bona<br />

P., Bruno V., Molinaro G., Pappalardo G., Messina A.,<br />

Palmigiano A., Garozzo D., Nicoletti F., Rizzarelli E., Copani<br />

A. (Catania, Palermo, Rome, Pozzilli)<br />

IN VITRO PHARMACOLOGICAL CHARACTERIZATION OF<br />

GF-4, A NOVEL NON-PEPTIDE ANTAGONIST FOR THE<br />

NOCICEPTIN/ORPHANIN FQ RECEPTOR<br />

Molinari S., Trapella C., Fischetti C., Camarda V., Guerrini<br />

R., Salvadori S., Regoli D., Calò G. (Ferrara)<br />

CONJUGATED LINOLEIC ACID ISOMERS INDUCE ABC<br />

HALF-TRANSPORTER RELATIVE GENE EXPRESSION AND<br />

MODIFY PROTEIN PROFILE IN X- LINKED<br />

ADRENOLEUKODYSTROPHY<br />

35<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/65<br />

P-1/1/66<br />

P-1/1/67<br />

P-1/1/68<br />

P-1/1/69<br />

P-1/1/70<br />

P-1/1/71<br />

P-1/1/72<br />

Cappiello L., Iannone A., Banni S., Blasevich M., Della<br />

Casa L., Rossi E., Giordano E., Cordeddu L., Petroni A.<br />

(Milan, Modena, Cagliari)<br />

INHIBITION OF ENDOGENOUS DIPEPTIDYL PEPTIDASE-4<br />

IN ALZHEIMER’S PRONE MICE<br />

Di Filippo C., Marfella R., Ferraraccio F., Paolisso G., Rossi<br />

F., D'Amico M. (Naples)<br />

THE PARAVENTRICULAR NUCLEUS OF THE<br />

HYPOTHALAMUS IS A NEUROANATOMICAL SUBSTRATE<br />

FOR THE INHIBITION OF PALATABLE FOOD INTAKE BY<br />

NEUROPEPTIDE S<br />

Cannella N., Cifani C., Fedeli A., Braconi S., Economidou<br />

D., Kallupi M., Massi M., Ciccocioppo R. (Camerino)<br />

CONGENIC DA.WOKW FEMALES COULD BE SUITABLE<br />

MODELS TO ELUCIDATE THE GENETICS OF BINGE<br />

EATING?<br />

Micioni Di Bonaventura M., Cifani C., Wilke B., Massi M.,<br />

Polidori C., Kloting I. (Camerino, Karlsburg)<br />

SP PROTECTS CEREBELLAR GRANULE CELLS AGAINST β-<br />

AMYLOID-INDUCED APOPTOSIS BY DOWN-REGULATION<br />

AND REDUCED ACTIVITY OF KV4 POTASSIUM CHANNELS<br />

Marolda R., Pieri M., Amadoro G., Carunchio I., Ciotti M.,<br />

Possenti R., Zona C., Petrella C., Severini C. (Rome)<br />

STUDY OF BRAIN DERIVED NEUROTROPHIC FACTOR<br />

(BDNF) CONTENT CHANGE IN AN EXPERIMENTAL MODEL<br />

OF CHRONIC RENAL FAILURE<br />

Stiaccini G., Mannari C., Guidi A., Silvano E., Migliori M.,<br />

Scalori V., Giovannini L. (Pisa, L'Aquila, Lido di Camaiore)<br />

NF-KB P50 REGULATES ADULT NEUROGENESIS IN THE<br />

HIPPOCAMPUS BUT NOT IN THE OLFACTORY BULB<br />

Bortolotto V., Dellarole A., Francese M., Denis-Donini S.,<br />

Grilli M. (Novara, Milan)<br />

AGE-RELATED MODIFICATIONS OF DISTRIBUTION,<br />

SIGNALLING AND FUNCTION OF A1 ADENOSINE<br />

RECEPTORS IN THE BRAIN OF A RAT MODEL OF ABSENCE<br />

EPILEPSY<br />

Torelli E., D'Alimonte I., Citraro R., Russo E., Nargi E.,<br />

Buccella S., Di Iorio P., Giuliani P., Romeno S., Ballerini P.,<br />

Caciagli F., De Sarro G., Ciccarelli R. (Chieti, Catanzaro)<br />

METABOLOMICS OF ENERGY-LINKED ENZYMES IN<br />

LYMPHOCYTES FROM ACUTE STROKE PATIENTS<br />

Villa R., Devecchi E., Brera F., Pero G., Gorini A. (Pavia,<br />

Lodi, Milan)<br />

36<br />

P-1/1/73<br />

P-1/1/74<br />

P-1/1/75<br />

P-1/1/76<br />

P-1/1/77<br />

P-1/1/78<br />

P-1/1/79<br />

PHARMACOLOGICAL MANIPULATION OF DOPAMINERGIC<br />

RECEPTORS AND mGLU5 METABOTROPIC GLUTAMATE<br />

RECEPTORS INCREASES THE NUMBER OF INTRASTRIATAL<br />

TYROSINE HYDROXYLASE-POSITIVE CELLS IN NEONATAL<br />

MOUSE STRIATUM<br />

Fardone E., Bucci D., Busceti C., Biagioni F., Trabucco A.,<br />

Mastroiacovo F., Riozzi B., Gradini R., Battaglia G., Bruno<br />

V., Fornai F., Nicoletti F. (Pozzilli, Rome, Pisa)<br />

mGLU4 METABOTROPIC GLUTAMATE RECEPTOR-LIKE<br />

IMMUNOREACTIVITY IN THE CEREBROSPINAL FLUID OF<br />

PATIENTS WITH MULTIPLE SCLEROSIS AND MICE WITH<br />

EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS<br />

Notartomaso S., D'Amore V., Maione T., Fazio F.,<br />

Scarselli P., Di Costanzo A., Bellantonio P., Battaglia G.,<br />

Storto M., Bruno V., Gradini R., Ferraguti F., Nicoletti F.,<br />

Di Marco R. (Pozzilli, Campobasso, Rome, Innsbruck)<br />

PHARMACOLOGICAL ACTIVATION OF METABOTROPIC<br />

GLUTAMATE RECEPTOR SUBTYPE 4 IS PROTECTIVE<br />

AGAINST FOCAL TRANSIENT ISCHEMIA<br />

Bernabucci M., Mastroiacovo F., Moyanova S., Kortesca<br />

L., Mitreva R., Ngomba R., Battaglia G., Bruno V., Nicoletti<br />

F. (Pozzilli, Rome, Sofia)<br />

THE THALAMIC EXPRESSION OF CANNABINOID<br />

RECEPTORS IS REDUCED IN A RAT MODEL OF ABSENCE<br />

EPILEPSY<br />

Cianci S., Ngomba R., Gaetani S., van Rijn C., van<br />

Luijtelaar G., Colangeli R., Santolini I., Cuomo V., Nicoletti<br />

F. (Rome, Nijmegen, Pozzilli, Bari)<br />

AMITRIPTYLINE ANTIDEPRESSANT ACTIVITY IS MEDIATED<br />

BY ARTEMIN, A GLIAL NEUROTROPHIC-DERIVED FACTOR<br />

Ghelardini C., Vivoli E., Salvicchi A., Di Cesare Mannelli<br />

L., Schiavone N., Bartolini A. (Florence)<br />

SOCIAL MEMORY IMPAIRMENT IN A TRIPLE-TRANSGENIC<br />

MOUSE MODEL OF ALZHEIMER’S DISEASE IS<br />

ACCOMPAINED BY MONOAMINERGIC ALTERATIONS<br />

Romano A., Cassano T., Gaetani S., Laconca L., Macheda<br />

T., Righetti L., Cianci S., Morgese M., Mastrantonio T.,<br />

Oddo S., Laferla F., Cuomo V. (Rome, Foggia, San<br />

Antonio, Irvine, Bari)<br />

IDENTIFICATION AND IN VITRO CHARACTERIZATION OF<br />

THE NOVEL NEUROPEPTIDE S RECEPTOR ANTAGONIST<br />

[TBU-D-GLY 5 ]NPS<br />

Camarda V., Guerrini R., Marzola E., Trapella C., Rizzi A.,<br />

Ruzza C., Fiorini S., Reinscheid R., Regoli D., Salvadori S.,<br />

37<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/80<br />

P-1/1/81<br />

P-1/1/82<br />

P-1/1/83<br />

P-1/1/84<br />

P-1/1/85<br />

P-1/1/86<br />

P-1/1/87<br />

Calo' G. (Ferrara, Irvine)<br />

TRIMETHYLETHIAZOLINE-INDUCED ANXIETY AS A MODEL<br />

FOR THE STUDY OF THE MOLECULAR TARGETS OF<br />

PREGABALIN IN MICE<br />

Marchiafava M., Matrisciano F., Scaccianoce S., Busceti<br />

C., Biagioni F., Nasca C., Orlando R., Melchiorri D.,<br />

Nicoletti F. (Rome, Pozzilli, Catania)<br />

PRECONDITIONING BY NMDA AND DHPG INDUCES<br />

TOLERANCE WITH DIFFERENTIAL MECHANISMS IN RAT<br />

ORGANOTYPIC HIPPOCAMPAL SLICES EXPOSED TO<br />

EXCITOTOXICITY<br />

Scartabelli T., Gerace E., Zianni E., Landucci E., Gardoni<br />

F., Berlinguer-Palmini R., Mannaioni G., Moroni F., Di Luca<br />

M., Pellegrini-Giampietro D. (Florence, Milan)<br />

MICROARRAY ANALYSIS IN HIPPOCAMPUS OF RATS<br />

TREATED WITH ESCITALOPRAM IN THE CHRONIC ESCAPE<br />

DEFICIT MODEL OF DEPRESSION<br />

Caggia F., Alboni S., Valensisi C., Benatti C., Corsini D.,<br />

Ferrari F., Tagliafico E., Mendlewicz J., Tascedda F.,<br />

Brunello N. (Modena, Brussels)<br />

ROLE OF THE ENDOCANNABINOID SYSTEM IN A RAT<br />

ORGANOTYPIC HIPPOCAMPAL SLICE MODEL OF CEREBRAL<br />

ISCHEMIA<br />

Landucci E., Scartabelli T., Gerace E., Boscia F., Moroni<br />

F., Pellegrini-Giampietro D. (Florence, Naples)<br />

GUANOSINE INDUCES NEURONAL DIFFERENTIATION IN<br />

THE HUMAN NEUROBLASTOMA SH-SY5Y CELL LINE<br />

Zanette C., Dell'Ovo V., Traversa U., Florio C. (Trieste)<br />

GPR35 EXPRESSION AND MODULATION OF CAMP<br />

PRODUCTION AND INTRACELLULAR CA 2+<br />

CONCENTRATION IN CULTURED ASTROCYTES<br />

Masi A., Cavone L., Sili M., Cozzi A., Berlinguer Palmini<br />

R., Cosi C., Mannaioni G., Moroni F. (Florence)<br />

ACTIVATION OF TRPV4 CHANNELS REDUCE MIGRATION<br />

OF GN11 CELLS, A NEUROENDOCRINE MODEL FOR<br />

MIGRATION<br />

Fornarelli A., Zaninetti R., Tacchi S., Mesenzani O.,<br />

Ciarletta M., Distasi C., Cariboni A., Canonico P. L.,<br />

Caldarelli A., Genazzani A. (Novara, Milan)<br />

PPARγ MEDIATES CANNABIDIOL ANTIINFLAMMATORY AND<br />

NEUROPROTECTIVE EFFECTS IN AN IN VITRO MODEL OF<br />

ALZHEIMER’S DISEASE<br />

Scuderi C., Blasio A., Valenza M., Steardo A., De Filippis<br />

38<br />

P-1/1/88<br />

P-1/1/89<br />

P-1/1/90<br />

P-1/1/91<br />

P-1/1/92<br />

P-1/1/93<br />

P-1/1/94<br />

P-1/1/95<br />

D., Iuvone T., Esposito G., Steardo L. (Rome, Naples)<br />

LEPTOMENINGEAL STEM/PROGENITOR CELLS (LESC)<br />

FROM RATS OF DIFFERENT AGES: CHARACTERIZATION,<br />

IN VITRO EXPANSION AND ASSESSMENT OF NEURAL<br />

DIFFERENTIATION POTENTIAL<br />

Decimo I., Bifari F., Bersan E., Malpeli G., Bonetti B.,<br />

Pizzolo G., Krampera M., Chiamulera C., Fumagalli G.<br />

(Verona)<br />

ON THE ROLE OF POLY(ADP-RIBOSE)POLYMERASE-1 IN A<br />

IN VIVO MODEL OF BRAIN ISCHEMIC PRECONDITIONING<br />

Blasi F., Faraco G., Moroni F., Chiarugi A. (Florence,<br />

Rende)<br />

COMPARISON OF CIGUATOXINS AND BREVETOXINS<br />

POTENCY ON HUMAN VOLTAGE GATED SODIUM<br />

CHANNELS OF BRAIN AND PERIPHERAL SENSORY<br />

NEURONS EXPRESSED IN HUMAN EMBRYONIC KIDNEY<br />

CELLS<br />

Dell'Ovo V., Bottein M., Tubaro A., Ramsdell J. (Trieste,<br />

Charleston)<br />

CANNABINOID AND PPAR RECEPTORS: NOVEL TARGETS<br />

FOR THE TREATMENT OF LEVODOPA-INDUCED<br />

DYSKINESIAS<br />

Morgese M., Trabace L., Giuffrida A. (Foggia, San<br />

Antonio)<br />

SOLUBLE ΒETA-AMYLOID1-42 INDUCES DEPRESSIVE-LIKE<br />

BEHAVIOUR IN RATS<br />

Colaianna M., Tucci P., Cuomo V., Trabace L. (Foggia,<br />

Rome)<br />

SPECIFIC NPY-Y1 RECEPTOR DELETION IN Y5R<br />

CONTAINING NEURONS IMPAIRS ANXIOUS BEHAVIOUR<br />

BUT NOT FEEDING BEHAVIOUR<br />

Longo A., Oberto A., Bertocchi I., Mele P., Palanza P.,<br />

Sprengel R., Eva C. (Turin, Parma, Heidelberg)<br />

EFFECTS OF SYSTEMIC ADMINISTRATION OF THE<br />

ESSENTIAL OIL OF BERGAMOT ON GROSS BEHAVIOUR<br />

AND EEG POWER SPECTRA RECORDED FROM THE<br />

HIPPOCAMPUS AND CEREBRAL CORTEX OF RAT<br />

Rombolà L., Corasaniti M., Rotiroti D., Tassorelli C.,<br />

Sakurada S., Bagetta G., Morrone L. (Rende, Catanzaro,<br />

Pavia, Sendai)<br />

EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON<br />

DOPAMINE METABOLISM IN PC12 CELLS<br />

Spissu Y., Rocchitta G., Iaccarino C., Crosio C., Galiotto<br />

39<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/1/96<br />

P-1/1/97<br />

M., Desole M., Migheli R. (Sassari)<br />

TRANSCRIPTIONAL SIGNATURES IN<br />

NEURODEGENERATIVE DISEASES<br />

Diamanti D., Pollio G., Tarditi A., Remelli R., Terstappen<br />

G., Caricasole A. (Siena)<br />

HIGH AFFINITY AND LOW AFFINITY N-METHYL-D-<br />

ASPARTATE AUTORECEPTORS FACILITATE RESPECTIVELY<br />

EXOCYTOSIS AND CARRIER-MEDIATED RELEASE OF<br />

GLUTAMATE IN RAT HIPPOCAMPUS<br />

Summa M., Musante V., Raiteri M., Pittaluga A. (Genoa)<br />

40<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/2/1<br />

P-1/2/2<br />

P-1/2/3<br />

P-1/2/4<br />

P-1/2/5<br />

Poster Session<br />

P-1/2: RECEPTORS AND SIGNAL TRANSDUCTION<br />

MECHANISMS<br />

Poster Commission Members:<br />

President: Clementi F. (Milan)<br />

Members: Pizzi M. (Brescia), Taglialatela M.<br />

(Campobasso)<br />

THIAZOLIDINEDIONES ACTIVATE THE GLUCOCORTICOID<br />

RECEPTOR<br />

Tersigni M., Matthews L., Berry A., Ray D., Ianaro A.<br />

(Naples, Manchester)<br />

SONIC HEDGEHOG (SHH) INDUCES PROLIFERATION OF<br />

NEURAL PROGENITOR CELLS ISOLATED FROM RAT<br />

POSTNATAL CEREBELLUM<br />

Barbierato M., Soffia S., Zusso M., Negro A., Skaper S.,<br />

Trevisan L., Debetto P., Giusti P. (Padua)<br />

DEFICIENCY OF POLYCYSTIC KIDNEY DISEASE-1 GENE<br />

(PKD1) EXPRESSION INCREASES A3 ADENOSINE<br />

RECEPTORS IN HUMAN RENAL CELLS<br />

Varani K., Aguiari G., Vincenzi F., Tosi A., Gessi S.,<br />

Sacchetto V., Bogo M., Del Senno L., Borea PA. (Ferrara)<br />

THERMODYNAMIC ANALYSIS IN DRUG-RECEPTOR<br />

BINDING: THE A3 ADENOSINE RECEPTOR<br />

Vincenzi F., Varani K., Targa M., Tosi A., Gessi S., Merighi<br />

S., Borea P. (Ferrara)<br />

PHARMACOLOGICAL CHARACTERIZATION OF NOVEL<br />

ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE<br />

RECEPTORS<br />

Tosi A., Varani K., Romegnoli R., Vincenzi F., Targa M.,<br />

Preti D., Baraldi P., Borea PA. (Ferrara)<br />

P-1/2/6 A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-<br />

41<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/2/7<br />

P-1/2/8<br />

P-1/2/9<br />

P-1/2/10<br />

P-1/2/11<br />

P-1/2/12<br />

P-1/2/13<br />

INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN<br />

CANCER CELLS<br />

Simioni C., Merighi S., Gessi S., Varani K., Mirandola P.,<br />

Leung E., Maclennan S., Baraldi P., Borea PA. (Ferrara,<br />

Parma, Cary)<br />

L163,255, A SYNTHETIC GROWTH HORMONE<br />

SECRETAGOGUE, ALTERS CA 2+ HOMEOSTASIS AND<br />

MODULATES CELL VIABILITY OF SKELETAL MUSCLE<br />

Gramegna G., Liantonio A., Giannuzzi V., Conte Camerino<br />

D. (Bari)<br />

PERINATAL HYPOXIA IN NEONATAL AND ADULT BRAIN:<br />

P2X7 ACTIVITY AND GLUTAMATE RELEASE<br />

Barbieri R., Alloisio S., Cervetto C., Mazzotta M., Marcoli<br />

M., Maura G., Nobile M. (Genoa)<br />

ACTIVATION OF mGLU2/3 METABOTROPIC GLUTAMATE<br />

RECEPTORS NEGATIVELY REGULATES THE STIMULATION<br />

OF INOSITOL PHOSPHOLIPID HYDROLYSIS MEDIATED BY<br />

5-HT2A SEROTONIN RECEPTORS IN THE FRONTAL CORTEX<br />

OF LIVING MICE<br />

Molinaro G., Traficante A., Riozzi B., Di Menna L., Curto<br />

M., Pallottino S., Iacovelli L., Nicoletti F., Bruno V.,<br />

Battaglia G. (Perugia, Rome, Pozzilli)<br />

PRESYNAPTIC UROTENSIN RECEPTORS IN THE CERVICAL<br />

SPINAL MOTONEURONS: FACILITATION OF<br />

ACETYLCHOLINE RELEASE<br />

Cervetto C., Mazzotta M., Bruzzone F., Diaspro A.,<br />

Bianchini P., Vallarino M., Maura G., Leprince J., Vaudry<br />

H., Marcoli M. (Genoa, Mont-Saint-Aignan)<br />

C-TERMINAL DOMAIN REQUIREMENT FOR P2X7 RECEPTOR<br />

TO FUNCTION AS A CHANNEL/PORE FOR GLUTAMATE<br />

Mazzotta M., Cervetto C., Alloisio S., Nobile M., Maura G.,<br />

Marcoli M. (Genoa)<br />

SYNERGISTIC INHIBITION OF AGS GASTRIC CANCER CELL<br />

GROWTH BY COMBINED TREATMENT WITH SMALL<br />

MOLECULE RECEPTOR TYROSINE KINASE INHIBITORS<br />

AND/OR PROTEASOME INHIBITORS<br />

Damiano V., Troiani T., Piegari E., Russo R., Morgillo F.,<br />

Martinelli E., Ciardello F., Rossi F., Berrino L. (Naples)<br />

CYTOPLASMIC FES TYROSINE KINASE IS A DOWN-<br />

STREAM EFFECTOR OF THE INSULIN-LIKE GROWTH<br />

FACTORS (IGFS)/IGF-I RECEPTOR (IGF-IR) SYSTEM OF<br />

NEUROBLASTOMA CELLS<br />

Gnemmi I., Condorelli F., Canonico P. L. (Novara)<br />

42<br />

P-1/2/14<br />

P-1/2/15<br />

P-1/2/16<br />

IN NEUROBLASTOMA CELL LINES, CYTOPLASMIC FES<br />

TYROSINE KINASE LINKS THE INSULIN-LIKE GROWTH<br />

FACTOR-I RECEPTOR (IGF-IR) ACTIVATION TO STAT3-<br />

DEPENDENT ANTI-APOPTOTIC EFFECTS<br />

Sanzone S., Condorelli F., Canonico P. L. (Novara)<br />

CHARACTERIZATION OF THE ENZYME RESPONSIBLE FOR<br />

THE DEGRADATION OF THE SECOND MESSENGER NAADP<br />

Grolla A., Travelli C., Polzonetti V., Del Grosso E.,<br />

Billington R., Canonico P. L., Genazzani A. (Novara,<br />

Plymouth)<br />

A GENOME-SCALE RNAI SCREEN IDENTIFIES EFFECTORS<br />

OF FLT3-ITD IN ACUTE MYELOID LEUKEMIA<br />

Caldarelli A., Paskow-Rozas M., Mueller J., Koch S.,<br />

Kittler R., Genazzani A., Canonico P. L., Ding L., Kasper S.,<br />

Fisher T., Boehmer F., Buchholz F. (Novara, Dresden,<br />

Jena, Magdeburg)<br />

43<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/3/1<br />

P-1/3/2<br />

P-1/3/3<br />

P-1/3/4<br />

P-1/3/5<br />

Poster Session<br />

P-1/3: PHARMACOLOGY OF ION CHANNELS AND<br />

SYNAPTIC TRANSMISSION<br />

Poster Commission Members:<br />

President: Clementi F. (Milan)<br />

Members: Pizzi M. (Brescia),<br />

Taglialatela M. (Campobasso)<br />

ALTERED REGULATION OF GLUTAMATE RELEASE BY<br />

CANNABINOIDS AND DECREASED FUNCTIONAL ACTIVITY<br />

AND EXPRESSION OF GLT1 AND GLAST GLUTAMATE<br />

TRANSPORTERS IN THE HIPPOCAMPUS OF ADOLESCENT<br />

RATS PERINATALLY EXPOSED TO Δ 9 -THC<br />

Castaldo P., Magi S., Cataldi M., Arcangeli S., Capeci W.,<br />

Ferraro L., Tomasini MC., Antonelli T., Cassano T., Cuomo<br />

V., Amoroso S. (Ancona, Rome, Foggia, Naples, Ferrara)<br />

MECHANISMS OF GLYCINE RELEASE FROM MOUSE SPINAL<br />

CORD AND HIPPOCAMPAL GLYCINERGIC NERVE<br />

TERMINALS IN RESPONSE TO IDENTICAL DEPOLARIZING<br />

STIMULI<br />

Romei C., Luccini E., Raiteri L. (Genoa)<br />

NEUROPEPTIDE S INHIBITS THE RELEASE OF 5-HT AND<br />

NORADRENALINE FROM MOUSE FRONTAL CORTEX<br />

SYNAPTOSOMES<br />

Luccini E., Romei C., Salvadori S., Raiteri L. (Genoa,<br />

Ferrara)<br />

L-ASPARTATE AS AN AMINO ACID NEUROTRANSMITTER:<br />

MECHANISMS OF THE DEPOLARIZATION-INDUCED<br />

RELEASE FROM CEREBROCORTICAL SYNAPTOSOMES<br />

Cavallero A., Marte A., Fedele E. (Genoa)<br />

ALTERATIONS OF GLUTAMATE RELEASE IN THE SPINAL<br />

CORD OF MICE AFFECTED BY EXPERIMENTAL<br />

AUTOIMMUNE ENCEPHALOMYELITIS<br />

44<br />

P-1/3/6<br />

P-1/3/7<br />

P-1/3/8<br />

P-1/3/9<br />

P-1/3/10<br />

P-1/3/11<br />

P-1/3/12<br />

P-1/3/13<br />

Marte A., Cavallero A., Raiteri M., Uccelli A., Morando S.,<br />

Fedele E. (Genoa)<br />

VOLUME-REGULATED ANION CHANNELS IN RAT CORTICAL<br />

ASTROCYTES: INHIBITION BY CARBENOXOLONE<br />

Cervetto C., Benfenati V., Caprini M., Nicchia G., Rossi A.,<br />

Dovizio M., Mazzotta M., Marcoli M., Maura G., Alloisio S.,<br />

Nobile M., Ferroni S. (Genoa, Bari, Bologna)<br />

STIMULUS-SELECTIVE NEUROMODULATORY ACTION OF<br />

BETA-AMYLOID<br />

Mura E., Govoni S., Preda S., Frattini P., Giudici D., Grilli<br />

M., Lagomarsino F., Marchi M. (Pavia, Genoa)<br />

TYPE 1 CANNABINOID RECEPTOR (CB1R) AGONISTS<br />

PROMOTE RAT CEREBELLAR NEURAL PROGENITOR CELL<br />

PROLIFERATION THROUGH ACTIVATION OF THE ERK AND<br />

AKT PATHWAYS<br />

Soffia S., Barbierato M., Zusso M., Skaper S., Giusti P.,<br />

Debetto P. (Padua)<br />

EXPOSURE TO AN ENRICHED ENVIRONMENT SELECTIVELY<br />

INCREASES THE FUNCTIONAL RESPONSE OF THE<br />

PRESYNAPTIC NMDA RECEPTORS WHICH MODULATE<br />

NORADRENALINE RELEASE IN MOUSE HIPPOCAMPUS<br />

Grilli M., Zappettini S., Zanardi A., Lagomarsino F.,<br />

Pittaluga A., Zoli M., Marchi M. (Genoa, Modena)<br />

CALCIUM ACTIVATED K + CHANNEL AS A TARGET OF<br />

PROMPT-TO-USE DRUGS IN NEUROMUSCULAR<br />

DISORDERS<br />

Mele A., Carbonara G., Fracchiolla G., Loiodice F., Latorre<br />

R., Conte Camerino D., Tricarico D. (Bari, Valparaìso)<br />

MODULATION OF GLYCINE EXOCYTOSIS FROM MOUSE<br />

SPINAL CORD AND HIPPOCAMPUS GLYCINERGIC NERVE<br />

TERMINALS BY PRESYNAPTIC GABAB RECEPTORS<br />

Raiteri L., Luccini E., Romei C. (Genoa)<br />

CPVT –RELATED RYR2 MUTATION: IMPACT OF AN<br />

ARRHYTHMOGENIC DISORDER ON THE MECHANICAL<br />

PROPERTIES OF MYOCARDIUM. INSIGHTS FROM A<br />

TRANSGENIC MOUSE MODEL<br />

Coppini R., Ferrantini C., Poggesi C., Cerbai E. (Florence)<br />

DIFFERENTIAL REGULATION OF EXCITATORY AND<br />

INHIBITORY NEUROTRANSMITTER RELEASE BY LARGE-<br />

CONDUCTANCE CA 2+ - AND VOLTAGE-ACTIVATED K +<br />

(BKCA) CHANNELS<br />

Martire M., Panza E., Barrese V., Iannotti F., D'Amico M.,<br />

Calciano S., Viggiano D., Taglialatela M. (Rome, Naples,<br />

45<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/3/14<br />

P-1/3/15<br />

P-1/3/16<br />

Campobasso)<br />

FUNCTIONAL CONSEQUENCES OF BFNS-CAUSING<br />

MUTATION IN THE VOLTAGE SENSOR OF KV7.2 CHANNELS<br />

AND GATING CURRENTS FROM NEURONAL KV7 CHANNELS<br />

Miceli F., Soldovieri M., Cilio M., Bezanilla F., Taglialatela<br />

M. (Naples, Rome, Campobasso, Chicago)<br />

KV7 (KCNQ1-5) POTASSIUM CHANNEL SUBUNITS<br />

CONTROL SKELETAL MUSCLE PROLIFERATION,<br />

DIFFERENTIATION, AND RESPONSE TO MYOTOXIC<br />

INSULTS<br />

Iannotti F., Panza E., Barrese V., Viggiano D.,<br />

Taglialatela M. (Naples, Campobasso)<br />

LARGE SCREENING OF NEWLY SYNTHESIZED MEXILETINE<br />

AND TOCANIDE ANALOGS AS POTENT USE-DEPENDENT<br />

BLOCKERS OF SKELETAL MUSCLE SODIUM CHANNELS:<br />

IDENTIFICATION OF THE STRUCTURAL REQUIREMENTS<br />

FOR IMPROVING ANTIMYOTONIC ACTIVITY<br />

De Bellis M., De Luca A., Conte Camerino D., Lentini G.,<br />

Carocci A., Corbo F., Franchini C. (Bari)<br />

46<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/4/1<br />

P-1/4/2<br />

P-1/4/3<br />

P-1/4/4<br />

P-1/4/5<br />

P-1/4/6<br />

Poster Session<br />

P-1/4: CELL DEATH AND PROLIFERATION<br />

Poster Commission Members:<br />

President: Pepeu G. (Florence)<br />

Members: Abbracchio M. P. (Milan), Florio T. (Genoa)<br />

INHIBITION OF APOPTOSIS-DRIVEN REGRESSION OF<br />

HAIR BULB<br />

Carelli S., Traversa M. V., Giuliani G., Marzani B.,<br />

Benedusi A., Di Giulio A., Gorio A. (Milan, Rozzano)<br />

SIGNALING PATHWAYS INVOLVED IN THE APOPTOTIC<br />

ACTION OF OUABAIN IN TWO DIFFERENT CANCER CELL<br />

LINES<br />

Trenti A., Cusinato F., Bertoldo A., Luciani S., Trevisi L.<br />

(Padua)<br />

NEMO-BINDING DOMAIN PEPTIDE INDUCES APOPTOSIS<br />

IN HUMAN MELANOMA CELLS: AN EFFECT ASSOCIATED<br />

TO INHIBITION OF CONSTITUTIVE NF-KB ACTIVATION<br />

Ianaro A., Tersigni M., Belardo G., Naplestano M.,<br />

Ascierto P., Ialenti A. (Naples, Rome)<br />

INHIBITION OF DBTRG PROLIFERATION AND MIGRATION<br />

IN VITRO BY THC AND CANNABIDIOL: A CELLULAR BASIS<br />

FOR THE EFFECTS OF CANNABIS SATIVA ON<br />

GLIOBLASTOMA<br />

Fiore G., Montefrancesco G., Fiaschi A., Giorgi G.,<br />

Cerretani D. (Siena)<br />

EFFECTS OF BERGAMOT ESSENTIAL OIL BERGAPTENE-<br />

FREE IN CARRAGEENAN-INDUCED PAW OEDEMA IN RAT<br />

Navarra M., Mannucci C., Trapasso E., Pergolizzi S., Miceli<br />

N., Calapai G. (Messina)<br />

THE mGLU(5) RECEPTOR ANTAGONIST 2-METHYL-6-<br />

(PHENYLETHYNYL)PYRIDINE (MPEP) PROTECTS RAT<br />

LIVERS AGAINST WARM AND COLD ISCHEMIA INJURY<br />

47<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/4/6<br />

P-1/4/7<br />

P-1/4/8<br />

P-1/4/9<br />

P-1/4/10<br />

P-1/4/11<br />

P-1/4/12<br />

P-1/4/13<br />

P-1/4/14<br />

Ferrigno A., Rizzo V., Storto M., Riozzo B., Gregotti C.,<br />

Richelmi P., Nicoletti F., Vairetti M. (Pavia, Pozzilli, Rome)<br />

PROMOTER METHYLATION OF TSC2 GENE IS IMPORTANT<br />

FOR PATHOGENESIS OF TSC AND LAM LESIONS<br />

Ancona S., Lesma E., Sirchia S., Grande V., Chiaramonte<br />

E., Di Giulio A., Gorio A. (Milan)<br />

METHYLGUANIDINE INCREASES THE OXIDATIVE STRESS<br />

APOPTOSIS IN RAT GLIOMA CELL LINE<br />

Marzocco S., Popolo A., Bianco G., Pinto A., Autore G.<br />

(Fisciano)<br />

ROLE OF HMG-COA REDUCTASE INHIBITORS IN<br />

CONTROLLING TSC2 -/- ASM CELL GROWTH AND<br />

PROLIFERATION<br />

Grande V., Lesma E., Ancona S., Chiaramonte E., Di<br />

Giulio A., Gorio A. (Milan)<br />

ROLE OF SESTRIN2 IN THE INDUCTION OF AUTOPHAGY<br />

Maiuri M. C., De Stefano D., Carnuccio R., Kroemer G.<br />

(Villejuif, Naples)<br />

EFFECT OF BOTH STATINS AND FARNESYLTRANSFERASE<br />

INHIBITORS ON PRIMARY CULTURES OF NON SMALL<br />

LUNG CANCER CELLS PROLIFERATION<br />

Gallelli L., Falcone D., Santoro L., Pelaia G., Maselli R.,<br />

Savino R., De Sarro G. (Catanzaro, Naples)<br />

EARLY DEFECT OF TRANSFORMING GROWTH FACTOR β-1<br />

FORMATION IN HUNTINGTON’S DISEASE<br />

Riozzi B., Cannella M., Battaglia G., Orobello S., Maat-<br />

Schieman M., Aronica E., Busceti C., Ciarmiello A.,<br />

Sassone J., Ciammola A., Pouladi M., Hayden M., Sipione<br />

S., Bruno V., Nicoletti F., Squitieri F. (Pozzilli, Leiden,<br />

Amsterdam, La Spezia, Milan, Vancouver, Edmonton,<br />

Rome)<br />

IN VITRO BIOLOGICAL EFFECTS OF PISTACIA LENTISCUS<br />

ESSENTIAL OIL<br />

Casarin E., Buriani A., Fortinguerra S., Carrara M.<br />

(Padua)<br />

EXPRESSION AND FUNCTION OF SDF1 AND CXCR4 IN<br />

HUMAN NORMAL PITUITARY AND PITUITARY ADENOMAS:<br />

AN INSIGHT TO PUTATIVE HYPOPHYSEAL TUMOR STEM<br />

CELLS<br />

Barbieri F., Bajetto A., Pattarozzi A., Gatti M., Wurth R.,<br />

Mannino E., Florio T. (Genoa)<br />

P-1/4/15 COUNTER REGULATORY EFFECTS OF PKC DELTA AND<br />

48<br />

P-1/4/16<br />

P-1/4/17<br />

P-1/4/18<br />

P-1/4/19<br />

P-1/4/20<br />

P-1/4/21<br />

P-1/4/22<br />

P-1/4/23<br />

EPSILON ON ENDOTHELIAL NOS AND CELL DYSFUNCTION<br />

Monti M., Donnini S., Giachetti A., Mochly Rosen D., Ziche<br />

M. (Siena, Stanford)<br />

ANTIPROLIFERATIVE EFFECTS OF BERGAMOT JUICE ON<br />

SH-SY5Y HUMAN NEUROBLASTOMA CELLS<br />

Trapasso E., Ursino Maria Rita M., Calapai G., Navarra M.,<br />

Bramanti P. (Messina)<br />

PROTECTIVE ROLE OF RAPAMYCIN IN NEONATAL<br />

HYPOXIA-ISCHEMIA INDUCED BRAIN INJURY<br />

Carloni S., Girelli S., Buonocore G., Marzocchi B., Balduini<br />

W. (Urbino, Siena)<br />

SIMVASTATIN REDUCES HYPOXIA-ISCHEMIA INDUCED<br />

BRAIN DAMAGE IN THE IMMATURE RAT VIA AKT<br />

ACTIVATION AND REDUCTION OF INFLAMMATORY CELL<br />

RECRUITMENT<br />

Girelli S., Carloni S., Buonocore G., Longini M., Balduini<br />

W. (Urbino, Siena)<br />

NGF TREATMENT DECREASES THE INVASIVE CAPABILITY<br />

OF METASTATIC PROSTATE CANCER CELL LINES<br />

THROUGH THE MODIFICATION OF PROTEINS INVOLVED<br />

IN CELL MOTILITY AND ADHESION<br />

Bodei S., Bedussi F., Arrighi N., Zani D., Missale C.,<br />

Simeone C., Cosciani Cunico S., Spano P. F., Sigala S.<br />

(Brescia)<br />

EFFECTS OF FR235222 IN PROLIFERATION AND<br />

APOPTOSIS OF HUMAN LEUKAEMIA CELL LINES: ROLE OF<br />

ANNEXIN A1 AND ITS MEMBRANE LOCALIZATION<br />

D'Acunto C., Festa M., Parente L., Petrella A. (Salerno)<br />

THE SELECTIVE ENHANCER OF TYPE-4 METABOTROPIC<br />

GLUTAMATE RECEPTORS, PHCCC, REDUCES<br />

PROLIFERATION OF CULTURED RAT PANCREATIC DUCTAL<br />

CELLS<br />

Grimaldi A., Spinsanti P., De Vita T., Anastasi E., Nicoletti<br />

F., Melchiorri D. (Rome, Pozzilli)<br />

DIFFERENTIATION-ASSOCIATED LOSS OF RYANODINE<br />

RECEPTORS: A STRATEGY ADOPTED BY<br />

MONOCYTES/MACROPHAGES TO PREVENT THE DNA<br />

SINGLE-STRAND BREAKAGE INDUCED BY PEROXYNITRITE<br />

Guidarelli A., Cerioni L., Fiorani M., Cantoni O. (Urbino)<br />

DICKKOPF-1, AN ENDOGENOUS ANTAGONIST OF THE<br />

WNT PATHWAY, IS INCREASED IN THE SERUM AFTER<br />

BRAIN ISCHEMIA<br />

Mastroiacovo F., Busceti C., Biagioni F., Riozzi B., Storto<br />

49<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/4/24<br />

P-1/4/25<br />

P-1/4/26<br />

P-1/4/27<br />

P-1/4/28<br />

P-1/4/29<br />

P-1/4/30<br />

M., Bucci D., Pallottino S., Ottaviani S., Gradini R.,<br />

Battaglia G., Bruno V., Sobrado M., Nicoletti F. (Pozzilli,<br />

Rome, Madrid)<br />

EFFECTS OF PRAMIPEXOLE ON NEUROSPHERES:<br />

DIFFERENTIATION TOWARD THE NEURONAL AND GLIAL<br />

LINEAGE<br />

Spampinato S., Merlo S., Buerger E., Canonico P. L.,<br />

Sortino M. (Catania, Novara, Biberach an der Riss)<br />

CELECOXIB SYNERGIZES THE ANTI-LEUKEMIC EFFECTS<br />

OF IMATINIB BY INDUCING ENDOPLASMIC RETICULUM<br />

STRESS (ERS)-DEPENDENT AUTOPHAGY VIA NON-COX2<br />

TARGETS<br />

De Dominici M., Riva B., Condorelli F., Canonico P. L.<br />

(Novara)<br />

CHARACTERIZATION OF FK866, A NOVEL ANTICANCER<br />

AGENT TARGETING NAD METABOLISM, AND OF NEWLY<br />

SYNTHESISED CHEMICAL ANALOGUES<br />

Travelli C., Colombano G., Billington R., Grolla A., Galli<br />

U., Tron G., Condorelli F., Canonico P. L., Genazzani A.<br />

(Novara, Plymouth)<br />

DOWN-REGULATION OF RYANODINE RECEPTORS: A<br />

NOVEL STRATEGY ADOPTED BY<br />

MONOCYTES/MACROPHAGES TO COPE WITH<br />

PEROXYNITRITE, BASED ON PREVENTION OF<br />

MITOCHONDRIAL H2O2 FORMATION<br />

Cerioni L., Guidarelli A., Cantoni O. (Urbino)<br />

GSH-DEPENDENT REGULATION OF CA2+ MOBILIZATION<br />

FROM THE RYANODINE RECEPTOR IS OF PIVOTAL<br />

IMPORTANCE FOR PREVENTION OF DNA STRAND<br />

SCISSION AND FOR SURVIVAL OF ASTROCYTES EXPOSED<br />

TO PEROXYNITRITE<br />

Amadori A., Guidarelli A., Palomba L., Giordano G., Costa<br />

L., Cantoni O. (Urbino)<br />

EXPLOITATION OF THE ESSENTIAL OIL OF BERGAMOT IN<br />

CELL-CYCLE PROGRESSION, CELL PROLIFERATION AND<br />

VIABILITY STUDIES IN CULTURED HUMAN SH-SY5Y<br />

NEUROBLASTOMA CELLS<br />

Ciociaro A., Maida S., Russo R., Berliocchi L., Ragusa S.,<br />

Rotiroti D., Bagetta G., Corasaniti M. (Catanzaro, Cosenza)<br />

A NOVEL PHARMACOLOGICAL TARGET FOR IMMUNE-<br />

MEDIATED VASCULAR DISEASES: GENDER DIFFERENCES<br />

IN OXIDATIVE STRESS AND APOPTOSIS INDUCED BY<br />

AUTOANTIBODIES SPECIFIC TO RLIP76<br />

Ascione B., Colasanti T., Margutti P., Matarrese P.,<br />

Vacirca D., Malorni W., Ortona E. (Rome)<br />

50<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/5/1<br />

P-1/5/2<br />

P-1/5/3<br />

P-1/5/4<br />

P-1/5/5<br />

P-1/5/6<br />

Poster Session<br />

P-1/5: PAIN PHARMACOLOGY<br />

Poster Commission Members:<br />

President: Navarra P. (Rome)<br />

Members: Grilli M. (Novara), Nicoletti F. (Rome)<br />

BASAL EXPRESSION OF ENDOGENOUS OPIOID GENES IN<br />

MICE NEURONAL TISSUES INVOLVED IN PAIN CONTROL<br />

D'Addario C., Romaudi P., Candeletti S. (Bologna)<br />

ST JOHN’S WORT INDUCES A PROLONGED PROTEIN<br />

KINASE C-MEDIATED, OPIOID-RELATED<br />

ANTINOCICEPTION IN MICE<br />

Vivoli E., Galeotti N., Ghelardini C., Salvicchi A., Bartolini<br />

A. (Florence)<br />

ANTIHYPERALGESIC PROPERTY OF ST JOHN’S WORT IN A<br />

RAT MODEL OF NEUROPATHIC PAIN THROUGH A<br />

HYPERICIN-MEDIATED INHIBITION OF THE PROTEIN<br />

KINASE C, G AND E ACTIVITY<br />

Salvicchi A., Galeotti N., Ghelardini C., Vivoli E., Bartolini<br />

A. (Florence)<br />

A RAT MODEL OF NARCOTIC BOWEL SYNDROME<br />

Agostini S., Eutamene H., Broccardo M., Improta G.,<br />

Petrella C., Theodorou V., Bueno L. (Rome, Toulouse)<br />

PERITONITIS INDUCED HYPERNOCICEPTION DEPENDS ON<br />

SYSTEMIC RELEASE OF ENDOGENOUS BV8/PK2<br />

Nicotra A., Canestrelli M., Giannini E., Balboni G.,<br />

Salvadori S., Lattanzi R. (Rome, Ferrara)<br />

INVOLVEMENT OF CB1 RECEPTORS ON THE<br />

ANTINOCICEPTIVE EFFECT OF ACETYLSALICYLIC ACID IN<br />

TWO PAIN TESTS IN THE RAT<br />

Sandrini M., Vitale G., Ruggieri V., Filaferro M., Frigeri C.,<br />

Pini L. (Modena)<br />

51<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/5/7<br />

P-1/5/8<br />

P-1/5/9<br />

P-1/5/10<br />

P-1/5/11<br />

P-1/5/12<br />

P-1/5/13<br />

P-1/5/14<br />

INVOLVEMENT OF OPIOID AND CANNABINOID<br />

RECEPTORS IN THE OXYTOCIN-INDUCED<br />

ANTIHYPERALGESIC EFFECT FOLLOWING ICV<br />

ADMINISTRATION<br />

Russo R., La Rana G., Sasso O., D'Agostino G., Calignano<br />

A. (Naples)<br />

OXALIPLATIN-INDUCED NEUROPATHIC PAIN: GLIAL<br />

ACTIVATION AND CHARACTERISTIC NERVOUS TISSUE<br />

ALTERATION<br />

Di Cesare Mannelli L., Pacini A., Carovani M., Ghelardini<br />

C., Bartolini A. (Florence)<br />

ROLE OF P2Y RECEPTORS IN NEURON-GLIA SIGNALLING<br />

AND IN PAIN TRANSMISSION IN THE SPINAL TRIGEMINAL<br />

SYSTEM<br />

Villa G., Ceruti S., Fumagalli M., Colombo L., Verderio C.,<br />

Bhargava A., Jasmin L., Ohara P., Abbracchio M. P. (Milan,<br />

San Francisco, Los Angeles)<br />

EPIGENETIC CONTROL OF CHRONIC PAIN MECHANISMS<br />

Zammataro M., Copani A., Nicolai R., Nicoletti F.,<br />

Chiechio S. (Catania, Pomezia, Rome, Pozzilli)<br />

TRIGEMINAL GANGLION SATELLITE GLIAL CELLS CAN BE<br />

ACTIVATED UNDER PRO-INFLAMMATORY STIMULI AND<br />

INFLUENCE TRIGEMINAL NEURON ACTIVITY: RESULTS<br />

FROM A “SIMPLIFIED” IN VITRO MODEL OF NEURON-GLIA<br />

INTERACTION<br />

Capuano A., De Corato A., Lisi L., Tringali G., Navarra P.,<br />

Dello Russo C. (Rome)<br />

FUNCTIONAL INTERACTION BETWEEN TRPV1 AND µ-<br />

OPIOID RECEPTORS IN DESCENDING ANTINOCICEPTIVE<br />

PATHWAY ACTIVATES GLUTAMATE TRANSMISSION AND<br />

INDUCES ANALGESIA<br />

Guida F., Migliozzi A., Palazzo E., Scafuro A., Rossi F., Di<br />

Marzo V., Maione S. (Naples)<br />

GROUP III mGLUR7 AND mGLUR8 IN THE AMYGDALA<br />

DIFFERENTIALLY MODULATE NOCIFENSIVE AND<br />

AFFECTIVE PAIN BEHAVIOUR<br />

Palazzo E., De Chiaro M., Marabese I., Neugebauer V., de<br />

Novellis V., Maione S. (Naples, Galveston)<br />

METABOTROPIC GLUTAMATE RECEPTOR SUBTYPES 7 AND<br />

8 MEDIATE OPPOSITE EFFECTS ON GLUTAMATE RELEASE<br />

IN THE STRIATUM AND DECREASE NOCICEPTIVE<br />

RESPONSES IN NEUROPATHIC RATS<br />

Marabese I., Palazzo E., Rossi C., De Chiaro M.,<br />

52<br />

P-1/5/15<br />

P-1/5/16<br />

Soukupova M., Scafuro M., Maione S., de Novellis V.<br />

(Naples, Prague)<br />

THE AGONIST OF N-FORMYL PEPTIDE RECEPTORS FMLF<br />

AFFECTED OPIOID TOLERANCE<br />

Mastriota M., Colucci M., Pieretti S., Di Giannuario A.<br />

(Rome)<br />

PROTECTIVE EFFECTS OF ANTIOXIDANTS IN NITRIC<br />

OXIDE/COX2 INTERACTION DURING ACUTE<br />

INFLAMMATORY PAIN: THE ROLE OF NITRATION<br />

Dagostino C., Di Girolamo F., Crispo G., Guadagni F.,<br />

Costa N., Casale F., Ventrice D., Rizzo M., Mollace V.,<br />

Muscoli C. (Catanzaro, Rome, Catania)<br />

53<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/6/1<br />

P-1/6/2<br />

P-1/6/3<br />

P-1/6/4<br />

P-1/6/5<br />

P-1/6/6<br />

Poster Session<br />

P-1/6: DRUGS OF ABUSE<br />

Poster Commission Members:<br />

President: Navarra P. (Rome)<br />

Members: Grilli M. (Novara), Nicoletti F. (Rome)<br />

PRE-TREATMENT WITH K + CHANNEL BLOCKERS 4-AP AND<br />

TEA PREVENTS THE DEVELOPMENT OF OPIOID<br />

DEPENDENCE IN GUINEA-PIG ILEUM (GPI) UNMASKING<br />

OPIOID AND ADENOSINE A1 CONSTITUTIVE ACTIVITY<br />

Mhillaj E., Romenelli L., Valeri P., Palmery M. (Rome)<br />

BIOLOGICAL AND MOLECULAR EFFECTS OF HIGH DOSES<br />

OF ANABOLIC STEROIDS<br />

Piccione F., Abbadessa G., Cangemi L., De Francia S.,<br />

Esculapio P., Penna C., Tullio F., Portaleone P., Pagliaro P.,<br />

Di Carlo F., Racca S. (Orbassano, Turin)<br />

EFFECTS OF MDMA ON N/OFQ-NOPR SYSTEM USING IN<br />

VITRO AND IN VIVO APPROACHES<br />

Di Benedetto M., Cavina C., Candeletti S., Romualdi P.<br />

(Bologna)<br />

EFFECTS OF FENTANYL TREATMENT ON MOP AND NOP<br />

GENE EXPRESSION IN HUMAN NEUROBLASTOMA SH-SY5Y<br />

CELLS<br />

Cannarsa R., Candeletti S., Romualdi P. (Bologna)<br />

INDIVIDUALIZING NICOTINE REPLACEMENT THERAPY BY<br />

MEANS OF PLASMA NICOTINE AND COTININE ANALYSIS<br />

IN CIGARETTES’ SMOKERS<br />

Baraldo M., Feruglio M., Cojutti P., Savio S., Furlanut M.<br />

(Udine)<br />

INHIBITION OF FATTY ACID AMIDE HYDROLASE<br />

DIFFERENTIALLY AFFECT ETHANOL RELAPSE BEHAVIOUR<br />

IN WISTAR AND IN GENETICALLY SELECTED ALCOHOL<br />

54<br />

P-1/6/7<br />

P-1/6/8<br />

P-1/6/9<br />

P-1/6/10<br />

P-1/6/11<br />

P-1/6/12<br />

P-1/6/13<br />

P-1/6/14<br />

PREFERRING RATS<br />

Braconi S., Cippitelli A., Cannella N., Kallupi M., Ubaldi<br />

M., Salvucci C., Ciccocioppo R. (Camerino)<br />

NEUROPEPTIDE S FACILITATES ETHANOL SEEKING<br />

BEHAVIOUR THROUGH STIMULATION OF HYPOTHALAMIC<br />

HYPOCRETIN SYSTEM<br />

Cannella N., Kallupi M., Economidou D., Ruggeri B.,<br />

Ubaldi M., Massi M., Ciccocioppo R. (Camerino)<br />

REDUCTION OF ALCOHOL DRINKING AND ALCOHOL<br />

WITHDRAWAL-ASSOCIATED SYMPTOMS FOLLOWING<br />

ACTIVATION OF CENTRAL NOCICEPTIN/ORPHANIN FQ<br />

RECEPTORS<br />

Stopponi S., Braconi S., Economidou D., Cippitelli A.,<br />

Ubaldi M., Clementi S., Massi M., Ciccocioppo R.<br />

(Camerino)<br />

NEUROPETIDE S POTENTLY STIMULATES COCAINE-<br />

SEEKING BEHAVIOUR: AN EFFECT MEDIATED BY<br />

ACTIVATION OF THE HYPOTHALAMIC HYPOCRETIN<br />

SYSTEM<br />

Kallupi M., Cannella N., Economidou D., de Guglielmo G.,<br />

Ruggeri B., Massi M., Ciccocioppo R. (Camerino)<br />

NEUROPETIDE S RECEPTOR GENE EXPRESSION IN<br />

ALCOHOL WITHDRAWAL AND PROTRACTED ABSTINENCE<br />

IN POST-DEPENDENT RATS<br />

Ruggeri B., Braconi S., Cannella N., Kallupi M., Soverchia<br />

L., Ciccocioppo R., Ubaldi M. (Camerino)<br />

STRESS AND COCAINE INTERACT TO MODULATE BRAIN<br />

DERIVED NEUROTROPHIC FACTOR (BDNF) EXPRESSION<br />

IN RAT BRAIN<br />

Caffino L., Racagni G., Riva M., Fumagalli F. (Milan)<br />

CLINICAL MINIMAL INTERVENTION IN SMOKING<br />

CESSATION<br />

Russo G., Calzavara E., Carnì A., Mannucci C., Pieratti A.,<br />

Navarra M., Caputi A. P., Calapai G. (Messina)<br />

MODELING NATURAL RECOVERY FROM DRUG ABUSE<br />

Montefrancesco G., Mocenni C., Tiezzi S., Giorgi G.<br />

(Siena)<br />

THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-<br />

ALPHA AGONIST METHOLEOYLETHANOLAMIDE<br />

MODULATES NICOTINE EFFECTS IN THE BRAIN REWARD<br />

CIRCUIT IN THE RAT<br />

Lecca S., Luchicchi A., Carta S., Pillolla G., Pistis M.<br />

(Cagliari)<br />

55<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/6/15<br />

P-1/6/16<br />

DECLINE OF SMOKING AFTER A SMOKING BAN IN PUBLIC<br />

PLACES IN ITALY<br />

Grassi M., Enea D., Ferketich A., Lu B., Nencini P. (Rome)<br />

GROUP COUNSELING AND VARENICLINE FOR SMOKING<br />

CESSATION TREATMENT: A ONE-YEAR FOLLOW-UP STUDY<br />

Grassi M., Enea D., Pasquariello S., Marchetti R., Nencini<br />

P. (Rome)<br />

56<br />

THURSDAY, October 15, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-1/7/1<br />

P-1/7/2<br />

P-1/7/3<br />

P-1/7/4<br />

P-1/7/5<br />

P-1/7/6<br />

Poster Session<br />

P-1/7: AGING, BEHAVIOUR AND TOXICOLOGY<br />

Poster Commission Members:<br />

President: Cuomo V. (Rome)<br />

Members: Hrelia P. (Bologna), Marinovich M. (Milan)<br />

DULOXETINE IN THE TREATMENT OF BULIMIA NERVOSA:<br />

A CASE REPORT<br />

Capasso A., Siano C., Nolfe G., Petrella C., Milan L., Milan<br />

W. (Fisciano)<br />

CONFORMATIONALLY ALTERED P53: A POTENTIAL<br />

PREDICTIVE MARKER FROM MCI TO ALZHEIMER’S<br />

DISEASE?<br />

Stanga S., Lanni C., Uberti D., Mazzini G., Sinforiani E.,<br />

Memo M., Govoni S., Racchi M. (Pavia, Brescia)<br />

EFFECT OF ANTIOXIDANTS IN RATS TREATED WITH<br />

PYRETHROID INSECTICIDES<br />

Nasuti C., Gabbianelli R., Falcioni M., Sekar D.<br />

(Camerino)<br />

LIVER INJURY INDUCED BY TEUCRIUM CHAMAEDRYS<br />

INFUSION: AN ANALYSIS OF TWO RECIDIVOUS CASES<br />

Nencini C., Galluzzi P., Pippi F., Giorgi G., Micheli L.<br />

(Siena)<br />

NIVALENOL AND DEOXYNIVALENOL TRICHOTHECENES<br />

AFFECT J774A.1 MURINE MACROPHAGES VIABILITY<br />

Marzocco S., Russo R., Bianco G., Severino L., Autore G.<br />

(Fisciano, Naples)<br />

EFFECT OF AMYLOID-BETA PEPTIDES ON ZEBRAFISH<br />

(DANIO RERIO) EMBRYOS<br />

Cetti E., Solito R., Corti F., Santini R., Donnini S.,<br />

Giachetti A., Cotelli F., Ziche M. (Siena, Milan)<br />

57<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

P-1/7/7<br />

P-1/7/8<br />

P-1/7/9<br />

P-1/7/10<br />

P-1/7/11<br />

P-1/7/12<br />

P-1/7/13<br />

P-1/7/14<br />

IN VITRO EVALUATION ON THE ANTI-APOPTOTIC AND<br />

ANTI-OXIDANT EFFECT OF A SERIES OF NATURAL<br />

POLYPHENOLS ON UVB-IRRADIATED NORMAL HUMAN<br />

KERATINOCYTES AND MELANOCYTES<br />

Bruni E., Giudice S., Veratti E., Magnoni C., Benassi L.,<br />

Pellati F., Benvenuti S., Rossi T. (Modena)<br />

A MODEL OF BINGE EATING IN FEMALE RATS UNDER<br />

OPERANT SELF-ADMINISTRATION CONDITIONS<br />

Cifani C., Zanoncelli A., Tessari M., Righetti C., Di<br />

Francesco C., Micioni Di Bonaventura M., Ciccocioppo R.,<br />

Massi M., Melotto S. (Camerino, Verona)<br />

EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL<br />

DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE<br />

Alghisi M., Baiguera C., Pinna A., De Luca M., Benarese<br />

M., Monfardini S., Sarnico I., Morelli M., Spano P. F., Pizzi<br />

M. (Brescia, Cagliari)<br />

EMBRYONIC STEM CELLS AS A MODEL TO STUDY THE<br />

EFFECT OF ANTINEOPLASTIC DRUGS<br />

Suffredini S., Sartiani L., Stillitano F., Mugelli A., Cerbai<br />

E. (Florence)<br />

DRUG METABOLISM AND ANTIOXIDANT DEFENSE<br />

MODULATION-BASED ANTICANCER STRATEGY: “5 A DAY<br />

FOR A BETTER HEALTH” ALIMENTARY PLAN VERSUS<br />

MONO-COLOR VEGETARIAN DIETS<br />

Bonamassa B., Canistro D., Longo V., Messina A.,<br />

Lubrano V., Sapone A., Andeotti C., Costa G., Biagi G.,<br />

Paolini M. (Bologna, Pisa)<br />

ANTIMUTAGENICITY OF A SECOISOPIMARANE<br />

DITERPENOID FROM SALVIA CINNABARINA M. MARTENS<br />

ET GALEOTTI IN AMES TEST AND MICRONUCLEUS ASSAY<br />

ON CULTURED HUMAN LYMPHOCYTES<br />

Di Sotto A., Carbone F., Maffei F., Hrelia P., Mazzanti G.<br />

(Rome, Bologna)<br />

ACUTE ADMINISTRATION OF OLEOYLETHANOLAMIDE<br />

AFFECTS BEHAVIORAL SATIETY SEQUENCE IN MICE: A<br />

COMPARATIVE STUDY WITH RIMONABANT EFFECTS<br />

Righetti L., Romano A., Coccurello R., Dipasquale P.,<br />

Bellantuono S., D’Amato F., Cuomo V., Moles A., Gaetani<br />

S. (Rome)<br />

EFFECTS OF ESTROGENS AND GENISTEIN ON RAT<br />

URINARY BLADDER CONTRACTILITY AND THEIR<br />

NEUROPROTECTIVE ROLE AGAINST ISCHAEMIA AND<br />

REPERFUSION INJURY<br />

Valeri A., Sgaragli G., Valoti M., Pessina F. (Siena)<br />

58<br />

P-1/7/15<br />

P-1/7/16<br />

P-1/7/17<br />

P-1/7/18<br />

P-1/7/19<br />

P-1/7/20<br />

P-1/7/21<br />

P-1/7/22<br />

P-1/7/23<br />

P-1/7/24<br />

RAT INTESTINAL PRECISION-CUT SLICES AS TOOL TO<br />

STUDY XENOBIOTIC INTERACTIONS WITH TRANSPORT<br />

PROTEINS<br />

Franco G., Possidente M., Frosini M., Dragoni S., Valoti M.<br />

(Siena)<br />

TOXIC EFFECTS OF AIRBORNE PM10 ON PRIMARY<br />

CULTURE OF HUMAN CELLS<br />

Chirafisi J., Speciale A., Trombetta D., Cristani M.,<br />

Naccari C., Saija A., Cimino F. (Messina)<br />

THE MARINE TOXIN PALITOXIN EXERTS A POTENT<br />

CYTOTOXIC EFFECT ON HUMAN HACAT KERATINOCYTES<br />

Pelin M., Zanette C., Sosa S., Tubaro A., Florio C.<br />

(Trieste)<br />

ISOTHIOCYANATES AS POTENTIALS ALZHEIMER'S<br />

DISEASE-MODIFYING DRUGS<br />

Bolondi C., Tarozzi A., Merlicco A., Morroni F., Cantelli<br />

Forti G., Hrelia P. (Bologna)<br />

A NEW METHOD FOR NICOTINAMIDE MONONUCLEOTIDE<br />

(NMN) DETECTION IN VITRO AND IN VIVO REVEALS NEW<br />

ASPECTS OF NAD BIOCHEMISTRY AND PHARMACOLOGY<br />

Pittelli M., Formentini L., Moroni F., Chiarugi A. (Florence)<br />

EFFECTS OF CARBON NANOTUBES ON RAT MICROGLIAL<br />

CELLS<br />

Russier J., Fiorito S., Togna A., Latina V., Togna G.<br />

(Rome)<br />

EVALUATION OF CARDIOVASCULAR BIOMARKERS IN<br />

GROUPS OF SMOKERS AFTER A DECADE OF SMOKING<br />

Calapai G., Mannucci C., Bassi A., Morandi S., Gregg E.,<br />

Nunziata A., Caputi A. P. (Messina, Rome, Perugia,<br />

Southampton)<br />

AN ANALYSIS OF SIDE EFFECTS OF NATURAL PRODUCTS<br />

INVOLVING THE IMMUNE SYSTEM<br />

Nunziata A., Andreini I., Andreoli C., Calapai G. (Messina)<br />

EFFECTS OF DIETARY CHOLINE DEPRIVATION ON MOTOR<br />

SKILLS AND COGNITIVE FUNCTION IN THE RAT<br />

Massaro A., Coluccia A., Borracci P., Renna G., Carratù M.<br />

(Bari)<br />

GESTATIONAL EXPOSURE TO ALL-TRANS RETINOIC ACID:<br />

A LONGITUDINAL STUDY ON MOTOR SKILLS IN THE<br />

OFFSPRING OF SPRAGUE-DAWLEY RATS<br />

Massaro A., Coluccia A., Borracci P., Belfiore D., Carratù<br />

M. (Bari)<br />

59<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

4.00<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Arcobaleno – 4.00-4.30 pm<br />

PLENARY LECTURE<br />

Introduction: Meldolesi J. (Milan)<br />

HIGHLIGHTS ON SECOND MESSENGERS<br />

Pozzan T. (Padua)<br />

60<br />

THURSDAY, October 15, 2009<br />

Sala Arcobaleno – 4.45-6.45 pm<br />

Oral Communications<br />

PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 2)<br />

Chairpersons: Amoroso S. (Ancona), Biggio G. (Cagliari)<br />

4.45 pm NEUROPEPTIDE S RECEPTOR LIGANDS<br />

Calò G., Salvadori S., Rizzi A., Regoli D., Guerrini R.<br />

(Ferrara)<br />

5.00 pm THE EFFECTS OF OLEOYLETHANOLAMIDE ON FEEDING<br />

BEHAVIOUR INVOLVE HYPOTHALAMIC OXYTOCIN<br />

NEURONS<br />

Dipasquale P., Gaetani S., Fu J., Cassano T., Romano A.,<br />

Righetti L., Cianci S., Laconca L., Giannini E., Scaccianoce<br />

S., Piomelli D., Cuomo V. (Rome, Irvine, Foggia)<br />

5.15 pm NEUROTOXIC EFFECTS OF ANABOLIC-ANDROGENIC<br />

STEROIDS<br />

Caraci F., Pistarà V., Musumeci T., Corsaro A., Sortino M.,<br />

Nicoletti F., Copani A. (Catania, Pozzilli, Rome)<br />

5.30 pm EFFECT OF ADJUNCTIVE DULOXETINE TREATMENT ON THE<br />

PLASMA CONCENTRATIONS OF CLOZAPINE, OLANZAPINE<br />

AND RISPERIDONE IN PATIENTS WITH PSYCHOTIC<br />

DISORDERS<br />

D'Arrigo C., Santoro V., Migliardi G., Micò U., Muscatello<br />

M., Pandolfo G., Spina E. (Messina)<br />

5.45 pm ZIF268 GENE INVOLVEMENT IN MELANOCORTIN-INDUCED<br />

LONG-LASTING FUNCTIONAL RECOVERY FROM ISCHEMIC<br />

STROKE<br />

Giuliani D., Ottani A., Minutoli L., Di Stefano V.,<br />

Galantucci M., Bitto A., Altavilla D., Zaffe D., Botticelli A.,<br />

Squadrito F., Guarini S. (Modena, Messina, Pavia)<br />

6.00 pm INVOLVEMENT OF THE NADPH OXIDASE NOX2 IN THE<br />

DEVELOPMENT OF BEHAVIORAL AND PATHOLOGICAL<br />

ALTERATIONS IN ISOLATED RATS<br />

Schiavone S., Cuomo V., Trabace L., Krause K. (Rome,<br />

Geneva, Foggia)<br />

6.15 pm TRPV1 CHANNELS CONTROL SYNAPTIC PLASTICITY IN THE<br />

DEVELOPING SUPERIOR COLLICULUS<br />

Migliozzi A., Cristino L., Palazzo E., Di Marzo V., Salt T.,<br />

Maione S. (Naples, Pozzuoli, London)<br />

61<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

6.30 pm PALMITOYLETHANOLAMIDE, AN ENDOGENOUS PPAR-α<br />

AGONIST, MODULATES NEUROSTEROIDS DE NOVO<br />

SYNTHESIS<br />

Sasso O., La Rana G., Vitiello S., Russo R., D'Agostino G.,<br />

Iacono A., Cuzzocrea S., Piazza P., Meli R., Calignano A.<br />

(Naples, Bordeaux, Messina)<br />

62<br />

THURSDAY, October 15, 2009<br />

Sala Azzurra – 4.45-6.45 pm<br />

Oral Communications<br />

RECEPTORS AND SIGNAL TRANSDUCTION MECHANISMS<br />

(SESSION 1)<br />

Chairpersons: Florio T. (Genoa), Ziche M. (Siena)<br />

4.45 pm OXYTOCIN STIMULATES IN VITRO ANGIOGENESIS VIA A<br />

PYK-2/SRC–DEPENDENT MECHANISM<br />

Cattaneo M., Mazzolini S., Vicentini L. (Milan)<br />

5.00 pm REGULATION OF MITOCHONDRIAL DYNAMICS BY NITRIC<br />

OXIDE IS A KEY EVENT IN MYOGENESIS<br />

De Palma C., Falcone S., Pisoni S., Bassi M., Scorrano L.,<br />

Moncada S., Brunelli S., Clementi E. (Milan, Bosisio Parini,<br />

Padua, London)<br />

5.15 pm THE SELECTIVE ENHANCER OF mGLU4 METABOTROPIC<br />

GLUTAMATE RECEPTORS, PHCCC, REGULATES DENDRITE<br />

FORMATION BY AMPLIFYING THE EXPRESSION OF ORC3<br />

PROTEINS IN CULTURED CEREBELLAR GRANULE CELLS<br />

Cappuccio I., Colapicchioni C, Santangelo V., Sale P.,<br />

Bonelli M., Niccolini C., Nicoletti F., Melchiorri D. (Pavia,<br />

Rome, Pozzilli)<br />

5.30 pm PHARMACOLOGICAL CHARACTERIZATION OF PURINE<br />

RECEPTORS IN BOVINE FIBROBLAST-LIKE SYNOVIOCYTES<br />

Varani K., Vincenzi F., Tosi A., De Mattei M., Gessi S.,<br />

Merighi S., Caruso A., Borea P. A. (Ferrara)<br />

5.45 pm ROLE OF THE AKAP SCAFFOLDS AND THE UBIQUITIN-<br />

PROTEASOME PATHWAY IN THE PHYSIOLOGICAL<br />

RESPONSE TO BRAIN ISCHEMIA<br />

Carlucci A., Adornetto A., Scorziello A., Viggiano D.,<br />

Cuomo O., Annunziato L., Feliciello A. (Naples)<br />

6.00 pm PGE2 SYNERGIZES WITH FGF-2/FGFR1 PATHWAY TO<br />

ANGIOGENESIS<br />

Donnini S., Finetti F., Bocci E., Morbidelli L., Ziche M.<br />

(Siena)<br />

6.15 pm THE ENDOVANILLOID/ENDOCANNABINOID SYSTEM IN<br />

HUMAN OSTEOCLASTS<br />

Rossi F., Bellini G., Siniscalco D., Luongo L., De Petrocellis<br />

L., Petrosino S., Torella M., Santoro C., Nobili B., Perrotta<br />

S., Di Marzo V., Maione S. (Naples, Pozzuoli)<br />

63<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.15<br />

pm<br />

6.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Blu – 4.45-7.00 pm<br />

Symposium<br />

TEACHING PHARMACOLOGY IN THE MODERN EUROPE<br />

Chairpersons: Drago F. (Catania), Moilanen E. (Tampere)<br />

PHARMACOLOGY: FROM BASIC PRINCIPLES TO TRANSLATIONAL<br />

MEDICINE TO CLINICAL PRACTICE<br />

Theoharides T. (Boston - Athens)<br />

HOW CAN WE BEST PREPARE MEDICAL STUDENTS TO BE SAFE<br />

AND EFFECTIVE PRESCRIBERS?<br />

Maxwell S. (Edinburgh)<br />

TWO STEP EDUCATION IN MEDICAL PHARMACOLOGY IN<br />

GERMANY: EFFECTIVE SYLLABUS OR WASTE OF TIME<br />

Forstermann U. (Mainz)<br />

THE TEACHING OF PHARMACOLOGY IN ITALY: CURRENT<br />

PROBLEMS AND FUTURE PERSPECTIVES<br />

Mugelli A. (Florence)<br />

(Educational support from Sanofi-Aventis)<br />

FINAL TEST<br />

64<br />

4.45<br />

pm<br />

5.30<br />

pm<br />

6.15<br />

pm<br />

6.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Giardino d’Inverno – 4.45-7.00 pm<br />

Symposium<br />

NEW THERAPEUTIC PERSPECTIVES IN THE TREATMENT OF<br />

INVASIVE FUNGAL INFECTIONS: FROM PHARMACOLOGY TO THE<br />

CLINICAL EVIDENCE<br />

Chairpersons: Caputi A. P. (Messina), Mazzei T. (Florence)<br />

PHARMACOKINETIC PROFILE AS A TOOL FOR RATIONAL<br />

PRESCRIBING<br />

Mazzei T. (Florence)<br />

EVOLUTION IN THE TREATMENT OF INVASIVE FUNGAL<br />

INFECTIONS: THE ROLE OF ANIDULAFUNGIN<br />

Menichetti F. (Pisa)<br />

ANIDULAFUNGIN: CLINICAL EXPERIENCE IN THE TREATMENT OF<br />

FUNGAL INFECTIONS IN CRITICALLY ILL PATIENT<br />

Sganga G. (Rome)<br />

(Educational support from Pfizer Italia)<br />

FINAL TEST<br />

65<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

THURSDAY, October 15, 2009<br />

Sala Viola – 4.45-6.45 pm<br />

Oral Communications<br />

IMMUNOPHARMACOLOGY<br />

Chairpersons: Brunelleschi S. (Novara),<br />

Sacerdote P. (Milan)<br />

4.45 pm THERAPEUTIC KYNURENINES IN INFLAMMATION AND<br />

AUTOIMMUNITY<br />

Pallotta MT, Grohmann U., Volpi C., Orabona C., Vacca C.,<br />

Bianchi R., Belladonna ML., Puccetti P., Fioretti MC,<br />

Fallarino F. (Perugia)<br />

5.00 pm mGLU4 METABOTROPIC GLUTAMATE RECEPTOR<br />

NEGATIVELY REGULATES TH17 CELL-DRIVEN IMMUNE<br />

RESPONSES: A NEW TARGET FOR THE EXPERIMENTAL<br />

TREATMENT OF NEUROINFLAMMATORY AUTOIMMUNE<br />

DISORDERS<br />

Fazio F., Fallarino F., Notartomaso S., Busceti C., Volpi C.,<br />

Vacca C., Battaglia G., Bruno V., Nicoletti F., Grohmann U.,<br />

Di Marco R. (Pozzilli, Rome, Perugia, Campobasso)<br />

5.15 pm GITR ABLATION IN DENDRITIC CELLS MAKES T CELLS<br />

UNRESPONSIVE TO ACTIVATION IN AN IL-10-DEPENDENT<br />

MANNER<br />

Ronchetti S., Petrillo M., Bianchini R., Cannarile L.,<br />

Nocentini G., Riccardi C. (Perugia)<br />

5.30 pm NON-CANONICAL NF-κB AS A NOVEL TARGET FOR<br />

IMMUNOSUPPRESSION<br />

Volpi C., Fallarino F., Grohmann U., Puccetti P., Fioretti M.<br />

(Perugia)<br />

5.45 pm GLYCOGEN SYNTHASE KINASE 3BETA AS A TARGET FOR<br />

THE THERAPY OF INFLAMMATION, TRAUMA AND<br />

ISCHEMIA/REPERFUSION INJURY<br />

Genovese T., Di Paola R., Esposito E., Cuzzocrea S.<br />

(Messina)<br />

6.00 pm B7H TRIGGERING INHIBITS ADHESION OF HUMBILICAL<br />

VASCULAR ENDOTHELIAL CELLS TO COLON CARCINOMA<br />

CELL LINES AND POLYMORPHONUCLEAR CELLS<br />

Minelli R., Dianzani C. (Turin)<br />

66<br />

6.15 pm INVOLVEMENT OF NUCLEAR FACTOR KB ACTIVATION IN<br />

MODULATION OF APOPTOSIS BY AZIDOTHYMIDINE<br />

Macchi B., Matteucci C., Minutolo A., Balestrieri E., Grelli<br />

S., Mastino A. (Rome, Messina)<br />

66 67<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

4.45<br />

pm<br />

5.00<br />

pm<br />

5.15<br />

pm<br />

5.30<br />

pm<br />

5.45<br />

pm<br />

6.00<br />

pm<br />

6.15<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Arancione – 4.45-7.00 pm<br />

Symposium<br />

ROLE OF PURINOCEPTOR IN ACUTE AND CHRONIC INJURIES AT<br />

THE CENTRAL NERVOUS SYSTEM<br />

Chairpersons: Abbracchio M. P. (Milan), Pedata F. (Florence)<br />

A ROLE FOR THE P2Y-LIKE RECEPTOR GPR17 IN THE<br />

DEVELOPMENT OF TISSUE DAMAGE AND IN<br />

REMODELLING/REPAIR PROCESSES: A NEW SENSOR OF DAMAGE<br />

AND A POTENTIAL PHARMACOLOGICAL TARGET IN SPINAL CORD<br />

INJURY<br />

Ceruti S. (Milan)<br />

ACTIVATION OF MICROGLIA BY AMYLOID β REQUIRES P2X7<br />

RECEPTOR EXPRESSION<br />

Ferrari D. (Ferrara)<br />

A SELECTIVE ADENOSINE A2A RECEPTOR ANTAGONIST REDUCES<br />

JNK MAPK ACTIVATION IN OLIGODENDROCYTES AFTER<br />

CEREBRAL ISCHEMIA “IN VIVO”<br />

Melani A. (Florence)<br />

THE PRO-INFLAMMATORY ACTION OF MICROGLIAL P2<br />

RECEPTORS IS ENHANCED IN SOD1 MODELS FOR AMYOTROPHIC<br />

LATERAL SCLEROSIS<br />

D’Ambrosi N. (Rome)<br />

REMODELING OF STRIATAL NMDA RECEPTORS BY CHRONIC A2A<br />

RECEPTOR ACTIVATION OR BLOCKADE IN HUNTINGTON’S<br />

DISEASE MICE<br />

Martire A. (Rome)<br />

NEUROPROTECTION BY A2A RECEPTOR INACTIVATION,: ROLE OF<br />

FOREBRAIN AND GLIAL A2A RECEPTORS IN THE MPTP MOUSE<br />

MODEL OF PARKINSON'S DISEASE<br />

Morelli M. (Cagliari)<br />

NEUROLOGICAL SYNDROMES AND PURINE DISMETABOLISMS:<br />

NEW INSIGHT<br />

Tozzi M. G. (Pisa)<br />

68<br />

6.30<br />

pm<br />

6.45<br />

pm<br />

MICROPARTICLE RELEASE FROM REACTIVE GLIAL CELLS:<br />

POSSIBLE ROLE IN THE CONTROL OF NEURONAL ACTIVITY<br />

Verderio C. (Milan)<br />

FINAL TEST<br />

68 69<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.05<br />

pm<br />

6.25<br />

pm<br />

6.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Bianca – 4.45-7.00 pm<br />

Symposium<br />

NEW INSIGHTS ON THE PHARMACOLOGY AND TOXICOLOGY OF<br />

CANNABINOIDS<br />

Chairpersons: Cuomo V. (Rome), Tanganelli S. (Ferrara)<br />

MODULATORY ROLE OF CANNABINOIDS IN THE RESPONSE TO<br />

EMOTIONAL CHALLENGES<br />

Cuomo V. (Rome)<br />

SHORT AND LONG-TERM CONSEQUENCES OF GESTATIONAL<br />

EXPOSURE TO CANNABINOIDS ON RAT GLUTAMATE<br />

TRANSMISSION AND COGNITIVE FUNCTIONS<br />

Ferraro L. (Ferrara)<br />

THERAPEUTIC POTENTIAL OF THE ENDOCANNABINOID SYSTEM<br />

IN MAJOR DEPRESSION<br />

Rubino T. (Varese)<br />

LIPID RAFTS AS A PLATFORM FOR ENDOCANNABINOID<br />

SIGNALING<br />

Maccarrone M. (Rome)<br />

CANNABIS ABUSE: CLINICAL AND PRECLINICAL ASPECTS<br />

Fattore L. (Cagliari)<br />

FINAL TEST<br />

70<br />

THURSDAY, October 15, 2009<br />

Sala Verde – 4.45-6.45 pm<br />

Oral Communications<br />

GASTROINTESTINAL PHARMACOLOGY<br />

Chairpersons: Blandizzi C. (Pisa), Crema F. (Pavia)<br />

4.45 pm TLQP-21, A VGF-DERIVED PEPTIDE, STIMULATES<br />

EXOCRINE PANCREATIC SECRETION IN THE RAT<br />

Petrella C., Agostini S., Severini C., Linari G., Possenti R.,<br />

Broccardo M., Improta G. (Rome, Toulose)<br />

5.00 pm CONTROL OF COLONIC NEUROMUSCULAR FUNCTIONS BY<br />

A3 PURINERGIC RECEPTORS IN NORMAL COLON AND IN<br />

EXPERIMENTAL COLITIS<br />

Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M.,<br />

Giron M., Bin A., Zoppellaro C., Castagliuolo I., Gaion R.,<br />

Del Tacca M., Blandizzi C. (Pisa, Padua)<br />

5.15 pm THE NON-PEPTIDYL LOW MOLECULAR WEIGHT RADICAL<br />

SCAVENGER IAC PROTECTS RATS FROM DSS-INDUCED<br />

COLITIS<br />

Vasina V., Broccoli M., Ursino M., Soleti A., Paolini M., De<br />

Ponti F. (Bologna, Turin)<br />

5.30 pm IN VITRO ISCHAEMIA INCREASES PHOSPHORYLATION OF<br />

NMDA RECEPTOR NR1 SUBUNIT IN THE MYENTERIC<br />

PLEXUS OF THE GUINEA PIG ILEUM VIA PROTEIN KINASE C<br />

Giaroni C., Zanetti E., Oldrini R., Marchet S., Lorenzi T.,<br />

Moro E., Trinchera M., Crema F., Lecchini S., Frigo G.<br />

(Varese, Pavia)<br />

5.45 pm CANNABIDIOL CONTROLS INTESTINAL INFLAMMATION<br />

THROUGH THE MODULATION OF ENTERIC GLIAL CELLS.<br />

Iuvone T., De Filippis D., Esposito G., Cipriano M., Scuderi<br />

C., Cuomo R., De Man J., Steardo L. (Naples, Rome,<br />

Antwerp)<br />

6.00 pm EVALUATION OF ANTIULCER ACTIVITY OF THE<br />

ANTIOXIDANT COMPOUND IAC ON DIFFERENT<br />

EXPERIMENTAL ULCER MODELS IN RATS<br />

Carnevale G., Zanoli P., Corsi L., Geminiani E., Zavatti M.,<br />

Baraldi M. (Modena)<br />

6.15 pm A NEW MELANOCORTIN AGONIST REDUCES CERULEIN<br />

INDUCED PANCREATIC DAMAGE IN AN EXPERIMENTAL<br />

RAT MODEL<br />

71<br />

THURSDAY, October 15, 2009


THURSDAY, October 15, 2009<br />

Bitto A., Polito F., Minutoli L., Di Stefano V., Irrera N.,<br />

Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />

Squadrito F. (Messina, Modena)<br />

6.30 pm EFFECT OF CANNABIDIOL, A NON-PSYCHOTROPIC<br />

INGREDIENT OF CANNABIS SATIVA, ON DNBS-INDUCED<br />

COLITIS IN MICE<br />

Aviello G., Borrelli F., Romeno B., Capasso R., Maiello F.,<br />

Guadagno F., Petrosino S., Di Marzo V., Izzo A. (Naples,<br />

Pozzuoli)<br />

72<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.05<br />

pm<br />

6.25<br />

pm<br />

6.45<br />

pm<br />

THURSDAY, October 15, 2009<br />

Sala Rossa – 4.45-7.00 pm<br />

Symposium<br />

PHARMACOGENETICS: STATE-OF-THE-ART AND FUTURE<br />

Chairpersons: Clementi E. (Milan), Filippelli A. (Naples)<br />

THERAPEUTIC INNOVATION, DRUG DEVELOPMENT AND<br />

PHARMACOGENETICS<br />

Recchia G. (Verona)<br />

PHARMACOGENETICS IN ONCOLOGY<br />

Danesi R. (Pisa)<br />

GENETIC TESTING, GENOMIC BIOMARKERS AND PHARMACO<br />

GENETICS<br />

Novelli G. (Rome)<br />

PHARMACOGENETICS OF TRANSPLANT MEDICINE<br />

Cattaneo D. (Milan)<br />

THE COMPANY ‘S ROLE IN THE PERSONALIZED THERAPY<br />

Biondi F. (Jesi)<br />

FINAL TEST<br />

(Educational support from DiaTech)<br />

73<br />

THURSDAY, October 15, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Arcobaleno – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 3)<br />

Chairpersons: Brunello N. (Modena), Pizzi M. (Brescia)<br />

8.30 am PPAR-β/δ-MEDIATED PROTECTION IN RAT ORGANOTYPIC<br />

MODEL OF SPINAL CORD DAMAGE<br />

Esposito E., Paterniti I., Genovese T., Galuppo M., Meli R.,<br />

Bramanti P., Cuzzocrea S. (Messina, Naples)<br />

8.45 am ANTIDEPRESSANT PROPERTIES OF THE 5-HT4 RECEPTOR<br />

PARTIAL AGONIST, SL65.0155: BEHAVIORAL AND<br />

NEUROCHEMICAL STUDIES IN RATS<br />

Tamburella A., Micale V., Navarra A., Drago F. (Catania)<br />

9.00 am CORTISTATIN DISPLAYS EFFECTS OPPOSITE TO<br />

SOMATOSTATIN ON THE PRODUCTION AND RELEASE OF<br />

PROSTANOIDS FROM RAT CORTICAL MICROGLIA AND<br />

ASTROCYTES<br />

Tringali G., Dello Russo C., Navarra P. (Rome)<br />

9.15 am PLASMA CONCENTRATIONS OF OLANZAPINE DURING<br />

ADJUNCTIVE VALPROATE TREATMENT IN PATIENTS WITH<br />

BIPOLAR OR SCHIZOAFFECTIVE DISORDER<br />

Spina E., D'Arrigo C., Santoro V., Muscatello M., Pandolfo<br />

G., Zoccali R., Diaz F., de Leon J. (Messina, Medellin,<br />

Lexington)<br />

9.30 am MEMANTINE: POWERFUL ANTIMANIC AND MOOD<br />

STABILIZING EFFECT IN BIPOLAR DISORDER RESISTANT<br />

PATIENTS<br />

Koukopoulos A., Serra G. (Sassari, Rome)<br />

9.45 am HIPPOCAMPAL TRANSCRIPTIONAL PROFILES ASSOCIATED<br />

WITH VULNERABILITY AND RESILIENCE TO STRESS IN A<br />

BEHAVIOURAL MODEL OF DEPRESSION<br />

Tascedda F., Valensisi C., Caggia F., Alboni S., Benatti C.,<br />

Guidotti G., Blom J., Brunello N. (Modena)<br />

10.00 am PHARMACOLOGICAL MODULATION OF THE<br />

EXTRACELLULAR GLUTAMATE CHANGES INDUCED BY<br />

RETINAL ISCHEMIA/REPERFUSION IN RAT: TARGETS TO<br />

MINIMIZE RETINAL DAMAGE<br />

Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti<br />

M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />

74<br />

10.15 am PROTEIN KINASE C-DEPENDENT UP-REGULATION OF<br />

HUMAN MU-OPIOID RECEPTOR GENE (OPRM1)<br />

TRANSCRIPTION IS NEGATIVELY INFLUENCED BY THE<br />

TRANSCRIPTION FACTOR REST<br />

Bedini A., Baiula M., Spampinato S. (Bologna)<br />

75<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Azzurra – 8.30-10.30 am<br />

Oral Communications<br />

CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />

(SESSION 1)<br />

Chairpersons: Berrino L. (Naples), Geppetti P. (Florence)<br />

8.30 am OBESTATIN INDUCES CARDIOPROTECTION AND INHIBITS<br />

APOPTOSIS IN THE ISCHEMIC/REPERFUSED ISOLATED<br />

RAT HEART AND CULTURED CARDIOMYOCYTES<br />

Arnoletti E., Alloatti G., Ghè C., Muccioli G. (Turin)<br />

8.45 am PHARMACOLOGICAL DISSECTION OF SEXUAL HORMONES<br />

ACTIVITIES ON L-CYS/H2S PATHWAY IN ISOLATED RAT<br />

AORTA<br />

Bucci M., Vellecco V., De Gruttola L., Roviezzo F.,<br />

Brancaleone V., Cirino G. (Naples)<br />

9.00 am ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC<br />

BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL<br />

ATP-SENSITIVE POTASSIUM CHANNEL<br />

Calderone V., Testai L., Martelli A., Rapposelli S.,<br />

Digiacomo M., Balsamo A., Breschi M. (Pisa)<br />

9.15 am PLATELET BEHAVIOUR IN PATIENTS WITH DRUG-ELUTING<br />

STENTS AFTER THIENOPYRIDINE TREATMENT<br />

DISCONTINUATION<br />

Camera M., Trabattoni D., Villa D., Bartorelli A., Bogani<br />

P., Brambilla M., Tremoli E. (Milan)<br />

9.30 am OVEREXPRESSION OF CYCLO-OXYGENASE 2 (COX-2) IN<br />

ENDOTHELIUM MAY CONTRIBUTE TO VASCULAR<br />

PROTECTIVE EFFECTS OF ADIPONECTIN<br />

Nacci C., Tarquinio M., Addabbo F., Montagnani M. (Bari)<br />

9.45 am REDOX STATE, CELL FATE AND SEX DIFFERENCES IN<br />

VASCULAR SMOOTH MUSCLE CELLS<br />

Canu S., Straface E., Gambardella L., Vona R., Marino M.,<br />

Coinu R., Campesi I., Malorni W., Franconi F. (Rome,<br />

Sassari)<br />

10.00 am ROLE OF INFLAMMATION ON DENDRITIC CELL AND<br />

VASCULAR SMOOTH MUSCLE CELL INTERACTIONS<br />

Parenti A., Musilli C., Ledda F., Gerlini G., Borgognoni L.,<br />

Mugelli A. (Florence)<br />

76<br />

10.15 am MODULATORY ROLE OF THE NOCICEPTIN/ORPHANIN FQ-<br />

NOP RECEPTOR SYSTEM IN THE ALLERGEN-INDUCED<br />

AIRWAY HYPERRESPONSIVENESS<br />

Sullo N., Orlotti D., Matteis M., Russo M., D'Agostino B.,<br />

Rossi F. (Naples)<br />

77<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

9.50<br />

am<br />

10.10<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Blu – 8.30-10.30 am<br />

Symposium<br />

STEM CELLS FOR CARDIAC REPAIR: CURRENT STATUS AND<br />

FUTURE PERSPECTIVE<br />

Chairpersons: Cerbai E. (Florence), Rossi F. (Naples)<br />

STEM CELLS AND REGENERATIVE MEDICINE: POTENTIAL AND<br />

LIMITATIONS<br />

Galderisi U. (Naples)<br />

STRATEGIES FOR CARDIAC TISSUE REGENERATION AND<br />

ENGINEERING<br />

Jaconi M. (Geneva)<br />

EMBRYONIC STEM CELLS AS A MODEL FOR CARDIAC CELL<br />

DIFFERENTIATION AND MATURATION<br />

Sartiani L. (Florence)<br />

CARDIAC PROGENITOR CELLS AND DOXORUBICIN-INDUCED<br />

CARDIOMYOPATHY<br />

De Angelis A. (Naples)<br />

MESENCHYMAL STEM CELLS FOR CARDIAC REPAIR: FROM BENCH<br />

TO BEDSIDE<br />

Parini A. (Toulouse)<br />

(Educational support from Novartis Farma)<br />

78<br />

FRIDAY, October 16, 2009<br />

Sala Giardino d’Inverno – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />

(SESSION 1)<br />

Chairpersons: Caputi A. P. (Messina),<br />

Ferrazin F. (Rome)<br />

8.30 am RISK OF TORSADES DE POINTES WITH ANTIMICROBIALS:<br />

THE CONTRIBUTION FROM THE FDA ADVERSE EVENT<br />

REPORTING SYSTEM (AERS)<br />

Raschi E., Poluzzi E., Mortola D., Moretti U., De Ponti F.<br />

(Bologna, Verona)<br />

8.45 am ADVERSE DRUG REACTIONS INDUCED BY DRUG-DRUG<br />

INTERACTIONS: ANALYSIS OF A SPONTANEOUS<br />

REPORTING DATABASE<br />

Magro L., Conforti A., Moretti U., Donati M., Cutroneo P.,<br />

Moschini M., Motola D., Tuccori M., Leone R. (Verona,<br />

Messina, Florence, Bologna, Pisa)<br />

9.00 am PSYCHIATRIC SIDE EFFECTS OF PROTON PUMP<br />

INHIBITORS: A SIGNAL FROM THE ITALIAN<br />

PHARMACOVIGILANCE SYSTEM<br />

Cutroneo P., Russo A., Polimeni G., Borsellino L., Tuccori<br />

M., D'Incau P., Motola D., Scotto S., Venegoni M.,<br />

Sottosanti L., Pagano I., Conforti A., Caputi A. P. (Messina,<br />

Palermo, Pisa, Verona, Bologna, Milan, Rome)<br />

9.15 am SAFETY PROFILE OF FLUOROQUINOLONES: AN ANALYSIS<br />

ON ADVERSE DRUG REACTIONS (ADRS) RELATED TO<br />

PRESCRIPTION DATA<br />

Vannacci A., Motola D., Montanaro N., Tuccori M., Leoni<br />

O., Cocci A., Leone R., Conforti A., Mazzaglia G., Mugelli<br />

A., Lapi F., Mazzei T. (Bologna, Pisa, Milan, Cremona,<br />

Verona, Florence)<br />

9.30 am PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: AN<br />

EFFECT OF IMMUNODEFICIENCY OR AN ADVERSE DRUG<br />

REACTION?<br />

Piccinni C., Sacripanti C., Poluzzi E., Motola D., Magro L.,<br />

Moretti U., Conforti A., Montanaro N. (Bologna, Verona)<br />

9.45 am VACCINES PHARMACOVIGILANCE: DATA FROM THE<br />

ITALIAN SPONTANEOUS REPORTING SYSTEM<br />

Costantini D., Magro L., Opri S., Russo A., Lapi F., Biagi<br />

79<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

C., Cocci A., Magistro L., Moretti U. (Verona, Messina,<br />

Florence, Bologna, Milan)<br />

10.00 am NON VACCINE-RELATED ADVERSE DRUG REACTIONS IN<br />

CHILDREN: DATA FROM THE ITALIAN SPONTANEOUS<br />

REPORTING SYSTEM<br />

Opri S., Costantini D., Magro L., Cutroneo P., Lapi F.,<br />

Motola D., Tuccori M., Scotto S., Rivolta A., Velo G.<br />

(Verona, Messina, Florence, Bologna, Pisa, Milan)<br />

10.15 am TRENDS IN SPONTANEOUS ADVERSE DRUG REACTION<br />

REPORTS TO THE ITALIAN PHARMACOVIGILANCE SYSTEM<br />

(2001-2008)<br />

Sottosanti L., Potenza S., Rossi F., Venegoni M. (Rome,<br />

Naples)<br />

80<br />

8.30<br />

am<br />

8.45<br />

am<br />

9.00<br />

am<br />

9.15<br />

am<br />

9.30<br />

am<br />

9.50<br />

am<br />

10.10<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Viola – 8.30-10.30 am<br />

Symposium<br />

PURINE ACTIVITY IN PERIPHERAL CELLS<br />

Chairpersons: Borea P. A. (Ferrara), Caciagli F. (Chieti)<br />

DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF<br />

NEW A2B ADENOSINE ANTAGONISTS<br />

Baraldi P. G. (Ferrara)<br />

SYNERGISTIC ANTI-FIBROTIC EFFECT OF PURINERGIC AND<br />

CANNABINOID SYSTEM MODULATION IN HUMAN SCLERODERMIC<br />

FIBROBLASTS<br />

Castrichini M. (Siena)<br />

TRANSCRIPTIONAL PROFILE OF GTP-MEDIATED<br />

DIFFERENTIATION OF C2C12 SKELETAL MUSCLE CELLS<br />

Pietrangelo T. (Chieti)<br />

MECHANISMS UNDERLYING THE ANTI-INFLAMMATORY EFFECTS<br />

OF ADENOSINE DEAMINASE INHIBITORS IN EXPERIMENTAL<br />

COLITIS<br />

Fornai M. (Pisa)<br />

DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF NEW P2X3<br />

RECEPTOR LIGANDS<br />

Volpini R. (Camerino)<br />

EXPRESSION PROFILE AND PHARMACOLOGICAL EFFECTS OF<br />

ADENOSINE RECEPTORS IN MACROPHAGES AND FOAM CELLS<br />

Gessi S. (Ferrara)<br />

INVOLVEMENT OF THE PROTEASOME SYSTEM ACTIVATION IN<br />

THE ANTI-APOPTOTIC ACTIVITY OF GUANINE-BASED PURINES<br />

Tarozzi A. (Bologna)<br />

81<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Arancione – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOLOGY OF ION CHANNELS AND SYNAPTIC<br />

TRANSMISSION<br />

Chairpersons: Conte Camerino D. (Bari),<br />

Taglialatela M. (Campobasso)<br />

8.30 am MOLECULAR DETERMINANTS OF HUMAN VOLTAGE-GATED<br />

SODIUM CHANNELS BLOCKADE BY LUBELUZOLE<br />

Costanza T., Bruno C., Franchini C., Lentini G., Conte<br />

Camerino D., Desaphy JF. (Bari)<br />

8.45 am MASSIVE ENDOCYTOSIS (MEND) ACTIVATED BY CA 2+ AND<br />

POLYAMINES IN FIBROBLASTS AND CARDIAC MYOYCTES:<br />

DEPENDENCIES ON NUCLEOTIDES, PIP2, CHOLESTEROL,<br />

CLATHRIN, AND OTHER FACTORS<br />

Lariccia V., Hilgemann D. (Ancona, Dallas)<br />

9.00 am MASSIVE ENDOCYTOSIS (MEND) ACTIVATED BY CA 2+ AND<br />

POLYAMINES IN FIBROBLASTS AND CARDIAC MYOCYTES:<br />

OPTICAL STUDIES OF MEMBRANE AND NA + /CA 2+<br />

EXCHANGER (NCX1) INTERNALIZATION, THE POSSIBLE<br />

ROLE OF CA 2+ ACTIVATED TRANSGLUTAMINASE IN MEND,<br />

AND THE POSSIBLE FUNCTION OF MEND IN CARDIAC<br />

MYOCYTES<br />

Magi S., Yaradanakul A., Llaguno M., Lin M., Shen C., Fine<br />

M., Nicoll D., Hilgemann D. (Ancona, Dallas, Los Angeles)<br />

9.15 am SIGMA-1 (σ1) RECEPTOR MODULATION OF THE DOPAMINE<br />

TRANSPORTER (DAT) ACTIVITY IN A CELL MODEL<br />

Fazio N., Spampinato S. (Bologna)<br />

9.30 am SYNAPTIC LOCALIZATION OF GLUR1 IS REGULATED BY<br />

ADAM10 ACTIVITY AND N-CADHERIN CLEAVAGE<br />

Gardoni F., Malinverno M., Sala C., Carta M., Mulle C., Di<br />

Luca M. (Milan, Bordeaux)<br />

9.45 am MERGING AMYLOID-BETA CASCADE AND ACTIVITY-<br />

DEPENDENT PLASTICITY IN HIPPOCAMPUS: A POSSIBLE<br />

ROLE FOR ADAM10<br />

Marcello E., Gardoni F., Vara-Rivera H., Epis R., Cattabeni<br />

F., Giustetto M., Perez-Otaño I., Di Luca M. (Milan, Turin,<br />

Pamplona)<br />

10.00 am SYNAPTOPROTEOMIC ANALYSIS OF ANIMAL MODELS OF<br />

82<br />

DEPRESSION REVEALS INVOLVEMENT OF ENERGY<br />

METABOLISM PROTEINS<br />

Mallei A., Giambelli R., Tardito D., Mathè A., El K y A.,<br />

Gruber S., Vollmayr B., Gass P., Racagni G., Popoli M.<br />

(Milan, Stockholm, Heidelberg)<br />

83<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

8.30<br />

am<br />

9.15<br />

am<br />

10.00<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Bianca – 8.30-10.30 am<br />

SIC-<strong>SIF</strong> Symposium<br />

THE NEW ANTIMICROBIALS FULFILL THE NEEDS OF CLINICAL<br />

PRACTICE?<br />

Chairpersons: Mazzei T. (Florence), Scaglione F. (Milan)<br />

EPIDEMIOLOGY OF RESISTANCE: COMPARISION BETWEEN OLD<br />

AND NEW DRUGS<br />

Stefani S. (Catania)<br />

NEW ANTIBIOTICS: VALUE AND LIMITS<br />

Scaglione F. (Milan)<br />

THE NEW ANTIFUNGALS: VALUE AND LIMITS<br />

Novelli A. (Florence)<br />

84<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Verde – 8.30-10.30 am<br />

Symposium<br />

BRAIN DEVELOPMENT: INFLUENCE OF STRESS AND<br />

NEUROACTIVE STEROIDS<br />

Chairpersons: Concas A. (Cagliari), Serra M. (Cagliari)<br />

EFFECT OF DEVELOPMENTAL EXPOSURE TO LOW-DOSE<br />

ESTROGENIC ENDOCRINE DISRUPTORS ON EXPLORATION AND<br />

EMOTIONAL RESPONSES IN MICE<br />

Palanza P. (Parma)<br />

CHANGES IN NEUROACTIVE STEROID LEVELS, GABAA RECEPTOR<br />

PLASTICITY AND SENSITIVITY TO ANXIOLYTIC DRUGS INDUCED<br />

BY NEONATAL EXPOSURE TO ESTROGEN<br />

Concas A. (Cagliari)<br />

EFFECT OF MATERNAL CARE ON EMOTIONAL AND FEEDING<br />

BEHAVIOUR IN NPY-Y1R CONDITIONAL KNOCKOUT MICE<br />

Eva C. (Turin)<br />

CHANGES IN NEURONAL PLASTICITY AND ETHANOL SENSITIVITY<br />

BY JUVENILE SOCIAL ISOLATION STRESS<br />

Serra M. (Cagliari)<br />

85<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Rossa – 8.30-10.30 am<br />

Oral Communications<br />

PHARMACOLOGY OF METABOLISM, ENDOCRINE SYSTEM<br />

AND ERECTILE DYSFUNCTION (SESSION 1)<br />

Chairpersons: Cella S. (Milan), Cocchi D. (Brescia)<br />

8.30 am PKCß/HUR/VEGF PATHWAY AND ITS IMPLICATION IN<br />

DIABETIC RETINOPATHY<br />

Bucolo C., Amadio M., Drago F., Govoni S., Pascale A.<br />

(Catania, Pavia)<br />

8.45 am PALMITOYLETHANOLAMIDE INDUCES NEUROSTEROIDS<br />

SYNTHESIS IN C6 CELLS TROUGH PPAR-ALPHA<br />

DEPENDENT MECHANISM<br />

Mattace Raso G., Esposito E., Iacono A., D'Agostino G.,<br />

La Rana G., Sasso O., Russo R., Calignano A., Meli R.<br />

(Naples, Messina)<br />

9.00 am EFFECTS OF SOY ISOFLAVONE GENISTEIN AGLYCONE ON<br />

SKIN CHANGES INDUCED BY EXPERIMENTAL MENOPAUSE:<br />

A COMPARISON WITH ESTRADIOL AND RALOXIFENE<br />

Polito F., Marini H., Bitto A., Minutoli L., Di Stefano V.,<br />

Irrera N., Altavilla D., Calò M., Caputi A. P., Squadrito F.<br />

(Messina)<br />

9.15 am BRAIN-BODY METABOLIC PROGRAMMING AND<br />

FUNCTIONAL DERANGEMENT IN A TYPE-2 DIABETES<br />

MODEL IN MALE MICE: THE ROLE EXERTED BY OPIOID<br />

AND HPA SYSTEMS<br />

Loizzo S., Campana G., Spampinato S., Capasso A.,<br />

Fortuna A., Franconi F., Renzi P., Loizzo A. (Rome,<br />

Bologna, Salerno, Sassari)<br />

9.30 am PTH1-34 STIMULATION OF EARLY BONE FRACTURE<br />

HEALING<br />

Marino S., Portigliatti Barbos M., Barberis A., Di Carlo F.,<br />

Mognetti B. (Orbassano)<br />

9.45 am CHRONIC TRYPTOPHAN DEFICIENCY IMPAIRS BONE<br />

METABOLISM AND REDUCES BONE ACCRUAL IN GROWING<br />

RATS<br />

Sibilia V., Pagani F., Greco A., Guidobono F. (Milan)<br />

10.00 am THE PHYTOESTROGEN FERUTININ COUNTERACTS THE<br />

BONE LOSS INDUCED BY OVARIECTOMY IN RATS<br />

86<br />

Zavatti M., Zanoli P., Carnevale G., Bertoni L., Resca E.,<br />

Cavani F., Benelli A., Ferretti M., Palumbo C. (Modena)<br />

10.15 am ESTROGEN RECEPTOR BETA-1 STIMULATION BY<br />

AGLYCONE GENISTEIN REDUCES ENDOMETRIAL<br />

HYPERPLASIA IN PRE-MENOPAUSAL WOMEN: A<br />

RANDOMIZED DOUBLE-BLIND PLACEBO AND<br />

PROGESTERONE CONTROLLED STUDY<br />

Bitto A., Altavilla D., D'Anna R., Marini H., Squadrito F.<br />

(Messina)<br />

87<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

10.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Blu – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Spano P. F. (Brescia)<br />

PHARMACOLOGICAL MODULATION OF ENDOGENOUS<br />

NEUROGENESIS: IMPACT ON FUTURE TREATMENT OF<br />

NEUROPSYCHIATRIC DISORDERS<br />

Grilli M. (Novara)<br />

(Educational support from Pfizer Italia)<br />

88<br />

10.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Giardino d’Inverno – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Caputi A. P. (Messina)<br />

NEXT GENERATION OF GLP-1 ANALOGUES: LIRAGLUTIDE<br />

Nicolucci A. (Chieti)<br />

(Educational support from Novo Nordisk Farmaceutici)<br />

89<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

10.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Viola – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Mini E. (Florence)<br />

INNOVATION NEVER STOPS: TOWARDS THE SECOND<br />

GENERATION OF TARGETED CANCER MEDICINES<br />

Hilberg F. (Vienna)<br />

(Educational support from Boehringer Ingelheim Italia)<br />

90<br />

10.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Arancione – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Pepeu G. (Florence)<br />

MULTIPLE SCLEROSIS: FTY 720 (FINGOLIMOD)<br />

Nicoletti F. (Rome)<br />

(Educational support from Novartis Farma)<br />

91<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

10.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Bianca – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Viano I. (Novara)<br />

ECHINOCANDINS: PHARMACOLOGY OF A NEW CLASS OF<br />

SYSTEMIC ANTIFUNGAL DRUGS<br />

Scaglione F. (Milan)<br />

(Educational support from Astellas Pharma)<br />

92<br />

11.15<br />

am<br />

11.40<br />

am<br />

12.05<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Azzurra – 11.15 am-12.35 pm<br />

Symposium<br />

PHARMACOLOGICAL THERAPY OF ATRIAL FIBRILLATION: OLD<br />

DISAPPOINTMENTS, NEW HOPES<br />

Chairpersons: Mugelli A. (Florence), Rossi F. (Naples)<br />

HISTORICAL PERSPECTIVE OF ANTIARRHYTHMIC DRUGS: THE<br />

UNMET NEEDS<br />

Cerbai E. (Florence)<br />

CURRENT PHARMACOLOGICAL AND NON-PHARMACOLOGICAL<br />

TREATMENT OF ATRIAL FIBRILLATION AND DRONEDARONE<br />

Capucci A. (Ancona)<br />

FUTURE PERSPECTIVES OF DRONEDARONE USE IN CLINICAL<br />

CARDIOLOGY<br />

Perrone Filardi P. (Napoli)<br />

(Educational support from Sanofi-Aventis)<br />

93<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

11.15<br />

am<br />

11.45<br />

am<br />

12.15<br />

pm<br />

12.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Blu – 11.15 am-1.15 pm<br />

SINPF-<strong>SIF</strong> Symposium<br />

NEUROBIOLOGY AND PHARMACOLOGY OF PSYCHOSIS<br />

Chairpersons: Biggio G. (Cagliari), Canonico P. L. (Novara)<br />

NEUROBIOLOGY OF COGNITIVE FUNCTIONS<br />

Biggio G. (Cagliari)<br />

PHARMACOLOGICAL CHARACTERISTICS OF ZIPRASIDONE: A<br />

STARTING POINT FOR CLINICIANS<br />

Pani L. (Cagliari)<br />

FROM CLINICAL TRIAL TO REAL WORLD: THE UNMET NEEDS OF<br />

ATYPICAL ANTIPSYCHOTIC THERAPY<br />

Mencacci C., Cerveri G. (Milan)<br />

COGNITIVE PROCESSES AND SCHIZOPHRENIA<br />

Aguglia E. (Catania)<br />

(Educational support from Pfizer Italia)<br />

94<br />

11.15<br />

am<br />

11.45<br />

am<br />

12.15<br />

pm<br />

12.35<br />

pm<br />

12.55<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Giardino d’Inverno – 11.15 am-1.15 pm<br />

Symposium<br />

TYPE 2 DIABETES: THE PANDEMIC OF XXI CENTURY<br />

Chairpersons: Caputi A. P. (Messina), Cricelli C. (Florence)<br />

DIABETES EPIDEMIOLOGY IN ITALY: REGIONAL DATA FROM MNS<br />

PROJECT<br />

Nicolucci A. (Chieti)<br />

TREATMENT GUIDELINES, STANDARD OF CARE AND UNMET<br />

MEDICAL NEEDS<br />

Consoli A. (Chieti)<br />

OLD DRUGS AND NEW DRUGS: NOVEL THERAPEUTIC OPTIONS<br />

Cucinotta D., Russo G. T. (Messina)<br />

INDICATORS AND STANDARD OF CARE IN DIABETOLOGY:<br />

COMPARISON BETWEEN NATIONAL AND INTERNATIONAL DATA<br />

Mazzaglia G. (Florence)<br />

DIABETES COSTS IN ITALY: AN ECONOMIC ANALYSIS<br />

Mantovani L. (Naples)<br />

(Educational support from Bristol Myers Squibb and AstraZeneca)<br />

95<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

11.15<br />

am<br />

11.45<br />

am<br />

FRIDAY, October 16, 2009<br />

Sala Viola – 11.15 am-0.15 pm<br />

Symposium<br />

HEALTH TECHNOLOGY ASSESSMENT AND GOVERNANCE<br />

Chairpersons: Caputi A. P. (Messina), Preziosi P. (Rome)<br />

PRESCRIBING APPROPRIATENESS IN CLINICAL PRACTICE<br />

Pagliaro L. (Palermo)<br />

HTA: A MULTIDISCIPLINARY APPROACH TO CLINICAL<br />

GOVERNANCE<br />

Zappia M. (Palermo)<br />

(Educational support from GlaxoSmithKline)<br />

96<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/1/1<br />

P-2/1/2<br />

P-2/1/3<br />

P-2/1/4<br />

P-2/1/5<br />

Poster Session<br />

P-2/1: CARDIOVASCULAR AND PULMONARY<br />

PHARMACOLOGY<br />

Poster Commission Members:<br />

President: Brunelleschi S. (Novara)<br />

Members: Montuschi P. (Rome), Sala A. (Milan),<br />

Trabace L. (Foggia)<br />

METABOLITE I OF ERDOSTEINE POSSESSES A FREE<br />

RADICAL SCAVENGING ACTIVITY: ELECTRON<br />

PARAMAGNETIC RESONANCE (EPR) SPECTROSCOPY<br />

ANALYSIS<br />

Braga P., Culici M., Dal Sasso M., Falchi M., Spallino A.<br />

(Milan)<br />

TREATMENT OF SPONTANEOUSLY HYPERTENSIVE RATS<br />

(SHR) WITH ROSIGLITAZONE AMELIORATES<br />

CARDIOVASCULAR PATHOPHYSIOLOGY VIA ANTI-<br />

OXIDANT MECHANISMS IN THE VASCULATURE<br />

Potenza M., Gagliardi S., De Benedictis L., Quon M.,<br />

Montagnani M. (Bari, Bethesda)<br />

INTERACTION BETWEEN ENDOTHELIAL PRECURSOR<br />

CELLS AND VASCULAR WALL CELLS<br />

Musilli C., Ledda F., Mugelli A., Parenti A. (Florence)<br />

KIDNEY CLC-K CHLORIDE CHANNELS AS NEW TARGETS<br />

FOR ANTIHYPERTENSIVE AND DIURETIC DRUGS: EFFECT<br />

OF ACUTE IN VIVO ADMINISTRATION OF CLC-K<br />

BLOCKERS IN RATS<br />

Liantonio A., Gramegna G., Laghezza A., Fracchiolla G.,<br />

Loiodice F., Camerino G., Dinardo M., Mastrofrancesco L.,<br />

Lasorsa D., Procino G., Svelto M., Valenti G., Conte<br />

Camerino D. (Bari)<br />

THE NOVEL MELANOCORTIN MC4 RECEPTOR AGONIST PG-<br />

931 REVERSES HEMORRHAGIC SHOCK AND PREVENTS<br />

MULTIPLE ORGAN DAMAGE<br />

97<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/1/6<br />

P-2/1/7<br />

P-2/1/8<br />

P-2/1/9<br />

P-2/1/10<br />

P-2/1/11<br />

P-2/1/12<br />

P-2/1/13<br />

Galantucci M., Giuliani D., Ottani A., Zaffe D., Botticelli<br />

A., Grieco P., Novellino E., Jochem J., Guarini S. (Modena,<br />

Pavia, Naples, Bytom)<br />

EVIDENCE OF TLR-4 AND PAR2 RECEPTORS CROSS-TALK<br />

IN RAT VASCULAR REACTIVITY<br />

Vellecco V., Mattace Raso G., Brancaleone V., Roviezzo<br />

F., Bucci M., Cirino G. (Naples)<br />

BIOSYNTHESIS OF HYDROGEN SULPHIDE IS IMPAIRED IN<br />

DIABETIC CONDITIONS<br />

Brancaleone V., Roviezzo F., Vellecco V., De Gruttola L.,<br />

Bucci M., Cirino G. (Naples)<br />

PPAR-β/D ACTIVATION PROTECTS AGAINST RENAL<br />

ISCHEMIA/REPERFUSION INJURY IN DIABETIC RATS<br />

Collino M., Benetti E., Miglio G., Castiglia S., Rosa A.,<br />

Thiemermann C., Fantozzi R. (Turin, London)<br />

PPAR STIMULATION PROTECTS HUMAN PODOCYTES FROM<br />

SERUM DEPRIVATION-INDUCED CELL DEATH<br />

Miglio G., Rosa A., Rattazzi L., Benetti E., Collino M.,<br />

Fantozzi R. (Turin)<br />

THERAPEUTIC DRUG MONITORING: HYDROQUINIDINE<br />

ADMINISTRATION IN A NEWBORN INFANT WITH SHORT<br />

QT SYNDROME. A CASE REPORT<br />

Pirro E., De Francia S., Banaudi E., Riggi C., De Martino<br />

F., Piccione F., Di Carlo F. (Orbassano, Turin)<br />

A NOVEL NITRIC OXIDE RELEASING ANTI-DIABETIC DUAL<br />

DRUG: FROM THE DESIGN TO THE CHARACTERIZATION<br />

OF THE PHARMACOLOGICAL PROFILE<br />

Martelli A., Breschi M., Testai L., Balsamo A., Digiacomo<br />

M., Rapposelli S., Marchetti P., Torri S., Calderone V.<br />

(Pisa)<br />

MELANOCORTIN-INDUCED CARDIOPROTECTION AGAINST<br />

ISCHEMIA/REPERFUSION INJURY IS ASSOCIATED WITH A<br />

COUNTERACTION OF INFLAMMATORY AND APOPTOTIC<br />

RESPONSES<br />

Ottani A., Giuliani D., Galantucci M., Zaffe D., Botticelli<br />

A., Guarini S. (Modena, Pavia)<br />

NEUTROPHIL-DEPENDENT CEREBRAL OEDEMA IN MALE<br />

RAT: ROLE OF TRANSCELLULAR SYNTHESIS OF<br />

CYSTEINYL LEUKOTRIENES AND CYSLT2 RECEPTOR<br />

ACTIVATION<br />

Brivio I., Buccellati C., Di Gennaro A., Folco G., Sala A.<br />

(Milan, Stockholm)<br />

98<br />

P-2/1/14<br />

P-2/1/15<br />

P-2/1/16<br />

P-2/1/17<br />

P-2/1/18<br />

P-2/1/19<br />

P-2/1/20<br />

P-2/1/21<br />

P-2/1/22<br />

PRO-ANGIOGENIC ACTIVITY OF UROTENSIN-II ON<br />

CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS<br />

Sorato E., Albertin G., Spinazzi R., Mascarin A.,<br />

Oselladore B., Guidolin D., Giusti P. (Padua)<br />

POSSIBLE ROLE OF HYDROGEN SULPHIDE (H2S) IN THE<br />

ANTIHYPERTENSIVE EFFECT OF ZOFENOPRIL<br />

Bucci M., Vellecco V., Brancaleone V., De Gruttola L.,<br />

Roviezzo F., Evangelista S., Cirino G. (Naples, Florence)<br />

NBD PEPTIDE, A SELECTIVE INHIBITOR OF NF-κB,<br />

REDUCES NEOINTIMAL FORMATION IN A RAT MODEL OF<br />

VASCULAR INJURY<br />

Grassia G., Maddaluno M., Maffia P., Musilli C., Parenti A.,<br />

De Stefano D., Carnuccio R., Ianaro A., Grieco P., Ialenti<br />

A. (Naples, Strathclyde, Florence)<br />

ENDOTHELIAL PROTECTIVE EFFECTS OF ACE INHIBITORS:<br />

WHAT’S BEYOND?<br />

Morbidelli L., Donnini S., Terzuoli E., Pezzatini S., Ziche<br />

M. (Siena)<br />

A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL<br />

STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE<br />

Zanotti I., Pedrelli M., Calabresi L., Kempen H., Bernini F.<br />

(Parma, Milan, Basel)<br />

PROBUCOL ABOLISHES MEMBRANE RUFFLING AND<br />

RESTORES CELLULAR MIGRATION INDUCED BY FREE<br />

CHOLESTEROL IN MACROPHAGES FOAM CELLS<br />

Favari E., Adorni M., Granata A., Corsini A., Ronda N.,<br />

Gatti R., Bernini F. (Parma, Milan)<br />

STATIN AND FIBRATE TIME-DEPENDENTLY AFFECT THE<br />

CLC-1 CHLORIDE CHANNEL FUNCTION AND EXPRESSION<br />

AND MODIFY THE PROTEOMIC PROFILE IN RAT SKELETAL<br />

MUSCLE<br />

Camerino G., Pierno S., Digennaro C., Dinardo M.,<br />

Pellegrino M., George A., Bottinelli R., Conte Camerino D.<br />

(Bari, Pavia, Nashville)<br />

PALMITOYLETHANOLAMIDE RELAXES THE BOVINE<br />

OPHTHALMIC ARTERY THROUGH PEROXISOME<br />

PROLIFERATOR-ACTIVATED RECEPTORS (PPARS) IN<br />

ENDOTHELIUM-INDEPENDENT MANNER<br />

Lograno M., Romeno MR. (Bari)<br />

CARDIAC DEVELOPMENT REGULATES MEMBRANE LIPID<br />

RAFTS AND HYPERPOLARIZATION-ACTIVATED CYCLIC<br />

NUCLEOTIDE GATED CHANNELS<br />

Spinelli V., Del Lungo M., Sartiani L., Cerbai E. (Florence)<br />

99<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/1/23<br />

P-2/1/24<br />

P-2/1/25<br />

P-2/1/26<br />

P-2/1/27<br />

P-2/1/28<br />

P-2/1/29<br />

P-2/1/30<br />

P-2/1/31<br />

ADENOSINE MODULATES NO RELEASE IN EXPERIMENTAL<br />

INFLAMMATION MODEL OF RAT VASCULAR SMOOTH<br />

MUSCLE CELLS<br />

Malorgio F., Cignarella A., Bolego C., Pelosi V., Gaion R.<br />

(Padua)<br />

EFFECT OF PROBUCOL DERIVATE SUCCINOBUCOL (AGI-<br />

1067) ON CELLULAR CHOLESTEROL EFFLUX PATHWAYS<br />

Adorni M., Stocker R., Bernini F., Favari E. (Parma,<br />

Sydney)<br />

PROTECTIVE EFFECT OF DMSO ON ACUTE MYOCARDIAL<br />

INFARCTION IN RATS<br />

Gargiulo L., Parisi A., Alfieri A., Mascolo N., Cicala C.<br />

(Naples)<br />

COX-1 AND COX-2 COOPERATE TOWARD THE SYNTHESIS<br />

OF PROSTACYCLIN IN HUMAN ENDOTHELIAL CELLS<br />

THROUGH THE MODIFICATION OF HYDROPEROXIDE TONE<br />

Bolego C., Buccellati C., Folco G., Gaion M., Sala A.<br />

(Padua, Milan)<br />

LOW-DOSE NAPROXEN AND THE ANTIPLATELET EFFECT<br />

OF ASPIRIN IN HEALTHY SUBJECTS<br />

Anzellotti P., Capone M., Tontodonati P., Grossi L., Bruno<br />

A., Tacconelli S., Patrignani P. (Chieti)<br />

DENTAL PULP DERIVED MESENCHYMAL STEM CELLS IN<br />

MYOCARDIAL INFARCTION EXPERIMENTAL MODELS:<br />

PRELIMINARY RESULTS<br />

Di Scipio F., Sprio A., Folino A., Salamone P., Rastaldo R.,<br />

Pagliaro P., Di Carlo F., Berta G. (Orbassano)<br />

RESIDUAL THROMBOXANE BIOSYNTHESIS IS<br />

ASSOCIATED WITH PLATELET ACTIVATION IN HIGH RISK<br />

PATIENTS TREATED WITH LOW-DOSE ASPIRIN<br />

Grossi L., Meneguzzi A., Capone M., Evangelista V.,<br />

Levantesi G., Porreca E., Di Febbo C., Ferraro R.,<br />

Tontodonati P., Manarini S., Moretta V., Fava C., Minuz P.,<br />

Patrignani P. (Chieti, Verona, Vasto, Santa Maria Imbaro)<br />

ANGIOTENSIN II SUBTYPE-2-RECEPTOR STIMULATION<br />

PROVIDES END-ORGAN PROTECTION IN STROKE-PRONE<br />

RATS<br />

Gelosa P., Pignieri A., Castiglioni L., Fandriks L., de<br />

Gasparo M., Hallberg A., Turolo L., Tremoli E., Sironi L.<br />

(Milan, Goteborg, Rossemaison, Uppsala)<br />

THE ACE INHIBITOR CAPTOPRIL PARTIALLY RESTORES<br />

THE EFFICACY OF POSTCONDITIONING IN HYPERTENSIVE<br />

100<br />

P-2/1/32<br />

P-2/1/33<br />

P-2/1/34<br />

P-2/1/35<br />

P-2/1/36<br />

P-2/1/37<br />

P-2/1/38<br />

P-2/1/39<br />

RAT HEARTS.<br />

Penna C., Marino S., Tullio F., Folino A., Moro F., Mognetti<br />

B., Pagliaro P. (Turin)<br />

REMODELING OF PERIPHERAL RESISTANCE ARTERIES IN<br />

MICE WITH HYPERTENSION INDUCED BY ANGIOTENSIN II<br />

INFUSION: ROLE OF CYCLOOXYGENASE-1<br />

Rugani I., Virdis A., Daghini E., Duranti E., Colucci R.,<br />

Fornai M., Basolo F., Blandizzi C., Del Tacca M., Taddei S.<br />

(Pisa)<br />

ROLE OF P2 RECEPTORS IN A CARDIOMYOCYTES<br />

ISCHEMIC HYPOXIA MODEL<br />

Cosentino S., Barcella S., Luo H., Burbiel J., Muller C.,<br />

Tremoli E., Banfi C., Abbracchio MP. (Milan, Bonn)<br />

ANTIARRHYTHMIC EFFECT OF ACUTE OXYGEN-OZONE<br />

ADMINISTRATION TO RATS<br />

Di Filippo C., di Ronza C., Rossi C., Cervone C., Marfella<br />

R., Lettieri B., Luongo C., Rossi F., D'Amico M. (Naples)<br />

MYOCARDIAL RECRUITMENT OF ENDOTHELIAL<br />

PROGENITOR CELLS FOLLOWING ADMINISTRATION OF<br />

OXYGEN/OZONE MIXTURE IN INFARCTED RAT HEART<br />

Di Filippo C., Rossi C., di Ronza C., Cervone C., Luongo<br />

C., Ferraraccio F., Lettieri B., Rossi F., D'Amico M. (Naples)<br />

LONG TERM INCUBATION WITH β-AMYLOID PEPTIDES<br />

IMPAIRS ENDOTHELIUM-DEPENDENT VASODILATATION<br />

AND eNOS PHOSPHORYLATION (AT SERINE 1177) IN<br />

ISOLATED RAT BASILAR ARTERY<br />

Salomone S., Chisari M., Merlo S., Sortino M. (Catania)<br />

ROLE OF CALPAIN IN DOXORUBICIN CARDIOTOXICITY IN<br />

VIVO: EFFECTS OF DIFFERENT EXPOSURE TIMES TO THE<br />

SAME CUMULATIVE DOSE<br />

Vitelli M., Piegari E., Leone L., Costantino S., Marino L.,<br />

Rossi F., Berrino L. (Naples)<br />

PERIPHERAL BLOOD BIOMARKERS OF METABOLIC<br />

SYNDROME: A GENDER PERSPECTIVE<br />

Straface E., Gambardella L., Gabrielli N., Metere A.,<br />

Mattatelli A., Labbadia A., Canali E., Agati L., Malorni W.<br />

(Rome)<br />

LOSARTAN COUNTERACTS THE HYPER-REACTIVITY TO<br />

ANGIOTENSIN II AND ROCK1 OVER-ACTIVATION IN<br />

AORTAS ISOLATED FROM STREPTOZOTOCIN-INJECTED<br />

DIABETIC RATS<br />

Failli P., Alfarano C., Mannucci E., Cerbai E., Mugelli A.,<br />

Raimondi L. (Florence)<br />

101<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/1/40<br />

P-2/1/41<br />

P-2/1/42<br />

P-2/1/43<br />

P-2/1/44<br />

P-2/1/45<br />

P-2/1/46<br />

P-2/1/47<br />

P-2/1/48<br />

PLASMA LEVELS OF ADIPONECTIN ARE AN INDEX OF<br />

UNBALANCED OXIDATIVE STRESS IN TYPE 1 DIABETIC<br />

RATS<br />

Lodovici M., Bigagli E., Tarantini F., Mannucci E., Alfarano<br />

C., Di Serio C., Raimondi L. (Florence)<br />

SMOOTH MUSCLE CELLS TRANSDIFFERENTIATION TO<br />

MACROPHAGE-LIKE CELLS<br />

Bellosta S., Canavesi M., Anelli C., Corsini A. (Milan)<br />

CHOLESTEROL MODULATION AFFECTS TISSUE FACTOR<br />

INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 IN<br />

ENDOTHELIAL CAVEOLAE<br />

Banfi C., Barcella S., Brioschi M., Pirillo A., Tremoli E.,<br />

Mussoni L. (Milan)<br />

FLUVASTATIN SYNERGISTICALLY IMPROVES THE<br />

ANTIPROLIFERATIVE EFFECT OF EVEROLIMUS ON RAT<br />

SMOOTH MUSCLE CELLS BY ALTERING P27 KIP1 /CYCLIN E<br />

EXPRESSION<br />

Ferri N., Granata A., Torti F., Pfister P., Dorent R., Corsini<br />

A. (Milan, Sophia Antipolis, Paris)<br />

EVEROLIMUS INHIBITS MONOCYTE MIGRATION AND<br />

THEIR ACCUMULATION IN CAROTID LESIONS OF<br />

CHOLESTEROL-FED RABBITS<br />

Baetta R., Granata A., Ferri N., Arnaboldi L., Canavesi M.,<br />

Bellosta S., Pfister P., Corsini A. (Milan, Basel)<br />

IN VITRO EFFECTS OF 2NTX-99, AN ANTI-<br />

ATHEROTHROMBOTIC AGENT IN LUNG PREPARATIONS<br />

Brivio I., Buccellati C., Pinna C., Casagrande C., Hodge J.,<br />

Folco G. (Milan, San Francisco)<br />

ANTI-AGGREGATING EFFECT OF CVM-01 A NOVEL HYBRID<br />

NITRIC OXIDE-RELEASING NONSTEROIDAL ANTI-<br />

INFLAMMATORY PRODRUG<br />

Coppo L., Velazquez C., Di Giuseppe D., Di Simplicio P.,<br />

Priora R. (Siena, Edmonton)<br />

MR IMAGING OF ATHEROSCLEROTIC PLAQUES IN<br />

BRACHIOCEPHALIC ARTERIES OF APOLIPOPROTEIN E<br />

KNOCKOUT MICE<br />

Parolini C., Rigamonti E., Marchesi M., Cabella C., Miragoli<br />

L., Poggi L., Valbusa G., Sirtori C., Chiesa G. (Milan,<br />

Colleretto Giacosa)<br />

ALLOGENIC BONE MARROW-DERIVED MESENCHYMAL<br />

STEM CELLS LIMIT STENOSIS PROGRESSION IN A MODEL<br />

OF RAT CAROTID ARTERIOTOMY: DISSECTING THEIR<br />

MECHANISMS OF ACTION<br />

102<br />

P-2/1/49<br />

P-2/1/50<br />

P-2/1/51<br />

P-2/1/52<br />

P-2/1/53<br />

P-2/1/54<br />

P-2/1/55<br />

P-2/1/56<br />

Forte A., Finicelli M., Grossi M., Cobellis G., De Feo M.,<br />

Cotrufo M., Berrino L., Rossi F., Cipollaro M., Galderisi U.<br />

(Naples)<br />

PHARMACOLOGICAL MODULATION OF NUMBER AND<br />

FUNCTION OF THE CD4 + CD25 + REGULATORY T CELLS<br />

POPULATION IN ATHEROSCLEROSIS<br />

Schembri L., Guasti L., Cosentino M., Maio R., Rasini E.,<br />

Legnaro M., De Bernardi S., Castiglioni L., Maroni L.,<br />

Venco A., Lecchini S. (Varese)<br />

REGULATION OF CELLULAR SIGNALS FROM CYANIDIN-3-<br />

O-GLUCOSIDE IN ENDOTHELIUM: A SPECIFIC ROLE<br />

BEYOND ANTIOXIDANT ACTIVITY<br />

Speciale A., Chirafisi J., Ermito S., Saija A., Morabito G.,<br />

Cimino F. (Messina)<br />

NITRIC OXIDE DONORS: ANTI-AGGREGATING EFFECTS<br />

AND INACTIVATION OF FIBRINOGEN RECEPTOR<br />

(ALPHAIIBBETA3)<br />

Priora R., Margaritis A., Coppo L., Frosali S., Di Giuseppe<br />

D., Aldinucci C., Maiorca S., Pessina G., Di Stefano A., Di<br />

Simplicio P. (Siena)<br />

ANABOLIC ANDROGENIC STEROIDS CARDIOTOXICITY:<br />

INVOLVEMENT OF THE NERVE GROWTH FACTOR SYSTEM<br />

Trefiletti G., Togna A., Scaccianoce S., Carretta M.,<br />

Togna G. (Rome)<br />

THREE-DIMENSIONAL IMAGING OF ATHEROSCLEROTIC<br />

PLAQUES IN APOLIPOPROTEIN E-DEFICIENT MICE<br />

Dever G., Rodolico G., Berrino L., McInnes I., Brewer J.,<br />

Garside P., Maffia P. (Glasgow, Naples)<br />

EFFECTS OF A NEW LOW MOLECULAR WEIGHT BIO-<br />

HEPARIN ON CARDIAC ISCHEMIA-REPERFUSION-INDUCED<br />

INJURY<br />

Lanzi C., Mastroianni R., Vinci M., Caterina U., Bani D.,<br />

Cinci L., Collino M., Masini E. (Florence, Turin)<br />

ROLE OF CARBON MONOXIDE IN HYPERDYNAMIC<br />

CIRCULATION IN CIRRHOTIC PATIENTS<br />

Mastroianni R., Tarquini R., Santosuosso U., La Villa G.,<br />

Laffi G., Masini E. (Florence)<br />

EFFECTS OF AMLODIPINE AND ZOFENOPRIL ON<br />

OXIDATIVE STRESS–INDUCED HYPERTENSION.<br />

De Gennaro Colonna V., Sitia S., Tomasoni L., Turiel M.<br />

(Milan)<br />

103<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/2/1<br />

P-2/2/2<br />

P-2/2/3<br />

P-2/2/4<br />

P-2/2/5<br />

Poster Session<br />

P-2/2: GASTROINTESTINAL PHARMACOLOGY<br />

Poster Commission Members:<br />

President: Tonini M. (Pavia)<br />

Members: Blandizzi C. (Pisa), Conte Camerino D. (Bari)<br />

NMDA RECEPTORS AND PROTEIN KINASE C MODULATE<br />

NITRIC OXIDE FORMATION IN THE GUINEA PIG ILEUM<br />

FOLLOWING IN VITRO ISCHAEMIA<br />

Crema F., Moro E., Oldrini R., Lorenzi T., Marchet S.,<br />

Zanetti E., Giaroni C., Lecchini S., Frigo G. (Pavia, Busto<br />

Arsizio)<br />

FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX,<br />

REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL<br />

MODEL OF ACUTE PANCREATITIS<br />

Irrera N., Polito F., Minutoli L., Bitto A., Di Stefano V.,<br />

Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />

Squadrito F. (Messina, Modena)<br />

ALTERATIONS IN NITRERGIC NEUROMUSCULAR<br />

TRANSMISSION OF ILEAL CIRCULAR MUSCLE FROM<br />

PATIENTS WITH CROHN’S DISEASE: EFFECT OF CR3294,<br />

NEW ANTI-INFLAMMATORY COMPOUND<br />

Trisolini P., Pezzolla F., Demma I., Caruso M., Letari O.,<br />

Caselli G., Maselli M. (Bari, Monza)<br />

NOCICEPTIN/ORPHANIN FQ CAUSES MUCOSAL MAST CELL<br />

ACTIVATION IN THE RAT GASTRIC FUNDUS<br />

Grandi D., Solenghi E., Massi M., Morini G. (Parma,<br />

Camerino)<br />

EFFECTS OF PERIPHERAL ADMINISTRATION OF THE NOP<br />

RECEPTOR ANTAGONIST, UFP101, ON MUCOSAL<br />

FUNCTIONS IN THE RAT STOMACH<br />

Grandi D., Solenghi E., Guerrini R., Massi M., Morini G.<br />

(Parma, Ferrara, Camerino)<br />

104<br />

P-2/2/6<br />

P-2/2/7<br />

P-2/2/8<br />

P-2/2/9<br />

P-2/2/10<br />

P-2/2/11<br />

P-2/2/12<br />

P-2/2/13<br />

P-2/2/14<br />

FUNCTIONAL ROLE OF EXOGENOUS AMP IN RAT<br />

INTESTINAL MOTOR ACTIVITY<br />

Bin A., Zoppellaro C., Castagliuolo I., Gaion R., Giron M.<br />

(Padua)<br />

SMALL BOWEL FUNCTIONAL ABNORMALITIES IN AN IN<br />

VIVO ANIMAL MODEL OF HERPES SIMPLEX VIRUS-1<br />

INFECTION OF THE ENTERIC NERVOUS SYSTEM<br />

Zoppellaro C., Brun P., Bin A., Gaion R., Castagliuolo I.,<br />

Giron M. (Padua)<br />

CANNABIDIOL, A NON PSYCHOTROPIC PLANT<br />

CANNABINOID, PREVENTS OXIDATIVE STRESS IN<br />

INTESTINAL EPITHELIAL CELLS<br />

Romano B., Aviello G., Capasso R., Capasso F., Izzo A.,<br />

Borrelli F. (Naples)<br />

GASTRIC EFFECTS OF HISTAMINE: ANY ROLE FOR H4<br />

RECEPTORS?<br />

Adami M., Pozzoli C., Smits R., Leurs R., Coruzzi G.<br />

(Parma, Amsterdam)<br />

CA ++ -DEPENDENT PKCS PARTICIPATE TO THE ADAPTIVE<br />

CHANGES OF M OPIOID PATHWAYS TO SYMPATHETIC<br />

DENERVATION IN THE GUINEA PIG COLON<br />

Oldrini R., Zanetti E., Pascale A., Marchet S., Amadio M.,<br />

Chiaravalli A., Giaroni C., Lecchini S., Frigo G. (Varese,<br />

Pavia)<br />

DETERMINATION OF INTESTINAL PERMEABILITY BY<br />

MEASURING NON-METABOLIZED SUGARS HAS BEEN<br />

USED TO ASSESS THE INTEGRITY OF INTESTINAL<br />

MUCOSA<br />

Fucile C., Isola L., Marini V., Martelli A., Mattioli F.<br />

(Genoa)<br />

ROLE OF THE CANNABINOID SYSTEM IN THE EXOCRINE<br />

PANCREAS<br />

Petrella C., Alemà S., Agostini S., Broccardo M., Casolini<br />

P., Giuli C., Improta G., Linari G. (Rome)<br />

IN VITRO STIMULATION OF GUINEA PIG ILEUM MOTILITY<br />

BY N-FORMYL-MET-LEU-PHE (FMLF): INVOLVEMENT OF<br />

NEUROTRANSMITTERS AND PROSTANOIDS AND<br />

INFLUENCE OF ADENOSINE AND OPIATE SYSTEMS IN THE<br />

FMLF-INDUCED TACHYPHYLAXIS<br />

Colucci M., Maione F., Mastriota M., Di Giannuario A.,<br />

Valeri P., Mascolo N., Pieretti S. (Rome, London, Naples)<br />

SYNTHESIS OF NEW COMPOUNDS STRUCTURALLY<br />

RELATED TO THE DITERPENOID SCB, ISOLATED FROM<br />

105<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

SALVIA CINNABARINA, WITH SEDATIVE AND<br />

ANTISPASMODIC ACTIVITY IN MICE<br />

Mastriota M., Colucci M., Bonito M., Di Giannuario A.,<br />

Romussi G., Mascolo N., Pieretti S. (Rome, Naples, Genoa)<br />

106<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/3/1<br />

P-2/3/2<br />

P-2/3/3<br />

P-2/3/4<br />

P-2/3/5<br />

Poster Session<br />

P-2/3: PHARMACOLOGY OF METABOLISM, ENDOCRINE<br />

SYSTEM AND ERECTILE DYSFUNCTION<br />

Poster Commission Members:<br />

President: Tonini M. (Pavia)<br />

Members: Blandizzi C. (Pisa), Conte Camerino D. (Bari)<br />

ARIPIPRAZOLE REDUCES RISPERIDONE-INDUCED<br />

HYPERPROLACTINEMIA: TWO CASE REPORTS<br />

Capasso A., Milan W., Milan L., Siano C., Petrella C.<br />

(Fisciano)<br />

ORAL DELIVERY OF INSULIN LOADED INTO PEPTIDE-<br />

CONJUGATED POLYMERIC NANOPARTICLES IN DIABETIC<br />

RATS<br />

Tosi G., Vergoni A., Ruozi B., Costantino L., Bondioli L.,<br />

Forni F., Vandelli M., Tacchi R., Ferrari A., Spaccapelo L.,<br />

Bertolini A. (Modena)<br />

EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED<br />

RECEPTORS (PPARS) RECEPTORS FOLLOWING CHRONIC<br />

EXPOSURE TO VEGETABLE OMEGA-3 AND OMEGA-6 FATTY<br />

ACIDS<br />

Campioli E., Avallone R., Rustichelli C., Baraldi M.<br />

(Modena)<br />

GHRELIN O-ACYLTRANSFERASE (GOAT) EXPRESSION AND<br />

PHARMACOLOGICAL MODULATION IN CULTURED<br />

CHONDROCYTES<br />

Gomez R., Bianco G., Autore G., Conte J., Lopez M.,<br />

Gomez-Reino J., Dieguez C., Lago F., Gualillo O. (Santiago<br />

de Compostela, Salerno)<br />

EFFECTS OF PDRN ON SPERMATOGENETIC ACTIVITY<br />

DURING THE PROGRESSION OF TESTICULAR ISCHEMIA<br />

AND REPERFUSION IN RATS<br />

Minutoli L., Antonuccio P., Squadrito F., Polito F., Bitto A.,<br />

107<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/3/6<br />

P-2/3/7<br />

P-2/3/8<br />

P-2/3/9<br />

P-2/3/10<br />

P-2/3/11<br />

P-2/3/12<br />

P-2/3/13<br />

Di Stefano V., Irrera N., Romeo C., Caputi A. P., Altavilla<br />

D. (Messina)<br />

EFFECTS OF THE 2-H-1,4 BENZOXAZINE DERIVATIVES ON<br />

PANCREATIC KATP CHANNEL: A MOLECULAR<br />

DETERMINANT RESPONSIBLE FOR THE SELECTIVITY OF<br />

THE 2-H-1,4 BENZOXAZINE DERIVATIVES ON THE<br />

PANCREATIC KATP CHANNELS VERSUS SKELETAL MUSCLE<br />

SUBTYPE<br />

Tricarico D., Rolland J., Cippone V., Mele A., Cannone G.,<br />

Laghezza A., Fracchiolla G., Loiodice F., Conte Camerino<br />

D. (Bari)<br />

EXPRESSION OF DETERMINANTS OF GLUCOCORTICOID<br />

SENSITIVITY IN ANDROGEN-DEPENDENT AND<br />

ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER<br />

CELL LINES<br />

Dovio A., Sartori M., De Francia S., Piccione F.,<br />

Abbadessa G., Racca S., Di Carlo F., Angeli A. (Orbassano)<br />

AMP-ACTIVATED PROTEIN KINASE (AMPK) IN THE<br />

ANTERIOR PITUITARY AND GH-IGF-1 AXIS ACTIVITY: IN<br />

VIVO AND IN VITRO STUDIES<br />

Tulipano G., Giovannini M., Giustina A., Cocchi D.<br />

(Brescia)<br />

STRESS-INDUCED CORTISOL SECRETION AND IN VIVO<br />

METABOLISM OF ARACHIDONIC ACID<br />

Simeoni S., Maccarrone P., Rocca B., Patacchioli F.<br />

(Rome)<br />

GENDER LONG TERM HPA ALTERATIONS INDUCED BY<br />

NEONATAL STRESS<br />

Campana G., Loizzo S., Loizzo A., Spampinato S.<br />

(Bologna, Rome)<br />

RAPID EFFECTS OF T3 AND T2 ON INTRACELLULAR<br />

CALCIUM AND NITRIC OXIDE IN PITUITARY GH3 CELLS<br />

Del Viscovo A., Secondo A., Esposito A., Moreno M.,<br />

Silvestri E., Lanni A., Goglia F., Canzoniero L. (Benevento,<br />

Naples, Caserta)<br />

ALTERED N-6 FATTY ACID METABOLISM IN DIFFERENT<br />

CYSTIC FIBROSIS CELL LINES<br />

Mauro N., Ghezzi S., Risè P., Melotti P., Assael B., Galli C.<br />

(Milan, Verona)<br />

EFFECTS OF SHORT-TERM TREATMENT WITH GHRELIN<br />

AND SYNTHETIC GHS IN AN ANIMAL MODEL OF CACHEXIA<br />

Rizzi L., Bresciani E., Caporali S., Frigerio E., Tamiazzo L.,<br />

Perissoud D., Locatelli V., Torsello A. (Monza, Frankfurt)<br />

108<br />

P-2/3/14<br />

LIMBIC NEUROPEPTIDE Y-Y1 RECEPTOR EXPRESSING<br />

NEURONS ARE MANDATORY FOR ANXIOLYTIC-RELATED<br />

BEHAVIOUR AND BODY WEIGHT CONTROL<br />

Bertocchi I., Oberto A., Longo A., Mele P., Palanza P.,<br />

Sprengel R., Eva C. (Turin, Parma, Heidelberg)<br />

109<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/4/1<br />

P-2/4/2<br />

P-2/4/3<br />

P-2/4/4<br />

P-2/4/5<br />

Poster Session<br />

P-2/4: CHEMOTHERAPY<br />

Poster Commission Members:<br />

President: Viano I. (Novara)<br />

Members: Bertazzoni Minelli E. (Verona),<br />

D’Alessandro N. (Palermo)<br />

THYMOL INHIBITS GARDNERELLA VAGINALIS ADHESION<br />

TO HUMAN VAGINAL CELLS<br />

Braga P., Dal Sasso M., Spallino A., Culici M., Sturla C.<br />

(Milan, Gallarate)<br />

NEW HPLC–MS METHOD FOR THE SIMULTANEOUS<br />

QUANTIFICATION IN HUMAN PLASMA OF THE<br />

ANTILEUKEMIA DRUGS IMATINIB, DASATINIB, AND<br />

NILOTINIB<br />

De Francia S., D’Avolio A., De Martino F., Pirro E.,<br />

Piccione F., Racca S., Di Carlo F. (Orbassano, Turin)<br />

MITOTANE: THE IMPORTANCE OF MONITORING IN<br />

ADRENOCORTICAL CANCER PATIENTS<br />

De Martino F., De Francia S., Pirro E., Piccione F., Terzolo<br />

M., Daffara D., Di Carlo F. (Orbassano)<br />

ANTI-ENDOTHELIAL EFFECTS OF LOW DOSE CERAMIDE<br />

ANALOGS IN VITRO AND IN VIVO<br />

Fioravanti A., Orlandi P., Di Desidero T., Canu B., Danesi<br />

R., Del Tacca M., Bocci G. (Pisa)<br />

IRINOTECAN AND AXITINIB SYNERGISTICALLY INHIBIT<br />

PANCREATIC CANCER IN VITRO AND IN VIVO BY<br />

MODULATING VEGFR-2, ABCG2 AND ATP7A GENE<br />

EXPRESSION AND TSP-1 SECRETION<br />

Canu B., Fioravanti A., Di Desidero T., Orlandi P., Danesi<br />

R., Del Tacca M., Bocci G. (Pisa)<br />

P-2/4/6 THE IGF1R INHIBITOR NVP-AEW541 DISRUPTS A PRO-<br />

110<br />

P-2/4/7<br />

P-2/4/8<br />

P-2/4/9<br />

P-2/4/10<br />

P-2/4/11<br />

P-2/4/12<br />

P-2/4/13<br />

P-2/4/14<br />

SURVIVAL AND PRO-ANGIOGENIC IGF-STAT3-HIF1<br />

PATHWAY IN HUMAN GLIOBLASTOMA CELLS<br />

Ravizza R., Molteni R., Monti E., Gariboldi M. (Busto<br />

Arsizio)<br />

MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS<br />

BY A3 ADENOSINE RECEPTORS<br />

Gessi S., Sacchetto V., Fogli E., Merighi S., Varani K.,<br />

Baraldi P., Tabrizi M., Leung E., Mac Lennan S., Borea P.<br />

A. (Ferrara, Cary)<br />

THERMODYNAMICS OF A2B ADENOSINE RECEPTOR<br />

BINDING DISCRIMINATES AGONISTIC FROM<br />

ANTAGONISTIC BEHAVIOUR<br />

Sacchetto V., Gessi S., Fogli E., Varani K., Merighi S.,<br />

Leung E., MacLennan S., Borea P. A. (Ferrara, Cary)<br />

GEMCITABINE-LOADED PEGYLATED UNILAMELLAR<br />

LIPOSOMES VS GEMZAR ® : BIODISTRIBUTION,<br />

PHARMACOKINETIC FEATURES AND IN VIVO ANTITUMOR<br />

ACTIVITY<br />

D’Agostino M., Paolino D., Cosco D., Celano M.,<br />

Racanicchi L., Trapasso E., Celia C., Iannone M., Puxeddu<br />

E., Costante G., Russo D., Fresta M. (Catanzaro, Milan,<br />

Messina, Roccelletta di Borgia, Perugia)<br />

CORRELATION BETWEEN IN VITRO AND IN VIVO<br />

CYTIDINE DEAMINASE PHENOTYPE AND GEMCITABINE<br />

PHARMACOKINETICS IN PATIENTS WITH SOLID TUMORS<br />

Gusella M., Modena J., Barile C., Toso S., Bononi A.,<br />

Menon D., Pasini F., Padrini R. (Rovigo, Padua)<br />

PRELIMINARY IN VITRO BIOLOGICAL EVALUATIONS OF<br />

NEW PRODRUGS DESIGNED AS ANTIMELANOMA AGENTS<br />

Nassi A., Ruzza P., Rosato A., Rondina M., Rossi C.,<br />

Floreani M., Quintieri L. (Padua)<br />

CURCUMIN INCREASES SENSITIVITY OF RESISTANT<br />

OVARIAN TUMOUR CELLS TO PLATINUM DRUGS:<br />

APOPTOTIC EFFECTS AND CELL-CYCLE ALTERATIONS<br />

Montopoli M., Ragazzi E., Froldi G., Dorigo P., Caparrotta<br />

L. (Padua)<br />

AN EVALUATION OF ANTIBIOTIC USE AND RESISTANCE IN<br />

AN ITALIAN UNIVERSITY HOSPITAL<br />

Silvani M., Poluzzi E., Motola D., Biagi C., Nanetti A.,<br />

Ambretti S., Fiacchi P., Puggioli C., Vaccheri A., Montanaro<br />

N. (Bologna)<br />

IN VITRO INVESTIGATION OF SULINDAC DERIVATIVES AS<br />

POTENTIAL ANTICANCER AGENTS<br />

111<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/4/15<br />

P-2/4/16<br />

P-2/4/17<br />

P-2/4/18<br />

P-2/4/19<br />

P-2/4/20<br />

Fogli S., Banti I., Digiacomo M., Macchia M., Lapucci A.,<br />

Breschi M. (Pisa)<br />

HPβCDS COMPLEXING RESVERATROL: A NOVEL<br />

APPROACH FOR CHEMOPREVENTION OF SQUAMOUS CELL<br />

CARCINOMA<br />

Salamone P., Sprio A., Di Scipio F., Marinos L., Cavalli R.,<br />

Carlotti M., Sapino S., Di Carlo F., Berta G. (Orbassano,<br />

Turin)<br />

HISTONE DEACETYLASE (HDAC) INHIBITION MODULATES<br />

INTRACELLULAR DEOXYNUCLEOTIDES (DNTP) POOLS AND<br />

POTENTIATES THE ANTITUMOR EFFECTS OF THE<br />

RIBONUCLEOTIDE REDUCTASE (RR) INHIBITOR 3’-<br />

METHYL-ADENOSINE (3’-ME-ADO) IN PROMYELOCITIC<br />

LEUKAEMIA CELL LINES<br />

Meli M., Tolomeo M., Grifantini M., Mai A., Cappellacci L.,<br />

Franchetti P., Saiko P., Dusonchet L. (Palermo, Camerino,<br />

Rome, Vienna)<br />

THE mGLU3 RECEPTOR ANTAGONIST, LY341495,<br />

ENHANCES CHEMOSENSITIVITY OF COLORECTAL CANCER<br />

STEM CELLS TO STANDARD CYTOTOXIC CHEMOTHERAPY<br />

Mosillo P., Turriziani B., Ricci-Vitiani L., Ciceroni C.,<br />

Cappuccio I., Spinsanti P., Sale P., Nicoletti F., Melchiorri<br />

D. (Rome, Pavia, Pozzilli)<br />

THERAPEUTIC DRUG MONITORING OF DAPTOMICYN:<br />

DEVELOPMENT, VALIDATION AND APPLICATION OF A<br />

HPLC METHOD<br />

Polillo M., Di Paolo A., Tascini C., Lastella M., Gemignani<br />

G., Ciofi L., Taddei R., Menichetti F., Danesi R., Del Tacca<br />

M. (Pisa)<br />

PHARMACOKINETICS AND TOXICITY OF AN EARLY SINGLE<br />

INTRAVESICAL INSTILLATION OF MITOMYCIN-C AFTER<br />

ENDOSCOPIC RESECTION OF SUPERFICIAL BLADDER<br />

CANCER<br />

Mattioli F., Campodonico F., Fucile C., Marini V.,<br />

Maffezzini M., Martelli A. (Genoa)<br />

DECOLONIZATION OF S. AUREUS CARRIERS IN<br />

ORTHOPEDIC SURGICAL TEAM MEMBERS: IMPACT ON<br />

SURGICAL SITE INFECTIONS<br />

Portigliatti Barbos M., Barberis A., Marino S., Pecoraro S.,<br />

Picco W., Veglio V., Di Carlo F., Mognetti B. (Orbassano,<br />

Turin)<br />

112<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/5/1<br />

P-2/5/2<br />

P-2/5/3<br />

P-2/5/4<br />

P-2/5/5<br />

P-2/5/6<br />

Poster Session<br />

P-2/5: PHARMACOLOGY OF INFLAMMATION<br />

Poster Commission Members:<br />

President: Patrono C. (Rome)<br />

Members: Tremoli E. (Milan), Ziche M. (Siena)<br />

ETHYL PYRUVATE REDUCES THE DEVELOPMENT OF<br />

ZYMOSAN-INDUCED GENERALIZED INFLAMMATION IN<br />

MICE<br />

Di Paola R., Mazzon E., Genovese T., Crisafulli C.,<br />

Bramanti P., Caminiti R., Esposito E., Fink M., Cuzzocrea<br />

S. (Messina, Naples, Waltham)<br />

MYRTUCOMMULONE FROM MYRTUS COMMUNIS EXHIBITS<br />

POTENT ANTI-INFLAMMATORY EFFECTIVENESS IN VIVO<br />

Rossi A., Di Paola R., Mazzon E., Pergola C., Koeberle A.,<br />

Werz O., Cuzzocrea S., Sautebin L. (Naples, Messina,<br />

Tuebingen)<br />

ROLE OF PALMITOYLETHANOLAMIDE ON MODULATION OF<br />

THE MAST CELL-T CELL INTERACTIONS: AN IN VITRO<br />

STUDY<br />

Valenti M., Massi P., Parolaro D. (Varese, Milan)<br />

HYDROGEN SULPHIDE INDUCES MOUSE HIND PAW<br />

OEDEMA<br />

Coletta C., d'Emmanuele di Villa Bianca R., Mitidieri E.,<br />

Bucci M., Cirino G., Sorrentino R. (Naples)<br />

A LIPID A FROM HALOMONAS MAGADIENSIS INHIBITS<br />

ENTERIC LPS-INDUCED TLR4 ACTIVATION IN HUMAN<br />

MONOCYTES<br />

Tersigni M., Ialenti A., Lanzetta R., Grant W., Ianaro A.<br />

(Naples, Leicester)<br />

POTENT ANTIOXIDANT PROFILE OF FLAVOCOXID, A<br />

NATURAL DUAL INHIBITOR OF CYCLOOXYGENASE AND 5-<br />

113<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/5/7<br />

P-2/5/8<br />

P-2/5/9<br />

P-2/5/10<br />

P-2/5/11<br />

P-2/5/12<br />

P-2/5/13<br />

P-2/5/14<br />

P-2/5/15<br />

LIPOXYGENASE<br />

Bitto A., Polito F., Minutoli L., Irrera N., Di Stefano V.,<br />

Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />

Squadrito F. (Messina, Modena)<br />

HIGH MOBILITY GOUP BOX-1 EXPRESSION CORRELATES<br />

WITH OUTCOME IN CRITICAL ILL PATIENTS<br />

Bonaiuto A., Polito F., Bitto A., Minutoli L., Irrera N., Di<br />

Stefano V., Altavilla D., Giuliani D., Guarini S., Ottani A.,<br />

Caputi A. P., Squadrito F. (Messina, Modena)<br />

INFLUENCE OF GENDER IN THE MESENTERIC ISCHEMIA/<br />

REPERFUSION MODEL IN MICE<br />

Ghizzardi P., Gobbetti T., Bertoni S., Vegezzi G., Barocelli<br />

E. (Parma)<br />

G-NBD, A NOVEL CELL-PERMEABLE PEPTIDE, INHIBITS<br />

NF-κB ACTIVATION<br />

Maddaluno M., Grassia G., De Stefano D., Carnuccio R.,<br />

De Simone L., Neri E., Grieco P., Ialenti A. (Naples)<br />

ANTINFLAMMATORY PROPERTIES OF NOVEL 5-<br />

AMINO[1,2,4]-TRIAZOLO[4,3-A][1,8]NAPHTHYRIDINES-<br />

CAROBOXAMIDES DERIVATIVES<br />

Giorgio C., Tognolini M., Rome G., Di Braccio M.,<br />

Ballabeni V., Barocelli E. (Parma, Genoa)<br />

ANTI-INFLAMMATORY EFFECTS OF INDICAXANTHIN ON<br />

CARRAGEENIN-INDUCED RAT PLEURISY<br />

Tersigni M., Allegra M., Tesoriere L., Livrea M., Ianaro A.<br />

(Naples, Palermo)<br />

EVIDENCE FOR THE INVOLMENTE OF ADENOSINE A2A<br />

RECEPTOR IN CARRAGEENIN-INDUCED RAT PAW EDEMA<br />

Parisi A., Gargiulo L., Alfieri A., Cicala C. (Naples)<br />

LEUKOCYTE-DERIVED MICROPARTICLES (MP) DEEPLY<br />

AFFECT MONOCYTE/MACROPHAGE RESPONSIVENESS<br />

Bardelli C., Zeng H., Amoruso A., Fresu L., Palma A.,<br />

Brunelleschi S. (Novara)<br />

SMOKING AND RHEUMATOLOGIC DISEASES<br />

Calzavara E., Bartolone S., Russo G., Carnì A., Mannucci<br />

C., Pieratti A., Caputi A. P., Calapai G. (Messina)<br />

THE EFFICACY OF XILOIAL, A NEW ARTIFICIAL TEAR, IN<br />

AN EXPERIMENTAL MODEL OF DRY EYE IN RATS<br />

Mannari C., Guidi A., Stiaccini G., Scalori V., Sansò M.,<br />

Giovannini L. (Pisa)<br />

114<br />

P-2/5/16<br />

P-2/5/17<br />

P-2/5/18<br />

ANTI-INFLAMMATORY EFFECTS OF NCX 4040, A NITRIC<br />

OXIDE-DONATING ASPIRIN, BY INHIBITING IKB-ALPHA<br />

DEGRADATION IN HUMAN MONOCYTES<br />

Di Francesco L., Ricciotti E., Dovizio M., Anzellotti P.,<br />

Monopoli A., Patrignani P. (Chieti, Philadelphia, Bresso)<br />

ODN DECOY TO NF-KB RELEASED FROM RESPIRABLE<br />

PLGA LARGE POROUS PARTICLES: A POTENTIAL<br />

STRATEGY FOR TREATING CYSTIC FIBROSIS?<br />

De Stefano D., Giovino C., Ungaro F., Coletta C.,<br />

d’Emmanuele di Villa Bianca R., Sorrentino R., Quaglia F.,<br />

Carnuccio R. (Naples)<br />

EFFECT OF 1-PHENYL-6,7-DIHYDROXY-ISOCHROMEN ON<br />

LPS-INDUCED GLIAL ACTIVATION<br />

Latina V., Togna A., Trefiletti G., Marra C., Togna G.<br />

(Rome)<br />

115<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/6/1<br />

P-2/6/2<br />

P-2/6/3<br />

P-2/6/4<br />

P-2/6/5<br />

P-2/6/6<br />

Poster Session<br />

P-2/6: IMMUNOPHARMACOLOGY<br />

Poster Commission Members:<br />

President: Patrono C. (Rome)<br />

Members: Tremoli E. (Milan), Ziche M. (Siena)<br />

ACUTE PANCREATITIS IS REDUCED BY GENETIC OR<br />

PHARMACOLOGICAL INHIBITION OF GLUCOCORTICOID-<br />

INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR)<br />

Galuppo M., Nocentini G., Mazzon E., Esposito E., Di<br />

Paola R., Crisafulli C., Genovese T., Riccardi C., Cuzzocrea<br />

S. (Messina, Perugia, Naples)<br />

POST-TRANSLATIONAL MODIFICATION OF GILZ BY SUMO-<br />

1<br />

Pozzesi N., Riccardi C., Delfino D. (Perugia)<br />

GITR + CD25 - CELLS REPRESENT A HUMAN REGULATORY T<br />

CELLS SUBSET DEREGULATED IN SYSTEMIC LUPUS<br />

ERYTHEMATOSUS<br />

Bianchini R., Nocentini G., Petrillo M., Bistoni O., Alunno<br />

A., Ronchetti S., Bartoloni Bocci E., Gerli R., Riccardi C.<br />

(Perugia)<br />

EXPRESSION AND SIGNALLING OF PPAR-GAMMA IN SH-<br />

SY5Y, A HUMAN NEUROBLASTOMA CELL LINE<br />

Palma A., Amoruso A., Fresu L., Bardelli C., Brunelleschi<br />

S. (Novara)<br />

IMPACT OF TOBACCO SMOKE IN PPAR-GAMMA<br />

EXPRESSION IN MONOCYTE/MACROPHAGES ISOLATED<br />

FROM CORONARY HEART DISEASE (CHD) PATIENTS<br />

Amoruso A., Bardelli C., Fresu L., Palma A., Brunelleschi<br />

S. (Novara)<br />

MYCOPHENOLIC ACID THERAPEUTIC DRUG MONITORING<br />

BY MEANS OF A LIMITED SAMPLING STRATEGY IN ADULT<br />

116<br />

P-2/6/7<br />

P-2/6/8<br />

P-2/6/9<br />

P-2/6/10<br />

HEART TRANSPLANT PATIENTS<br />

Baraldo M., Feruglio M., Cojutti P., Tursi V., Livi U.,<br />

Furlanut M. (Udine)<br />

SULFATIDE AS AN ENDOGENOUS MODULATOR OF<br />

INDOLEAMINE 2,3-DIOXYGENASE IN ANTIGEN<br />

PRESENTING CELLS<br />

Fallarini S., Altomare E., Mossotti M., Panza L., Lombardi<br />

G. (Novara)<br />

ENDOGENOUS CATECHOLAMINES IN HUMAN NATURAL<br />

KILLER CELLS: BASIC EVIDENCE AND CLINICAL<br />

IMPLICATIONS<br />

Maio R., Bozzo L., Brunetta E., Bonaldo S., Marino F.,<br />

Mavilio D., Cosentino M. (Varese, Rozzano)<br />

POSSIBLE LINK BETWEEN HISTORY OF<br />

HYPERSENSITIVITY TO A SPECIFIC NON-STEROIDAL<br />

ANTI-INFLAMMATORY DRUG (NSAID) AND POSITIVE<br />

RESULTS FOLLOWING CHALLENGE TEST TO ALTERNATIVE<br />

NSAIDS<br />

Naccari C., Trombetta D., Imbesi S., Vita G., Isola S.,<br />

Minciullo P., Saija A., Gangemi S. (Messina)<br />

IMPAIRMENT OF DENDRITIC CELL FUNCTION IS CRUCIAL<br />

FOR PROTECTION AFFORDED BY PARP-1 INHIBITORS IN<br />

EXPERIMENTAL MODELS OF MULTIPLE SCLEROSIS<br />

Cavone L., Aldinucci A., Ballerini C., Biagioli T., Massacesi<br />

L., Moroni F., Chiarugi A. (Florence)<br />

117<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/7/1<br />

P-2/7/2<br />

P-2/7/3<br />

P-2/7/4<br />

P-2/7/5<br />

P-2/7/6<br />

Poster session<br />

P-2/7: PHARMACOEPIDEMIOLOGY, PHARMACOVIGILANCE,<br />

PHARMACOECONOMY, DRUG INFORMATION, VACCINES<br />

Poster Commission Members:<br />

President: De Sarro G. B. (Catanzaro)<br />

Members: De Ponti F. (Bologna), Spina E. (Messina)<br />

BILATERAL PAPILLEDEMA FOLLOWING HPV VACCINATION<br />

Rossi M., Pagano C., Pannini S., Barlocco E., Giorgi G.<br />

(Siena, Grosseto)<br />

MILIARY TUBERCULOSIS AFTER ENDOVESICAL<br />

INSTILLATION OF BACILLUS CALMETTE-GUÉRIN FOR<br />

BLADDER CANCER: A CASE-REPORT<br />

Parini F., Valenti L., Radaeli E., Spano P.F., Sigala S.<br />

(Brescia)<br />

EVALUATION OF THE USE OF PSYCHOTROPIC DRUGS IN<br />

TERMINALLY ILL CANCER PATIENTS<br />

Mussa M., Magnetti C., De Francia S., Pirro E., Piccione<br />

F., Dimonte V., Fantò F., Di Carlo F. (Turin, Orbassano)<br />

INFODOPING: A CONFIDENTIAL TELEPHONE SERVICE<br />

PROVIDING INFORMATION ON DRUGS AND SUBSTANCES<br />

IN SPORT AND SOCIETY<br />

Cojutti P., Furlanut M., Baraldo M. (Udine)<br />

ANTIDEPRESSANT DRUG (AD) PRESCRIBING PATTERNS<br />

DURING THE YEARS 1999-2008<br />

Mercanti G., Chinellato A., Terrazzani G., Bortolami A.,<br />

Debetto P., Giusti P. (Padua, Treviso)<br />

EU-ADR PROJECT: NOVEL SYSTEM FOR DETECTION OF<br />

DRUG SAFETY SIGNALS BY INTEGRATIVE MINING OF<br />

ELECTRONIC HEALTH CARE RECORDS AND BIOMEDICAL<br />

KNOWLEDGE<br />

Trifirò G., Sturkenboom M., Kors J., Diaz Acedo C., Boyer<br />

118<br />

P-2/7/7<br />

P-2/7/8<br />

P-2/7/9<br />

P-2/7/10<br />

P-2/7/11<br />

P-2/7/12<br />

S., Cantarutti L., Fourier-Reglat A., Gini R., Gurwitz D.,<br />

Herings R., Hippisley-Cox J., Loza M., Mazzaglia G.,<br />

Molokhia M., Oliveira J., Pedersen L., Romio S., Sanz F.,<br />

van der Lei J. (Messina, Rotterdam, Barcelona, Mölndal,<br />

Padua, Bordeaux, Florence, Tel Aviv, Utrecht, Nottingham,<br />

Santiago de Compostela, London, Aveiro, Aarhus, Milan)<br />

DATA MINING ON ELECTRONIC HEALTH RECORD<br />

DATABASES FOR SIGNAL DETECTION IN<br />

PHARMACOVIGILANCE: WHICH EVENTS TO MONITOR?<br />

Trifirò G., Pariente A., Coloma P., Kors J., Polimeni G.,<br />

Miremont-Salamé G., Catania M. A., Salvo F., David A.,<br />

Moore N., Caputi A. P., Sturkenboom M., Molokhia M.,<br />

Hippisley-Cox J., Diaz Acedo C., van der Lei J., Fourrier-<br />

Reglat A. (Messina, Rotterdam, Bordeaux, London,<br />

Nottingham, Barcelona)<br />

PROMOTING CONTINUING EDUCATION IN<br />

PHARMACOVIGILANCE: THE EXPERIENCE OF<br />

“PHARMASEARCH”, A NETWORK OF GENERAL<br />

PRACTITIONERS REPORTING ADVERSE DRUG REACTIONS<br />

Catania M. A., Salvo F., Oteri A., Polimeni G., Russo A.,<br />

Fava G., Giustini S., Sessa A., Tuccori M., Mattioli F.,<br />

Martelli A., Del Tacca M., Caputi A. P. (Messina, Pisa,<br />

Genoa)<br />

SAFETY PROFILES OF TICLOPIDINE AND CLOPIDOGREL: A<br />

CASE/NON CASE STUDY ON THE BASIS OF THE<br />

SPONTANEOUS ADRS REPORTING IN ITALY<br />

Motola D., Biagi C., Roberto G., Donati M., Lapi F., Salvo<br />

F., Leoni O., Montanaro N. (Bologna, Verona, Florence,<br />

Messina, Milan)<br />

DRUG SAFETY INFORMATION THROUGH THE INTERNET.<br />

THE EXPERIENCE OF AN ITALIAN WEBSITE<br />

Polimeni G., Russo A., Catania M. A., Sportiello L., Oteri<br />

A., Trifirò G., Calapai G., Sautebin L., Iacobelli M., Caputi<br />

A. P. (Messina, Naples, Milan)<br />

OBSERVATIONAL ITALIAN STUDY ON ANTENATAL<br />

DEPRESSION AND DRUG USE IN PREGNANCY<br />

Donati M., Imperadore G., Moretti U., Conforti A., Bisoffi<br />

G., D'Incau P., Leone R., Bellantuono C. (Verona,<br />

Ancona)<br />

ADVERSE REACTIONS TO ERLOTINIB: A CASE OF<br />

DERMATITIS BULLOSA<br />

Oteri A., Cattaneo M., Clementi E., Filippazzi V., Ferrario<br />

S., Gamabaro A., Isabella L., Radice S., Tosca N., Piazza<br />

E. (Milan, Messina)<br />

119<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/7/13<br />

P-2/7/14<br />

P-2/7/15<br />

P-2/7/16<br />

P-2/7/17<br />

P-2/7/18<br />

P-2/7/19<br />

P-2/7/20<br />

P-2/7/21<br />

MEDICINAL PLANTS AND HERBAL REMEDIES IN PATIENTS<br />

WITH MULTIPLE SCLEROSIS: A NATION-WIDE SURVEY IN<br />

ITALY<br />

Loraschi A., Bombelli R., Zaffaroni M., Ghezzi A., Marino<br />

F., Lecchini S., Comi G., Cosentino M. (Varese, Gallarate,<br />

Milan)<br />

DIETARY SUPPLEMENTS USE BY NON PROFESSIONAL<br />

ATHLETES: A PILOT STUDY IN NORTHERN ITALY<br />

Loraschi A., Caliari A., Cosentino M. (Varese)<br />

TRENDS IN ANTIBIOTIC THERAPY OF RESPIRATORY<br />

TRACT INFECTIONS: A PHARMACOEPIDEMIOLOGICAL<br />

SURVEY IN GENERAL PRACTICE IN NORTHERN ITALY AREA<br />

Cipolla G., Crema F., Moro E., Frigo G. (Pavia)<br />

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: A<br />

REPORT OF TWO CASES IN PATIENTS WITH LYMPHOMAS<br />

ON MAINTENANCE THERAPY WITH RITUXIMAB<br />

Montagnani S., Tuccori M., Focosi D., Maggi F., Cosottini<br />

M., Meini B., Blandizzi C., Petrini M., Del Tacca M. (Pisa,<br />

Florence, Livorno)<br />

CEFTRIAXONE-INDUCED PANCREATITIS IN A PEDIATRIC<br />

PATIENT: A CASE REPORT<br />

Ruggiero S., Di Nardo R., Polimeno T., Rafaniello C.,<br />

Rossi F., Capuano A. (Naples)<br />

MANAGEMENT OF PAEDIATRIC PAIN RELATED TO VEIN<br />

CANNULATION: A SYSTEMATIC OVERVIEW<br />

Gallo M., Capuano A., Clavenna A., Rossi F., Bonati M.<br />

(Milan)<br />

ADHERENCE TO IRON-CHELATION THERAPY IN<br />

THALASSEMIC PATIENTS. A SURVEY ON PSYCHOSOCIAL<br />

ASPECTS<br />

Felisi M., Baiardi P., Padula R., Bonifazi D., Ceci A. (Pavia,<br />

Bari)<br />

AN OBSERVATIONAL STUDY OF ANTIPSYCHOTICS USE IN<br />

PATIENTS WITH BEHAVIOURAL AND PSYCHOLOGICAL<br />

SYMPTOMS OF DEMENTIA (BPSD)<br />

Potenza S., Formica R., Putaturo I., Scognamiglio M.,<br />

Forgione L., Postiglione A., Galdi M., De Martino G., Forte<br />

M., Rea G., Liquori G., Genovese T., Schipani G., Albano<br />

G., Scarpa R., Arcaro G., Ferrara F., Rabasca A., Di Maio<br />

G., De Angelis A., Caterino L., Irpino A., Rossi F., Capuano<br />

A. (Naples)<br />

DRUG-INDUCED TASTE AND SMELL ALTERATIONS: A<br />

CASE/NON-CASE STUDY ON AN ITALIAN DATABASE OF<br />

120<br />

P-2/7/22<br />

P-2/7/23<br />

P-2/7/24<br />

P-2/7/25<br />

P-2/7/26<br />

P-2/7/27<br />

P-2/7/28<br />

ADVERSE DRUG REACTIONS<br />

Tuccori M., Lapi F., Testi A., Cutroneo P., Leoni O.,<br />

Rivolta A., Costantini D., Opri S., Motola D., Venegoni M.,<br />

Santuccio C., Sottosanti L., Blandizzi C., Mugelli A., Del<br />

Tacca M. (Pisa, Florence, Messina, Milan, Verona, Bologna,<br />

Rome)<br />

PHARMACOKINETICS OF PROPOFOL DURING MONITORED<br />

ANAESTHESIA IN OBESE PATIENTS UNDERGOING<br />

BILIOPANCREATIC DIVERSION<br />

Fucile C., Di Noto A., Spagnolo L., Martelli A., Mattioli F.<br />

(Genoa)<br />

PHONE SURVEY ON DRUG RISK PERCEPTION IN GENERAL<br />

POPULATION: A FEASIBILITY STUDY<br />

Salvo F., Gentile M., Iannello C., Caputi A. P., Calapai G.<br />

(Messina)<br />

DRUG CARE NETWORK:INTERACTIVE MODELS<br />

PHYSICIAN- PHARMACIST- PATIENT<br />

Franceschini L., Sigala S., Brignoli O., Rastrelli F., Agabiti<br />

Rosei E., Spano P. F. (Brescia)<br />

HIGH LEVELS OF CHROMOGRANIN A AND SEROTONIN<br />

ASSOCIATED WITH ESOMEPRAZOLE TREATMENT IN A<br />

PATIENT ON FOLLOW-UP AFTER SURGERY FOR<br />

PANCREATIC NEURO-ENDOCRINE TUMOUR<br />

Gori G., Spinelli G., Spinelli C., Tuccori M., Blandizzi C.,<br />

Del Tacca M. (Pisa)<br />

CARDIOVASCULAR AND RESPIRATORY ADVERSE EVENTS<br />

DUE TO THE CHANGING INPOSITION DURING SPINAL<br />

ANAESTHESIA WITH 1% HYPERBARIC BUPIVACAINE<br />

Rafaniello C., Ianniello B., Riso C., Cillo B., Mercogliano<br />

A., Capodanno P., Delle Donne D., Di Bella O., Lettieri B.,<br />

Rossi F., Capuano A. (Naples)<br />

USE OF ANTIEPILEPTIC DRUGS IN AN ITALIAN SETTING<br />

OF ELDERLY OUTPATIENTS DURING THE YEARS 2004-<br />

2007: THE EFFECT OF HEALTH POLICY INTERVENTION<br />

Gagliostro M. S., Oteri A., Moretti S., Tari D., Caputi A.<br />

P., Spina E., Arcoraci V. (Messina, Caserta)<br />

PRESCRIBING PATTERN OF AROMATASE INHIBITORS AND<br />

SELECTIVE ESTROGEN RECEPTOR MODULATORS IN AN<br />

ITALIAN OUTPATIENT SETTING: A POPULATION-BASED<br />

STUDY DURING 2004-2007<br />

Cutroneo P., Gagliostro M. S., Oteri A., Moretti S., Tari<br />

D., Caputi A. P., Arcoraci V. (Messina, Caserta)<br />

P-2/7/29 SEVERE HYPOGLYCEMIA ASSOCIATED WITH<br />

121<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/7/30<br />

P-2/7/31<br />

P-2/7/32<br />

P-2/7/33<br />

P-2/7/34<br />

P-2/7/35<br />

LEVOFLOXACIN<br />

Giorgi G., Sbrilli M., Nencini C., Micheli L. (Siena)<br />

DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES IN THE<br />

ITALIAN PAEDIATRIC POPULATION<br />

Baiardi P., Ceci A., Cantarutti L., Giaquinto C., Girotto S.,<br />

Felisi M., Padula R., Sturkenboom M., Baraldi E. (Pavia,<br />

Padua, Venezia, Rotterdam)<br />

SYSTEMATIC SURVEILLANCE OF ADVERSE DRUG EVENTS<br />

IN EMERGENCY DEPARTMENT IN LOMBARDIA REGION<br />

Oteri A., Conti V., Muserra G., Strippoli A., Ferri C.,<br />

Barrosi C., Vighi G. (Milan)<br />

“IN SILICO” COST/EFFECTIVENESS EVALUATION FOR<br />

TREATMENT WITH STATINS OF DIABETIC PATIENTS<br />

Cristani M., Monteleone D., Saija A., Tomaino A.<br />

(Messina)<br />

GOLDEN STANDARDS FOR QUALITY AND SAFETY IN THE<br />

PARENTERAL FORMULATIONS<br />

Martorana M., Arcoraci T., Saija A., Tomaino A. (Messina)<br />

ADVERSE REACTIONS OF MEDICINALS PRODUCTS: A<br />

SURVEY ON SICILIAN WOMEN<br />

Pieratti A., Calapai G., Crupi D., De Sarro A. (Messina)<br />

ACUTE LIVER FAILURE COMPLICATING TURP SYNDROME<br />

AFTER ABSORPTION OF IRRIGATION FLUID DURING<br />

TRANSURETHRAL RESECTION OF PROSTATE: A CASE<br />

REPORT<br />

Montagnani S., Tuccori M., Blandizzi C., Del Tacca M., Di<br />

Paolo M. (Pisa, Florence)<br />

122<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/8/1<br />

P-2/8/2<br />

P-2/8/3<br />

P-2/8/4<br />

P-2/8/5<br />

P-2/8/6<br />

Poster Session<br />

P-2/8: COMPLEMENTARY MEDICINES<br />

Poster Commission Members:<br />

President: Fantozzi R. (Turin)<br />

Members: Leone R. (Verona), Sautebin L. (Naples)<br />

USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE<br />

(CAM) BY PATIENTS WITH CHRONIC NON-MALIGNANT<br />

PAIN: COMPARISON BETWEEN PRIMARY HEADACHE AND<br />

RHEUMATIC DISEASE<br />

Spaccapelo L., Giuggioli D., Tacchi R., Ferrari A.<br />

(Modena)<br />

SUPERIORITY OF ENDOGENOUS VERSUS DIETARY<br />

ANTIOXIDANTS TO PREVENT OXIDATIVE DAMAGE IN RAT<br />

BRAIN<br />

Barone E., Guido P., Siciliano R., Lofaro A., Mancuso C.<br />

(Rome)<br />

GINKGO BILOBA EXTRACT, EGB 761, DECREASES LIPID<br />

PEROXIDATION AND IMPROVES COGNITIVE IMPAIRMENT<br />

IN PATIENTS WITH ISCHEMIC CEREBROPATHY<br />

Fiaschi A., Cerretani D., Fiore G., Cianchi C., Mancuso M.<br />

(Siena, Grosseto)<br />

OXIDATIVE STRESS AND SPA (SALUS PER AQUAM)<br />

THERAPY<br />

Costantino M., Filippelli A. (Naples)<br />

SCREENING OF ANTIOXIDANT PROPERTIES OF<br />

SPONTANEOUS ALLIUM SPECIES FROM ITALY<br />

Micheli L., Nencini C. (Siena)<br />

STUDIES IN VITRO OF PHARMACOLOGICAL PROPERTIES<br />

OF ECUADORIAN BLOOD-RED SAP FROM CROTON<br />

LECHLERI<br />

Froldi G., Montopoli M., Caparrotta L., Dorigo P. (Padua)<br />

123<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/8/7<br />

P-2/8/8<br />

P-2/8/9<br />

P-2/8/10<br />

P-2/8/11<br />

P-2/8/12<br />

P-2/8/13<br />

P-2/8/14<br />

USE OF COMPLEMENTARY/ALTERNATIVE MEDICATIONS<br />

AMONG PATIENTS UNDERGOING ANAESTHESIOLOGIC<br />

PREOPERATIVE ASSESSMENT<br />

Lapi F., Gallo E., Paoletti A., Di Pirro M., Pugi A., Vietri M.,<br />

Banchelli G., Moschini M., Cecchi E., Lupi P., La Torre M.,<br />

Diddi G., Gori L., Firenzuoli F., Mugelli A., Vannacci A.,<br />

Giommoni F. (Florence, Empoli, Prato)<br />

ATTITUDES TOWARDS HERBAL REMEDIES AMONG<br />

PHYSICIANS AND PATIENTS: A COMPARISON SURVEY IN<br />

FIVE TUSCANY HOSPITALS<br />

Pugi A., Gallo E., Paoletti A., Di Pirro M., Vietri M.,<br />

Banchelli G., Moschini M., Cecchi E., Fazzini A., Gori L.,<br />

Firenzuoli F., Mugelli A., Vannacci A., Lapi F. (Florence,<br />

Empoli)<br />

AN ANTI-HYPERTENSIVE HERBAL SUPPLEMENT<br />

CONTAINING NOT-DECLARED RESERPINE: A POSSIBLE<br />

RISK FOR PATIENTS' HEALTH<br />

Vannacci A., Giocaliere E., Paoletti A., Di Pirro M., Pugi<br />

A., Vietri M., Banchelli G., Moschini M., Cecchi E., Fazzini<br />

A., Gallo E., Pieraccini G., Moneti G., Gori L., Firenzuoli F.,<br />

Lapi F., Mugelli A. (Florence, Empoli)<br />

NATURAL PRODUCTS DURING PREGNANCY: ARE THEY<br />

SAFE?<br />

Vitalone A., Costa L. (Rome, Seattle)<br />

AN HEPATOTOXICITY STUDY AFTER PROLONGED ORAL<br />

ADMINISTRATION OF CASSIA ANGUSTIFOLIA L. IN<br />

WISTAR RATS<br />

Vitalone A., Di Sotto A., Franchitto A., Mammola C.,<br />

Mariani P., Mastrangelo S., Paoletti A., Mazzanti G. (Rome)<br />

DIFFERENCE OF FLAVONOIDS CONTENT AND<br />

ANTIOXIDANT ACTIVITY OF FRESH AND CANNED CHERRY<br />

TOMATO EXTRACTS<br />

Morabito G., Arcoraci T., Cristani M., Trombetta D.,<br />

Martorana M., Mancari F., Ferreri A. (Messina)<br />

A HUMAN “BIOREACTOR” MODEL TO UNDERSTAND THE<br />

BIOLOGICAL EFFECTS OF PLANT-DERIVED ACTIVE<br />

COMPOUNDS: A STUDY ON HUMAN ENDOTHELIAL CELLS<br />

Cimino F., Canali R., Virgili F., Saija A., Ricciardi E.,<br />

Chirafisi J., Speciale A. (Messina, Rome)<br />

BIOACCESSIBILITY OF PHENOLS FROM ALMOND SKINS<br />

USING AN “IN VITRO” DYNAMIC DIGESTION MODEL<br />

Arcoraci T., Mandalari G., Martorana M., Bisignano C.,<br />

Wickham M., Monteleone D., Bisignano G., Tomaino A.<br />

124<br />

P-2/8/15<br />

(Messina, Norwich)<br />

STUDY OF ANTIOXIDANT ACTIVITY AND PHENOLIC<br />

PROFILE OF PISTACHIO (PISTACIA VERA L. VAR. BRONTE)<br />

NUT<br />

Martorana M., Arcoraci T., Monteleone D., Giovinazzo C.,<br />

Saija A., Tomaino A. (Messina)<br />

125<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Poster Area<br />

Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />

Author’s attendance at poster site: the author in bold will be available at the<br />

poster site between 2.00 and 4.00 pm<br />

Poster board<br />

No.:<br />

P-2/9/1<br />

P-2/9/2<br />

P-2/9/3<br />

P-2/9/4<br />

P-2/10/1<br />

Poster Session<br />

P-2/9, P-2/10 and P-2/11: INNOVATIVE AND<br />

BIOTECHNOLOGICAL DRUGS, PHARMACOGENETICS,<br />

CLINICAL TRIALS<br />

Poster Commission Members:<br />

President: Spina E. (Messina)<br />

Members: Danesi R. (Pisa), Genazzani A. (Novara)<br />

ADIPOSE-DERIVED STEM CELLS (ASCS) FOR THE<br />

TREATMENT OF OSTEOCHONDRAL DEFECTS:<br />

COMPARISON BETWEEN HUMAN AND PORCINE ASCS FOR<br />

FUTURE PRE-CLINICAL MODELS<br />

Arrigoni E., Lopa S., de Girolamo L., Stanco D., Brini A.<br />

(Milan)<br />

HUMAN ADIPOSE-DERIVED STEM CELLS (HASCS): A<br />

USEFUL TOOL TO SCREEN BIOMATERIALS FOR BONE<br />

REGENERATIOM<br />

Lopa S., Arrigoni E., de Girolamo L., Stanco D., Chiesa R.,<br />

Brini A. (Milan)<br />

DENTAL PULP MESENCHYMAL STEM CELLS PLASTICITY: A<br />

PROMISING TOOL IN DAMAGED TISSUES RESTORING<br />

Sprio A., Di Scipio F., Raimondo S., Salamone P., Folino<br />

A., Geuna S., Di Carlo F., Berta G. (Orbassano)<br />

PREFERENTIAL KILLING OF CANCER CELLS USING SIC<br />

QDS<br />

Barberis A., Marino S., Geloen A., Lysenko V., Mancardi<br />

D., Merlino A., Di Carlo F., Mognetti B. (Orbassano, Lyon)<br />

PHARMACOGENETICS OF CITALOPRAM IN PALLIATIVE<br />

CARE OF CANCER<br />

Schillani G., Giraldi T., Capozzo M., Conte M. (Trieste,<br />

San Vito al Tagliamento)<br />

P-2/10/2 DISTRIBUTION OF CB2 CANNABINOID RECEPTOR<br />

126<br />

P-2/10/3<br />

P-2/10/4<br />

P-2/10/5<br />

P-2/10/6<br />

P-2/10/7<br />

P-2/10/8<br />

P-2/10/9<br />

P-2/10/10<br />

POLYMORPHISMS IN AN ITALIAN POPULATION<br />

Minocci D., Martino A., Massei J., Rossi A., Nieri P. (Pisa)<br />

DRUG RELATED-GENE POLYMORPHISMS MAY PREDICT<br />

SURVIVAL IN ESOPHAGEAL CANCER PATIENTS RECEIVING<br />

NEO-ADJUVANT RADIO-CHEMOTHERAPY<br />

Bertolaso L., Gusella M., De Manzoni G., Bruscagin S.,<br />

Stievano L., Zanoni A., Ferrazzi E., Cordiano C., Padrini R.,<br />

Pasini F. (Rovigo, Verona, Padua)<br />

PRECLINICAL STUDIES OF COMBINATION OF<br />

GEMCITABINE AND VANDETANIB IN BLADDER<br />

TRANSITIONAL CANCER CELLS<br />

Mey V., Ricciardi S., Del Tacca M., Danesi R. (Pisa)<br />

SYNERGISTIC CYTOTOXICITY AND MOLECULAR<br />

INTERACTION ON DRUG TARGETS OF SORAFENIB AND<br />

GEMCITABINE IN HUMAN PANCREAS CANCER AND NSCLC<br />

CELL LINES<br />

Ricciardi S., Mey V., Pasqualetti G., Del Tacca M., Danesi<br />

R. (Pisa)<br />

ABCB1 POLYMORPHISMS ARE ASSOCIATED WITH<br />

CLOZAPINE PLASMA LEVELS IN PSYCHOTIC PATIENTS<br />

Lastella M., Consoli G., Polillo M., Ciapparelli A., Ciofi L.,<br />

Di Paolo A., Dell'Osso L., Del Tacca M., Danesi R. (Pisa)<br />

THIOPURINE S-METHYLTRANSFERASE<br />

PHARMACOGENETICS ON A LARGE-SCALE HEALTHY<br />

ITALIAN-CAUCASIAN POPULATION: DIFFERENCE IN<br />

ENZYME ACTIVITY<br />

Serpe L., Calvo P., Muntoni E., D'Antico S., Giaccone M.,<br />

Barbera C., Pera A., Ferretti C., Eandi M., Zara G.,<br />

Canaparo R. (Turin)<br />

ASSOCIATION BETWEEN SNPS IN CLOCK GENES AND<br />

ANTICANCER DRUG TOXICITY<br />

Caronno A., Pannacci M., Benfante R., Pirovano M.,<br />

Fornasari D., Scaglione F. (Milan)<br />

CYP3A5 POLYMORPHISMS AND CARBAMAZEPINE PLASMA<br />

LEVELS IN EPILEPTIC PATIENTS<br />

Magliulo L., Fallarini S., Viana M., Scordo M., Dahl M.,<br />

Monaco F., Lombardi G. (Novara, Uppsala)<br />

ROLE OF GENETIC POLYMORPHISMS IN THE CLINICAL<br />

RESPONSE TO GLUCOCORTICOIDS IN PEDIATRIC<br />

INFLAMMATORY BOWEL DISEASES<br />

De Iudicibus S., Londero M., Martelossi S., Stocco G.,<br />

Decorti G., Bartoli F., Ventura A. (Trieste)<br />

127<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

P-2/10/11<br />

P-2/10/12<br />

P-2/11/1<br />

P-2/11/2<br />

P-2/11/3<br />

GENETICS INTERACTIONS BETWEEN CITALOPRAM<br />

ANTIDEPRESSANT ACTIVITY AND MAO-A VNTR<br />

POLYMORPHISM IN PALLIATIVE CARE OF CANCER<br />

Era D., Schillani G., Capozzo M., Conte M., Giraldi T.<br />

(Trieste, San Vito al Tagliamento)<br />

A GENETIC PERSPECTIVE TO THE RESPONSE TO PT-<br />

BASED CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL<br />

LUNG CANCER (NSCLC) PATIENTS: TOWARD A<br />

CUSTOMIZED CHEMOTHERAPY<br />

Affatato A., Papi M., Valli M., Angelini S., Hrelia P.,<br />

Ravaioli A., Cantelli Forti G. (Bologna, Rimini)<br />

PHARMACOKINETIC AND PHARMACODINAMIC<br />

EVALUATIONS OF METRONOMIC CHEMOTHERAPY WITH<br />

ORAL URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE<br />

(CTX) AND CELECOXIB (CXB) IN PRETREATED PATIENTS<br />

WITH ADVANCED GASTROINTESTINAL CANCERS<br />

Di Desidero T., Allegrini G., Barletta M., Fioravanti A.,<br />

Orlandi P., Canu B., Di Paolo A., Danesi R., Falcone A.,<br />

Loupakis F., Masi G., Del Tacca M., Bocci G. (Pisa, Livorno,<br />

Pontedera)<br />

CLINICAL TRIALS ON “NON PHARMACEUTICAL<br />

PRODUCTS”, A NEW ASPECT OF EVIDENCE BASED<br />

MEDICINE<br />

Nunziata A., Bianco S. (Pomezia)<br />

RECURRENT URETHRAL STENOSIS: A PILOT CLINICAL<br />

STUDY OF LOCAL PACLITAXEL TREATMENT<br />

Robbiano L., Fucile C., Marini V., Gallo F., Giberti C.,<br />

Martelli A., Mattioli F. (Genoa, Savona)<br />

128<br />

4.00<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Arcobaleno – 4.00-4.30 pm<br />

PLENARY LECTURE<br />

Introduction: Drago F. (Catania)<br />

THE PHARMACOLOGICAL RESEARCH IN EUROPE: A BID FOR THE<br />

TWENTY-FIRST CENTURY<br />

Moilanen E. (Tampere)<br />

129<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Arcobaleno – 4.45-6.45 pm<br />

Oral Communications<br />

PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 4)<br />

Chairpersons: Pedata F. (Florence),<br />

Romualdi P. (Bologna)<br />

4.45 pm FUNCTIONAL CROSS-TALK BETWEEN INTERLEUKIN-1<br />

RECEPTOR AND NMDA RECEPTOR<br />

Gardoni F., Boraso M., Zianni E., Galli C., Cattabeni F.,<br />

Marinovich M., Di Luca M., Viviani B. (Milan)<br />

5.00 pm SELECTIVE ADENOSINE A2A RECEPTOR AGONISTS REDUCE<br />

THE APOPTOSIS IN AN EXPERIMENTAL MODEL OF SPINAL<br />

CORD TRAUMA<br />

Genovese T., Melani A., Esposito E., Mazzon E., Di Paola<br />

R., Bramanti P., Linden J., Pedata F., Cuzzocrea S.<br />

(Messina, Florence, Naples, Charlottesville)<br />

5.15 pm NOX2-DEFICIENCY PREVENTS KETAMINE-INDUCED<br />

BEHAVIOURAL AND BIOCHEMICAL ALTERATIONS IN MICE<br />

Sorce S., Schiavone S., Tucci P., Dubois-Dauphin M.,<br />

Trabace L., Krause K. (Geneva, Rome, Foggia)<br />

5.30 pm ADAM10/SAP97 ASSOCIATION IS DEFECTIVE IN<br />

ALZHEIMER DISEASE PATIENTS’ HIPPOCAMPUS<br />

Marcello E., Epis R., Gardoni F., Saraceno C., Cattabeni<br />

F., Borroni B., Padovani A., Di Luca M. (Milan, Brescia)<br />

5.45 pm ROLE OF PURINERGIC P2 RECEPTORS ON SYNAPTIC<br />

TRANSMISSION, NEURONAL SURVIVAL AND MAPK<br />

ACTIVATION DURING OXYGEN-GLUCOSE DEPRIVATION IN<br />

THE RAT CA1 HIPPOCAMPUS<br />

Traini C., Pugliese A., Cipriani S., Mello T., Andrea G.,<br />

Giovannini M., Pedata F. (Florence)<br />

6.00 pm NEW INSIGHT FOR A THERAPEUTICAL APPROACH TO<br />

ALCOHOLISM: STUDY OF TOXICITY, TOLERANCE AND<br />

ETHANOL DEPENDENCE MECHANISMS BY REGULATION OF<br />

TRANSCRIPTION, MOLECULAR IMAGING AND EPIGENETIC<br />

ANALYSIS<br />

D'Addario C., Caputi F., Candeletti S., Vukojevic V.,<br />

Ogren S., Terenius L., Romualdi P. (Bologna, Stockholm)<br />

6.15 pm CENTRAL INFUSION OF [NPHE 1 , ARG 14 , LYS 15 ] N/OFQ-NH2<br />

(UFP-101), A POTENT NOP RECEPTOR ANTAGONIST,<br />

130<br />

REVERSES BEHAVIOURAL EFFECTS IN A CHRONIC MODEL<br />

OF STRESS: CELLULAR AND MOLECULAR IMPLICATIONS<br />

Vitale G., Ruggieri V., Zucchini S., Frigeri C., Filaferro M.,<br />

Cifani C., Simonato M., Massi M. (Modena, Ferrara,<br />

Camerino)<br />

6.30 pm STRESS ENHANCES THE EXPRESSION OF THE WNT<br />

ANTAGONIST, DICKKOPF-1, IN THE MOUSE<br />

HIPPOCAMPUS: A KEY PROTEIN OF STRESS-INDUCED<br />

NEURODEGENERATION?<br />

Bucci D., Matrisciano F., Busceti C., Caruso A., Orlando<br />

R., Scaccianoce S., Biagioni F., Cappuccio I., Battaglia G.,<br />

Bruno V., Caraci F., Gradini R., Copani A., Melchiorri D.,<br />

Nicoletti F. (Pozzilli, Rome, Pavia, Catania)<br />

131<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.15<br />

pm<br />

6.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Azzurra – 4.45-7.00 pm<br />

Symposium<br />

FOCUS ON TARGETED ANTITUMOR DRUGS: ACTIVITY,<br />

RESISTANCE, CARDIOVASCULAR SAFETY<br />

Chairpersons: Menard S. (Milan), Minotti G. (Rome)<br />

TARGETED ANTI-TUMOR DRUGS: MOLECULAR MECHANISMS OF<br />

ACTIVITY AND RESISTANCE<br />

Menard S. (Milan)<br />

CLINICAL CORRELATES OF ACTIVITY AND RESISTANCE<br />

Di Maio M. (Naples)<br />

ANTINEOPLASTICS AND THE HEART: FROM ANTHRACYCLINES TO<br />

TARGETED DRUGS<br />

Minotti G. (Rome)<br />

CARDIOVASCULAR SAFETY OF TARGETED THERAPIES:<br />

TRASTUZUMAB AND OTHER CLINICAL PARADIGMS<br />

Gianni L., Bianchi G. (Milan)<br />

FINAL TEST<br />

132<br />

4.45<br />

pm<br />

5.05<br />

pm<br />

5.25<br />

pm<br />

5.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Blu – 4.45-6.00 pm<br />

Symposium<br />

ACTUAL AND FUTURE PERSPECTIVES IN PAIN THERAPY<br />

Chairperson: Canonico P. L. (Novara)<br />

THE USE OF THE OPIOIDS IN ITALY<br />

Navarra P. (Rome)<br />

RECENT ADVANCES IN THE MOLECULAR PHARMACOLOGY OF<br />

OPIOIDS ARE DRIVING TO A BETTER PAIN THERAPY<br />

Sacerdote P. (Milan)<br />

TAPENTADOL: A NOVEL µ OPIOID RECEPTOR AGONIST/<br />

NORADRENALINE REUPTAKE INHIBITOR WITH ANALGESIC<br />

PROPERTIES IN ACUTE NOCICEPTIVE AND CHRONIC<br />

NEUROPATHIC PAIN<br />

Jahnel U. (Aachen)<br />

(Educational support from Grünenthal-Italia)<br />

FINAL TEST<br />

133<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.05<br />

pm<br />

6.25<br />

pm<br />

6.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Giardino d’Inverno – 4.45-7.00 pm<br />

<strong>SIF</strong> Clinical Section Symposium<br />

PLACEBO AND CLINICAL TRIALS: UPDATE AND FUTURE ISSUES<br />

Chairpersons: Mugelli A. (Florence), Borea P. A. (Ferrara)<br />

THE PLACEBO EFFECTS<br />

Benedetti F. (Turin)<br />

PLACEBO AND CLINICAL TRIALS WITH CENTRAL NERVOUS<br />

SYSTEM DRUGS<br />

De Ponti F. (Bologna)<br />

PLACEBO AND CLINICAL TRIALS WITH CARDIOVASCULAR DRUGS<br />

Patrono C. (Rome)<br />

PLACEBO AND CLINICAL TRIALS IN ONCOLOGY<br />

Di Costanzo F. (Florence)<br />

DISCUSSION<br />

Geppetti P., Del Tacca M. (Florence, Pisa)<br />

FINAL TEST<br />

134<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.15<br />

pm<br />

6.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Viola – 4.45-7.00 pm<br />

Symposium<br />

CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY<br />

Chairpersons: Ceci A. (Bari), Conte Camerino D. (Bari)<br />

ANTITUMORAL CHEMOTHERAPIES WITH HIGH NEUROTOXIC<br />

POTENTIAL<br />

Mazzei T. (Florence)<br />

MOLECULAR MECHANISMS RESPONSIBLE FOR NEUROTOXICITY<br />

INDUCED BY CHEMOTHERAPEUTICS AND POSSIBLE<br />

THERAPEUTIC APPROACHES<br />

Desaphy J. F. (Bari)<br />

INDIVIDUATION OF RISK FACTORS AND DIAGNOSIS IN A<br />

MULTIDISCIPLINARY CONTEXT<br />

Cavaletti G. (Monza)<br />

THE CONTROL OF CHEMOTHERAPY-INDUCED NEUROPATHY IN<br />

CLINICAL PRACTICE<br />

Amadori D. (Forlì)<br />

(Educational support from “Gianni Benzi” Foundation)<br />

FINAL TEST<br />

135<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Arancione – 4.45-6.45 pm<br />

Oral Communications<br />

CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />

(SESSION 2)<br />

Chairpersons: Padrini R. (Padua), Sala A. (Milan)<br />

4.45 pm DETERMINANTS OF THE VARIABILITY OF THROMBOXANE<br />

INHIBITION BY ASPIRIN IN PATIENTS WITH<br />

CARDIOVASCULAR DISEASE<br />

Capone M., Grossi L, Anzellotti P, Evangelista V, Levantesi<br />

G., Porreca E., Di Febbo C., Moretta V., Meneguzzi A.,<br />

Ferraro R., Tontodonati P., Manarini S., Fava C., Minuz P.,<br />

Patrignani P. (Chieti, Verona, Santa Maria Imbaro)<br />

5.00 pm TIMING OF PHARMACOLOGICAL INTERVENTION AFTER<br />

OVARIECTOMY DICTATES THE VASOPROTECTIVE ACTIONS<br />

OF ESTROGEN RECEPTOR-α SELECTIVE AGONISTS<br />

Cignarella A., Pinna C., Sanvito P., Pelosi V., Gaion R.,<br />

Bolego C. (Padua, Milan)<br />

5.15 pm ROSUVASTATIN PREVENTS ENDOTHELIAL DYSFUNCTION<br />

IN MESENTERIC RESISTANCE ARTERIES FROM RATS WITH<br />

ANGIOTENSIN II-INDUCED HYPERTENSION<br />

Colucci R., Virdis A., Ghisu N., Antonioli L., Fornai M.,<br />

Duranti E., Blandizzi C., Taddei S., Del Tacca M. (Pisa)<br />

5.30 pm ELECTROPHYSIOLOGICAL EVALUATION OF NOVEL<br />

BLOCKERS OF IF CURRENT<br />

Del Lungo M., Melchiorre M., Sartiani L., Biel M., Varro A.,<br />

Mugelli A., Romenelli M., Cerbai E. (Florence, Munchen,<br />

Szeged)<br />

5.45 pm APOLIPOPROTEIN A-I DEGRADATION AFTER TREATMENT<br />

WITH ALTEPLASE AND TENECTEPLASE: IN VITRO AND IN<br />

VIVO STUDIES<br />

Gomaraschi M., Pozzi S., Sinagra G., Franceschini G.,<br />

Calabresi L. (Milan, Trieste)<br />

6.00 pm PPARS EXPRESSION IN MONOCYTE/MACROPHAGES: A<br />

POSSIBLE GENDER DIFFERENCE IN PATIENTS WITH<br />

CORONARY HEART DISEASE (CHD)<br />

Amoruso A., Bardelli C., Fresu L., Palma A., Brunelleschi<br />

S. (Novara)<br />

136<br />

6.15 pm BENEFICIAL EFFECTS OF A HEPARIN-LIKE SEMI-<br />

SYNTHETIC DERIVATIVE IN A RAT MODEL OF CEREBRAL<br />

ISCHEMIA/REPERFUSION INJURY<br />

Collino M., Castiglia S., Manoni M., Salsini L., Chini J.,<br />

Masini E., Fantozzi R. (Turin, Montale, Florence)<br />

6.30 pm A SELECTIVE H4R ANTAGONIST PREVENTS ANTIGEN-<br />

INDUCED AIRWAY INFLAMMATION IN GUINEA PIG: A<br />

PIVOTAL ROLE OF ANNEXIN-A1<br />

Vinci M., Lanzi C., Mastroianni R., Uliva C., Cinci L., Bani<br />

D., Thurmond R., Masini E. (Florence, San Diego)<br />

137<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

4.45<br />

pm<br />

5.15<br />

pm<br />

5.45<br />

pm<br />

6.15<br />

pm<br />

6.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Bianca – 4.45-7.00 pm<br />

SITOX-<strong>SIF</strong> Symposium<br />

NEW APPROACHES FOR ASSESSING SAFETY OF DRUG<br />

IMPURITIES<br />

Chairpersons: Galli C. L. (Milan), Hrelia P. (Bologna)<br />

DEFINITION OF THE SAFETY DOSE IN RISK CHARACTERIZATION<br />

Galli C. L. (Milan)<br />

APPLICATION OF THE TTC (THRESHOLD OF TOXICOLOGICAL<br />

CONCERN) TO DRUG IMPURITIES EVALUATION<br />

Marinovich M. (Milan)<br />

IN SILICO MODELS FOR GENOTOXICITY: THE APPROACH OF<br />

CAESAR AND OTHER INITIATIVES<br />

Benfenati E. (Milan)<br />

EMEA APPROACH IN THE NON CLINICAL EVALUATION OF<br />

POTENTIALLY GENOTOXIC IMPURITIES IN PHARMACEUTICAL<br />

DRUG SUBSTANCES<br />

Meneguz A. (Rome)<br />

FINAL TEST<br />

138<br />

4.45<br />

pm<br />

5.05<br />

pm<br />

5.25<br />

pm<br />

5.45<br />

pm<br />

6.05<br />

pm<br />

6.25<br />

pm<br />

6.45<br />

pm<br />

FRIDAY, October 16, 2009<br />

Sala Verde – 4.45-7.00 pm<br />

Symposium<br />

HDAC INHIBITORS: EMERGING DRUGS WITH PLEIOTYPIC<br />

THERAPEUTIC POTENTIAL<br />

Chairpersons: Chiarugi A. (Florence), Mascagni P. (Milan)<br />

TARGETING HISTONE DEACETYLASES: VORINOSTAT AND NOVEL<br />

CLASSES OF HDACI<br />

Steinkühler C. (Rome)<br />

HDACS AND APOPTOSIS: IS HDAC4 A GOOD TARGET?<br />

Brancolini C. (Udine)<br />

HDAC INHIBITORS AS NOVEL ANTI-INFLAMMATORY AGENTS<br />

Dinarello C. A. (Denver)<br />

EPIGENETIC BASIS OF MUSCLE REGENERATION IN MUSCULAR<br />

DYSTROPHY<br />

Puri P. L. (Rome)<br />

HISTONE DEACETYLASE INHIBITORS IN CANCER: GIVINOSTAT, A<br />

CASE STUDY<br />

Fossati G. (Milan)<br />

REGULATION OF SELF-RENEWAL IN CANCER STEM CELLS<br />

Pelicci P. G. (Milan)<br />

FINAL TEST<br />

139<br />

FRIDAY, October 16, 2009


FRIDAY, October 16, 2009<br />

FRIDAY, October 16, 2009<br />

Sala Rossa – 4.45-6.45 pm<br />

Oral Communications<br />

PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />

(SESSION 2)<br />

Chairpersons: Sautebin L. (Naples), Velo G. P. (Verona)<br />

4.45 pm THE RISK OF CARDIAC VALVE REGURGITATION WITH<br />

ERGOT AND NON-ERGOT DERIVED DOPAMINE AGONIST<br />

USE IN PARKINSON’S DISEASE<br />

Trifirò G., Mokhles M., Dieleman J., van Soest E.,<br />

Mazzaglia G., Vehramme K., Lesaffre E., Colao A.,<br />

Haverkamp H., van Camp G., Schade R., Brusselle G.,<br />

Zanettini R., de Luise C., Sturkenboom M. (Messina,<br />

Rotterdam, Florence, Naples, Berlin, Brussels, Gent, Milan,<br />

New York)<br />

5.00 pm DRUG-INDUCED HEPATIC INJURY IN CHILDREN: ANALYSIS<br />

OF SPONTANEOUS REPORTS OF SUSPECTED ADVERSE<br />

DRUG REACTIONS IN THE WHO DATABASE<br />

Ferrajolo C., Capuano A., Verhamme K., Schuemie M.,<br />

Rossi F., Stricker B., Sturkenboom M. (Naples, Rotterdam)<br />

5.15 pm INDEPENDENT DRUG INFORMATION: THE <strong>SIF</strong> “FARMACI<br />

IN EVIDENZA” INPUT<br />

Luppino M. R., Rosa A. C., Casale F., Cerbai E., Fantozzi<br />

R. (Messina, Turin, Florence)<br />

5.30 pm SAFETY AND TOLERABILITY OF ADHD MEDICATIONS: AN<br />

INTENSIVE MONITORING PROGRAMME IN THE CAMPANIA<br />

REGION<br />

Basilicata G., Pascotto A., Bravaccio C., Grimaldi G.,<br />

Granato R., Gallo M., Rafaniello C., Ianniello B., Potenza<br />

S., Ruggiero S., Formica R., Rossi F., Capuano A. (Naples,<br />

Aversa)<br />

5.45 pm NOTIFICATION OF UNDESIRABLE EFFECTS OF COSMETICS<br />

AND TOILETRIES<br />

Sportiello L., Cammarota S., de Portu S., Sautebin L.<br />

(Naples)<br />

6.00 pm THE SOS PROJECT (SAFETY OF NSAIDS): PRELIMINARY<br />

RESULTS OF PUBLISHED META-ANALYSES REVIEW<br />

Salvo F., Pariente A., Gulmez S., Guillaume Y.,<br />

Castellsague J., Haag M., Sturkenboom M., Moore N.,<br />

Fourrier-Réglat A. (Messina, Bordeaux, Barcelona,<br />

140<br />

Rotterdam)<br />

6.15 pm HOSPITAL-BASED CASE-CONTROL NETWORKS FOR<br />

SURVEILLANCE OF ADVERSE DRUG REACTIONS: A CASE-<br />

CONTROL STUDY IN ITALY<br />

Loraschi A., Volontè A., Catherine K., Castelletti C., Tosi<br />

L., Malesci A., Monina G., Cosentino M. (Varese, Busto<br />

Arsizio, Pavia, Gallarate)<br />

6.30 pm ASSESSING THE RISK OF OSTEONECROSIS OF THE JAWS<br />

(ONJ) DUE TO BISPHOSPHONATES THERAPY IN THE<br />

SECONDARY PREVENTION OF OSTEOPOROTIC<br />

FRACTURES: A NESTED CASE-CONTROL STUDY USING<br />

REGIONAL CLAIMS DATABASES<br />

Lapi F., Corrao G., Montanaro N., Sturkenboom M.,<br />

Geppetti P., Gregori D., Carle F., Menna A., Vestri A.,<br />

Valenti M., Caputi A. P., Mazzaglia G. (Florence, Milan,<br />

Bologna, Rotterdam, Turin, Pescara, Rome, L'Aquila,<br />

Messina)<br />

141<br />

FRIDAY, October 16, 2009


SATURDAY, October 17, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Azzurra – 8.30-10.30 am<br />

Symposium<br />

PHARMACOEPIDEMIOLOGY FOR MONITORING OF DRUG SAFETY<br />

AND RATIONAL DRUG USE: A GOOD CASE FOR TRANSLATION<br />

MEDICINE<br />

Chairperson: Patrignani P. (Chieti)<br />

SELECTED EXAMPLES OF PHARMACOEPIDEMIOLOGIC STUDIES<br />

USING PRIMARY CARE DATABASES<br />

Garcia Rodriguez L. (Madrid)<br />

HOW TO DESIGN A PHARMACOEPIDEMIOLOGY STUDY<br />

ASSOCIATED WITH ANALYSIS OF GENETICS FOR ASSESSMENT<br />

OF GASTROINTESTINAL RISK AMONG USERS OF INDIVIDUAL<br />

TRADITIONAL NSAIDS AND SELECTIVE COX-2 INHIBITORS<br />

Lanas A. (Zaragoza)<br />

THE PROACTIVE MODEL IN PHARMACOVIGILANCE AND THE ROLE<br />

OF PRIMARY CARE DATABASES: THE CASE OF BIFAP IN SPAIN<br />

de Abajo F. (Madrid)<br />

THE PROACTIVE MODEL IN PHARMACOVIGILANCE AND THE ROLE<br />

OF INDEPENDENT RESEARCH FUNDING IN ITALY<br />

Traversa G. (Oleggio)<br />

(Sponsored by EPHAR with support from the British Pharmacological Society,<br />

educational support from Pfizer Italia)<br />

142<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Blu – 8.30-10.30 am<br />

Symposium<br />

INDIVIDUALIZATION OF DRUG THERAPY IN THE TREATMENT OF<br />

PSYCHIATRIC DISORDERS<br />

Chairpersons: Gennarelli M. (Brescia), Spina E. (Messina),<br />

FACTORS OF VARIABILITY IN THE RESPONSE TO PSYCHOTROPIC<br />

DRUGS<br />

Torta R. (Turin)<br />

USEFULNESS AND LIMITATIONS OF THERAPEUTIC DRUG<br />

MONITORING OF PSYCHOTROPIC DRUGS<br />

Spina E. (Messina)<br />

PHARMACOGENETICS OF PSYCHOTROPIC DRUGS: PHARMACO-<br />

KINETICS ASPECTS<br />

Fornasari D. (Milan)<br />

PHARMACOGENETICS OF PSYCHOTROPIC DRUGS: PHARMACO-<br />

DYNAMICS ASPECTS<br />

Gennarelli M. (Brescia)<br />

143<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Giardino d’Inverno – 8.30-10.30 am<br />

Symposium<br />

THE GLUTAMATERGIC SYNAPSE - A MAJOR SITE FOR DISEASE<br />

AND DRUG ACTION<br />

Chairpersons: Nicoletti F. (Rome), Nisticò R. (Rende)<br />

INTERACTION BETWEEN EPHRINS AND mGLU5 METABOTROPIC<br />

GLUTAMATE RECEPTORS IN THE INDUCTION OF LONG-TERM<br />

SYNAPTIC DEPRESSION IN THE HIPPOCAMPUS<br />

Piccinin S. (Rome)<br />

ROLES FOR KAINATE RECEPTORS IN SYNAPTIC TRANSMISSION<br />

AND PLASTICITY IN THE HIPPOCAMPUS<br />

Bortolotto Z. A., Collingridge G. L. (Bristol)<br />

PRESYNAPTIC MECHANISMS OF AUTO-REGULATION OF<br />

GLUTAMATE RELEASE IN MAMMALIAN BRAIN<br />

Pittaluga A. (Genoa)<br />

D-ASPARTATE, A NOVEL MODULATOR OF HIPPOCAMPAL<br />

SYNAPTIC PLASTICITY AND SPATIAL MEMORY<br />

Nisticò R. (Rende)<br />

144<br />

8.30<br />

am<br />

8.50<br />

am<br />

9.10<br />

am<br />

9.30<br />

am<br />

9.50<br />

am<br />

10.10<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Viola – 8.30-10.30 am<br />

Symposium<br />

WOMEN AGING: FROM BASIC RESEARCH NOVEL THERAPEUTIC<br />

OPPORTUNITIES<br />

Chairperson: Franconi F. (Sassari)<br />

ESTROGEN RECEPTOR FUNCTION AND CARDIOMETABOLIC RISK<br />

IN POST-MENOPAUSAL WOMEN<br />

Cignarella A. (Padua)<br />

TO FISH OUT PERIPHERAL BLOOD BIOMARKERS OF METABOLIC<br />

SYNDROME IN A GENDER PERSPECTIVE: A PILOT STUDY<br />

Straface E. (Rome)<br />

BIOTECHNOLOGICAL ANIMAL MODELS FOR THE STUDY OF NOVEL<br />

DRUGS<br />

Ciana P. (Milan)<br />

ROLE OF ESTROGEN IN THE REGULATION OF LUNG<br />

INFLAMMATION<br />

Cuzzocrea S. (Messina)<br />

A NOVEL, HIGHLY RELIABLE REPORTER MOUSE TO STUDY NF-KB<br />

ACTIVITY IN LIVING ANIMALS<br />

Rizzi N. (Sant'Angelo Lodigiano)<br />

ESTROGEN AND BRAIN INFLAMMATION: RESULTS FROM THE<br />

"EWA" EUROPEAN PROJECT ON ESTROGEN AND WOMEN AGING<br />

Vegeto E. (Milan)<br />

145<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Arancione – 8.30-10.30 am<br />

Oral Communications<br />

ANTIBACTERIAL, ANTIVIRAL AND ANTICANCER<br />

CHEMOTHERAPY<br />

Chairpersons: Giraldi T. (Trieste), Hrelia P. (Bologna)<br />

8.30 am CYTOTOXIC DRUGS REGULATE VEGF AND IL-8<br />

EXPRESSION IN HUMAN MELANOMA CELLS BY A2A AND<br />

A3 ADENOSINE RECEPTORS<br />

Merighi S., Simioni C., Mirandola P., Gessi S., Varani K.,<br />

Tabrizi M., Baraldi P., Borea P. A. A. (Ferrara, Parma)<br />

8.45 am CLINICAL AND PHARMACODYNAMIC EVALUATION OF<br />

METRONOMIC CYCLOPHOSPHAMIDE, CELECOXIB AND<br />

DEXAMETHASONE IN ADVANCED HORMONE-REFRACTORY<br />

PROSTATE CANCER<br />

Bocci G., Fontana A., Orlandi P., Fioravanti A., Galli L.,<br />

Galli C., Allegrini G., Fontana E., Antonuzzo A.,<br />

D'Arcangelo M., Danesi R., Falcone A., Del Tacca M. (Pisa,<br />

Livorno, Lucca)<br />

9.00 am IDENTIFICATION OF PHARMACOGENOMIC MARKERS OF 5-<br />

FLUOROURACIL-BASED CHEMOTHERAPY IN COLORECTAL<br />

CANCER<br />

Nobili S., Naples C., Landini I., Morganti M., Cianchi F.,<br />

Valanzano R., Tonelli F., Mazzei T., Mini E. (Florence)<br />

9.15 am 5-FLUOROURACIL INFLUENCES ITS OWN<br />

PHARMACOKINETICS: ASSOCIATION WITH TREATMENT<br />

TOLERABILITY<br />

Di Paolo A., Ibrahim T., Amatori F., Ravaioli E., Mercatali<br />

L., Lastella M., Del Tacca M., Danesi R., Amadori D. (Pisa,<br />

Meldola)<br />

9.30 am EFFECT OF HIF-1 MODULATION ON THE RESPONSE OF<br />

TWO- AND THREE-DIMENSIONAL CULTURES OF HUMAN<br />

COLON CANCER CELLS TO 5-FLUOROURACIL,<br />

OXALIPLATIN AND DOXORUBICIN<br />

Molteni R., Ravizza R., Gariboldi M., Monti E. (Busto<br />

Arsizio)<br />

9.45 am INFLUENCE OF TYMS GENE EXPRESSION AND GENOTYPE<br />

ON THE CLINICAL OUTCOME OF COLORECTAL CANCER<br />

PATIENTS TREATED WITH 5-FLUOROURACIL<br />

Vignoli M., Nobili S., Naples C., Putignano A., Morganti<br />

146<br />

M., Papi L., Valanzano R., Cianchi F., Tonelli F., Mazzei T.,<br />

Genuardi M., Mini E. (Florence, Sesto Fiorentino)<br />

10.00 am ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED<br />

ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION<br />

CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND<br />

CHEMOSENSITIZING ACTIVITIES<br />

Labbozzetta M., Baruchello R., Marchetti P., Gueli M.,<br />

Poma P., Notarbartolo M., Simoni D., D'Alessandro N.<br />

(Palermo, Ferrara)<br />

10.15 am CYTOTOXICITY OF HEMIDESMUS INDICUS EXTRACT IS<br />

ASSOCIATED WITH APOPTOSIS BY ACTIVATION OF<br />

MITOCHONDRIAL PATHWAY AND INTERRUPTION OF CELL-<br />

CYCLE PROGRESSION BY MODULATION OF CYCLIN A2<br />

AND P21 IN HUMAN JURKAT T CELLS<br />

Fimognari C., Lenzi M., Cantelli Forti G., Hrelia P.<br />

(Bologna)<br />

147<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

8.30<br />

am<br />

9.00<br />

am<br />

9.30<br />

am<br />

10.00<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Bianca – 8.30-10.30 am<br />

SITOX-<strong>SIF</strong> Symposium<br />

FOOD SUPPLEMENTS<br />

Chairpersons: Calapai G. (Messina), Galli C. L. (Milan)<br />

SAFETY ASSESSMENT OF BOTANICALS AND BOTANICAL<br />

PREPARATIONS USED AS FOOD SUPPLEMENTS<br />

Galli C. L. (Milan)<br />

PHARMACOLOGY OF NATURAL PRODUCTS<br />

Mazzanti G. (Rome)<br />

PHYTOTHERAPY: FROM TRADITIONAL MEDICINE TO CLINICAL<br />

EVIDENCE<br />

Firenzuoli F. (Florence)<br />

HERBAL MEDICINES: FOOD OR DRUGS?<br />

Calapai G. (Messina)<br />

148<br />

SATURDAY, October 17, 2009<br />

Sala Verde – 8.30 -10.30 am<br />

Oral Communications<br />

PAIN PHARMACOLOGY<br />

Chairpersons: Bartolini A. (Florence), Negri L. (Rome)<br />

8.30 am PPAR-ALPHA AND NF-KB ACTIVATION. IMPLICATION IN<br />

PAIN PRINCIPIATION AND CHRONIC PAIN<br />

ESTABLISHMENT<br />

D'Agostino G., La Rana G., Russo R., Sasso O., Iacono<br />

A., Esposito E., Meli R., Calignano A. (Naples)<br />

8.45 am INTRA-PERIAQUEDUCTAL GRAY GLYCINE AND D-SERINE<br />

EXERT DUAL EFFECTS ON ROSTRAL VENTROMEDIAL<br />

MEDULLA ON AND OFF CELL ACTIVITY AND<br />

THERMOCEPTIVE THRESHOLD IN THE RAT<br />

de Novellis V., Marabese I., Siniscalco D., Migliozzi A.,<br />

Guida F., Rossi F., Maione S. (Naples)<br />

9.00 am ANTI-HYPERALGESIC PROFILE OF PRAMIRACETAM IN<br />

MODELS OF NEUROPATHIC PAIN<br />

Ghelardini C., Galeotti N., Salvicchi A., Vivoli E., Bennett<br />

G., Bartolini A. (Florence, Montreal)<br />

9.15 am TARGETING BV8/PROKINETICIN RECEPTORS IN<br />

INFLAMMATORY PAIN<br />

Giannini E., Lattanzi R., Nicotra A., Balboni G., Salvadori<br />

S., Franchi S., Sacerdote P., Negri L. (Rome, Ferrara,<br />

Milan)<br />

9.30 am PERIPHERAL ANTINOCICEPTIVE ACTIVITY OF LOW DOSES<br />

OF NALOXONE: RESULTS FROM AN IN VIVO AND AN IN<br />

VITRO MODEL OF TRIGEMINAL NOCICEPTION<br />

Capuano A., De Corato A., Tringali G., Treglia M., Dello<br />

Russo C., Navarra P. (Rome)<br />

9.45 am MICROGLIA ACTIVATION IN NEUROPATHIC PAIN IS<br />

REGULATED BY CANNABINOID SYSTEM<br />

Luongo L., Giordano C., Gatta L., Marabese I., Palazzo E.,<br />

de Novellis V., Malcangio M., Rossi F., Maione S. (Naples,<br />

London)<br />

10.00 am THE PROTECTIVE EFFECT OF BERGAMOT DERIVED<br />

FLAVONOID ON THE POST-TRANSLATIONAL MODULATION<br />

OF GLUTAMATE TRANSMISSION: A NEW THERAPEUTIC<br />

APPROACH FOR OPIOID TOLERANCE<br />

149<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

Muscoli C., Dagostino C., Ventrice D., Goffredo B., Rizzo<br />

M., Casale F., Strongoli M., Vecchio I., Rotiroti D., Muraca<br />

M., Nisticò G., Mollace V. (Catanzaro, Rome, Catania)<br />

10.15 am HUMAN MESENCHYMAL STEM CELLS TRANSPLANTED IN<br />

THE CEREBRAL VENTRICLE ARE ABLE TO DECREASE<br />

NOCICEPTIVE BEHAVIOURS AND PAIN-ASSOCIATED<br />

CELLULAR AND MOLECULAR CHANGES IN NEUROPATHIC<br />

MICE<br />

Siniscalco D., Giordano C., Luongo L., de Novellis V.,<br />

Rossi F., Maione S. (Naples)<br />

150<br />

10.45<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Azzurra – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Drago F. (Catania)<br />

OLD AND NEW TARGETS FOR THE TREATMENT OF<br />

OSTEOARTHRITIS: PHARMACOLOGY AND CLINICAL<br />

PHARMACOLOGY<br />

Rovati L. (Monza)<br />

(Educational support from ROTTAPHARM MADAUS)<br />

151<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

10.45<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Blu – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Bertazzoni Minelli E. (Verona)<br />

ROLE OF M-TOR INHIBITION ON ANTITUMOUR THERAPY<br />

Danesi R. (Pisa)<br />

(Educational support from Novartis Farma)<br />

152<br />

10.45<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Giardino d’Inverno – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Patrono C. (Rome)<br />

HEMOPHILIA: PAST, PRESENT AND FUTURE<br />

Mannucci P. M. (Milan)<br />

(Educational support from Wyeth Lederle)<br />

153<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

10.45<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Viola – 10.45-11.15 am<br />

LECTURE<br />

Introduction: Rossi F. (Naples)<br />

THE RECURRENT IDIOPATHIC PERICARDITIS: A NEW TREATMENT<br />

FOR AN OLD DISEASE<br />

Palmieri G. (Milan)<br />

154<br />

11.15<br />

am<br />

SATURDAY, October 17, 2009<br />

Sala Arcobaleno – 11.15-11.45 am<br />

LECTURE<br />

Introduction: Scaglione F. (Milan)<br />

PANDEMIC INFLUENZA H1N1: GUIDANCE FOR PREVENTION AND<br />

TREATMENT<br />

Rizzardini G. (Milan)<br />

155<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

11.15<br />

am<br />

12.00<br />

pm<br />

12.45<br />

pm<br />

1.15<br />

pm<br />

1.45<br />

pm<br />

2.15<br />

pm<br />

2.30<br />

pm<br />

SATURDAY, October 17, 2009<br />

Sala Azzurra – 11.15 am-2.30 pm<br />

Gender Pharmacology <strong>SIF</strong> Group Symposium<br />

GENDER AND EQUITY IN HEALTHCARE<br />

Chairpersons: Brunelleschi S. (Novara), Franconi F. (Sassari),<br />

Vella S. (Rome)<br />

THE DETERMINING GENDER: ITALIAN EXPERIENCES<br />

Franconi F. (Sassari)<br />

PRIMARY PREVENTION AND EQUITY<br />

Rosano G. (Milan)<br />

EQUITY IN DAILY HEALTH-CARE<br />

Michieli R. (Florence)<br />

EQUITY IN HOSPITAL HEALTH-CARE<br />

Moretti A. M. (Bari)<br />

REGIONS AND GENDER EQUITY<br />

Giorni L. (Florence)<br />

ROTTAPHARM-MADAUS-<strong>SIF</strong> AWARDS<br />

FINAL TEST<br />

156<br />

SATURDAY, October 17, 2009<br />

Sala Blu – 11.15 am-1.15 pm<br />

Oral Communications<br />

PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />

(SESSION 3)<br />

Chairpersons: Garcia Rodriguez L. (Madrid),<br />

Leone R. (Verona)<br />

11.15 am CARDIOVASCULAR OUTCOMES OF STATIN TREATMENTS<br />

IN GENERAL POPULATION: A 3 YEAR RECORD-LINKAGE<br />

STUDY ON PRESCRIPTION AND HOSPITAL DISCHARGE<br />

DATABASES<br />

Carta P., Poluzzi E., Puccini A., Silvani M., Vaccheri A.,<br />

Montanaro N. (Bologna)<br />

11.30 am ADHERENCE TO EVIDENCE-BASED DRUG THERAPY AFTER<br />

ACUTE MYOCARDIAL INFARCTION: DIFFERENCES IN<br />

PATIENT AND HEALTH CARE CHARACTERISTICS IN A<br />

POPULATION-BASED COHORT IN ROME, ITALY<br />

Kirchmayer U., Belleudi V., Agabiti N., Davoli M., Fusco<br />

D., Stafoggia M., Arcà M., Barone A., Perucci C. (Rome)<br />

11.45 am RISK OF ISCHEMIC STROKE ASSOCIATED WITH<br />

ANTIDEPRESSANT DRUG USE IN ELDERLY PERSONS<br />

Trifirò G., Dieleman J., Sen E., Gambassi G., Caputi A. P.,<br />

Sturkenboom M. (Messina, Rotterdam, Rome)<br />

12.00 pm PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN<br />

PATIENTS RECEIVING RITUXIMAB: A SURVEY ON HIV-<br />

NEGATIVE PATIENTS<br />

Tuccori M., Focosi D., Montagnani S., Blandizzi C., Petrini<br />

M., Del Tacca M. (Pisa)<br />

0.15 pm PERSISTENCE AND ADHERENCE TO ORAL ANTIDIABETIC<br />

THERAPY AMONG ‘NAÏVE’ PATIENTS: A COMPARISON OF<br />

MONOTHERAPY, COMBINATION THERAPY AND FIXED-<br />

DOSE COMBINATION THERAPY<br />

Leoni O., Papagni M., Roi C., Conti V., Pisani S., Oria C.,<br />

Soma R. (Varese)<br />

12.30 pm INCIDENCE OF ADVERSE DRUG REACTIONS (ADRS) IN<br />

HOSPITALIZED CHILDREN IN THE CAMPANIA REGION<br />

Gallo M., Siani P., De Seta L., Maglione U., Saitta F.,<br />

Tarallo L., Vetrano G., Rafaniello C., Ianniello B., Ruggiero<br />

S., Illiano M., Basilicata G., Potenza S., Formica R., Irpino<br />

A., Bonati M., Rossi F., Capuano A. (Naples, Pozzuoli,<br />

157<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

Castellammare di Stabia, Benevento, Milan)<br />

12.45 pm USE OF MEDICINAL PRODUCTS AND DIETARY<br />

SUPPLEMENTS IN A POPULATION OF AMATEUR SWIMMERS<br />

Brossa A., Monico E., Giron M. (Venezia, Padua)<br />

1.00 pm OPIOID CONSUMPTION: INFLUENCE OF LAW CHANGES<br />

AND NEW DRUGS<br />

Bortolami A., Chinellato A., Terrazzani G., Roggeri D.,<br />

Skaper S., Giusti P. (Treviso, Padua)<br />

158<br />

SATURDAY, October 17, 2009<br />

Sala Giardino d’Inverno – 11.15 am-1.15 pm<br />

Oral Communications<br />

RECEPTORS AND SIGNAL TRANSDUCTION MECHANISMS<br />

(SESSION 2)<br />

Chairpersons: Balduini W. (Urbino),<br />

Spampinato S. (Bologna)<br />

11.15 am PPAR- CONTRIBUTES TO THE ANTI-INFLAMMATORY<br />

ACTIVITY OF 17-β-ESTRADIOL<br />

Crisafulli C., Bruscoli S., Mazzon E., Di Paola R.,<br />

Genovese T., Bramanti P., Migliorati G., Cuzzocrea S.<br />

(Messina, Perugia)<br />

11.30 am EXPRESSION OF THE TRANSCRIPTION FACTOR REST AT<br />

DIFFERENT STAGES OF NEURONAL DIFFERENTIATION:<br />

CONTRIBUTION OF PKC AND WNT/β-CATENIN SIGNALING<br />

Baiula M., Bedini A., Carbonari G., Spampinato S.<br />

(Bologna)<br />

11.45 am ROLE OF mGLU2 AND mGLU3 METABOTROPIC GLUTAMATE<br />

RECEPTORS IN MECHANISMS OF NEURODEGENERATION/<br />

NEUROPROTECTION<br />

Di Menna L., Battaglia G., Molinaro G., Caraci F., Copani<br />

A., Bruno V., Nicoletti F. (Pozzilli, Catania, Rome)<br />

12.00 pm CYCLOOXYGENASE-2 MEDIATES HYDROGEN PEROXIDE-<br />

INDUCED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS<br />

Eligini S., Arenaz I., Barbieri S., Faleri M., Crisci M.,<br />

Tremoli E., Colli S. (Milan, Zaragoza)<br />

12.15 pm INVESTIGATION OF HOMOLOGOUS AND HETEROLOGOUS<br />

DESENSITIZATION PROCESSES ACTIVATED BY A<br />

PROLONGED EXPOSURE OF NEURONAL CELLS TO A -<br />

OPIOID AGONIST<br />

Spartà A., Campbell G., Spampinato S. (Bologna)<br />

12.30 pm ACTIVATION OF µ OPIOID RECEPTORS AMELIORATES<br />

MUCOSAL INJURY INDUCED BY INTESTINAL ISCHEMIA<br />

AND REPERFUSION IN MICE<br />

Saccani F., Anselmi L., Jaramillo I., Bertoni S., Barocelli<br />

E., Sternini C. (Los Angeles, Parma)<br />

159<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Viola – 11.15 am-1.15 pm<br />

Oral Communications<br />

CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />

(SESSION 3)<br />

Chairpersons: Cerbai E. (Florence), Squadrito F.<br />

(Messina)<br />

11.15 am BINDARIT, AN INHIBITOR OF MONOCYTE<br />

CHEMOATTRACTANT PROTEIN-1 SYNTHESIS, REDUCES<br />

NEOINTIMA HYPERPLASIA BOTH IN RATS AND IN<br />

HYPERCOLESTEROLEMIC MICE<br />

Ialenti A., Maddaluno M., Grassia G., Mangano G.,<br />

Bartella C., Neri E., De Simone L., Maffia P., Guglielmotti<br />

A. (Naples, Pomezia, Glasgow)<br />

11.30 am POSITIVE MODULATION OF PROSTAGLANDIN E2 AND EP3<br />

ACTIVATION ON PLATELET AGGREGATION<br />

Petrucci G., Rocca B., Patrono C. (Rome)<br />

11.45 am DOXORUBICIN TRIGGERS REPLICATIVE SENESCENCE AND<br />

DEATH OF CARDIAC PROGENITOR CELLS<br />

Piegari E., De Angelis A., Cappetta D., Marino L., Filippelli<br />

A., Berrino L., Martins-Ferreira J., Zheng H., Hosoda T.,<br />

Rota M., Urbanek K., Kajstura J., Leri A., Anversa P., Rossi<br />

F. (Naples, Boston)<br />

12.00 pm KININERGIC RECEPTORS: A NEW PHARMACOLOGICAL<br />

TARGET IN THE CEREBRAL ISCHEMIA- REPERFUSION<br />

PROCESS<br />

Volpe A., Cesare P., Orsini F., Carmignani M. (L'Aquila)<br />

12.15 pm PHYSICAL ACTIVITY AFFECT THE RISK OF RESPIRATORY<br />

TRACT INFECTION<br />

Pannacci M., Lucini V., Caronno A., Scaglione F. (Milan)<br />

12.30 pm SYSTEMIC ADMINISTRATION OF SPHINGOSINE-1-<br />

PHOSPHATE POSITIVELY MODULATES AIRWAYS<br />

REACTIVITY<br />

Roviezzo F., De Gruttola L., Brancaleone V., Bucci M., De<br />

Palma R., D’Agostino B., Cirino G. (Naples)<br />

12.45 pm STUDY OF THE EFFECT OF PPAR LIGANDS ON AN IN VITRO<br />

MODEL OF HOMOLOGOUS DESENSITIZATION OF β2-<br />

ADRENOCEPTORS<br />

Fogli S., Stefanelli F., Breschi M. (Pisa)<br />

160<br />

1.00 pm EFFICACY OF GENISTEIN AGLYCONE ON SOME<br />

CARDIOVASCULAR RISK FACTORS: A FOLLOW-UP STUDY<br />

Marini H., Bitto A., Altavilla D., Polito F., Di Stefano V.,<br />

Minutoli L., Arcoraci V., Adamo E., Caputi A. P., Squadrito<br />

F. (Messina)<br />

161<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Arancione – 11.15 am-1.15 pm<br />

Oral Communications<br />

PHARMACOLOGY OF CELL DEATH AND PROLIFERATION<br />

(SESSION 2)<br />

Chairpersons: Simonato L. (Ferrara), Vicentini L. (Milan)<br />

11.15 am UP-REGULATION OF DICKKOPF-3 IN ISCHEMIC BRAIN<br />

TISSUES IN EXPERIMENTAL ANIMAL MODELS OF<br />

CEREBRAL ISCHEMIA<br />

Busceti C., Rubattu S., Scarpino S., Biagioni F.,<br />

Mastroiacovo F., Bucci D., Battaglia G., Bruno V., Fornai F.,<br />

Nicoletti F. (Pozzilli, Rome, Pisa)<br />

11.30 am THE mGLU2/3 METABOTROPIC GLUTAMATE RECEPTOR<br />

ANTAGONIST, LY341495, ENHANCES CHEMOSENSITIVITY<br />

OF GLIOBLASTOMA-DERIVED STEM CELLS TO<br />

TEMOZOLOMIDE<br />

Bonelli M., Ciceroni C., Mastrantoni E., Laurenza M.,<br />

Niccolini C., Spinsanti P., Stocchi F., Arcella A., Ricci-Vitiani<br />

L., Oliva M., Nicoletti F., Melchiorri D. (Rome, Pozzilli)<br />

11.45 am HUMAN SMOOTH MUSCLE TSC2 -/- CELLS CAUSE<br />

LYMPHANGIOLEIOMYOMATOSIS-LIKE LUNG DESTRUCTION<br />

IN NUDE MICE. PHARMACOLOGICAL REPAIR<br />

Lesma E., Chiaramonte E., Ancona S., Grande V., Adami<br />

R., Di Giulio A., Gorio A. (Milan)<br />

12.00 pm ACTIVATION OF CORTICOTROPIN RELEASING FACTOR<br />

TYPE 1 RECEPTOR (CRF-R1) INHIBITS CELL GROWTH OF<br />

HUMAN NEUROBLASTOMA CELL LINES VIA THE<br />

MODULATION OF P18 INK4C GENE EXPRESSION<br />

De Simone M., Noviello L., Dello Russo C., Tringali G.,<br />

Mastrella D., Navarra P., Pozzoli G. (Rome)<br />

12.15 pm ADENOSINE RECEPTOR STIMULATION BY<br />

POLYDEOXYRIBONUCLEOTIDE ACTIVATES CELL CYCLE<br />

AND IMPROVES SKIN HEALING IN THE GENETICALLY<br />

DIABETIC MOUSE<br />

Bitto A., Polito F., Irrera N., Minutoli L., Altavilla D.,<br />

Giuliani D., Guarini S., Ottani A., Caputi A. P., Squadrito F.<br />

(Messina, Modena)<br />

12.30 pm ACTIVATION OF MUSCARINIC RECEPTORS STIMULATE<br />

CELL PROLIFERATION IN PRIMARY CULTURES OF HUMAN<br />

DETRUSOR MUSCLE CELLS<br />

162<br />

Arrighi N., Bodei S., Lucente A., Zani D., Simeone C.,<br />

Peroni A., Mirabella G., Cosciani Cunico S., Spano P. F.,<br />

Sigala S. (Brescia)<br />

12.45 pm EFFECTS OF GLUCOSE-REGULATED PROTEIN94 (GRP94)<br />

AND COMPLEXES OF GRP94 WITH IGG ON CELLS OF THE<br />

INNATE AND ADAPTIVE IMMUNITY<br />

Tramentozzi E., Pagetta A., Montopoli M., Zamarchi R.,<br />

Rossi E., Tibaldi E., Finotti P. (Padua)<br />

163<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Bianca – 11.15 am-1.15 pm<br />

Oral Communications<br />

PHARMACOLOGY OF INFLAMMATION<br />

Chairpersons: Cuzzocrea S. (Messina),<br />

Patrignani P. (Chieti)<br />

11.15 am EVALUATION OF THE POTENTIAL INVOLVEMENT OF<br />

ANGIOTENSIN II IN FUNCTIONAL, BIOPHYSICAL AND<br />

HISTOLOGICAL ALTERATION OF DYSTROPHIC MUSCLE:<br />

EFFECTS OF A CHRONIC TREATMENT WITH THE<br />

ANGIOTENSIN-CONVERTING ENZYME INHIBITOR<br />

ENALAPRIL IN A MOUSE MODEL OF DUCHENNE MUSCULAR<br />

DYSTROPHY<br />

Cozzoli A., Sblendorio V., Capogrosso R., Nico B., Conte<br />

Camerino D., De Luca A. (Bari)<br />

11.30 am EFFECTS OF NSAIDs ON MITOCHONDRIAL METABOLISM<br />

AND GLUTATHIONE LEVELS IN SKELETAL MUSCLE OF<br />

PRESYMPTOMATIC SOD1 G93A TRANSGENIC MICE<br />

Verri M., Pastoris O., Bongiorno A., Bendotti C., Daleno<br />

C., Dossena M. (Pavia, Milan)<br />

11.45 am CRITICAL ROLE FOR THE SPHINGOSINE-1-PHOSPHATE/<br />

SPHINGOSINE KINASE PATHWAY IN ACUTE<br />

INFLAMMATION<br />

De Gruttola L., Brancaleone V., Vellecco V., Bucci M.,<br />

Roviezzo F., Cirino G. (Naples)<br />

12.00 pm HYPERBARIC OXYGEN THERAPY REDUCES TOLL-LIKE<br />

RECEPTORS SIGNALLING PATHWAY IN A RAT MODEL OF<br />

ZYMOSAN-INDUCED MULTIPLE ORGAN FAILURE<br />

SYNDROME<br />

Rinaldi B., Donniacquo M., Imperatore F., Di Paola R.,<br />

Mazzon E., Cuzzocrea S., Luongo C., Rossi C., Di Palma D.,<br />

Sodano L., Rossi F. (Naples, Messina)<br />

12.15 pm AF3442, A NOVEL INHIBITOR OF HUMAN MPGES-1, DOES<br />

NOT REDIRECT PROSTANOID METABOLISM IN HUMAN<br />

WHOLE BLOOD IN VITRO<br />

Bruno A., Coletta I., Polenzani L., Milanese C., Anzellotti<br />

P., Ricciotti E., Dovizio M., Patrignani P. (Chieti, Pomezia)<br />

12.30 pm TRANSCELLULAR METABOLISM OF CYSTEINYL<br />

LEUKOTRIENES IN VIVO<br />

Zarini S., Gijon M., Murphy R., Sala A. (Milan, Denver)<br />

164<br />

12.45 pm ANTI-INFLAMMATORY EFFECTS OF THE NITRIC OXIDE<br />

(NO) RELEASING PRAVASTATIN NCX 6550 IN MONOCYTE/<br />

MACROPHAGES OF HEALTHY DONORS: PPAR-GAMMA<br />

EXPRESSION, NF-KB ACTIVATION AND CYTOKINE<br />

RELEASE<br />

Bardelli C., Amoruso A., Fresu L., Palma A., Ongini E.,<br />

Brunelleschi S. (Novara, Milan)<br />

1.00 pm THE 5-LIPOXYGENASE INHIBITOR ZILEUTON SUPPRESSES<br />

PROSTAGLANDIN BIOSYNTHESIS BY INHIBITION OF<br />

ARACHIDONIC ACID RELEASE IN MACROPHAGES<br />

Rossi A., Pergola C., Koeberle A., Bramanti P., Cuzzocrea<br />

S., Werz O., Sautebin L. (Naples, Messina, Tuebingen)<br />

165<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Verde – 11.15 am-1.15 pm<br />

Oral Communications<br />

PHARMACOLOGY OF METABOLISM, ENDOCRINE SYSTEM<br />

AND ERECTILE DYSFUNCTION (SESSION 2)<br />

Chairpersons: Cirino G. (Naples), Sigala S. (Brescia)<br />

11.15 am DIFFERENT ANTIOXIDANT DEFENSE IN POORLY<br />

CONTROLLED TYPE 2 DIABETIC PATIENTS WITH AND<br />

WITHOUT COMPLICATIONS<br />

Bigagli E., Raimondi L., Bardini G., Rotella C., Lodovici M.<br />

(Florence)<br />

11.30 am MUSCLE EXPRESSIONS OF MGF, IGF-I, AND MYOSTATIN<br />

IN INTACT AND HYPOPHYSECTOMIZED RATS: EFFECTS OF<br />

RHGH AND TESTOSTERONE ALONE OR COMBINED<br />

Bonomo S., Rigamonti A., Giunta M., Locatelli L., Molinari<br />

F., Müller E., Cella S. (Milan)<br />

11.45 am EFFECTS OF A NEW SYMBIOTIC FORMULATION,<br />

FLORTEC®, IN A MODEL OF INSULIN RESISTANCE AND<br />

NONALCOHOLIC STEATOHEPATITIS IN YOUNG RATS<br />

Iacono A., Mattace Raso G., Esposito E., D'Agostino G., Di<br />

Costanzo M., Berni Canani R., Calignano A., Meli R.<br />

(Naples, Messina)<br />

12.00 pm TESTOSTERONE REGULATES 5-LIPOXYGENASE VIA ERK<br />

AND CAUSES GENDER-SPECIFIC DIFFERENCES IN<br />

LEUKOTRIENE BIOSYNTHESIS<br />

Pergola C., Dodt G., Rossi A., Neunhoeffer E., Lawrenz B.,<br />

Northoff H., Samuelsson B., Rådmark O., Sautebin L.,<br />

Werz O. (Tuebingen, Naples, Stockholm)<br />

12.15 pm TESTOSTERONE AMELIORATES SEXUAL AND METABOLIC<br />

PROFILE IN AN ANIMAL MODEL OF METABOLIC SYNDROME<br />

Filippi S., Vignozzi L., Morelli A., Chalvamane A., Fibbi B.,<br />

Vannelli G., Forti G., Maggi M. (Florence)<br />

12.30 pm UROTENSIN II: A NOVEL TARGET IN HUMAN CORPUS<br />

CAVERNOSUM<br />

Mitidieri E., d'Emmanuele di Villa Bianca R., Coletta C.,<br />

Grassia G., Roviezzo F., Grieco P., Novellino E., Imbimbo<br />

C., Mirone V., Cirino G., Sorrentino R. (Naples)<br />

12.45 pm HYDROGEN SULPHIDE AS A MEDIATOR OF HUMAN<br />

CORPUS CAVERNOSUM<br />

166<br />

d'Emmanuele di Villa Bianca R., Mitidieri E., Coletta C.,<br />

Maffia P., Fusco F., Mirone V., Sorrentino R., Cirino G.<br />

(Naples)<br />

1.00 pm ESTROGENS ABOLISH THE TNF--INDUCED DECREASE IN<br />

LEUKOCYTE EXPRESSION OF CD36, A CLASS B<br />

SCAVENGER RECEPTOR INVOLVED IN THE CLEARANCE OF<br />

β-AMYLOID<br />

Giunta M., Rigamonti A., Bonomo S., Müller E., Cella S.<br />

(Milan)<br />

167<br />

SATURDAY, October 17, 2009


SATURDAY, October 17, 2009<br />

SATURDAY, October 17, 2009<br />

Sala Rossa – 11.15 am-1.15 pm<br />

Oral Communications<br />

PHARMACOLOGY AND EXPERIMENTAL AND CLINICAL<br />

TOXICOLOGY<br />

Chairpersons: Cantelli Forti G. (Bologna),<br />

Marinovich M. (Milan)<br />

11.15 am IDENTIFICATION OF GENETIC MARKER FOR EARLY<br />

DETECTION OF COLORECTAL CANCER<br />

Maffei F., Carbone F., Cantelli Forti G., Festi D., Vestito<br />

A., Hrelia P. (Bologna)<br />

11.30 am CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED<br />

PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL<br />

STUDY IN THE MOUSE<br />

Carozzi V., Canta A., Oggioni N., Chiorazzi A., Meregalli<br />

C., Sala B., Cavaletti G. (Monza)<br />

11.45 am BILIRUBIN AND NITRIC OXIDE INTERACTION: THE<br />

FORMATION OF A NEW CHEMICAL ENTITY<br />

Mancuso C., Barone E., Trombino S., Cassano R., Guido<br />

P., Sgambato A., Picci N. (Rome, Rende)<br />

12.00 pm EFFECTS OF NON PLANAR POLYCHLORINATED BIPHENYL<br />

CONGENERS (PCB 101, PCB 180, AND PCB 153) ALONE OR<br />

MIXED IN J774A.1 MACROPHAGE CELL LINE:<br />

MODIFICATION OF APOPTOTIC AND INFLAMMATORY<br />

PATHWAYS<br />

Esposito E., Ferrante M., Iacono A., Bilancione M.,<br />

Mattace Raso G., Meli R. (Messina, Naples)<br />

12.15 pm A NEW MODEL OF BINGE EATING IN FEMALE RATS:<br />

EFFECT OF SIBUTRAMINE, FLUOXETINE, TOPIRAMATE AND<br />

MIDAZOLAM<br />

Cifani C., Micioni Di Bonaventura M., Polidori C., Melotto<br />

S., Ciccocioppo R., Massi M. (Camerino)<br />

12.30 pm MICE LACKING FATTY ACID AMIDE HYDROLASE (FAAH -/- )<br />

SHOWED INCREASED SEROTONERGIC<br />

NEUROTRANSMISSION AND REDUCED EMOTIONAL<br />

REACTIVITY<br />

Laconca L., Cassano T., Morgese M., Macheda T., Cuomo<br />

V., Piomelli D. (Rome, Foggia, Irvine)<br />

168<br />

12.45 pm ROLE OF SIRT1 IN HUMAN ENDOTHELIAL CELLS DURING<br />

AGING AND OXIDATIVE STRESS<br />

Simeon V., Conti V., Corbi G., Stiuso P., Dicitore A.,<br />

Russomanno G., Filippelli W., Ferrara N., Filippelli A.<br />

(Naples, Campobasso)<br />

1.00 pm EFFECTS OF RESVERATROL IN AGING: AN IN VITRO<br />

STUDY IN HUMAN FIBROBLASTS<br />

Pitozzi V., Jacomelli M., Mocali A., Cifola I., Battaglia C.,<br />

Beltrame L., Mulinacci N., Dolara P., Giovannelli L.<br />

(Florence)<br />

169<br />

SATURDAY, October 17, 2009


Index of Authors<br />

and Chairpersons


Abbadessa G. 54 108<br />

Abbracchio MP. 9 33 47 52 68<br />

101<br />

Abrignani S. 30<br />

Adami M. 105<br />

Adami R. 30 162<br />

Adami S. 23<br />

Adamo E. 161<br />

Addabbo F. 76<br />

Addis A. 24<br />

Adornetto A. 63<br />

Adorni MP. 99 100<br />

Affatato A. 128<br />

Agabiti N. 157<br />

Agabiti Rosei E. 121<br />

Agati L. 101<br />

Agnati L. 32<br />

Agostini S. 51 71 105<br />

Aguglia E. 94<br />

Aguiari G. 41<br />

Aiello M. 13<br />

Albano G. 120<br />

Albertin G. 99<br />

Alboni S. 38 74<br />

Aldinucci A. 117<br />

Aldinucci C. 103<br />

Alemà S. 105<br />

Alfano S. 7<br />

Alfarano C. 101 102<br />

Alfieri A. 100 114<br />

Alghisi M. 58<br />

Allegra M. 114<br />

Allegrini G. 128 146<br />

Alloatti G. 76<br />

Alloisio S. 42 45<br />

Altavilla D. 31 61 72 86 87<br />

104 107 114 161 162<br />

Altavilla G. 33<br />

Altomare E. 117<br />

Alunno A. 116<br />

Amadio M. 86 105<br />

Amadori A. 50<br />

Amadori D. 135 146<br />

Amadoro G. 36<br />

Amantea D. 9 33<br />

Amatori F. 146<br />

Ambretti S. 111<br />

Ambrosi G. 32<br />

Amoroso S. 44 61<br />

Amoruso A. 114 116 136 165<br />

Anaelle D. 119<br />

Anastasi E. 49<br />

Ancona S. 48 162<br />

Andeotti C. 58<br />

Andreini I. 59<br />

Andreoli C. 59<br />

Andreoli N. 32<br />

Anelli C. 102<br />

Angeli A. 108<br />

Angelini S. 128<br />

Annunziato L. 9 63<br />

Anselmi L. 159<br />

Antonelli T. 44<br />

Antonioli L. 71 81 136<br />

Antonucci F. 68<br />

Antonuccio P. 107<br />

Antonuzzo A. 146<br />

Anversa P. 78 160<br />

Anzellotti P. 100 115 136 164<br />

Apolloni S. 68<br />

Appendino G. 12 14<br />

Arcà M. 157<br />

Arcangeli S. 44<br />

Arcaro G. 120<br />

Arcella A. 162<br />

Arcoraci T. 122 124 125<br />

Arcoraci V. 121 161<br />

Arena S. 14<br />

Arenaz I. 159<br />

Armentero M. 32<br />

Armida M. 68<br />

Armogida M. 33<br />

Arnaboldi L. 102<br />

Arnoletti E. 76<br />

Aronica E. 48<br />

Arrighi N. 49 163<br />

Arrigoni E. 126<br />

Ascierto P. 47<br />

Ascione B. 50<br />

Assael B. 108<br />

Autore G. 48 57 107<br />

Avallone R. 107<br />

Avato P. 31<br />

Aviello G. 72 105<br />

Avoli M. 35<br />

Awwad O. 81<br />

Badiali L. 35<br />

Baetta R. 102<br />

Bagetta G. 5 9 30 33 39<br />

50 74<br />

Baiardi P. 120 122<br />

Baiguera C. 58<br />

Baiula M. 75 159<br />

Bajetto A. 48<br />

Balboni G. 51 149<br />

Baldelli P. 4<br />

Balduini W. 8 49 159<br />

Balestrieri E. 67<br />

Ballabeni V. 34 114<br />

Ballerini C. 117<br />

Ballerini P. 36<br />

Balsamo A. 76 98<br />

Banaudi E. 98<br />

Banchelli G. 124<br />

Banfi C. 101 102<br />

Bani D. 103 137<br />

Banni S. 36<br />

Banti I. 112<br />

Baraldi E. 122<br />

Baraldi M. 30 71 107<br />

Baraldi PG. 41 42 81 111 146<br />

Baraldi S. 81<br />

Baraldo M. 54 117 118<br />

Barbaro G. 35<br />

Barbera C. 127<br />

Barberi L. 31<br />

Barberis A. 86 110 112 126<br />

Barbierato M. 41 45<br />

Barbieri F. 48<br />

Barbieri R. 42<br />

Barbieri S. 159<br />

Barbiero V. 4<br />

Barcella S. 101 102<br />

Bardelli A. 14<br />

Bardelli C. 114 116 136 165<br />

Bardini G. 166<br />

Barile C. 111<br />

Barletta M. 128<br />

Barlocco E. 118<br />

Barocelli E. 34 114 159<br />

Barone A. 157<br />

Barone E. 123 168<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Barrese V. 45 46<br />

Barrosi C. 122<br />

Bartella C. 160<br />

Bartoli F. 127<br />

Bartolini A. 37 51 52 149<br />

Bartolone S. 114<br />

Bartoloni Bocci E. 116<br />

Bartorelli A. 76<br />

Baruchello R. 147<br />

Basilicata G. 140 157<br />

Basolo F. 101<br />

Bassi A. 59<br />

Bassi MT. 63<br />

Basso D. 14<br />

Bastianelli A. 7<br />

Battaglia C. 169<br />

Battaglia F. 4<br />

Battaglia G. 7 15 34 37 48<br />

49 66 130 159 162<br />

Bazzu G. 4 34<br />

Bedini A. 75 159<br />

Bedussi F. 49<br />

Belardo G. 47<br />

Belfiore D. 59<br />

Belladonna ML. 42 66<br />

Bellantonio P. 37<br />

Bellantuono C. 119<br />

Bellantuono S. 58<br />

Belleudi V. 157<br />

Bellini G. 63<br />

Bellini M. 15<br />

Bellosta S. 102<br />

Belluardo N. 7<br />

Beltrame L. 169<br />

Benarese M. 9 58<br />

Benassi L. 58<br />

Benatti C. 38 74<br />

Bendotti C. 164<br />

Benedetti F. 134<br />

Benedusi A. 47<br />

Benelli A. 87<br />

Benetti E. 98<br />

Benfante R. 127<br />

Benfenati E. 138<br />

Benfenati F. 4<br />

Benfenati V. 45<br />

Bennett G. 149<br />

Benvenuti S. 58<br />

Bereshchenko O. 7<br />

Berlinguer Palmini R. 38<br />

Berliocchi L. 50<br />

Bernabucci M. 37<br />

Berni Canani R. 166<br />

Bernini F. 21 99 100<br />

Berrino L. 42 76 78 101 103<br />

160<br />

Berry A. 41<br />

Bersan E. 39<br />

Berta G. 100 112 126<br />

Bertario L. 14<br />

Bertazzoni Minelli E. 110 152<br />

Bertocchi I. 39 109<br />

Bertolaso L. 127<br />

Bertoldo A. 47<br />

Bertolini A. 28 35 107<br />

Bertolotti P. 32<br />

Bertoni L. 87<br />

Bertoni S. 34 114 159<br />

Bezanilla F. 46<br />

Bhargava A. 52<br />

Biagi C. 79 111 119<br />

Biagi GL. 58<br />

Biagioli T. 117<br />

Biagioni F. 15 37 38 49 130<br />

162<br />

Bianchi G. 23 132<br />

Bianchi R. 42 66<br />

Bianchini P. 42<br />

Bianchini R. 66 116<br />

Bianco F. 68<br />

Bianco G. 48 57 107<br />

Bianco S. 128<br />

Biasco G. 14<br />

Biel M. 136<br />

Bifari F. 39<br />

Bigagli E. 102 166<br />

Biggio G. 4 61 94<br />

Bilancione M. 168<br />

Billington R. 43 50<br />

Bin A. 71 105<br />

Biondi F. 73<br />

Bisignano C. 124<br />

Bisignano G. 124<br />

Bisoffi G. 119<br />

Bistoni O. 116<br />

Bitto A. 31 61 72 86 87<br />

104 107 114 161 162<br />

Bizzozero L. 7<br />

Blandini F. 32<br />

Blandizzi C. 15 71 81 101 104<br />

107 120 121 122 136<br />

157<br />

Blasevich M. 36<br />

Blasi F. 39<br />

Blasio A. 38<br />

Blom J. 74<br />

Bocci E. 63<br />

Bocci G. 110 128 146<br />

Boda E. 33<br />

Bodei S. 49 163<br />

Boehmer F. 43<br />

Bogani P. 76<br />

Bogliolo V. 29<br />

Bogo M. 41<br />

Bolego C. 100 110 136<br />

Bolognini D. 8<br />

Bombelli R. 120<br />

Bonaiuto A. 114<br />

Bonaldo S. 117<br />

Bonamassa B. 58<br />

Bonanno G. 4 29 30<br />

Bonati M. 120 157<br />

Bondioli L. 107<br />

Bonelli M. 63 162<br />

Bonetti B. 39<br />

Bongiorno A. 164<br />

Bonifacino T. 4 29 30<br />

Bonifazi D. 120<br />

Bonini S. 7<br />

Bonito M. 106<br />

Bono G. 14<br />

Bonomo S. 166 167<br />

Bononi A. 111<br />

Boraso M. 130<br />

Borea PA. 41 42 63 81 111<br />

134 146<br />

Borgognoni L. 76<br />

Borracci P. 59<br />

Borrelli F. 72 105<br />

Borroni B. 130<br />

Borsellino L. 79<br />

Bortolami A. 118 157<br />

Bortolotto V. 7 36<br />

Bortolotto ZA. 144<br />

Boscia F. 38<br />

Bottai D. 29 30<br />

Bottein M. 39<br />

Botticelli A. 61 98<br />

Bottinelli R. 33 99<br />

Bozzo L. 117<br />

Braconi S. 36 55<br />

Braga PC. 97 110<br />

Braghiroli D. 30<br />

Bramanti P. 30 32 49 74 113<br />

130 159 165<br />

Brambilla M. 76<br />

Brancaleone V. 30 76 98 99 160<br />

164<br />

Brancolini C. 139<br />

Bravaccio C. 140<br />

Brera F. 36<br />

Breschi MC. 76 98 112 160<br />

Bresciani E. 108<br />

Brewer J. 103<br />

Brignoli O. 121<br />

Brini A. 126<br />

Brioschi M. 102<br />

Brivio I. 98 102<br />

Brocca L. 33<br />

Brocca Cofano E. 33<br />

Broccardo M. 51 71 105<br />

Broccoli M. 71<br />

Brossa A. 158<br />

Brun P. 105<br />

Brunelleschi S. 66 97 114 116 136<br />

156 165<br />

Brunelli S. 63<br />

Brunello N. 25 28 38 74<br />

Brunetta E. 117<br />

Bruni E. 58<br />

Bruni P. 68<br />

Bruno A. 14 100 164<br />

Bruno C. 82<br />

Bruno V. 7 15 28 34 35<br />

37 48 49 66 130<br />

159 162<br />

Bruscagin S. 127<br />

Bruscoli S. 7 159<br />

Brusselle G. 140<br />

Bruzzone F. 42<br />

Buccella S. 36 81<br />

Buccellati C. 98 100 102 110<br />

Bucci D. 7 15 37 49 130<br />

162<br />

Bucci M. 30 76 98 99 113<br />

160 164<br />

Buchholz F. 43<br />

Bucolo C. 86<br />

Bueno L. 51<br />

Buerger E. 50<br />

Buffo A. 9 33<br />

Buonocore G. 8 49<br />

Burbiel J. 101<br />

Buriani A. 48<br />

Busceti C. 7 15 37 38 48<br />

49 66 130 162<br />

Buzzega D. 32<br />

Cabella C. 102<br />

Cabras M. 30<br />

Caciagli F. 36 81<br />

Caffino L. 55<br />

Caggia F. 38 74<br />

Calabresi L. 99 136<br />

Calapai G. 47 49 55 59 114<br />

119 121 122 148<br />

Calciano S. 45<br />

Caldarelli A. 38 43<br />

Calderone V. 76 98<br />

Calia G. 34<br />

Caliari A. 120<br />

Calignano A. 52 62 86 149 166<br />

Calmieri G. 25<br />

Calò G. 35 61<br />

Calò M. 86<br />

Calo' G. 37<br />

Calvo PL. 127<br />

Calzavara E. 55 114<br />

Camarda V. 35 37<br />

Cambiaghi M. 4<br />

Camera M. 76<br />

Camerino G. 33 97 99<br />

Camici M. 68<br />

Caminiti R. 30 32 113<br />

Cammarota S. 140<br />

Campana G. 86 108<br />

Campbell G. 159<br />

Campesi I. 76<br />

Campioli E. 107<br />

Campodonico F. 112<br />

Campolongo P. 4<br />

Canali E. 101<br />

Canali R. 124<br />

Canaparo R. 127<br />

Canarile L. 7<br />

Canavesi M. 102<br />

Cancelliere C. 14<br />

Candeletti S. 51 54 130<br />

Canestrelli M. 51<br />

Cangemi L. 54<br />

Canistro D. 58<br />

Cannarile L. 66<br />

Cannarsa R. 54<br />

Cannazza G. 30<br />

Cannella M. 48<br />

Cannella N. 36 55<br />

Cannone G. 108<br />

Canonico PL. 7 23 28 34 38<br />

42 43 50 94 133<br />

Canta A. 168<br />

Cantarutti L. 118 122<br />

Cantelli Forti G. 14 59 81 128 147<br />

168<br />

Cantoni O. 7 49 50<br />

Canu B. 110 128<br />

Canu S. 76<br />

Canzoniero L. 108<br />

Caparrotta L. 111 123<br />

Capasso A. 28 31 57 86 107<br />

Capasso F. 105<br />

Capasso R. 72 105<br />

Capecchi PL. 81<br />

Capeci W. 44<br />

Capodanno P. 121<br />

Capogrosso R. 164<br />

Capone M. 14 100 136<br />

Caponnetto C. 30<br />

Caporali S. 108<br />

Capozzo M. 126 128<br />

Cappelani A. 30<br />

Cappellacci L. 112<br />

Cappetta D. 78 160<br />

Cappiello L. 36<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Cappuccio I. 63 112 130<br />

Caprini M. 45<br />

Capuano A.ro 52 149<br />

Capuano A.sa 120 121 140 157<br />

Capucci A. 93<br />

Caputi AP. 3 31 55 59 65<br />

72 79 86 89 95<br />

96 104 108 114 119<br />

121 141 157 161 162<br />

Caputi F. 130<br />

Caputo A. 33<br />

Caraci F. 25 35 61 130 159<br />

Carbonara G. 45<br />

Carbonari G. 159<br />

Carbone F. 58 168<br />

Carelli S. 29 47<br />

Cariboni A. 38<br />

Caricasole A. 10 40<br />

Carle F. 141<br />

Carloni S. 8 49<br />

Carlotti M. 112<br />

Carlucci A. 63<br />

Carmignani M. 160<br />

Carnevale G. 30 71 87<br />

Carnì A. 55 114<br />

Carnuccio R. 48 99 114 115<br />

Carocci A. 46<br />

Carone C. 32<br />

Caronno A. 127 160<br />

Carovani M. 52<br />

Carozzi V. 168<br />

Carrara M. 48<br />

Carraro L. 34<br />

Carratù MR. 59<br />

Carretta MT. 103<br />

Carrì MT. 68<br />

Carta A. 68<br />

Carta M. 82<br />

Carta P. 157<br />

Carta S. 55<br />

Carunchio I. 36<br />

Caruso A.ra 130<br />

Caruso A.lo 63<br />

Caruso ML. 104<br />

Casagrande C. 102<br />

Casale F.ca 53 150<br />

Casale F.co 140<br />

Casarin E. 48<br />

Casazza S. 30<br />

Caselli G. 104<br />

Casolini P. 105<br />

Cassano R. 168<br />

Cassano T. 15 33 37 44 61<br />

168<br />

Castagliuolo I. 71 105<br />

Castaldo P. 44<br />

Castelletti C. 141<br />

Castellsague J. 140<br />

Castiglia S. 98 137<br />

Castiglioni L.ra 100<br />

Castiglioni L.na 103<br />

Castrichini M. 81<br />

Cataldi M. 35 44<br />

Cataldo S. 35<br />

Catania MA. 119<br />

Catapano A. 21<br />

Caterino L. 120<br />

Cathala A. 28<br />

Cattabeni F. 82 130<br />

Cattaneo D. 73<br />

Cattaneo M. 6<br />

Cattaneo MG. 63<br />

Cattaneo MT. 119<br />

Cavaletti G. 135 168<br />

Cavaliere F. 5 30 74<br />

Cavallero A. 44 45<br />

Cavalli R. 112<br />

Cavani F. 87<br />

Cavazza C. 3<br />

Cavina C. 54<br />

Cavone L. 38 117<br />

Cazzato D. 7<br />

Cecchi E. 124<br />

Ceci A. 120 122 135<br />

Celano M. 111<br />

Celia C. 111<br />

Cella S. 86 166 167<br />

Cerbai E. 45 58 78 93 99<br />

101 136 140 160<br />

Cereda C. 28<br />

Cerioni L. 7 49 50<br />

Cerretani D. 47 123<br />

Ceruti S. 52 68<br />

Cerveri G. 94<br />

Cervetto C. 42 45<br />

Cervone C. 101<br />

Cesare P. 160<br />

Cetti E. 57<br />

Chalvamane A. 166<br />

Chen J. 29<br />

Chiamulera C. 39<br />

Chiaramonte E. 48 162<br />

Chiaravalli A. 105<br />

Chiarugi A. 9 39 59 117 139<br />

Chiechio S. 52<br />

Chiesa G. 102<br />

Chiesa R. 126<br />

Chinellato A. 118 157<br />

Chini J. 137<br />

Chiodi V. 29 68<br />

Chiorazzi A. 168<br />

Chiozzi P. 68<br />

Chirafisi J. 59 103 124<br />

Chisari M. 101<br />

Ciammola A. 48<br />

Ciana P. 145<br />

Cianchi C. 123<br />

Cianchi F. 146<br />

Cianci S. 37 61<br />

Ciapparelli A. 127<br />

Ciaramella N. 14<br />

Ciardiello F. 42<br />

Ciarletta M. 38<br />

Ciarmiello A. 48<br />

Cicala C. 100 114<br />

Ciccarelli R. 36 81<br />

Cicchetti A. 22<br />

Ciccocioppo R. 35 36 55 58 168<br />

Ciceroni C. 112 162<br />

Cifani C. 36 58 130 168<br />

Cifola I. 169<br />

Cignarella A. 100 136 145<br />

Cigognini D. 30<br />

Cilio MR. 46<br />

Cillo B. 121<br />

Cimino F. 59 103 124<br />

Cimino M. 9<br />

Cinci L. 103 137<br />

Ciociaro A. 50<br />

Ciofi L. 112 127<br />

Ciotti MT. 36<br />

Cipolla G. 120<br />

Cipollaro M. 103<br />

Cippitelli A. 55<br />

Cippone V. 108<br />

Cipriani S. 33 68 130<br />

Cipriano M. 29 71<br />

Ciriana O. 66<br />

Cirino G. 27 30 76 98 99<br />

113 160 164 166 167<br />

Citraro R. 31 36<br />

Clavenna A. 120<br />

Clementi E. 7 41 44 63 68<br />

73 119<br />

Clementi S. 55<br />

Clerici M. 29<br />

Clini E. 13<br />

Cobellis G. 103<br />

Cocchi D. 86 108<br />

Cocci A. 79<br />

Coccurello R. 58<br />

Coinu R. 76<br />

Cojutti PG. 28 54 117 118<br />

Colaianna M. 39 68<br />

Colangeli R. 37<br />

Colao A. 140<br />

Colapicchioni C. 63<br />

Colasanti T. 50<br />

Coletta C. 113 115 166 167<br />

Coletta I. 164<br />

Colli S. 159<br />

Collingridge G. 144<br />

Collino M. 98 103 137<br />

Colombano G. 50<br />

Colombo L. 52<br />

Colucci M. 53 105 106<br />

Colucci R. 15 71 81 101 136<br />

Coluccia A. 59<br />

Comi G. 120<br />

Concas A. 4 85<br />

Condorelli F. 42 43 50<br />

Conforti A. 79 119<br />

Consoli A. 95<br />

Consoli G. 127<br />

Conte J. 107<br />

Conte MA. 126 128<br />

Conte Camerino D. 33 42 45 46 82<br />

97 99 104 107 108<br />

135 164<br />

Conti V.no 122 157<br />

Conti V.ia 14 169<br />

Copani A. 35 52 61 130 159<br />

Coppini R. 45<br />

Coppo L. 102 103<br />

Coppo M. 7<br />

Corallini A. 33<br />

Corasaniti MT. 5 9 30 39 50<br />

74<br />

Corbi G. 169<br />

Corbo F. 46<br />

Cordeddu L. 36<br />

Cordiano C. 127<br />

Corrao G. 141<br />

Corsaro A. 61<br />

Corsi L. 30 71<br />

Corsi M. 7<br />

Corsini A. 16 99 102<br />

Corsini D. 38<br />

Corti C. 7<br />

Corti F.co 57<br />

Corti F.ca 33<br />

Coruzzi G. 105<br />

Cosciani Cunico S. 49 163<br />

Cosco D. 111<br />

Cosentino M. 14 103 117 120 141<br />

Cosentino S. 101<br />

Cosi C. 38<br />

Cosottini M. 120<br />

Costa B. 11<br />

Costa F. 15<br />

Costa G. 58<br />

Costa L. 50 124<br />

Costa N. 53<br />

Costante G. 111<br />

Costantini D. 79 80 121<br />

Costantino L. 35 107<br />

Costantino M. 123<br />

Costantino S. 101<br />

Costanza T. 82<br />

Cotelli F. 57<br />

Cotrufo M. 103<br />

Cozzi A. 38<br />

Cozzoli A. 164<br />

Cozzolino M. 68<br />

Crema F. 71 104 120<br />

Cricelli C. 95<br />

Crisafulli C. 113 116 159<br />

Crisci M. 159<br />

Crispo G. 53<br />

Cristalli G. 81<br />

Cristani M. 59 122 124<br />

Cristino L. 31 61<br />

Crociara P. 7<br />

Crosio C. 39<br />

Crupi D. 122<br />

Crupi R. 4<br />

Cucchiaroni ML. 33<br />

Cucinotta D. 95<br />

Culici M. 97 110<br />

Cunha R. 29<br />

Cunningham K. 28<br />

Cuomo O. 9 63<br />

Cuomo R. 71<br />

Cuomo V. 3 4 15 33 37<br />

39 44 57 58 61<br />

70 168<br />

Cusinato F. 47<br />

Cutroneo P. 79 80 121<br />

Cuzzocrea S. 11 30 32 62 66<br />

68 74 113 116 130<br />

145 159 164 165<br />

D’Alessandro N. 110<br />

Da Settimo F. 81<br />

D'Acunto C. 49<br />

D'Addario C. 51 130<br />

Daffara F. 110<br />

Daghini E. 101<br />

Dagostino C. 53 150<br />

D'Agostino B. 77 160<br />

D'Agostino G. 52 62 86 149 166<br />

D'Agostino M. 111<br />

Dahl M. 127<br />

Dal Ben D. 81<br />

Dal Sasso M. 97 110<br />

Daleno C. 164<br />

D'Alessandro N. 147<br />

D'Alimonte I. 36<br />

D'Amato F. 58<br />

D'Ambrosi N. 68<br />

Damiano V. 42<br />

D'Amico M.le 36 101<br />

D'Amico M.ia 45<br />

D'Amore V. 37<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Danesi R. 18 73 110 112 126<br />

127 128 146 152<br />

D'Anna R. 87<br />

D'Antico S. 127<br />

D'Aquila P. 29 30<br />

D'Arcangelo M. 146<br />

D'Arrigo C. 61 74<br />

Davoli M. 157<br />

D'Avolio A. 110<br />

de Abajo F. 142<br />

De Angelis A.la 78 160<br />

De Angelis A.io 120<br />

De Bellis M. 46<br />

De Benedictis L. 97<br />

De Bernardi S. 103<br />

De Bona P. 35<br />

De Chiaro M. 52<br />

De Corato A. 52 149<br />

De Dominici M. 50<br />

De Fazio P. 31<br />

De Fazio S. 31<br />

De Feo M. 103<br />

De Filippis D. 29 38 71<br />

De Francia S. 54 98 108 110 118<br />

De Gaetano G. 6<br />

De Gasparo M. 100<br />

De Gennaro Colonna<br />

V.<br />

103<br />

De Girolamo L. 126<br />

De Gruttola L. 76 98 99 160 164<br />

De Guglielmo G. 35 55<br />

De Iudicibus S. 127<br />

De Leon J. 74<br />

De Luca A. 46 164<br />

De Luca M. 58<br />

De Luise C. 140<br />

De Man J. 71<br />

De Manzoni G. 127<br />

De Martino F. 98 110<br />

De Martino G. 120<br />

De Mattei M. 63<br />

De Novellis V. 52 149 150<br />

De Palma C. 63<br />

De Palma R. 160<br />

De Petrocellis L. 63<br />

De Ponti F. 71 79 110 118 134<br />

De Portu S. 140<br />

De Rosa G. 14<br />

De Sarro A. 122<br />

De Sarro GB. 31 36 48 118<br />

De Seta L. 157<br />

De Simone L. 114 160<br />

De Simone ML. 162<br />

De Stefano D. 48 99 114 115<br />

De Vita T. 49<br />

Debetto P. 22 34 41 45 118<br />

Decimo I. 39<br />

Decorti G. 127<br />

Del Grosso E. 43<br />

Del Lungo M. 99 136<br />

Del Senno L. 41<br />

Del Tacca M. 15 71 81 101 110<br />

Del Viscovo A.<br />

112 119 120 121 122<br />

127 128 134 136 146<br />

157<br />

108<br />

Delbarba A. 32<br />

Delfino D. 116<br />

Della Casa L. 36<br />

Dellarole A. 7 36<br />

Delle Donne D. 121<br />

Dello Russo C. 52 74 149 162<br />

Dell'Osso L. 127<br />

Dell'Ovo V. 38 39<br />

Demma I. 104<br />

D'Emmanuele di V.B.<br />

R.<br />

113 115 166 167<br />

Denis-Donini S. 7 36<br />

Desaphy JF. 33 82 135<br />

Desole M. 4 39<br />

Devecchi E. 36<br />

Dever G. 103<br />

Di Bella O. 121<br />

Di Benedetto M. 54<br />

Di Braccio M. 114<br />

Di Carlo F. 54 86 98 100 108<br />

110 112 118 126<br />

Di Cesare Mannelli L. 37 52<br />

Di Costanzo A. 37<br />

Di Costanzo F. 134<br />

Di Costanzo M. 166<br />

Di Desidero T. 110 128<br />

Di Febbo C. 100 136<br />

Di Filippo C. 36 101<br />

Di Francesco C. 58<br />

Di Francesco L. 115<br />

Di Gennaro A. 98<br />

Di Giannuario A. 53 105 106<br />

Di Girolamo F. 53<br />

Di Giulio AM. 29 30 47 48 162<br />

Di Giuseppe D. 102 103<br />

Di Iorio P. 36 81<br />

Di Liberto V. 7<br />

Di Luca M. 28 38 82 130<br />

Di Maio G. 120<br />

Di Maio M. 132<br />

Di Marco R. 37 66<br />

Di Marzo V. 29<br />

72<br />

31 52 61 63<br />

Di Menna L. 159<br />

Di Nardo R. 120<br />

Di Nicolantonio F. 14<br />

Di Noto A. 121<br />

Di Palma D. 164<br />

Di Paola R. 30 66 113 116 130<br />

Di Paolo A.<br />

159 164<br />

112 127 128 146<br />

Di Paolo M. 122<br />

Di Pirro M. 124<br />

Di Renzo G. 9<br />

Di Ronza C. 101<br />

Di Sante M. 7<br />

Di Scipio F. 100 112 126<br />

Di Serio C. 102<br />

Di Simplicio P. 102 103<br />

Di Sotto A. 58 124<br />

Di Stefano A. 103<br />

Di Stefano V. 31 61 72 86 104<br />

Di Viesti V.<br />

107 114 161<br />

30<br />

Di Virgilio F. 68<br />

Diamanti D. 40<br />

Dianzani C. 66<br />

Diaspro A. 42<br />

Diaz F. 74<br />

Diaz Acedo C. 118 119<br />

Dicitore A. 169<br />

Diddi G. 124<br />

Dieguez C. 107<br />

Dieleman J. 140 158<br />

Digennaro C. 33 99<br />

Digiacomo M. 76 98 112<br />

Dimonte V. 118<br />

Dinardo M. 33 97 99<br />

Dinarello C. 139<br />

D'Incau P. 79 119<br />

Ding L. 43<br />

Dipasquale P. 58 61<br />

Distasi C. 38<br />

Dixon D. 14<br />

Dobrowolny G. 33<br />

Dodt G. 166<br />

Dolara P. 169<br />

Domenici MR. 29 68<br />

Donati C. 68<br />

Donati M. 79 119<br />

Donato V. 7<br />

Donato Di Paola E. 31<br />

Donniacuo M. 164<br />

Donnini S. 49 57 63 99<br />

Dore R. 4<br />

Dorent R. 102<br />

Dorigo P. 111 123<br />

Dossena M.ta 32<br />

Dossena M.ia 164<br />

Dovio A. 108<br />

Dovizio M. 14 45 115 164<br />

Drago F. 25 31 64 74 86<br />

129 151<br />

Dragoni S. 59<br />

Dubois-Dauphin M. 130<br />

Duranti E. 81 101 136<br />

Dusonchet L. 112<br />

Eandi M. 127<br />

Economidou D. 36 55<br />

El Khoury A. 83<br />

Elif F. S. 158<br />

Eligini S. 159<br />

Enea D. 56<br />

Epis R. 82 130<br />

Era D. 128<br />

Erich G. 7<br />

Ermito S. 103<br />

Errico F. 144<br />

Errico S. 35<br />

Esculapio P. 54<br />

Esposito A. 108<br />

Esposito E.ga 9<br />

Esposito E.la 30 32 66 74 86<br />

113 116 130 149 166<br />

168<br />

Esposito G. 29 38 71<br />

Eutamene H. 51<br />

Eva C. 39 85 109<br />

Evangelista S. 99<br />

Evangelista V. 100 136<br />

Failli P. 101<br />

Falchi M. 97<br />

Falcioni ML. 57<br />

Falcone A. 128 146<br />

Falcone D. 48<br />

Falcone S. 63<br />

Faleri M. 159<br />

Fallarini S. 117 127<br />

Fallarino F. 42 66<br />

Falzoni S. 68<br />

Fandriks L. 100<br />

Fanò G. 81<br />

Fantò F. 118<br />

Fantozzi R. 14 19 24 98 123<br />

137 140<br />

Fantucci P. 33<br />

Faraco G. 9 39<br />

Fardone E. 37<br />

Farisello P. 4<br />

Fattore L. 70<br />

Fava C. 100 136<br />

Fava G. 119<br />

Favari E. 99 100<br />

Fazio F. 37 66<br />

Fazio N. 82<br />

Fazzini A. 124<br />

Fedele E. 44 45<br />

Fedeli A. 36<br />

Feliciello A. 9 63<br />

Felisi M. 120 122<br />

Fellin R. 68<br />

Ferketich A. 56<br />

Ferraguti F. 37<br />

Ferrajolo C. 140<br />

Ferran S. 118<br />

Ferrante A. 29 68<br />

Ferrante M. 168<br />

Ferrantini C. 45<br />

Ferrara F. 120<br />

Ferrara N. 169<br />

Ferraraccio F. 36 101<br />

Ferrari A. 28 107 123<br />

Ferrari D. 68<br />

Ferrari F. 38<br />

Ferrari M. 14<br />

Ferrari Toninelli G. 7<br />

Ferrario S. 119<br />

Ferraro L. 44 70<br />

Ferraro R. 100 136<br />

Ferrazzi E. 127<br />

Ferrazzin F. 79<br />

Ferreira S. 29<br />

Ferreri A. 124<br />

Ferretti C. 127<br />

Ferretti M. 87<br />

Ferretti R. 68<br />

Ferri A. 68<br />

Ferri C. 122<br />

Ferri N. 102<br />

Ferrigno A. 32 48<br />

Ferroni S. 45<br />

Feruglio M. 54 117<br />

Festa M. 7 31 49<br />

Festi D. 168<br />

Fiacchi P. 111<br />

Fiaschi A. 31 47 123<br />

Fibbi B. 166<br />

Filaferro M. 32 35 51 130<br />

Filippazzi V. 119<br />

Filippelli A. 73 78 123 160 169<br />

Filippelli W. 169<br />

Filippi S. 166<br />

Fimognari C. 147<br />

Fine M. 82<br />

Finetti F. 63<br />

Finicelli M. 103<br />

Fink M. 113<br />

Finocchi P. 68<br />

Finotti P. 163<br />

Fiorani M. 49<br />

Fioravanti A. 110 128 146<br />

Fiore G. 47 123<br />

Fioretti MC. 42 66<br />

Fiorini S. 37<br />

Fiorito S. 59<br />

Firenzuoli F. 124 148<br />

Fischetti C. 35<br />

Fisher T. 43<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Fitzgerald G. 14<br />

Flammini L. 34<br />

Flonta S. 14<br />

Floreani M. 111<br />

Florio C. 38 59<br />

Florio T. 34 47 48 63<br />

Focosi D. 120 157<br />

Fogli E. 81 111<br />

Fogli S. 112 160<br />

Folco G. 13 27 98 100 102<br />

110<br />

Folino A. 100 101 126<br />

Fontana A. 146<br />

Fontana E. 146<br />

Foresti G. 26<br />

Forgione L. 120<br />

Formentini L. 59<br />

Formica R. 120 140 157<br />

Fornai F. 15 37 162<br />

Fornai M. 71 81 101 136<br />

Fornarelli A. 38<br />

Fornasari D. 14 127 143<br />

Forni F. 35 107<br />

Forstermann U. 64<br />

Forte A. 103<br />

Forte M. 120<br />

Forti G. 166<br />

Fortinguerra S. 48<br />

Fortuna A. 86<br />

Fossati G. 139<br />

Fourrier-Réglat A. 118 119 140<br />

Fracchiolla G. 45 97 108<br />

Franceschi L. 28<br />

Franceschini G. 136<br />

Franceschini L. 121<br />

Francese MT. 7 34 36<br />

Franchetti P. 112<br />

Franchi S. 149<br />

Franchini C. 46 82<br />

Franchitto A. 124<br />

Franco G. 59<br />

Franco R. 33<br />

Franconi F. 76 86 145 156<br />

Frattini P. 45<br />

Fresta M. 111<br />

Fresu L. 114 116 136 165<br />

Frigeri C. 51 130<br />

Frigerio E. 108<br />

Frigo G. 71 104 105 120<br />

Froldi G. 111 123<br />

Frosali S. 103<br />

Frosini M. 59<br />

Fu J. 61<br />

Fucile C. 105 112 121 128<br />

Fulle S. 81<br />

Fumagalli F. 55<br />

Fumagalli G. 39<br />

Fumagalli M. 9 52<br />

Furlanut M. 28 54 117 118<br />

Fusco D. 157<br />

Fusco F. 167<br />

Gabbianelli R. 57<br />

Gabrielli N. 101<br />

Gaetani S. 37 58 61<br />

Gagliardi S. 97<br />

Gagliostro M. 121<br />

Gaion R. 71 100 105 110 136<br />

Gala R. 9<br />

Galantucci M. 31 61 98<br />

Galderisi U. 78 103<br />

Galdi M. 120<br />

Galeazzi M. 81<br />

Galeotti N. 51 149<br />

Galiotto M. 39<br />

Gallelli L. 48<br />

Galli A. 130<br />

Galli C.io 108<br />

Galli C.za 146<br />

Galli CL. 130 138 148<br />

Galli L. 146<br />

Galli U. 50<br />

Gallicchio M. 14<br />

Gallo E. 124<br />

Gallo F. 128<br />

Gallo M. 120 140 157<br />

Galluzzi P. 57<br />

Galuppo M. 30 32 74 116<br />

Gamabaro A. 119<br />

Gambaccini D. 15<br />

Gambardella L. 76 101<br />

Gambassi G. 158<br />

Gangemi S. 117<br />

Garcia Rodriguez LA. 142 157<br />

Gardoni F. 38 82 130<br />

Gareri P. 31<br />

Gargiulo L. 100 114<br />

Gariboldi M. 30 111 146<br />

Garozzo D. 35<br />

Garside P. 103<br />

Garzia A. 29<br />

Gass P. 83<br />

Gatta L. 149<br />

Gatti M. 48<br />

Gatti R. 99<br />

Gattorno M. 19<br />

Gaviraghi G. 3 10<br />

Géloen A. 110 126<br />

Gelosa P. 9 100<br />

Gemignani G. 112<br />

Geminiani E. 30 71<br />

Genazzani A. 14 28 38 43 50<br />

126<br />

Genedani S. 32<br />

Gennarelli M. 143<br />

Genovese T.na 30 32 66 68 74<br />

113 116 130 159<br />

Genovese T.so 120<br />

Gentile M. 121<br />

Genuardi M. 146<br />

George A. 99<br />

Geppetti P. 12 76 134 141<br />

Gerace E. 38<br />

Gerli R. 116<br />

Gerlini G. 76<br />

Gervasi N. 29<br />

Gessi S. 41 42 63 81 111<br />

146<br />

Geuna M. 14<br />

Geuna S. 126<br />

Ghè C. 76<br />

Ghelardini C. 37 51 52 149<br />

Ghezzi A. 120<br />

Ghezzi S. 108<br />

Ghi P. 7<br />

Ghisu N. 15 71 81 136<br />

Ghizzardi P. 114<br />

Giaccone M. 127<br />

Giachetti A. 49 57<br />

Giacobbe D. 81<br />

Giambelli R. 83<br />

Gianchecchi E. 81<br />

Gianni L. 132<br />

Giannini E. 51 61 149<br />

Giannuzzi V. 33 42<br />

Giaquinto C. 122<br />

Giaroni C. 71 104 105<br />

Giberti C. 128<br />

Gijon M. 164<br />

Gini R. 118<br />

Giocaliere E. 124<br />

Giommoni F. 124<br />

Giordano C. 149 150<br />

Giordano E. 36<br />

Giordano G. 50<br />

Giorgi G. 31 47 55 57 118<br />

122<br />

Giorgio C. 114<br />

Giorni L. 26 156<br />

Giovannelli L. 169<br />

Giovannini L. 36 114<br />

Giovannini MG. 68 130<br />

Giovannini M. 108<br />

Giovinazzo C. 125<br />

Giovino C. 115<br />

Giraldi T. 126 128 146<br />

Girelli S. 8 49<br />

Giron M. 71 105 158<br />

Girotto S. 122<br />

Giudice S. 58<br />

Giudici D. 45<br />

Giuffrida A. 33 39<br />

Giuffrida M. 35<br />

Giuggioli D. 123<br />

Giuli C. 105<br />

Giuliani D. 31 61 72 98 104<br />

114 162<br />

Giuliani G. 47<br />

Giuliani P. 36<br />

Giunta M. 166 167<br />

Giustetto M. 82<br />

Giusti P. 4 22 41 45 99<br />

118 157<br />

Giustina A. 108<br />

Giustini Saffi E. 119<br />

Gnemmi I. 42<br />

Gobbetti T. 114<br />

Goffredo B. 150<br />

Goglia F. 108<br />

Gomaraschi M. 136<br />

Gomez R. 107<br />

Gomez-Reino J. 107<br />

Gori G. 121<br />

Gori L. 124<br />

Gorini A. 36<br />

Gorio A. 29 30 47 48 162<br />

Govoni S. 45 57 86<br />

Gradini R. 37 49 130<br />

Gradnik R. 3<br />

Gramegna G. 33 42 97<br />

Granata A. 99 102<br />

Granato R. 140<br />

Grande V. 48 162<br />

Grandi D. 104<br />

Grant W. 113<br />

Grassi MC. 56<br />

Grassia G. 99 114 160 166<br />

Greco A. 86<br />

Gregg E. 59<br />

Gregori D. 141<br />

Gregotti C. 48<br />

Grelli S. 67<br />

Grieco P. 98 99 114 166<br />

Grifantini M. 112<br />

Grigoletto J. 4 34<br />

Grilli MG. 7 34 36 51 54<br />

88<br />

Grilli M. 32 45<br />

Grimaldi A. 49<br />

Grimaldi G. 140<br />

Grohmann U. 42 66<br />

Grolla A. 43 50<br />

Grossi L. 100 136<br />

Grossi M. 103<br />

Gruber S. 83<br />

Guadagni F. 53<br />

Guadagno F. 72<br />

Gualeni A. 29<br />

Gualillo O. 107<br />

Guarini S. 31 61 72 98 104<br />

114 162<br />

Guasti L. 103<br />

Guatteo E. 33<br />

Guaza C. 11<br />

Gudermann T. 12<br />

Gueli M. 147<br />

Guerrini R. 35 37 61 104<br />

Guerrini U. 9<br />

Guglielmotti A. 160<br />

Guida F. 52 149<br />

Guidarelli A. 49 50<br />

Guidi A. 36 114<br />

Guido P. 123 168<br />

Guidobono F. 86<br />

Guidolin D. 99<br />

Guidotti G. 74<br />

Guillaume Y. 140<br />

Gulmez S. 140<br />

Gurwitz D. 118<br />

Gusella M. 14 111 127<br />

Haag M. 140<br />

Hallberg A. 100<br />

Hauer D. 4<br />

Haverkamp H. 140<br />

Hayden M. 48<br />

Hen R. 4<br />

Hiberg F. 90<br />

Hilgemann D. 82<br />

Hippisley-Cox J. 118 119<br />

Hodge J. 102<br />

Hosoda T. 160<br />

Hrelia P. 14 57 58 59 81<br />

128 138 146 147 168<br />

Hutter-Paier B. 32<br />

Iaccarino C. 39<br />

Iacobelli M. 119<br />

Iacono A. 62 86 149 166 168<br />

Ialenti A. 47 99 113 114 160<br />

Ianaro A. 41 47 99 113 114<br />

Iannello C. 121<br />

Ianniello B. 121 140 157<br />

Iannone A. 36<br />

Iannone M. 111<br />

Iannotti F. 45 46<br />

Ibrahim T. 146<br />

Idzko M. 68<br />

Illiano ML. 157<br />

Imbesi S. 117<br />

Imbimbo B. 32<br />

Imbimbo C. 166<br />

Imperadore G. 119<br />

Imperatore F. 164<br />

Improta G. 51 71 105<br />

Incerti M. 34<br />

Inta I. 9<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Ipata P. 68<br />

Irpino A. 120 157<br />

Irrera N. 31 72 86 104 107<br />

114 162<br />

Isabella L. 119<br />

Isola L. 105<br />

Isola S. 117<br />

Iuvone T. 11 29 38 71<br />

Izzo A. 72 105<br />

Jacomelli M. 169<br />

Jaconi M. 78<br />

Jahnel U. 133<br />

Jaramillo I. 159<br />

Jasmin L. 52<br />

Jochem J. 98<br />

Kajstura J. 78 160<br />

Kallupi L. 35<br />

Kallupi M. 36 55<br />

Kasper S. 43<br />

Kempen H. 99<br />

Kirchmayer U. 157<br />

Kittler R. 43<br />

Klersy C. 141<br />

Kloting I. 36<br />

Koch S. 43<br />

Koeberle A. 113 165<br />

Kofalvi A. 29<br />

Kors J. 118 119<br />

Kortesca L. 37<br />

Koukopoulos A. 74<br />

Krampera M. 39<br />

Krause K. 61 130<br />

Kroemer G. 48<br />

La Motta C. 81<br />

La Rana G. 52 62 86 149<br />

La Rovere R. 81<br />

La Torre M. 124<br />

La Villa G. 103<br />

Labbadia A. 101<br />

Labbozzetta M. 147<br />

Laconca L. 37 61 168<br />

Laferla F. 37<br />

Laffi G. 103<br />

Laghezza A. 97 108<br />

Laghi Pasini F. 81<br />

Lago F. 107<br />

Lagomarsino F. 32 45<br />

Lamba S. 14<br />

Lambertucci C. 81<br />

Lanas A. 142<br />

Landini I. 146<br />

Landucci E. 38<br />

Lanni A. 108<br />

Lanni C. 57<br />

Lanzetta R. 113<br />

Lanzi C. 103 137<br />

Lanzillotta A. 9 32<br />

Lapi F. 79 80 119 121 124<br />

141<br />

Lapucci A. 112<br />

Lariccia V. 82<br />

Lars P. 118<br />

Lasorsa D. 97<br />

Lastella M. 112 127 146<br />

Latina V. 59 115<br />

Latorre R. 45<br />

Lattanzi R. 51 149<br />

Laurenza M. 162<br />

Lawrenz B. 166<br />

Lawson J. 14<br />

Lazzerini P. 81<br />

Lecca D. 9<br />

Lecca S. 55<br />

Lecchini S. 14 71 103 104 105<br />

120<br />

Ledda F. 76 97<br />

Leggio GM. 28 31<br />

Legnaro M. 103<br />

Lentini G. 46 82<br />

Lenzi M. 147<br />

Leo G. 32<br />

Leone L. 101<br />

Leone R. 79 119 123 157<br />

Leoni O. 79 119 121 157<br />

Leprince J. 42<br />

Leri A. 78 160<br />

Lesaffre E. 140<br />

Lesma E. 48 162<br />

Letari O. 104<br />

Lettieri B. 101 121<br />

Leung E. 42 81 111<br />

Leurs R. 105<br />

Levantesi G. 100 136<br />

Liantonio A. 33 42 97<br />

Lin M. 82<br />

Linari G. 71 105<br />

Linden J. 130<br />

Liquori G. 120<br />

Lisi L. 52<br />

Livi U. 117<br />

Livrea MA. 114<br />

Llaguno M. 82<br />

Lluis C. 33<br />

Locatelli L. 166<br />

Locatelli V. 108<br />

Lodovici M. 102 166<br />

Lofaro A. 123<br />

Lograno M. 99<br />

Loiodice F. 45 97 108<br />

Loizzo A. 86 108<br />

Loizzo S. 86 108<br />

Lombardi G. 117 127<br />

Londero M. 127<br />

Longhi R. 68<br />

Longini M. 49<br />

Longo A. 39 109<br />

Longo V. 58<br />

Lopa S. 126<br />

Lopez M. 107<br />

Loraschi A. 14 120 141<br />

Lorenzi T. 71 104<br />

Lorenzini S. 81<br />

Loupakis F. 128<br />

Loza M. 118<br />

Lu B. 56<br />

Lubrano V. 58<br />

Luccini E. 31 44 45<br />

Lucente A. 163<br />

Luchicchi A. 55<br />

Luciani S. 47<br />

Lucignani G. 29<br />

Lucini V. 160<br />

Lui R. 29<br />

Luisetti M. 27<br />

Lungarella G. 27<br />

Luo H. 101<br />

Luongo C. 101 164<br />

Luongo L. 63 149 150<br />

Lupi P. 124<br />

Luppino MR. 140<br />

Lysenko V. 110 126<br />

Maat-Schieman M. 48<br />

Mac Lennan S. 81 111<br />

Maccari F. 32<br />

Maccarrone M. 70<br />

Maccarrone P. 108<br />

Macchi B. 67<br />

Macchia M. 112<br />

Maccio L. 28<br />

Macheda T. 33 37 168<br />

Maciocco E. 4<br />

Maclennan S. 42 111<br />

Madaschi L. 29<br />

Maddaluno M. 99 114 160<br />

Maffei F. 58 168<br />

Maffezzini M. 112<br />

Maffia P. 99 103 160 167<br />

Maggi A. 3 145<br />

Maggi F. 120<br />

Maggi M. 166<br />

Magi S. 44 82<br />

Magistro L. 79<br />

Maglione U. 157<br />

Magliulo L. 127<br />

Magnani E. 33<br />

Magnetti C. 118<br />

Magnoni C. 58<br />

Magro L. 79 80<br />

Mai A. 112<br />

Maida S. 50<br />

Maiello F. 72<br />

Mainardi P. 31<br />

Maio R. 103 117<br />

Maione F. 105<br />

Maione S. 52 61 63 149 150<br />

Maione T. 37<br />

Maiorca S. 103<br />

Mairesse J. 34<br />

Malcangio M. 149<br />

Malesci A. 141<br />

Malinverno M. 82<br />

Mallei A. 4 83<br />

Malorgio F. 100<br />

Malorni W. 50 76 101<br />

Malpeli G. 39<br />

Mammola C. 124<br />

Manarini S. 100 136<br />

Mancardi D. 110 126<br />

Mancari F. 124<br />

Mancinelli R. 81<br />

Mancuso C. 123 168<br />

Mancuso M. 123<br />

Mandalari G. 124<br />

Mangano G. 160<br />

Mannaioni G. 38<br />

Mannari C. 36 114<br />

Mannino E. 48<br />

Mannucci C. 47 55 59 114<br />

Mannucci E. 101 102<br />

Mannucci PM. 153<br />

Manoni M. 137<br />

Mantovan T. 33<br />

Mantovani L. 95<br />

Marabese I. 52 149<br />

Marcello E. 82 130<br />

Marchesi M. 102<br />

Marchet S. 71 104 105<br />

Marchetti P.lo 147<br />

Marchetti P.ro 98<br />

Marchetti R. 56<br />

Marchi M. 32 45<br />

Marchi S. 15<br />

Marchiafava M. 38<br />

Marcoli M. 42 45<br />

Marfella R. 36 101<br />

Marfia G. 29<br />

Margaritis A. 103<br />

Margutti P. 50<br />

Mariani P. 124<br />

Marini H. 86 87 161<br />

Marini V. 105 112 128<br />

Marino F. 14 117 120<br />

Marino L. 78 101 160<br />

Marino M. 76<br />

Marino S. 86 101 110 112 126<br />

Marinos L. 112<br />

Marinovich M. 57 130 138 168<br />

Marolda R. 36<br />

Maroni L. 103<br />

Marra C. 115<br />

Marra F. 29<br />

Marra R. 31<br />

Marte A. 44 45<br />

Martelli A.ma 76 98<br />

Martelli A.ta 105 112 119 121 128<br />

Martelossi S. 127<br />

Martignoni E. 14<br />

Martinelli E. 42<br />

Martinez A. 33<br />

Martini C. 9<br />

Martini M. 14<br />

Martino A. 127<br />

Martins-Ferreira J. 160<br />

Martire A. 29 68<br />

Martire M. 45<br />

Martorana M. 122 124 125<br />

Marzani B. 47<br />

Marzocchi B. 49<br />

Marzocco S. 48 57<br />

Marzola E. 37<br />

Mascagni P. 139<br />

Mascarin A. 99<br />

Mascolo N. 100 105 106<br />

Maselli MA. 104<br />

Maselli R. 48<br />

Masi A. 38<br />

Masi G. 128<br />

Masini E. 103 137<br />

Massacesi L. 117<br />

Massaro A. 59<br />

Massei J. 127<br />

Massi M. 35 36 55 58 104<br />

130 168<br />

Massi P. 8 113<br />

Mastino A. 67<br />

Mastrangelo S. 124<br />

Mastrantoni E. 162<br />

Mastrantonio T. 37<br />

Mastrella D. 162<br />

Mastriota M. 53 105 106<br />

Mastrofrancesco L. 97<br />

Mastroiacovo F. 15 37 49 162<br />

Mastroianni R. 103 137<br />

Matarrese P. 50<br />

Mathè A. 83<br />

Matrisciano F. 38 130<br />

Mattace Raso G. 30 86 98 166 168<br />

Mattatelli A. 101<br />

Matteis M. 77<br />

Matteoli M. 68<br />

Matteucci C. 67<br />

Matthews L. 41<br />

Mattioli F. 105 112 119 121 128<br />

Maura G. 42 45<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Mauro N. 108<br />

Mavilio D. 117<br />

Maxwell S. 64<br />

Mazzaglia G. 79 95 118 140 141<br />

Mazzanti G. 58 124 148<br />

Mazzei T. 17 65 79 84 135<br />

146<br />

Mazzini G. 57<br />

Mazzolini S. 63<br />

Mazzon E. 30 32 68 113 116<br />

130 159 164<br />

Mazzotta MC. 42 45<br />

Mcgaugh J. 4<br />

Mcinnes I. 103<br />

Medico E. 14<br />

Meini B. 120<br />

Melani A. 68 130<br />

Melchiorre M. 136<br />

Melchiorri D. 38 49 63 112 130<br />

162<br />

Meldolesi J. 60<br />

Mele A. 45 108<br />

Mele P. 39 109<br />

Meli M. 112<br />

Meli R. 32 62 74 86 149<br />

166 168<br />

Mello T. 130<br />

Melloni E. 29<br />

Melotti P. 108<br />

Melotto S. 58 168<br />

Memo M. 7 57<br />

Menard S. 132<br />

Menarini M. 29 30<br />

Mencacci C. 94<br />

Mendlewicz J. 38<br />

Meneghini V. 34<br />

Meneguz A. 138<br />

Meneguzzi A. 100 136<br />

Menichetti F. 65 112<br />

Menna A. 141<br />

Menon D. 111<br />

Mercanti G. 118<br />

Mercatali L. 146<br />

Mercogliano A. 121<br />

Mercuri N. 33 144<br />

Meregalli C. 168<br />

Merighi S. 41 42 63 81 111<br />

146<br />

Merli D. 29<br />

Merlicco A. 59 81<br />

Merlino A. 110 126<br />

Merlo S. 34 50 101<br />

Mesenzani O. 38<br />

Messina A.ea 58<br />

Messina A.la 35<br />

Messina S. 31<br />

Metere A. 101<br />

Mey V. 127<br />

Mhillaj E. 54<br />

Micale V. 31 74<br />

Miceli F. 46<br />

Miceli N. 47<br />

Micheli L. 57 122 123<br />

Michieli R. 156<br />

Micioni Di<br />

Bonaventura M.<br />

36 58 168<br />

Micò U. 61<br />

Miele E. 4<br />

Migheli R. 34 39<br />

Migliardi G. 61<br />

Miglio G. 98<br />

Migliorati G. 159<br />

Migliori M. 36<br />

Migliozzi A. 52 61 149<br />

Milanese C. 164<br />

Milanese M. 4 29 30<br />

Milano L. 28 57 107<br />

Milano W. 28 57 107<br />

Minciullo P. 117<br />

Mini E. 90 146<br />

Minocci D. 127<br />

Minotti G. 132<br />

Minutoli L. 31 61 72 86 104<br />

Minutolo A.<br />

107 114 161 162<br />

67<br />

Minuz P. 100 136<br />

Mirabella G. 163<br />

Miracapillo R. 24<br />

Miragoli L. 102<br />

Mirandola P. 42 146<br />

Miremont-Salamé G. 119<br />

Mirone V. 166 167<br />

Missale C. 49<br />

Mitidieri E. 113 166 167<br />

Mitreva R. 37<br />

Mocali A. 169<br />

Mocenni C. 55<br />

Mochly Rosen D. 49<br />

Modde C. 30<br />

Modena J. 111<br />

Mognetti B. 86 101 110 112 126<br />

Moilanen E. 64 129<br />

Moison D. 28<br />

Mokhles M. 140<br />

Moles A. 58<br />

Molinari F. 166<br />

Molinari S. 35<br />

Molinaro G. 7 34 35 159<br />

Molinaro P. 9<br />

Mollace V. 53 150<br />

Molokhia M. 118 119<br />

Molteni R. 30 111 146<br />

Monaco F. 127<br />

Moncada S. 63<br />

Moneti G. 124<br />

Monfardini S. 58<br />

Monica D. 14<br />

Monico E. 158<br />

Monina G. 141<br />

Monopoli A. 115<br />

Montagnani M. 76 97<br />

Montagnani S. 120 122 157<br />

Montanaro N. 79 111 119 141 157<br />

Montecucco C. 22<br />

Montefrancesco G. 31 47 55<br />

Monteleone D. 122 124 125<br />

Monti E. 30 111 146<br />

Monti M. 49<br />

Montopoli M. 111 123 163<br />

Montuschi P. 13 97<br />

Moore N. 119 140<br />

Morabito G. 103 124<br />

Morandi S. 59<br />

Morando S. 45<br />

Morbidelli L. 63 99<br />

Morelli A. 166<br />

Morelli M. 58<br />

Moreno M. 108<br />

Mores N. 35<br />

Moretta V. 100 136<br />

Moretti AM. 156<br />

Moretti S. 121<br />

Moretti U. 79 110 119<br />

Morganti M. 146<br />

Morgese MG. 33 37 39 168<br />

Morgillo F. 42<br />

Morini G.ni 34<br />

Morini G.na 104<br />

Morlacchi S. 7<br />

Moro E. 71 104 120<br />

Moro F. 101<br />

Moro M. 30<br />

Moroni F. 38 39 59 117<br />

Morrone L. 5 30 39 74<br />

Morroni F. 59<br />

Mortola D. 79<br />

Moschini M. 79 124<br />

Mosillo P. 112<br />

Mossotti M. 117<br />

Mostallino MC. 4<br />

Motola D. 79 80 110 111 119<br />

121<br />

Moyanova S. 37<br />

Muccioli G. 76<br />

Mudò G. 7<br />

Müller E. 166 167<br />

Mueller J. 43<br />

Mugelli A. 21 58 64 76 78<br />

79 93 97 101 121<br />

124 134 136<br />

Mulinacci N. 169<br />

Mulle C. 82<br />

Muller C. 101<br />

Muntoni E. 127<br />

Mura E. 45<br />

Mura ML. 4<br />

Muraca M. 150<br />

Murphy R. 164<br />

Murru L. 4<br />

Musante V. 5 40<br />

Musarò A. 33<br />

Musazzi L. 4<br />

Muscatello MR. 61 74<br />

Muscoli C. 53 150<br />

Muserra G. 122<br />

Musilli C. 76 97 99<br />

Mussa M. 118<br />

Musso A. 34<br />

Mussoni L. 102<br />

Musumeci T. 61<br />

Naccari C. 59 117<br />

Nacci C. 76<br />

Nanetti A. 111<br />

Napoli C. 146<br />

Napolitano M. 47<br />

Nappi G. 14 28<br />

Nargi E. 36<br />

Nasca C. 38<br />

Naselli F. 29<br />

Nassi A. 111<br />

Nasuti C. 57<br />

Natale G. 81<br />

Natale M. 81<br />

Navarra M. 47 49 55<br />

Navarra P. 20 26 51 52 54<br />

74 133 149 162<br />

Navarria A. 74<br />

Negri L. 149<br />

Negro A. 4 34 41<br />

Nencini C. 57 122 123<br />

Nencini P. 56<br />

Neri E. 114 160<br />

Neugebauer V. 52<br />

Neunhoeffer E. 166<br />

Ngomba R. 34 37<br />

Nicchia G. 45<br />

Niccolini C. 63 162<br />

Nico B. 164<br />

Nicolai R. 52<br />

Nicoletti F. 7 13 15 34 35<br />

37 38 48 49 51<br />

52 54 61 63 66<br />

91 112 130 144 159<br />

162<br />

Nicoll D. 82<br />

Nicolucci A. 89 95<br />

Nicora E. 30<br />

Nicotra A. 51 149<br />

Nieri P. 127<br />

Nisi A. 14<br />

Nisoli E. 32<br />

Nisticò R. 33 144<br />

Nisticò G. 150<br />

Nistri A. 81<br />

Nizzari M. 34<br />

Nobile M. 42 45<br />

Nobili B. 63<br />

Nobili S. 146<br />

Nocentini G. 22 66 116<br />

Nolfe G. 57<br />

Northoff H. 166<br />

Nosi D. 68<br />

Notarbartolo M. 147<br />

Notartomaso S. 37 66<br />

Novelli A. 84<br />

Novelli G. 73<br />

Novellino E. 98 166<br />

Novellino L. 68<br />

Noviello L. 162<br />

Nunziata A. 59 128<br />

Oberto A. 39 109<br />

Oberwinkler J. 12<br />

Oddo S. 37<br />

Oggioni N. 168<br />

Ogren S. 130<br />

Ohara P. 52<br />

Oldrini R. 71 104 105<br />

Oliva MA. 162<br />

Oliveira J. 118<br />

Olivieri D. 13<br />

Ongini E. 165<br />

Opri S. 79 80 121<br />

Orabona C. 42<br />

Oria C. 157<br />

Orlandi P. 110 128 146<br />

Orlando R. 38 130<br />

Orlotti D. 77<br />

Orobello S. 48<br />

Orsetti M. 7<br />

Orsini F. 160<br />

Ortona E. 50<br />

Oselladore B. 99<br />

Oteri A. 119 121 122<br />

Ottani A. 31 61 72 98 104<br />

114 162<br />

Ottaviani S. 49<br />

Ottobrini L. 29<br />

Pacini A. 52<br />

Padovani A. 130<br />

Padovano V. 68<br />

Padrini R. 14 111 127 136<br />

Padula R.sa 120<br />

Padula R.ta 122<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Pagani F. 86<br />

Pagano C. 118<br />

Pagano I. 79<br />

Pagetta A. 163<br />

Pagliaro L. 96<br />

Pagliaro P. 54 100 101<br />

Palanza P. 39 85 109<br />

Palazzo E. 52 61 149<br />

Palfi S. 10<br />

Pallotta M. 66<br />

Pallottino S. 49<br />

Palma A. 114 116 136 165<br />

Palmery M. 54<br />

Palmieri G. 25 154<br />

Palmigiano A. 35<br />

Palomba L. 7 50<br />

Palumbo C. 87<br />

Pandolfo G. 61 74<br />

Pani L. 94<br />

Panmand D. 81<br />

Pannacci M. 127 160<br />

Pannini S. 118<br />

Pantaleo M. 14<br />

Panza E. 45 46<br />

Panza L. 117<br />

Paoletti A. 124<br />

Paoletti R. 16<br />

Paolini M. 58 71<br />

Paolino D. 111<br />

Paolisso G. 36<br />

Papagni M. 157<br />

Papi L. 146<br />

Papi M. 128<br />

Pappalardo G. 35<br />

Parente L. 7 49<br />

Parenti A. 76 97 99<br />

Pariente A. 119 140<br />

Parini A. 78<br />

Parini F. 118<br />

Parisi A. 100 114<br />

Parolaro D. 8 113<br />

Parolini C. 102<br />

Parravicini C. 33<br />

Pascale A. 86 105<br />

Pascotto A. 140<br />

Pasini F. 111 127<br />

Paskow-Rozas M. 43<br />

Pasqualetti G. 127<br />

Pasquariello S. 56<br />

Passalacqua M. 29<br />

Passarello F. 31<br />

Pastorino M. 34<br />

Pastoris O. 164<br />

Patacchini R. 12<br />

Patacchioli F. 108<br />

Paterniti I. 30 32 74<br />

Patrignani P. 6 14 100 115 136<br />

142 164<br />

Patrono C. 6 113 116 134 153<br />

160<br />

Pattarozzi A. 48<br />

Pecoraro S. 112<br />

Pedata F. 33 68 130<br />

Pederzoli F. 32<br />

Pedrazzi M. 29<br />

Pedrelli M. 99<br />

Pelà M. 35<br />

Pelaia G. 48<br />

Pelicci P. 139<br />

Pelin M. 59<br />

Pellati F. 58<br />

Pellegrini-Giampietro<br />

D.<br />

9 28 38<br />

Pellegrino M. 33 99<br />

Pelosi V. 100 136<br />

Pengo V. 14<br />

Penna C. 54 101<br />

Pepeu G. 10 47 91<br />

Pepponi R. 29<br />

Pera A. 127<br />

Perez-Otaño I. 82<br />

Pergola C. 113 165 166<br />

Pergolizzi S. 47<br />

Perissoud D. 108<br />

Pero G. 36<br />

Peroni A. 163<br />

Perrone Filardi P. 93<br />

Perrotta C. 7 68<br />

Perrotta S. 63<br />

Perucca E. 31<br />

Perucci C. 157<br />

Pessina F. 58<br />

Pessina G. 103<br />

Petrella A. 7 49<br />

Petrella C.la 36 51 71 105<br />

Petrella C.io 28 57 107<br />

Petrelli F. 9<br />

Petrillo MG. 66 116<br />

Petrini M. 120 157<br />

Petroni A. 36<br />

Petrosino S. 31 63 72<br />

Petrucci G. 35 160<br />

Pezzatini S. 99<br />

Pèzzola A. 68<br />

Pezzolla F. 104<br />

Pfister P. 102<br />

Piacentini P. 24<br />

Pianezzola C. 14<br />

Piazza E. 119<br />

Piazza PV. 28 62<br />

Picci N. 168<br />

Piccinin S. 144<br />

Piccinni C. 79<br />

Piccione F. 54 98 108 110 118<br />

Piccirilli S. 33<br />

Picco W. 112<br />

Piegari E. 42 78 101 160<br />

Pieraccini G. 124<br />

Pieratti A. 55 114 122<br />

Pieretti S. 53 105 106<br />

Pieri M. 36<br />

Pierno S. 33 99<br />

Pietrangelo T. 81<br />

Pietrini G. 68<br />

Pignataro B. 35<br />

Pignataro G. 9<br />

Pignieri A. 100<br />

Pillolla G. 55<br />

Pini L. 51<br />

Pinna A. 58<br />

Pinna C. 102 136<br />

Pinto A. 48<br />

Piomelli D. 61 168<br />

Pippi F. 57<br />

Pirillo A. 102<br />

Pirovano M. 127<br />

Pirro E. 98 110 118<br />

Pisani S. 157<br />

Pisoni S. 63<br />

Pistarà V. 61<br />

Pistis M. 55<br />

Pisu M. 4<br />

Pitozzi V. 169<br />

Pittaluga A. 5 33 40 45 144<br />

Pittelli M. 59<br />

Pizzi M. 9 32 41 44 58<br />

74<br />

Pizzolo G. 39<br />

Plebani M. 14<br />

Poggesi C. 45<br />

Poggi L. 102<br />

Polenzani L. 164<br />

Polidori C. 36 168<br />

Polidori P. 24<br />

Polillo M. 112 127<br />

Polimeni G. 79 119<br />

Polimeno T. 120<br />

Polito F. 31 72 86 104 107<br />

114 161 162<br />

Pollio G. 40<br />

Poluzzi E. 79 110 111 157<br />

Polzonetti V. 43<br />

Poma P. 147<br />

Pompella G. 81<br />

Popoli M. 4 83<br />

Popoli P. 29 68<br />

Popolo A. 48<br />

Porreca E. 100 136<br />

Portaleone P. 54<br />

Portigliatti Barbos M. 86 110 112<br />

Possenti R. 36 71<br />

Possidente M. 59<br />

Postiglione A. 120<br />

Potenza M. 97<br />

Potenza R. 68<br />

Potenza S. 80 120 140 157<br />

Pouladi M. 48<br />

Pozzan T. 60<br />

Pozzesi N. 116<br />

Pozzi S. 136<br />

Pozzoli C. 105<br />

Pozzoli G. 162<br />

Preciosa M. C. 119<br />

Preda S. 45<br />

Preti D. 41 81<br />

Preziosi P. 20 96<br />

Priora R. 102 103<br />

Procino G. 97<br />

Proudlove C. 24<br />

Puccetti P. 42 66<br />

Puccini A. 157<br />

Puggioli C. 111<br />

Puggioni G. 34<br />

Pugi A. 124<br />

Pugliese A. 130<br />

Puri PL. 139<br />

Putaturo I. 120<br />

Putignano A. 146<br />

Puxeddu E. 111<br />

Quadrato G. 7<br />

Quaglia F. 115<br />

Quintieri L. 111<br />

Quon M. 97<br />

Rabasca A. 120<br />

Racagni G. 4 25 55 83<br />

Racanicchi L. 111<br />

Racca S. 54 108 110<br />

Racchi M. 57<br />

Radaeli E. 118<br />

Radice S. 119<br />

Rådmark O. 166<br />

Rafaniello C. 120 121 140 157<br />

Ragazzi E. 111<br />

Ragusa S. 50<br />

Raimondi L. 101 102 166<br />

Raimondo S. 126<br />

Raiteri L. 31 44 45<br />

Raiteri M. 4 5 40 45<br />

Ramadori A. 81<br />

Ramsdell J. 39<br />

Ranghino G. 33<br />

Rapposelli S. 76 98<br />

Raschi E. 79 110<br />

Rasini E. 103<br />

Rassu C. 30<br />

Rastaldo R. 100<br />

Rastrelli F. 121<br />

Rattazzi L. 98<br />

Ravaioli A. 128<br />

Ravaioli E. 146<br />

Ravizza R. 30 111 146<br />

Ray D. 41<br />

Rea G. 120<br />

Reboldazzi G. 14<br />

Rebulla P. 30<br />

Recchia G. 73<br />

Regoli D. 35 37 61<br />

Reinscheid R. 37<br />

Remelli R. 40<br />

Renna G. 59<br />

Renzi P. 86<br />

Resca E. 87<br />

Riccardi C. 3 7 22 66 116<br />

Ricciardi E. 124<br />

Ricciardi S. 127<br />

Ricciotti E. 115 164<br />

Ricci-Vitiani L. 112 162<br />

Richelmi P. 32 48<br />

Rigamonti A. 166 167<br />

Rigamonti E. 102<br />

Riganti L. 68<br />

Riggi C. 98<br />

Righetti C. 58<br />

Righetti L. 37 58 61<br />

Rinaldi B. 14 164<br />

Rinaldi M. 28<br />

Riozzi B. 7 15 37 48 49<br />

Riozzo B. 48<br />

Ripamonti E. 30<br />

Risè P. 108<br />

Riso C. 121<br />

Riva B. 50<br />

Riva M. 55<br />

Rivasi F. 28<br />

Rivolta A. 80 121<br />

Rizzardini G. 155<br />

Rizzarelli E. 35<br />

Rizzi A. 35 37 61<br />

Rizzi L. 108<br />

Rizzi N. 145<br />

Rizzo M. 53 150<br />

Rizzo V. 32 48<br />

Rizzuto E. 33<br />

Robbiano L. 128<br />

Roberto G. 119<br />

Rocca B. 6 108 160<br />

Rocchitta G. 34 39<br />

Rodolico G. 103<br />

Roggeri D. 157<br />

Roi C. 157<br />

Rolland J. 108<br />

Roma G. 114<br />

Romagnoli R. 41 81<br />

Romanelli L. 54<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Romanelli M. 136<br />

Romano A. 37 58 61<br />

Romano B. 72 105<br />

Romano MR. 99<br />

Romano M. 35<br />

Romano S. 36 81<br />

Romaudi P. 51<br />

Rombola' L. 5 30 39 74<br />

Romei C. 31 44 45<br />

Romeo C. 107<br />

Romualdi P. 54 130<br />

Romussi G. 106<br />

Ron M.C. H. 118<br />

Ronchetti S. 66 116<br />

Ronda N. 99<br />

Rondina M. 111<br />

Roozendaal B. 4<br />

Rosa AC. 24 98 140<br />

Rosa P. 7 9 33 68<br />

Rosano G. 156<br />

Rosato A. 111<br />

Rossi And. 45<br />

Rossi AM. 127<br />

Rossi Ant. 113 165 166<br />

Rossi CR. 111<br />

Rossi C. 52 101 164<br />

Rossi Ele. 36<br />

Rossi Eli. 163<br />

Rossi F.ca 52 63<br />

Rossi F.co 3 14 21 36 42<br />

77 78 80 93 101<br />

103 120 121 140 149<br />

150 154 157 160 164<br />

Rossi G. 15<br />

Rossi M. 118<br />

Rossi T. 58<br />

Rota M. 78 160<br />

Rotella C. 166<br />

Rotiroti D. 39 50 150<br />

Rovati L. 151<br />

Roviezzo F. 30 76 98 99 160<br />

164 166<br />

Rubattu S. 162<br />

Ruberti G. 3<br />

Rubino T. 70<br />

Rugani I. 101<br />

Ruggeri B. 35 55<br />

Ruggieri V. 35 51 130<br />

Ruggiero F. 14<br />

Ruggiero S. 120 140 157<br />

Runci F. 31<br />

Ruozi B. 35 107<br />

Russier J. 59<br />

Russo A. 79 119<br />

Russo C. 34<br />

Russo D. 111<br />

Russo E. 31 36<br />

Russo GA. 55 114<br />

Russo GT. 95<br />

Russo M. 14 77<br />

Russo R.to 52 62 86 149<br />

Russo R.sa 42<br />

Russo R.io 57<br />

Russo R.la 5 30 50 74<br />

Russomanno G. 14 169<br />

Rustichelli C. 107<br />

Ruzza C. 35 37<br />

Ruzza P. 111<br />

Saccani F. 34 159<br />

Sacchetto V. 41 81 111<br />

Sacerdote P. 66 133 149<br />

Sacripanti C. 79<br />

Saffi-Giustini E. 26<br />

Saija A. 59 103 117 122 124<br />

125<br />

Saiko P. 112<br />

Saitta F. 157<br />

Sakurada S. 39<br />

Sala A. 13 97 98 100 110<br />

146 164<br />

Sala B. 168<br />

Sala C. 82<br />

Sala P. 14<br />

Salamone P. 100 112 126<br />

Sale P. 63 112<br />

Salomone S. 101<br />

Salsini L. 137<br />

Salt T. 61<br />

Salvadori S. 35 37 44 51 61<br />

149<br />

Salvicchi A. 37 51 149<br />

Salvo F. 119 121 140<br />

Salvucci C. 55<br />

Samuelsson B. 166<br />

Sances G. 28<br />

Sandrini M. 51<br />

Sanna E. 4<br />

Sansò M. 114<br />

Santini R. 57<br />

Santolini I. 34 37<br />

Santoro C. 63<br />

Santoro L. 48<br />

Santoro V. 61 74<br />

Santosuosso U. 103<br />

Santuccio C. 121<br />

Sanvito P. 136<br />

Sanz J. 68<br />

Sanzone S. 43<br />

Sapino S. 112<br />

Saponaro G. 81<br />

Sapone A. 58<br />

Saraceno C. 130<br />

Sarnico I. 9 32 58<br />

Sartiani L. 58 78 99 136<br />

Sartori ML. 108<br />

Sasso O. 52 62 86 149<br />

Sassone J. 48<br />

Saura J. 33<br />

Sautebin L. 113 119 123 140 165<br />

166<br />

Savino R. 48<br />

Savio S. 54<br />

Sblendorio V. 164<br />

Sbrilli M. 122<br />

Scaccianoce S. 38 61 103 130<br />

Scafuro A. 52<br />

Scafuro M. 52<br />

Scaglione F. 17 84 92 127 155<br />

160<br />

Scalori V. 36 114<br />

Scarpa R. 120<br />

Scarpino S. 162<br />

Scarselli P. 37<br />

Scartabelli T. 38<br />

Schade R. 140<br />

Schelling G. 4<br />

Schembri L. 103<br />

Schiavon S. 14<br />

Schiavone N. 37<br />

Schiavone S. 61 130<br />

Schillani G. 126 128<br />

Schintu N. 68<br />

Schipani G. 120<br />

Schuemie M. 140<br />

Schwaninger M. 9<br />

Scicchitano F. 31<br />

Sciulli M. 14<br />

Scognamiglio M. 120<br />

Scordo MG. 127<br />

Scorrano L. 63<br />

Scorziello A. 63<br />

Scott B. 118<br />

Scotto S. 79 80<br />

Scuderi C. 11 29 38 71<br />

Secci P. 4<br />

Secondo A. 108<br />

Segura Garcia C. 31<br />

Sekar D. 57<br />

Selvi E. 81<br />

Serafini L. 3<br />

Serpe L. 127<br />

Serra G.no 29 30 74<br />

Serra G.ia 29<br />

Serra MG. 4 28 85<br />

Serra PA. 4 34<br />

Serratosa J. 33<br />

Sessa A. 119<br />

Severi P. 5<br />

Severini C. 36 71<br />

Severino L. 57<br />

Sgambato A. 168<br />

Sganga G. 65<br />

Sgaragli G. 58<br />

Shen C. 82<br />

Shohreh R. 35<br />

Siani P. 157<br />

Siano C. 28 57 107<br />

Sibilia V. 86<br />

Siciliano R. 123<br />

Sigala S. 49 118 121 163 166<br />

Signorini S. 14<br />

Sili M. 38<br />

Silvana Antonietta R. 118<br />

Silvani M. 111 157<br />

Silvano E. 36<br />

Silvestri E. 108<br />

Simeon V. 169<br />

Simeone C. 49 163<br />

Simeoni S. 108<br />

Simioni C. 42 146<br />

Simonato L. 162<br />

Simonato M. 33 130<br />

Simoni D. 147<br />

Simonyi A. 34<br />

Sinagra G. 136<br />

Sinforiani E. 57<br />

Sinigaglia L. 23<br />

Siniscalco D. 63 149 150<br />

Sipione S. 48<br />

Sirabella R. 9<br />

Sirchia S. 48<br />

Sironi L. 9 100<br />

Sirtori C. 102<br />

Sitia S. 103<br />

Skaper S. 11 41 45 157<br />

Smits R. 105<br />

Sobrado M. 49<br />

Sodano L. 164<br />

Soffia S. 41 45<br />

Soldovieri M. 46<br />

Solenghi E. 104<br />

Soleti A. 71<br />

Solinas M. 8<br />

Solito R. 57<br />

Soma R. 157<br />

Sorato E. 99<br />

Sorce S. 130<br />

Sorrentino R. 113 115 166 167<br />

Sortino M. 28 34 50 61 101<br />

Sosa S. 59<br />

Sottosanti L. 79 80 121<br />

Soukupova M. 52<br />

Soverchia L. 35 55<br />

Spaccapelo L. 28 107 123<br />

Spagnolo L. 121<br />

Spallino A. 97 110<br />

Spampinato S.ti 75 82 86 108 159<br />

Spampinato S.na 34 50<br />

Spampinato U. 28<br />

Spano PF. 9 28 49 58 88<br />

118 121 163<br />

Sparatore B. 29<br />

Spartà A. 159<br />

Spatz L. 4<br />

Speciale A. 59 103 124<br />

Spina E. 4 25 61 74 118<br />

121 126 143<br />

Spinazzi R. 99<br />

Spinelli C. 121<br />

Spinelli G. 121<br />

Spinelli V. 99<br />

Spinsanti P. 7 49 112 162<br />

Spissu Y. 34<br />

Spissy Y. 39<br />

Sportiello L. 119 140<br />

Sprengel R. 39 109<br />

Sprio A. 100 112 126<br />

Squadrito F. 31 61 72 86 87<br />

104 107 114 160 161<br />

162<br />

Squitieri F. 48<br />

Stafoggia M. 157<br />

Stanco D. 126<br />

Stanga S. 57<br />

Steardo A. 38<br />

Steardo L. 11 29 38 71<br />

Stefanelli E. 3<br />

Stefanelli F. 160<br />

Stefani S. 84<br />

Steinkühler C. 139<br />

Stella G. 14<br />

Sternini C. 159<br />

Stiaccini G. 36 114<br />

Stievano L. 127<br />

Stillitano F. 58 78<br />

Stiuso P. 169<br />

Stocchi F. 162<br />

Stocco G. 127<br />

Stocker R. 100<br />

Stopponi S. 55<br />

Storto M. 7 37 48 49<br />

Straface E. 76 101 145<br />

Stricker B. 3 140<br />

Strippoli A. 122<br />

Strongoli M. 150<br />

Sturkenboom M. 118 119 122 140 141<br />

157<br />

Sturla C. 110<br />

Suffredini S. 58 78<br />

Sullo N. 77<br />

Summa M. 5 40<br />

Suto T. 18<br />

Svelto M. 97<br />

Index of Authors and Chairpersons


Index of Authors and Chairpersons<br />

Tabrizi M. 81 111 146<br />

Tacchi R. 28 107 123<br />

Tacchi S. 38<br />

Tacconelli S. 14 100<br />

Taddei R. 112<br />

Taddei S. 101 136<br />

Tagliafico E. 38<br />

Taglialatela M. 41 44 45 46 82<br />

Tamburella A. 31 74<br />

Tamiazzo L. 108<br />

Tanganelli S. 70<br />

Tarallo L. 157<br />

Tarantini F. 102<br />

Tarditi A. 40<br />

Tardito D. 4 83<br />

Targa M. 41<br />

Tari D. 121<br />

Tarozzi A. 59<br />

Tarquini R. 103<br />

Tarquinio M. 76<br />

Tascedda F. 38 74<br />

Tascini C. 112<br />

Tassorelli C. 39<br />

Tebano MT. 29<br />

Tempia F. 33<br />

Terenius L. 130<br />

Terrazzani G. 118 157<br />

Terrazzino S. 28<br />

Tersigni M. 41 47 113 114<br />

Terstappen G. 10 40<br />

Terzolo M. 110<br />

Terzuoli E. 99<br />

Tesoriere L. 114<br />

Tessari M. 58<br />

Testai L. 76 98<br />

Testi A. 121<br />

Theodorou V. 51<br />

Theoharides T. 64<br />

Thiemermann C. 98<br />

Thurmond R. 137<br />

Tibaldi E. 163<br />

Tiezzi S. 55<br />

Togna A. 59 103 115<br />

Togna G. 59 103 115<br />

Tognolini M. 114<br />

Tolomeo M. 112<br />

Tomaino A. 122 124 125<br />

Tomasini MC. 44<br />

Tomasoni L. 103<br />

Tonelli F. 146<br />

Tonini M. 26 104 107<br />

Tontodonati P. 100 136<br />

Torella M. 63<br />

Torelli E. 36<br />

Toro A. 14<br />

Torri S. 98<br />

Torsello A. 108<br />

Torta R. 143<br />

Torti F. 102<br />

Tosca N. 119<br />

Tosi A. 41 63<br />

Tosi G. 35 107<br />

Tosi L. 141<br />

Toso S. 111<br />

Tozzi MG. 68<br />

Trabace L. 31 39 61 68 97<br />

130<br />

Trabattoni D. 76<br />

Trabucco A. 37<br />

Traficante A. 7<br />

Traini C. 130<br />

Tramentozzi E. 163<br />

Trapasso E. 47 49 111<br />

Trapella C. 35 37<br />

Travelli C. 43 50<br />

Traversa G. 142<br />

Traversa MV. 47<br />

Traversa U. 38<br />

Trefiletti G. 103 115<br />

Treglia M. 149<br />

Tremoli E. 6 9 76 100 101<br />

102 113 116 159<br />

Trenti A. 47<br />

Trevisan L. 41<br />

Trevisani M. 12<br />

Trevisi L. 47<br />

Trezza V. 4<br />

Tricarico D. 45 108<br />

Trifirò G. 118 119 140 158<br />

Trincavelli L. 9<br />

Trinchera M. 71<br />

Tringali G. 52 74 149 162<br />

Tripodi F. 14<br />

Trisolini P. 104<br />

Troiani T. 42<br />

Trombetta D. 59 117 124<br />

Trombino S. 168<br />

Tron G. 50<br />

Tubaro A. 39 59<br />

Tucci P. 39 130<br />

Tuccori M. 71 79 80 119 120<br />

121 122 157<br />

Tulipano G. 108<br />

Tullio F. 54 101<br />

Turiel M. 103<br />

Turola E. 68<br />

Turolo L. 100<br />

Turrini E. 14<br />

Turriziani B. 112<br />

Tursi V. 117<br />

Ubaldi M. 35 55<br />

Uberti D. 57<br />

Uccelli A. 30 45<br />

Uliva C. 103 137<br />

Ungaro F. 115<br />

Urbanek K. 78 160<br />

Urbinati S. 21<br />

Ursino MG. 71<br />

Ursino MR. 49<br />

Usiello A. 144<br />

Vacca C. 42 66<br />

Vaccheri A. 111 157<br />

Vacirca D. 50<br />

Vairetti M. 32 48<br />

Valanzano R. 146<br />

Valbusa G. 102<br />

Valensisi C. 38 74<br />

Valente M. 34<br />

Valenti G. 97<br />

Valenti L. 118<br />

Valenti M.co 141<br />

Valenti M.ta 8 113<br />

Valenza M. 38<br />

Valeri A. 58<br />

Valeri P. 54 105<br />

Valeria S. 63<br />

Valerio A. 32<br />

Vallarino M. 42<br />

Valli M. 128<br />

Valoti M. 58 59<br />

Van Camp G. 140<br />

Van Der Lei J. 118 119<br />

Van Luijtelaar G. 34 37<br />

Van Rijn C. 37<br />

Van Soest E. 140<br />

Vandelli M. 35 107<br />

Vannacci A. 79 124<br />

Vannelli G. 166<br />

Vannucchi M. 68<br />

Varani K. 41 42 63 81 111<br />

146<br />

Varano G. 5 30 74<br />

Vara-Rivera H. 82<br />

Varro A. 136<br />

Vasina V. 71<br />

Vaudry H. 42<br />

Vecchio I. 150<br />

Vegeto E. 145<br />

Vegezzi G. 114<br />

Veglio V. 112<br />

Vehramme K. 140<br />

Velardi E. 7<br />

Velazquez C. 102<br />

Vella S. 156<br />

Vellecco V. 30 76 98 99 164<br />

Velo G. 80 140<br />

Venco A. 103<br />

Venegoni M. 79 80 121<br />

Ventrice D. 53 150<br />

Ventura A. 127<br />

Venturini F. 24<br />

Veratti E. 58<br />

Verderio C. 9 52 69<br />

Vergoni A. 35 107<br />

Verhamme K. 140<br />

Verri M. 164<br />

Vestito A. 168<br />

Vestri A. 141<br />

Vetrano G. 157<br />

Viale G. 35<br />

Viana M. 28 127<br />

Viano I. 92 110<br />

Vicentini L. 63 162<br />

Vietri M. 124<br />

Viggiano D. 45 46 63<br />

Vighi G. 122<br />

Vignoli M. 146<br />

Vignozzi L. 166<br />

Villa D. 76<br />

Villa G. 52 68<br />

Villa R. 36<br />

Vincenzi F. 41 63<br />

Vinci M. 103 137<br />

Virdis A. 101 136<br />

Virgili F. 124<br />

Vita G. 4 117<br />

Vitale G. 51 130<br />

Vitalone A. 124<br />

Vitelli M. 101<br />

Vitiello S. 62<br />

Viviani B. 130<br />

Vivoli E. 37 51 149<br />

Vollmayr B. 83<br />

Volontè A. 141<br />

Volontè C. 68<br />

Volpe A. 160<br />

Volpi C.la 66<br />

Volpi C.ia 42 66<br />

Volpi N. 32<br />

Volpini R. 81<br />

Vona R. 76<br />

Vukojevic V. 130<br />

Werz O. 113 165 166<br />

Wickham M. 124<br />

Wilke B. 36<br />

Windisch M. 32<br />

Wurth R. 48<br />

Yaradanakul A. 82<br />

Zaffaroni M. 120<br />

Zaffe D. 61 98<br />

Zamarchi R. 163<br />

Zambon C. 14<br />

Zammataro M. 52<br />

Zanardi A. 45<br />

Zanette C. 38 59<br />

Zanetti E. 71 104 105<br />

Zanettini R. 140<br />

Zangaglia R. 14<br />

Zani D. 49 163<br />

Zaninetti R. 38<br />

Zanoli P. 30 71 87<br />

Zanoncelli A. 58<br />

Zanoni A. 127<br />

Zanotti I. 99<br />

Zappettini S.na 4 29 30<br />

Zappettini S.ia 32 45<br />

Zappia M. 96<br />

Zara G. 127<br />

Zarini S. 164<br />

Zavatti M. 30 71 87<br />

Zecchin D. 14<br />

Zeng H. 114<br />

Zheng H. 160<br />

Zianni E. 38 130<br />

Ziche M. 49 57 63 99 113<br />

116<br />

Zoccali R. 74<br />

Zoli M. 32 45<br />

Zona C. 36<br />

Zoppellaro C. 71 105<br />

Zotti M. 31<br />

Zuccato C. 10<br />

Zucchini S. 33 130<br />

Zusso M. 34 41 45<br />

Index of Authors and Chairpersons


kidstudio<br />

Società Italiana<br />

di Farmacologia<br />

34° Congresso Nazionale<br />

della Società Italiana di Farmacologia<br />

<strong>PROGRAMMA</strong><br />

14-17 ottobre 2009<br />

Rimini, Palacongressi

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!